introduct\n—\nmigrain\nis\na\ncommon\nepisod\ndisord\n,\nthe\nhallmark\nof\nwhich\nis\na\ndisabl\nheadach\ngener\nassoci\nwith\nnausea\nand/or\nlight\nand\nsound\nsensit\n.\nthe\nacut\ntreatment\nof\nmigrain\nin\nadult\nis\nreview\nhere\n.\nprevent\ntreatment\nof\nmigrain\nin\nadult\nis\ndiscuss\nsepar\n.\n(\nsee\n``\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n.\n)\nthe\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nthe\nmigrain\nare\nalso\ndiscuss\nsepar\n.\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n.\n)\napproach\nto\ntreatment\n—\nthe\nabort\n(\nsymptomat\n)\ntherapi\nof\nmigrain\nrang\nfrom\nthe\nuse\nof\nsimpl\nanalges\nsuch\nas\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\nor\nacetaminophen\nto\ntriptan\n,\nantiemet\n,\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\nantagonist\n,\nlasmiditan\n,\nand\ndihydroergotamin\n.\nnoninvas\nneuromodul\ndevic\nare\ntypic\nuse\nfor\npatient\nwho\ndo\nnot\nrespond\nto\nor\ntoler\ndrug\ntreatment\nand\nthose\nwho\nwish\nto\navoid\nmedications.abort\ntreatment\nare\nusual\nmore\neffect\nif\nthey\nare\ngiven\nearli\nin\nthe\ncours\nof\nthe\nheadach\n;\na\nlarg\nsingl\ndose\ntend\nto\nwork\nbetter\nthan\nrepetit\nsmall\ndose\n.\nfor\nsome\npatient\n,\noral\nagent\nare\nless\neffect\nbecaus\nof\npoor\nabsorpt\nsecondari\nto\nmigraine-induc\ngastric\nstasi\nand\nvomiting.gener\nrecommend\nfor\nthe\ntreatment\nof\nacut\nmigrain\ninclud\nthe\nfollow\n[\n1-3\n]\n:\n●educ\nmigrain\nsuffer\nabout\ntheir\ncondit\nand\nit\ntreatment\nand\nencourag\nthem\nto\nparticip\nin\ntheir\nown\nmanagement.●us\nmigraine-specif\nagent\n(\neg\n,\ntriptan\n,\ncgrp\nantagonist\n,\nlasmiditan\n,\ndihydroergotamin\n)\nfor\npatient\nwith\nmore\nsever\nmigrain\nand\nin\nthose\nwhose\nheadach\nrespond\npoorli\nto\nnsaid\nor\ncombin\nanalgesics.●select\na\nnonor\nrout\nof\nadministr\nfor\npatient\nwhose\nmigrain\npresent\nearli\nwith\nsignific\nnausea\nor\nvomiting.●consid\na\nself-administ\nrescu\nmedic\nfor\npatient\nwith\nsever\nmigrain\nthat\ndo\nnot\nrespond\nwell\nto\nother\ntreatments.●guard\nagainst\nmedic\noverus\nheadach\nby\neduc\npatient\nabout\nrisk\nand\nuse\nprophylact\nmedic\nin\npatient\nwith\nfrequent\nheadach\n.\n(\nsee\n``\nmedic\noverus\nheadach\n:\netiolog\n,\nclinic\nfeatur\n,\nand\ndiagnosi\n''\nand\n``\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n.\n)\nthe\nearli\nuse\nof\nmigraine-specif\nmedic\nfor\nsever\nattack\nprovid\nthe\nbest\noutcom\nin\na\nrandom\ncontrol\ntrial\nof\n835\nadult\nwith\nmigrain\nthat\ncompar\nthese\nstrategi\n[\n4\n]\n.\none\ngroup\n(\nstep\ncare\nwithin\nattack\n)\nreceiv\naspirin\n(\n800\nto\n1000\nmg\n)\nplu\nmetoclopramid\n(\n20\nmg\n)\nas\niniti\ntherapi\nfor\nall\nattack\n;\npatient\nnot\nrespond\nto\ntreatment\nafter\ntwo\nhour\nin\neach\nattack\nescal\ntreatment\nto\nzolmitriptan\n(\n2.5\nmg\n)\n.\na\nsecond\ngroup\n(\nstep\ncare\nacross\nattack\n)\nreceiv\niniti\ntreatment\nwith\naspirin\n(\n800\nto\n1000\nmg\n)\nplu\nmetoclopramid\n(\n10\nmg\n)\n;\npatient\nnot\nrespond\nin\nat\nleast\ntwo\nof\nthe\nfirst\nthree\nattack\nswitch\nto\nzolmitriptan\n(\n2.5\nmg\n)\nfor\nthe\nnext\nthree\nattack\n.\nin\na\nthird\ngroup\n(\nstratifi\ncare\n)\n,\npatient\nwith\nmild\nheadach\nwere\ntreat\nwith\naspirin\nplu\nmetoclopramid\n,\nwhile\nthose\nwith\nmore\nsever\nheadach\nwere\ntreat\nwith\nzolmitriptan\n.\nthe\nlatter\ntwo\ngroup\nhad\nsignificantli\nbetter\noutcom\nthan\nthe\nfirst\ngroup\nas\nmeasur\nby\nheadach\nrespons\nand\ndisabl\ntime\n,\nalthough\npatient\nin\nthe\nstratifi\ngroup\nhad\nthe\ngreatest\nnumber\nof\nadvers\nevents.th\npharmacolog\napproach\nto\nmigrain\nis\ndirect\nmainli\nby\nthe\nsever\nof\nthe\nattack\n,\nthe\npresenc\nof\nassoci\nnausea\nand\nvomit\n,\nthe\ntreatment\nset\n(\noutpati\nor\nmedic\ncare\nfacil\n)\n,\nand\npatient-specif\nfactor\n,\nsuch\nas\nthe\npresenc\nof\nvascular\nrisk\nfactor\nand\ndrug\npreference.mild\nto\nmoder\nattack\n—\nfor\nmild\nto\nmoder\nmigrain\nattack\nnot\nassoci\nwith\nvomit\nor\nsever\nnausea\n,\nsimpl\nanalges\n(\nnsaid\n,\nacetaminophen\n)\nor\ncombin\nanalges\nare\noften\ntri\nfirst\nbecaus\nthey\ncan\nbe\neffect\nand\nare\nless\nexpens\nthan\nmigraine-specif\nagent\n[\n5,6\n]\n.\nfor\nattack\nunrespons\nto\nanalges\n,\nthe\ncombin\nuse\nof\nan\nnsaid\nwith\na\ntriptan\nappear\nto\nbe\nmore\neffect\nthan\nuse\neither\ndrug\nclass\nalon\n.\nwhen\nmild\nto\nmoder\nattack\nare\nassoci\nwith\nsever\nnausea\nor\nvomit\n,\nan\noral\nor\nrectal\nantiemet\ndrug\ncan\nbe\nuse\nin\nconjunct\nwith\nsimpl\nor\ncombin\nanalges\n.\n(\nsee\n'simpl\nanalges\n'\nbelow\nand\n'triptan\n'\nbelow\nand\n'triptan\nwith\nnsaid\n'\nbelow\nand\n'antiemet\n'\nbelow\n.\n)\nmoder\nto\nsever\nattack\n—\nfor\nmoder\nto\nsever\nmigrain\nattack\nnot\nassoci\nwith\nvomit\nor\nsever\nnausea\n,\noral\nmigraine-specif\nagent\nare\nfirst-lin\n,\ninclud\noral\ntriptan\nand\nthe\ncombin\nof\nsumatriptan-naproxen\n[\n5,6\n]\n.\nfor\nthose\nwith\ncontraind\nto\nor\nwho\ndo\nnot\ntoler\ntriptan\n,\na\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\nantagonist\nor\nlasmiditan\nmay\nbe\neffect\n.\nwhen\ncomplic\nby\nvomit\nor\nsever\nnausea\n,\nsever\nmigrain\nattack\ncan\nbe\ntreat\nwith\nan\nantiemet\ndrug\nor\nnonor\nmigraine-specif\nmedic\ninclud\nsubcutan\nsumatriptan\n,\nnasal\nsumatriptan\nand\nzolmitriptan\n,\nor\nparenter\ndihydroergotamin\n(\nsee\n'triptan\n'\nbelow\nand\n'triptan\nwith\nnsaid\n'\nbelow\nand\n'cgrp\nantagonist\n'\nbelow\nand\n'lasmiditan\n'\nbelow\nand\n'antiemet\n'\nbelow\nand\n'ergot\n'\nbelow\n.\n)\nstatu\nmigrainosu\n—\nfor\nsever\nintract\nmigrain\nattack\n,\nor\nstatu\nmigrainosu\n(\nie\n,\na\ndebilit\nattack\nlast\nfor\nmore\nthan\n72\nhour\n)\n,\npatient\nmay\nbe\ntreat\nwith\na\ncombin\nof\nintraven\nfluid\nplu\nparenter\nmedic\nsuch\nas\nketorolac\nand\na\ndopamin\nreceptor\nblocker\n.\nother\nparenter\nmedic\nsuch\nas\nvalproat\nand/or\ndihydroergotamin\n[\n7\n]\nmay\nalso\nbe\nwarrant\ndepend\non\nrespons\nto\niniti\ntherapi\n[\n8\n]\n.\ntreatment\noption\nare\nnot\nbase\non\nhigh-qual\nevid\nand\nmedic\nselect\ndepend\nupon\npatient-level\nfactor\n.\n(\nsee\n'nonsteroid\nanti-inflammatori\ndrug\n'\nbelow\nand\n'prochlorperazin\n'\nbelow\nand\n'metoclopramid\n'\nbelow\nand\n'other\n'\nbelow\n.\n)\nadministr\nof\nparenter\ndexamethason\nis\noften\nuse\nto\nprevent\nattack\nrelaps\n.\n(\nsee\n'abort\ntherapi\nplu\nparenter\ndexamethason\n'\nbelow\n.\n)\npatient\nmay\nrequir\nadmiss\nfor\npersist\ndisabl\nsymptom\ndespit\nthe\niniti\ntreatment\nregimen\nor\nfor\nwean\nof\nmedic\noverus\nto\nmonitor\nfor\nwithdraw\nsymptom\n[\n9-11\n]\n.\n(\nsee\n'emerg\nset\n'\nbelow\nand\n``\nmedic\noverus\nheadach\n:\ntreatment\nand\nprognosi\n''\n,\nsection\non\n'outpati\nand\ninpati\nstrategi\n'\nand\n'antiemet\n'\nbelow\nand\n'simpl\nanalges\n'\nbelow\nand\n'ergot\n'\nbelow\n.\n)\nvariabl\nattack\n—\nmani\npatient\nwith\nmigrain\nhave\nattack\nthat\nvari\nin\nsever\n,\ntime\nof\nonset\n,\nand\nassoci\nwith\nvomit\nand\nnausea\n[\n12\n]\n.\nthese\npatient\nmay\nrequir\ntwo\nor\nmore\noption\nfor\nself-manag\nof\nacut\nmigrain\n,\ninclud\noral\nmedic\nfor\nmild\nto\nmoder\nattack\nand\nnonor\nmedic\n(\neg\n,\nsubcutan\nor\nnasal\ntriptan\n)\nfor\nmore\nsever\nattack\nor\nthose\nassoci\nwith\nvomit\nor\nsever\nnausea.emerg\nset\n—\npatient\nwho\npresent\nwith\nmigrain\nin\nemerg\nset\ngener\nhave\nunusu\nsever\nattack\n,\nand\nin\nmani\ncase\ntheir\ncustomari\nacut\nmigrain\ntreatment\nha\nfail\nto\nprovid\nrelief\n[\n13\n]\n.\nthe\ntreatment\nof\nmigrain\nattack\nin\nthe\nemerg\ndepart\nor\nother\nurgent\ncare\nset\nfollow\nthe\nsame\nprincipl\nas\ntreatment\nin\nnonurg\nset\noutlin\nabov\n(\nsee\n'mild\nto\nmoder\nattack\n'\nabov\nand\n'moder\nto\nsever\nattack\n'\nabov\n)\n,\nwith\nthe\nobviou\ndiffer\nthat\nparenter\nmedic\nare\nmore\nreadili\navail\n.\nthe\nfollow\nare\nreason\noption\n,\nwith\nevid\nof\nefficaci\nfrom\nrandom\ntrial\n[\n13-20\n]\n:\n●sumatriptan\n6\nmg\nsubcutan\ninject\n(\nsee\n'triptan\n'\nbelow\n)\n●antiemetics-dopamin\nreceptor\nblocker\n(\nsee\n'antiemet\n'\nbelow\n)\n:\n•prochlorperazin\n10\nmg\nintraven\n(\niv\n)\nor\nintramuscular\n(\nim\n)\n•metoclopramid\n10\nmg\niv•chlorpromazin\n0.1\nmg/kg\n(\nor\n12.5\nmg\n)\nsingl\ndose\nas\na\nslow\niv\ninfus\n(\nmaximum\nrate\n1\nmg/minut\n)\n;\nmaximum\ncumul\ndose\n25\nmg●dihydroergotamin\n(\n1\nmg\niv\n)\ncombin\nwith\nmetoclopramid\n(\n10\nmg\niv\n)\n(\nsee\n'dihydroergotamin\n'\nbelow\n)\n●ketorolac\n30\nmg\niv\nor\n60\nmg\nim\n(\n15\nmg\niv\nor\n30\nmg\nim\nfor\npatient\n≥65\nyear\n,\n<\n50\nkg\n,\nor\nrenal\nimpair\n)\n(\nsee\n'nonsteroid\nanti-inflammatori\ndrug\n'\nbelow\n)\nfor\npatient\nwho\npresent\nto\nthe\nhospit\nemerg\ndepart\nwith\nsever\nmigrain\n,\nparticularli\nif\nthe\nmigrain\nis\naccompani\nby\nsever\nnausea\nor\nvomit\n,\nwe\nsuggest\niniti\ntreatment\nwith\neither\nsubcutan\nsumatriptan\nor\na\nparenter\nantiemet\n(\neg\n,\nprochlorperazin\n,\nmetoclopramid\n,\nchlorpromazin\n)\nat\nthe\ndose\nlist\nabov\n.\nwhen\ngive\nparenter\nantiemet\nfor\nmigrain\n,\nwe\nsuggest\nadjunct\nuse\nof\ndiphenhydramin\n(\n12.5\nto\n25\nmg\niv\neveri\nhour\nup\nto\ntwo\ndose\n)\nto\nprevent\nakathisia\nand\nother\ndyston\nreaction\n.\n(\nsee\n'antiemet\n'\nbelow\n.\n)\ndihydroergotamin\n(\ndhe\n45\n)\n1\nmg\niv\ncombin\nwith\nmetoclopramid\n10\nmg\niv\nis\nalso\na\nreason\naltern\nfor\ntreatment\nof\nintract\nsever\nmigrain\nin\nthe\nemerg\ndepart\n,\nand\nit\ncan\nbe\nuse\nif\nmetoclopramid\nmonotherapi\nis\nineffect\n.\nparenter\ndihydroergotamin\nshould\nnot\nbe\nuse\nas\nmonotherapi\n.\ndihydroergotamin\nis\ncontraind\nin\npatient\nwith\nischem\nvascular\ndiseas\ninvolv\ncardiac\n,\ncerebrovascular\n,\nor\nperipher\ncircul\n.\n(\nsee\n'dihydroergotamin\n'\nbelow\n.\n)\nfor\npatient\nwho\nare\ntreat\nin\nthe\nemerg\ndepart\nor\nclinic\nfor\nmigrain\nheadach\nwith\none\nof\nthe\nstandard\nmigrain\nabort\ntherapi\n,\nwe\nrecommend\nadjunct\ntreatment\nwith\ndexamethason\n(\n10\nto\n24\nmg\niv\nor\nim\n)\nto\nreduc\nthe\nrisk\nof\nearli\nheadach\nrecurr\n.\n(\nsee\n'abort\ntherapi\nplu\nparenter\ndexamethason\n'\nbelow\n.\n)\noverus\nof\nopioid\nmedic\nfor\nacut\nheadach\nin\nhospit\nemerg\ndepart\nappear\nto\nbe\nwidespread\nin\nthe\nunit\nstate\nand\ncanada\n[\n21,22\n]\n,\ndespit\navail\npractic\nguidelin\nthat\nrecommend\nnonopioid\nmedic\nas\nfirst-lin\ntherapi\nfor\nsever\nmigrain\n[\n2\n]\n,\nor\nrecommend\nthat\nopioid\nshould\nnot\nbe\nuse\nin\nthe\nacut\ntreatment\nof\nmigrain\n[\n23,24\n]\n.\npatient\ntreat\nwith\nopioid\nas\nfirst-lin\ntherapi\nare\nsignificantli\nmore\nlike\nto\nreturn\nto\nthe\nemerg\ndepart\nwith\na\nheadach\nwithin\nseven\nday\nof\nthe\norigin\nvisit\n[\n21,25\n]\n.pregnanc\n—\nthe\ntreatment\nof\nmigrain\nin\npregnant\npatient\ndiffer\nsomewhat\nfrom\nthe\ntreatment\nof\nother\nbecaus\nof\nconcern\nabout\nadvers\nfetal\ndrug\neffect\n.\nthi\naspect\nof\nacut\nmigrain\ncare\nis\nreview\nsepar\n.\n(\nsee\n``\nheadach\nin\npregnant\nand\npostpartum\nwomen\n''\n,\nsection\non\n'acut\nmigrain\ntreatment\n'\n.\n)\navoid\nof\nmedic\noverus\n—\nmedic\noverus\nheadach\n(\nmoh\n)\n,\nalso\ncall\nanalges\nrebound\nheadach\n,\nis\na\ncommon\ndisord\nwith\nsignific\nmorbid\n.\nmani\nsymptomat\nmedic\nuse\nto\ntreat\nheadach\nhave\nthe\npotenti\nfor\ncaus\nmoh\n.\nhowev\n,\nthe\ndegre\nof\nrisk\ndiffer\ndepend\nupon\nthe\nspecif\nmedic\nor\nclass\nof\nmedic\n.\nbase\nupon\nthe\nliteratur\nand\nclinic\nexperi\n,\nthe\nrisk\nfor\nmoh\nappear\nto\nbe\nhighest\nwith\nopioid\n,\nbutalbital-contain\ncombin\nanalges\n,\nand\naspirin-acetaminophen-caffein\ncombin\n.\nthe\nrisk\nwith\ntriptan\nis\nconsid\nintermedi\nby\nsome\nexpert\nbut\nhigh\nby\nother\n.\nmoh\nmay\nbe\navoid\nwith\nsome\ncgrp\nantagonist\n,\nwhich\nare\neffect\nfor\nprevent\nas\nwell\nas\nacut\ntreatment\nof\nmigrain\n[\n26-28\n]\n.\nthe\nrisk\nis\nlowest\nwith\nnsaid\n,\nwhich\nmay\neven\nbe\nprotect\nagainst\nthe\ndevelop\nof\nchronic\nmigrain\nfor\npatient\nwho\nhave\nless\nthan\n10\nheadach\nday\nper\nmonth\n.\n(\nsee\n``\nmedic\noverus\nheadach\n:\netiolog\n,\nclinic\nfeatur\n,\nand\ndiagnosi\n''\n,\nsection\non\n'causal\nmedic\n'\n.\n)\nin\norder\nto\nprevent\nthe\ndevelop\nof\nmoh\n,\nmost\nacut\nmedic\nshould\nbe\nlimit\nto\nless\nthan\n10\nday\nper\nmonth\n(\nor\nless\nthan\n15\nday\nper\nmonth\nfor\naspirin\n,\nacetaminophen\n,\nand\nnsaid\n)\n,\nand\nprevent\ntherapi\nshould\nbe\nuse\nas\nthe\nmainstay\nin\npatient\nwith\nfrequent\nheadach\n.\n(\nsee\n``\nmedic\noverus\nheadach\n:\netiolog\n,\nclinic\nfeatur\n,\nand\ndiagnosi\n''\n.\n)\nsimpl\nanalges\n—\nsome\npatient\nwith\nmigrain\nhave\nan\noptim\nrespons\nwith\nsimpl\nanalges\n,\ninclud\naspirin\n,\nother\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\n,\nand\nacetaminophen\n[\n20\n]\n.nonsteroid\nanti-inflammatori\ndrug\n—\nnsaid\nwith\nreport\nefficaci\nin\nrandom\nplacebo-control\ntrial\nof\nmigrain\ntherapi\ninclud\naspirin\n(\n900\nto\n1000\nmg\n)\n[\n29,30\n]\n,\nibuprofen\n(\n400\nto\n600\nmg\n)\n[\n31\n]\n,\nnaproxen\n(\n275\nto\n825\nmg\n)\n[\n32\n]\n,\ndiclofenac\n(\n50\nto\n100\nmg\n)\n[\n33\n]\n,\ndiclofenac\nepolamin\n(\n65\nmg\n)\n[\n34\n]\n,\ntolfenam\nacid\n(\n200\nmg\n)\n[\n35\n]\n,\ncelecoxib\n[\n36\n]\n,\nand\ndexketoprofen\n(\n50\nmg\n)\n[\n37,38\n]\n.\nsome\nof\nthese\nstudi\nare\nlimit\nby\nvari\noutcom\nmeasur\nand\ndefinit\nof\nmigrain\n.\na\n2013\nsystemat\nreview\nof\neight\nrandom\ntrial\nfound\nthat\nparenter\nketorolac\n(\n30\nmg\nintraven\n[\niv\n]\nor\n60\nmg\nintramuscular\n)\nwa\neffect\nfor\nacut\nmigrain\nin\ncomparison\nwith\nother\nagent\n,\ninclud\nintranas\nsumatriptan\n,\niv\nprochlorperazin\n,\niv\nchlorpromazin\n,\nand\niv\ndihydroergotamin\ncombin\nwith\nmetoclopramid\n[\n39\n]\n.one\ntrial\nshow\npowder\ndiclofenac\npotassium\n(\n50\nmg\n)\nproduc\nmore\nrapid\nand\neffect\npain\nrelief\nat\ntwo\nhour\nthan\ntablet\n[\n40\n]\n.although\nthe\ndata\nare\nlimit\n,\nbenefit\nmay\nbe\nseen\nwith\nindomethacin\nas\nabort\ntherapi\nfor\nmigrain\n.\nit\nis\na\npotent\nnsaid\nthat\nis\nalso\navail\nin\nsuppositori\nform\n,\nwhich\nmay\nbe\nhelp\nfor\nnauseat\npatient\n.\nindomethacin\nsuppositori\ncontain\n50\nmg\nof\nthe\ndrug\n;\nthe\nsuppositori\nmay\nbe\ncut\ninto\nhalv\nor\nthird\nfor\npatient\nwith\nrecurr\nattacks.ther\nare\nno\nstudi\ncompar\nthe\nrel\nefficaci\nof\ndiffer\nnsaid\n.\nif\none\nnsaid\nis\nineffect\n,\na\ndiffer\ndrug\nmay\nbe\ntri\n.\n(\nsee\n``\nnsaid\n:\ntherapeut\nuse\nand\nvariabl\nof\nrespons\nin\nadult\n''\n.\n)\nacetaminophen\n—\nacetaminophen\nis\nan\neffect\nabort\nagent\nin\nsome\npatient\n[\n41\n]\n.\nthi\nwa\nillustr\nin\na\npopulation-bas\nrandom\nplacebo-control\ntrial\nof\n289\npatient\nwith\nself-report\nmigrain\n,\nwhich\nfound\nacetaminophen\nat\na\ndose\nof\n1000\nmg\nto\nbe\nhighli\neffect\nfor\ntreat\npain\n,\nfunction\ndisabl\n,\nphotophobia\n,\nand\nphonophobia\n,\nalthough\nthe\nstudi\nexclud\npatient\nwith\nsever\nsymptom\nrequir\nbed\nrest\nor\nassoci\nwith\nvomit\nmore\nthan\n20\npercent\nof\nthe\ntime\n[\n42\n]\n.acetaminophen\ncan\nbe\nuse\nin\ncombin\nwith\nnsaid\n.\nthe\ncombin\nof\nacetaminophen-aspirin-caffein\nwa\nfound\nto\nallevi\nheadach\nin\npatient\nwith\nuncompl\nmigrain\nin\none\nreport\n[\n43\n]\n.triptan\n—\nthe\nserotonin\n1b/1d\nagonist\n(\ntriptan\n)\nare\neffect\nfor\nthe\nacut\ntreatment\nof\nmigrain\n[\n20\n]\n.\nthe\ntriptan\nwere\ndevelop\nspecif\nto\ntreat\nmigrain\n[\n1,2\n]\n.\nhowev\n,\ntriptan\nrespons\nshould\nnot\nbe\nconsid\ndiagnost\nof\nmigrain\n,\nas\nother\nprimari\nheadach\nand\nsecondari\nheadach\nmay\nalso\nimprov\nwith\ntriptan\ntreatment\n[\n44\n]\n.\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n.\n)\nall\nof\nthe\ntriptan\ninhibit\nthe\nreleas\nof\nvasoact\npeptid\n,\npromot\nvasoconstrict\n,\nand\nblock\npain\npathway\nin\nthe\nbrainstem\n[\n45\n]\n.\ntriptan\ninhibit\ntransmiss\nin\nthe\ntrigemin\nnucleu\ncaudali\n,\ntherebi\nblock\naffer\ninput\nto\nsecond\norder\nneuron\n;\nthi\neffect\nis\nprobabl\nmediat\nby\nreduc\nthe\nlevel\nof\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\n.\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n.\n)\ntriptan\nmay\nalso\nactiv\n5-ht\n1b/1d\nreceptor\nin\ndescend\nbrainstem\npain-modul\npathway\nand\ntherebi\ninhibit\ndural\nnocicept\n[\n46\n]\n.prepar\nand\nefficaci\n—\nthe\navail\ntriptan\ninclud\nsumatriptan\n,\nzolmitriptan\n,\nnaratriptan\n,\nrizatriptan\n,\nalmotriptan\n,\neletriptan\n,\nand\nfrovatriptan\n.\nsumatriptan\ncan\nbe\ngiven\nas\na\nsubcutan\ninject\n(\nusual\nadminist\nby\nautoinjector\nin\nthe\nthigh\n)\n,\nas\na\nnasal\nspray\n,\nas\na\nnasal\npowder\n,\nor\noral\n.\nzolmitriptan\nis\nalso\navail\nfor\nboth\nnasal\nand\noral\nuse\n.\nthe\nother\nare\navail\nfor\noral\nuse\nonly.a\nnumber\nof\nrandom\ncontrol\ntrial\nand\nsystemat\nreview\nhave\nfound\nall\nof\nthe\ntriptan\nto\nbe\neffect\nfor\nthe\ntreatment\nof\nacut\nmigrain\n[\n47\n]\n.\nthe\nrang\nof\nfind\nis\nillustr\nby\nthe\nfollow\nreport\n:\n●eletriptan\n–\nin\na\nmeta-analysi\nof\nsix\nrandom\ncontrol\ntrial\nof\neletriptan\ninvolv\n3224\npatient\n,\neletriptan\nat\ndose\nof\n20\n,\n40\n,\nand\n80\nmg\nwa\nsignificantli\nbetter\nthan\nplacebo\nfor\nall\nmain\noutcom\n(\ninclud\nheadach\nrespons\nat\none\nand\ntwo\nhour\nand\nsustain\nrelief\nover\n24\nhour\n)\n[\n48\n]\n.\npain\nrelief\nwa\ndose\ndepend\n,\nwith\nthe\n80\nmg\ndose\nprovid\nstatist\nsignific\ngreater\npain\nrelief\nthan\n40\nmg\nat\n2\nand\n24\nhour\n.\nthe\ndrug\nwa\nwell\ntoler\nand\ncaus\nno\nmajor\nharm\n.\nthe\nincid\nof\nminor\nside\neffect\nwa\nalso\ndose\nrelat\n,\nbut\nall\nadvers\neffect\nwere\ntransient\nand\nrevers\n.\neletriptan\nis\nnot\navail\nin\n80\nmg\ntablet\nin\nthe\nunit\nstate\n,\nand\n40\nmg\nis\nrecommend\nfor\nmost\npatient\n[\n49\n]\n.●naratriptan\n–\nat\nleast\nthree\nrandom\ntrial\nhave\nfound\nthat\nnaratriptan\nsignificantli\nimprov\nacut\nmigrain\nrelief\ncompar\nwith\nplacebo\n[\n50-52\n]\n.\nin\none\nof\nthe\nstudi\n,\na\ndose\nof\n2.5\nmg\nwa\nmost\neffect\nin\nproduc\nheadach\nrelief\nat\nfour\nhour\n,\nwith\nan\nadvers\nevent\nrate\nsimilar\nto\nplacebo\n[\n51\n]\n.\nadvers\nevent\ndid\nnot\nappear\nto\nbe\ndose\nrelated.in\na\nsecond\nstudi\n,\npatient\nwho\ndid\nnot\nrespond\nto\nsumatriptan\n50\nmg\nwith\na\nfirst\nattack\nhad\na\nsignificantli\nsuperior\nrespons\nto\nnaratriptan\n2.5\nmg\ncompar\nwith\nplacebo\ndure\na\nsecond\nmigrain\nattack\none\nweek\nlater\n,\nsuggest\nthat\npatient\nwho\ndo\nnot\nrespond\nto\none\ntriptan\nmay\nrespond\nto\nanoth\n[\n52\n]\n.\none\nproblem\nwith\nthi\nstudi\nis\nthat\nthe\n50\nmg\ndose\nof\nsumatriptan\nuse\nis\noften\nsuboptim\n[\n53\n]\n.\non\nthe\nother\nhand\n,\nit\nis\nworthwhil\nto\ntri\nanoth\ntriptan\nif\nthe\nrespons\nis\nnot\noptimal.●rizatriptan\n–\nthe\nefficaci\nof\nrizatriptan\nfor\nacut\nmigrain\nha\nbeen\ndemonstr\nin\na\nsystemat\nreview\nof\nmultipl\nrandom\nplacebo-control\nstudi\n[\n54\n]\n.\nsignific\nbenefit\nof\nrizatriptan\ncompar\nwith\nplacebo\nwa\nshown\nfor\nboth\nthe\n5\nand\n10\nmg\ndose\nof\nrizatriptan\nfor\nall\nfive\nmain\nefficaci\noutcom\n(\nrang\nfrom\nrelief\nat\n1\nto\n24\nhour\n)\n.\nthe\n10\nmg\ndose\nwa\nmore\neffect\nthan\n5\nmg\n.\nthe\nmost\ncommon\nadvers\neffect\nwere\ndizzi\n,\nasthenia/fatigu\n,\nnausea\n,\nand\nsomnol\n;\nin\none\nstudi\nthese\neffect\nwere\ndose\ndependent.●sumatriptan\n–\nthe\nsubcutan\n,\noral\n,\nand\nintranas\nprepar\nof\nsumatriptan\nhave\nproven\nefficaci\nin\nrandom\nplacebo-control\ntrial\nof\nacut\nmigrain\ntherapi\n,\nas\nestablish\nin\nsystemat\nreview\nand\nmeta-analys\n[\n55-58\n]\n.•oral\nsumatriptan\nis\ngiven\nat\n50\nto\n100\nmg\nonc\n.\nthe\nmost\neffect\ndose\nof\noral\nsumatriptan\nis\n100\nmg\n,\nwhile\nthe\n50\nmg\ndose\nmay\nprovid\nthe\nbest\ncombin\nof\nefficaci\nand\ntoler\n[\n58,59\n]\n.\nthe\ndose\n(\nsame\nstrength\nas\nthe\niniti\ndose\n)\nmay\nbe\nrepeat\nonc\nafter\ntwo\nhour\nif\nneed\n.\nthe\nmaximum\ndose\nis\n200\nmg\nper\n24\nhours.•subcutan\nsumatriptan\n(\n6\nmg\n)\nis\nmore\neffect\nthan\noral\nsumatriptan\n,\nbut\nit\nuse\nis\nassoci\nwith\nmore\nadvers\nevent\n[\n60\n]\n.\nsubcutan\nsumatriptan\nha\nthe\nfastest\nonset\nof\naction\n.\nfor\nacut\nmigrain\n,\nthe\nusual\niniti\ndose\nof\nsubcutan\nsumatriptan\nis\n6\nmg\n.\nthe\ndose\nmay\nbe\nrepeat\nonc\nif\nneed\nafter\none\nhour\n.\nfor\npatient\nwho\nare\nintoler\nof\nthe\n6\nmg\ndose\nbut\nneed\na\nparent\nformul\n(\neg\n,\ndue\nto\nprotract\nvomit\nwith\nmigrain\n)\n,\nsome\nexpert\ntri\na\nlower\ninitial/repeat\ndose\n(\neg\n,\n3\nor\n4\nmg\n)\n[\n61\n]\n.\nsumatriptan\nfor\ninject\nis\ncommerci\navail\nin\n3\nmg\n,\n4\nmg\n,\nand\n6\nmg\nformul\n.\nthe\nrecommend\nmaximum\nis\n6\nmg\nper\ndose\nand\n12\nmg\nper\n24\nhour\n.\nin\none\ntrial\nof\nsubcutan\nsumatriptan\nin\n639\npatient\n,\nadministr\nof\na\nsecond\ndose\nof\nthe\ndrug\n60\nminut\nafter\nthe\nfirst\nin\nthose\nwho\ndid\nnot\nrespond\nwell\niniti\nprovid\nlittl\naddit\nbenefit\n[\n62\n]\n.\ncommon\nside\neffect\nof\nsubcutan\nsumatriptan\ninclud\nan\ninject\nsite\nreaction\n,\nchest\npressur\nor\nheavi\n,\nflush\n,\nweak\n,\ndrowsi\n,\ndizzi\n,\nmalais\n,\na\nfeel\nof\nwarmth\n,\nand\nparesthesia\n.\nmost\nof\nthese\nreaction\noccur\nsoon\nafter\nthe\ninject\nand\nresolv\nspontan\nwithin\n30\nminutes.•intranas\nspray\nsumatriptan\n(\nliquid\n)\nis\ngiven\nas\none\ninsuffl\nof\n20\nmg\nin\na\nsingl\nnostril\n.\nthe\ndose\nmay\nbe\nrepeat\nonc\nafter\ntwo\nhour\nif\nneed\n.\nthe\nmaximum\ndose\nis\n40\nmg\nper\n24\nhour\n.\nintranas\nsumatriptan\nha\nfewer\nside\neffect\nthan\nthe\ninject\nformul\n[\n60\n]\n.\nthe\nmost\ncommon\nside\neffect\nof\nintranas\nsumatriptan\nis\nan\nunpleas\ntaste.•intranas\nsumatriptan\ncoformul\nwith\nddm\n(\na\npermeat\nenhanc\nfor\nmore\nrapid\nabsorpt\ninto\nthe\nsystem\ncircul\n)\nis\ngiven\nas\na\nsingl\ninsuffl\nof\n10\nmg\nin\none\nnostril\n[\n63\n]\n.\nthe\nmaximum\ndose\nis\n30\nmg\nper\n24\nhour\nwith\nindividu\ndose\nsepar\nby\nat\nleast\none\nhour\n.\nthe\nmost\ncommon\nadvers\nreaction\nrelat\nto\napplic\nwere\nnasal\ndiscomfort\n,\nunpleas\ntast\n,\nand\nthroat\nirritation.•nas\npowder\nsumatriptan\nis\ngiven\nas\na\n22\nmg\ndose\nuse\none\n11\nmg\ncapsul\ninsuffl\nin\neach\nnostril\nwith\na\nbreath-pow\ndeliveri\ndevic\n.\nthe\ndose\nmay\nbe\nrepeat\nonc\nafter\ntwo\nhour\nif\nneed\n.\nthe\nmaximum\ndose\nis\n44\nmg\nper\n24\nhour\n.\nthe\nmost\ncommon\nadvers\nreaction\nare\nan\nabnorm\nor\nunpleas\ntast\nand\nnasal\ndiscomfort.●zolmitriptan\n–\na\nnumber\nof\nrandom\nplacebo-control\ntrial\nand\na\nsystemat\nreview\nand\nmeta-analysi\n[\n64\n]\nhave\nproven\nthe\nefficaci\nof\nzolmitriptan\nas\nacut\nmigrain\ntherapi\n.\nas\nan\nexampl\n,\none\ntrial\nof\n1000\npatient\nwith\nmigrain\ncompar\nfour\ndose\nof\nzolmitriptan\n(\n1\n,\n2.5\n,\n5\n,\nand\n10\nmg\n)\nwith\nplacebo\n[\n65\n]\n.\nthere\nwa\na\ndose-respons\nrelationship\nin\nterm\nof\nboth\nefficaci\nand\nadvers\neffect\n;\n2.5\nmg\nappear\nto\nbe\nthe\noptim\nstart\ndose\n.\nthe\nmost\ncommon\nside\neffect\ninclud\nnausea\n,\ndizzi\n,\nsomnol\n,\nparesthesia\n,\nfatigu\n,\nand\ntight\nin\nthe\nthroat\nor\nchest\n.\nthe\nincid\nof\nunpleas\ntast\nis\nlower\nwith\nintranas\nzolmitriptan\n,\nas\ncompar\nwith\nthat\nreport\nin\ntrial\nof\nintranas\nsumatriptan.choic\nof\ntriptan\n—\nthe\nchoic\nof\na\ntriptan\nshould\nbe\nindividu\n;\ndiffer\npharmacolog\nproperti\nand\ndeliveri\nrout\nmay\nhelp\nguid\nthe\nchoic\n.\npatient\nwho\ndo\nnot\nrespond\nwell\nto\none\ntriptan\nmay\nrespond\nto\nanoth\n[\n66\n]\n.rel\nfew\ntrial\nhave\ncompar\nthe\ntriptan\nhead\nto\nhead\n,\nmake\nit\ndifficult\nto\ndecid\nwhether\nto\nuse\none\nversu\nanoth\n.\na\nmeta-analysi\nof\n53\nclinic\ntrial\nof\nthe\noral\nserotonin\nagonist\nthat\ninclud\nover\n24,000\npatient\nconclud\nthat\nall\nof\nthe\navail\noral\ndrug\nare\neffect\nand\nwell\ntoler\n[\n67\n]\n.\nthe\nhighest\nlikelihood\nof\nconsist\nsuccess\nwa\nfound\nwith\nrizatriptan\n(\n10\nmg\n)\n,\neletriptan\n(\n80\nmg\n)\n,\nand\nalmotriptan\n(\n12.5\nmg\n)\n.\nthe\nfind\nof\na\nsubsequ\nnetwork\nmeta-analysi\nsuggest\nthat\neletriptan\nwa\nthe\nmost\nlike\nof\nall\nthe\ntriptan\nto\nproduc\nshort-term\nand\nsustain\nbenefit\n[\n68\n]\n.\nthese\ndata\nand\nclinic\nexperi\nsuggest\nthat\nsumatriptan\n,\nrizatriptan\n,\neletriptan\n,\nalmotriptan\n,\nand\nzolmitriptan\nare\nveri\nsimilar\noral\n,\nwhile\nnaratriptan\nand\nfrovatriptan\nare\nslower\nin\nonset\nand\nhave\nlower\nefficacy.sumatriptan\noffer\nthe\nmost\noption\nfor\nrout\nof\ndrug\ndeliveri\n,\nwith\nsubcutan\nsumatriptan\noffer\nthe\nfastest\nonset\nof\naction\n.\nthe\ndose\nof\nrizatriptan\nmust\nbe\nadjust\ndownward\nin\npatient\nwho\ntake\npropranolol\n,\nsinc\npropranolol\nincreas\nrizatriptan\nlevel\nby\n70\npercent\n.\nnaratriptan\nand\nfrovatriptan\nhave\nthe\nslowest\nonset\nof\naction\namong\nthe\ntriptan\nand\nmay\nhave\nthe\nlowest\npropens\nto\ncaus\nside\neffect\n[\n69\n]\n.factor\npredict\nrespons\n—\nprompt\ntreatment\nof\nmigrain\nattack\nis\nconsid\nimport\nto\nsuccess\nacut\ntherapi\n[\n53,70,71\n]\n,\nbut\nfew\nrigor\nstudi\nhave\nexamin\nthe\nfactor\nthat\nmay\ninfluenc\nthe\nprobabl\nof\na\ngood\nrespons\nto\ntriptan\ntherapy.●in\na\nrandom\nplacebo-control\ntrial\nthat\nevalu\n403\npatient\nwith\nmigrain\n,\nalmotriptan\n12.5\nmg\nwa\neffect\nwhether\nstart\nwhen\nheadach\nwa\nearli\nand\nmild\n,\nor\nstart\nwhen\nheadach\nwa\nmoder\nto\nsever\n[\n72\n]\n.\nwhen\ntreatment\nwa\niniti\nwhile\nheadach\nintens\nwa\nmild\nand\nwithin\none\nhour\nof\nonset\n,\na\nsignificantli\ngreater\nproport\nof\npatient\nwere\npain-fre\nat\ntwo\nhour\nwith\nalmotriptan\nthan\nwith\nplacebo\n(\n49\nversu\n25\npercent\n)\n[\n72\n]\n.\nsimilarli\n,\nwhen\ntreatment\nwa\nstart\nwhen\nheadach\nintens\nwa\nmoder\nto\nsever\n,\nalmotriptan\nremain\nsignificantli\nbetter\nthan\nplacebo\non\nthe\nsame\noutcom\nmeasur\n(\n40\nversu\n15\npercent\n)\n.●anoth\nstudi\nanalyz\na\ndatabas\nof\n130,000\nmigrain\nattack\nin\n28,000\npatient\nwith\nmigrain\n[\n73\n]\n.\npretreat\npain\nsever\nwa\nthe\nstrongest\npredictor\nof\nboth\nheadach\nrelief\n(\ndefin\nas\nmild\nor\nno\npain\n)\nand\npain-fre\nrespons\ntwo\nhour\nafter\ntake\nsumatriptan\n,\nwith\nlower\nbaselin\nsever\npredict\na\nbetter\nrespons\n.\nthe\nresist\nof\nsever\npain\nto\ntriptan\ntherapi\nfound\nin\nthi\nstudi\nmay\nbe\ndue\nto\nthe\ndevelop\nof\ncentral\nsensit\ndure\nthe\nattack\n,\nwhich\nis\nthought\nto\ncounteract\nanalges\nand\ntriptan\ntherapi\n.\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n.\n)\nin\npatient\nsuscept\nto\ncutan\nallodynia\n(\nthe\npercept\nof\npain\nproduc\nby\ninnocu\nstimul\nof\nnormal\nskin\n)\n,\nlimit\ndata\nsuggest\nthat\ntriptan\nare\nless\neffect\nonc\nallodynia\nis\nestablish\ndure\nmigrain\nattack\n.\nin\na\nstudi\nof\n31\npatient\n,\ntriptan\ntreatment\nresult\nin\ncomplet\npain\nrelief\nby\ntwo\nhour\nin\nonli\n15\npercent\nof\n34\nallodyn\nattack\nversu\n97\npercent\nof\n27\nnonallodyn\nattack\n[\n74\n]\n.\nthe\nauthor\nconclud\nthat\npatient\nwho\ndevelop\nallodynia\n,\nwhich\ntake\none\nto\nfour\nhour\nto\nestablish\n[\n75\n]\n,\nshould\ntake\ntriptan\nas\nearli\nas\npossibl\nin\na\nmigrain\nattack\n.\nconvers\n,\npatient\nwho\nnever\ndevelop\nallodynia\ncan\nbenefit\nfrom\ntriptan\ntherapi\nat\nani\ntime\ndure\nan\nattack\n.\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n.\n)\nlimit\nto\nuse\n—\ntriptan\nhave\nproven\nto\nbe\nsafe\nand\neffect\nfor\nmost\npatient\nwith\nmigrain\n[\n76\n]\n.\na\nsystemat\nreview\nof\nobserv\nstudi\nfound\nno\nassoci\nbetween\ntriptan\nuse\nand\nthe\nrisk\nof\ncardiovascular\nevent\n,\nthough\nonli\nfour\nrelev\nstudi\nwere\nidentifi\n[\n77\n]\n.\nsimilarli\n,\nin\na\ncohort\nstudi\nof\n63,575\npatient\nwith\nmigrain\n,\n13,664\nof\nwhom\nwere\ntreat\nwith\na\ntriptan\n,\nthere\nwa\nno\nassoci\nbetween\ntriptan\nprescript\nand\nstroke\n,\nother\ncardiovascular\nevent\n,\nor\ndeath\n[\n78\n]\n.\nhowev\n,\nin\nthi\ncohort\n,\ntriptan\nwere\nprescrib\nto\nthose\nat\nless\nrisk\nof\nthese\nevents.al\ntriptan\nshould\nbe\nlimit\nto\nno\nmore\nthan\n10\nday\nof\nuse\nper\nmonth\nto\navoid\nmedic\noverus\nheadach\n.\nbase\non\nlimit\nevid\n,\nit\nis\nstill\nrecommend\nthat\ntriptan\nbe\navoid\nin\npatient\nwith\nhemipleg\nmigrain\n,\nbasilar\nmigrain\n,\nischem\nstroke\n,\nischem\nheart\ndiseas\n,\nprinzmet\n's\nangina\n,\nuncontrol\nhypertens\n,\nand\npregnanc\n[\n79\n]\n.combin\nwith\nmonoamin\noxidas\ninhibitor\nis\nrel\ncontraind\nwith\ntriptan\nbecaus\nof\nthe\nrisk\nof\nserotonin\nsyndrom\n.\ntriptan\nshould\nnot\nbe\nuse\nwithin\n24\nhour\nof\nthe\nuse\nof\nergotamin\nprepar\nor\na\ndiffer\ntriptan\nmedic\n[\n80\n]\n.\n(\nsee\n``\nserotonin\nsyndrom\n(\nserotonin\ntoxic\n)\n''\n.\n)\neletriptan\nis\nprimarili\nmetabol\nby\ncytochrom\np-450\nenzym\ncyp3a4\n.\ntherefor\n,\neletriptan\nshould\nnot\nbe\nuse\nwithin\nat\nleast\n72\nhour\nof\ntreatment\nwith\nother\ndrug\nthat\nare\npotent\ncyp3a4\ninhibitor\n,\nsuch\nas\nketoconazol\n,\nitraconazol\n,\nnefazodon\n,\ntroleandomycin\n,\nclarithromycin\n,\nritonavir\n,\nand\nnelfinavir.concern\nhave\nbeen\nrais\nabout\nthe\ndevelop\nof\na\nserotonin\nsyndrom\n(\nsee\n``\nserotonin\nsyndrom\n(\nserotonin\ntoxic\n)\n''\n)\nin\npatient\nwho\nuse\ntriptan\nin\ncombin\nwith\na\nselect\nserotonin\nreuptak\ninhibitor\n(\nssri\n)\nor\na\nselect\nserotonin-norepinephrin\nreuptak\ninhibitor\n(\nsnri\n)\n[\n81\n]\n.\nhowev\n,\nthe\nad\nrisk\nof\nserotonin\nsyndrom\npose\nby\nthe\ncombin\nuse\nof\na\ntriptan\nwith\nan\nssri\nor\nsnri\nappear\nto\nbe\nveri\nlow\nto\nnonexist\n[\n82-85\n]\n.\nthu\n,\nmani\nheadach\nexpert\nsuggest\nthat\ntriptan\nin\ncombin\nwith\nssri\nor\nsnri\ncan\nbe\nuse\nin\nmost\ncase\nwhere\nboth\nare\nneed\nas\nlong\nas\nthe\nrisk\nand\nbenefit\nare\ndiscuss\n,\nand\npatient\nare\nmonitor\nfor\nsymptom\nof\nserotonin\nsyndrom\n.\nthe\ncombin\nshould\nbe\ndiscontinu\nif\nsuch\nsymptom\narise.triptan\nwith\nnsaid\n—\nthe\ncombin\nuse\nof\na\ntriptan\nand\na\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\nto\ntreat\nacut\nmigrain\nappear\nto\nbe\nmore\neffect\nthan\nuse\neither\ndrug\nclass\nalon\n.\nthe\nbest-studi\ncombin\nis\nsumatriptan\nwith\nnaproxen\n.\na\nsystemat\nreview\nand\nmeta-analysi\n,\nupdat\nin\n2016\n,\nfound\nthat\nthe\ncombin\nof\nsumatriptan\nand\nnaproxen\nwa\nmore\neffect\nthan\neither\nagent\nalon\nfor\nthe\ntreatment\nof\nacut\nmigrain\nheadach\n[\n86\n]\n.\namong\nthe\nlargest\nof\nthe\ninclud\nstudi\nwere\ntwo\nrandom\nplacebo-control\ntrial\nof\nsimilar\ndesign\n,\ninvolv\na\ntotal\nof\nnearli\n3000\npatient\n,\nwhich\nevalu\na\nformul\nof\nsumatriptan\nsuccin\n85\nmg\nand\nnaproxen\nsodium\n500\nmg\nin\na\nsingl\ntablet\n(\ntreximet\n)\n[\n87\n]\n.\nthe\nfollow\nobserv\nwere\nreport\n:\n●at\ntwo\nhour\nafter\ndose\n,\nthe\ncombin\nof\nsumatriptan\nand\nnaproxen\nwa\nmore\neffect\nthan\nplacebo\nor\nsumatriptan\nalon\nfor\nheadach\nrelief\n(\ndefin\nas\nreduct\nof\npain\nfrom\nmoder\nor\nsever\nintens\nto\nmild\nintens\nor\nno\npain\nwithout\nuse\nof\nrescu\nmedic\n)\n●sumatriptan\nand\nnaproxen\nwa\nmore\neffect\nthan\nsumatriptan\nmonotherapi\nand\nnaproxen\nmonotherapi\nfor\nsustain\npain-fre\nrespons\n(\ndefin\nas\niniti\nmoder\nor\nsever\npain\nreduc\nto\nno\npain\nfrom\n2\nthrough\n24\nhour\nafter\ndose\nwithout\nuse\nof\nrescu\nmedic\n)\n●the\ncombin\nagent\nwa\nwell\ntoler\n;\ndizzi\n,\nsomnol\n,\nparesthesia\n,\nand\nnausea\nwere\nthe\nmost\ncommon\nside\neffectsin\ntwo\nrandom\nplacebo-control\ntrial\nwith\nmore\nthan\n1000\npatient\nthat\ntest\nearli\ntreatment\n(\nwithin\none\nhour\nof\nmigrain\nonset\nwhen\nthe\npain\nwa\nmild\n)\n,\na\npain-fre\nrespons\nat\ntwo\nhour\nwa\nsignificantli\nmore\nfrequent\nin\npatient\nassign\nto\nthe\ncombin\nsumatriptan\nand\nnaproxen\n85/500\nmg\n(\napproxim\n50\npercent\n,\nversu\napproxim\n16\npercent\nwith\nplacebo\n)\n[\n88\n]\n.\neven\nat\n30\nminut\n,\nthere\nwa\na\nstatist\nsignific\npain-fre\nrespons\nwith\ncombin\nsumatriptan\nplu\nnaproxen.wheth\nthe\nresult\nof\nthe\ntrial\ntest\nsumatriptan\nwith\nnaproxen\nare\ngeneraliz\nto\nother\ntriptan/nsaid\ncombin\nis\nuncertain\n.\nhowev\n,\na\ndouble-blind\ncontrol\ntrial\nof\n279\npatient\nfound\nthat\nthe\ncombin\nof\nfrovatriptan\n(\n2.5\nmg\n)\nand\ndexketoprofen\n(\n25\nmg\nor\n37.5\nmg\n)\nwa\nmore\neffect\nthan\nfrovatriptan\nalon\nfor\ntreat\nmigrain\nattack\n,\nas\nmeasur\nby\nthe\nproport\nof\nsubject\nwho\nwere\npain-fre\nat\ntwo\nhour\n(\n51\npercent\nfor\nfrovatriptan\nwith\neither\ndose\nof\ndexketoprofen\n,\nversu\n29\npercent\nfor\nfrovatriptan\nalon\n)\n[\n89\n]\n.antiemet\n—\nintraven\n(\niv\n)\nmetoclopramid\nand\niv\nor\nintramuscular\n(\nim\n)\nprochlorperazin\ncan\nbe\nuse\nas\nmonotherapi\nfor\nacut\nmigrain\nheadach\n.\nthese\nmedic\nact\nas\nantiemet\nmainli\nbecaus\nthey\nare\ndopamin\nreceptor\nantagonist\n.\nin\naddit\n,\nthey\nare\neffect\nfor\nreduc\nmigrain\nheadach\npain\n.\nthe\nbenefit\nof\nthese\nagent\nfor\nmigrain\nha\nbeen\ndemonstr\nin\nrandom\nplacebo-control\ntrial\nas\nwill\nbe\ndiscuss\nbelow\n.\nintraven\ndiphenhydramin\n(\n12.5\nto\n25\nmg\neveri\nhour\nfor\ntwo\nhour\n)\nis\nsometim\ngiven\nwith\nthese\ndrug\nto\nprevent\nakathisia\nand\nacut\ndyston\nreaction\n,\nwhich\nare\nthe\nmain\nside\neffect\nof\nthi\nclass\nof\nmedications.oth\nantiemet\nmedic\n(\nie\n,\nhaloperidol\n,\nchlorpromazin\n,\ndroperidol\n,\nand\nondansetron\n)\ncaus\ndose-depend\nprolong\nof\nthe\nqt\ninterv\non\nelectrocardiogram\n(\necg\n)\n,\nwhich\ncan\nlead\nto\na\nlife-threaten\ncardiac\narrhythmia\n,\ninclud\ntorsad\nde\npoint\n.\nthey\nmay\nbe\nuse\nfor\npatient\nwhen\nmigrain\nsymptom\nare\nunrespons\nto\nantiemet\nthat\ndo\nnot\nprolong\nthe\nqt\ninterv\n.\nthey\nshould\nbe\navoid\nin\npatient\nwith\ncongenit\nlong\nqt\nsyndrom\n,\nthose\nwith\npersist\ncorrect\nqt\ninterv\n(\nqtc\n)\n>\n500\nmillisecond\non\necg\n,\nand\nwith\nother\nrisk\nfactor\nfor\nacquir\nlong\nqt\nsyndrom\n(\ntabl\n1\n)\n.\n(\nsee\n``\nacquir\nlong\nqt\nsyndrom\n:\ndefinit\n,\ncaus\n,\nand\npathophysiolog\n''\n,\nsection\non\n'risk\nfactor\n'\n.\n)\nin\ncontrast\nwith\niv\nor\nim\nprepar\n,\noral\nantiemet\nshould\nnot\nbe\nconsid\nas\nmonotherapi\nin\nacut\nmigrain\n[\n1,2\n]\n.prochlorperazin\n—\nin\ncontrol\ntrial\n,\niv\nprochlorperazin\nappear\nto\nbe\nas\neffect\nor\nmore\neffect\nthan\niv\nmetoclopramid\nor\nsubcutan\nsumatriptan\n,\nand\nmore\neffect\nthan\nhydromorphon\nor\nplacebo\nin\nthe\nacut\ntreatment\nof\nmigrain\n[\n14,16,19,90,91\n]\n.\nin\nmost\nof\nthese\ntrial\n,\ndiphenhydramin\nwa\nuse\nas\nadjunct\ntreatment\nto\nprevent\nakathisia\nand\ndyston\nreaction\n,\nand\nthe\npossibl\nof\nmigrain\nbenefit\nfrom\ndiphenhydramin\ncan\nnot\nbe\ncomplet\ndiscounted.in\none\nrandom\ncontrol\ntrial\nevalu\nthat\n127\nadult\nwho\npresent\nto\nthe\nemerg\ndepart\nfor\nthe\ntreatment\nof\nmigrain\n,\nthe\ncombin\nof\niv\nprochlorperazin\n(\n10\nmg\n)\nand\niv\ndiphenhydramin\n(\n25\nmg\n)\nwa\nmore\neffect\nthan\niv\nhydromorphon\n(\n1\nmg\n)\nfor\nachiev\nsustain\nheadach\nrelief\n,\ndefin\nas\na\nreduct\nto\na\nlevel\nof\nmild\nor\nno\nheadach\nwithin\ntwo\nhour\nof\nmedic\nadministr\nand\nwithout\nrelaps\nor\nneed\nfor\nrescu\nmediat\nfor\n48\nhour\n[\n91\n]\n.in\nanoth\ndouble-blind\nrandom\ncontrol\ntrial\nthat\nevalu\nthe\nemerg\ndepart\ntreatment\nof\nmigrain\nin\n66\npatient\n,\nthe\ncombin\nof\niv\nprochlorperazin\n(\n10\nmg\n)\nand\niv\ndiphenhydramin\n(\n12.5\nmg\n)\nwa\nsignificantli\nmore\neffect\nthan\nsubcutan\nsumatriptan\n(\n6\nmg\n)\nfor\nthe\nreduct\nof\npain\nintens\nat\n80\nminut\nor\ntime\nof\ndischarg\n[\n92\n]\n.\na\nhigh\ndropout\nrate\nupon\nattempt\ntelephon\ncontact\nat\n72\nhour\npreclud\nmeaning\nassess\nof\nheadach\nrecurr\n,\nalthough\nnone\nof\nthe\nenrol\npatient\nreturn\nto\nthe\nemerg\ndepart\nwith\ncomplaint\nof\nheadache.metoclopramid\n—\niv\nmetoclopramid\nis\neffect\nfor\nacut\nmigrain\ntreatment\n,\nas\ndemonstr\nin\nsystemat\nreview\nand\nmeta-analys\n[\n14,16,19,93\n]\n.\none\nmeta-analysi\n,\npublish\nin\n2004\n,\nreview\n13\nclinic\ntrial\n[\n93\n]\n.\nstudi\nmethod\nvari\nconsider\n,\nand\nthe\nqualiti\nof\nthe\ninclud\nstudi\nwa\ngener\npoor\n.\nthe\nfollow\nobserv\nwere\nmade\n[\n93\n]\n:\n●in\npool\ndata\nfrom\nthree\nstudi\n,\nmetoclopramid\nwa\nmore\nlike\nto\nprovid\nheadach\npain\nreduct\nthan\nplacebo\n(\nodd\nratio\n[\nor\n]\n2.84\n;\n95\n%\nci\n1.05-7.68\n)\n.●the\nnnt\nto\nenabl\none\npatient\nto\nachiev\nsignific\nreduct\nin\npain\nwith\nmetoclopramid\nwa\nfour.●metoclopramid\nwa\nless\neffect\nthan\nchlorpromazin\nand\nprochlorperazin\nin\nreliev\npain\nand\nnausea\n,\nalthough\ndiffer\nwere\nnot\nalway\nstatist\nsignificant.●on\ntrial\nfound\nthat\nmetoclopramid\ntreatment\nwa\nnot\nstatist\ndiffer\nthan\nsumatriptan\nfor\nrate\nof\ncomplet\nresolut\nof\nmigrain\nor\nsignific\nreduct\nin\npain\nor\nnausea.or\nmetoclopramid\nmay\nbe\neffect\nwhen\ncombin\nwith\nother\ntreatment\n.\n(\nsee\n'use\nin\nadjunct\ntherapi\n'\nbelow\n.\n)\nother\n—\nchlorpromazin\n,\nondansetron\nor\ngranisetron\n,\ndroperidol\n,\nand\nhaloperidol\nappear\nto\nbe\neffect\nfor\nthe\nacut\ntreatment\nof\nmigrain\nbut\nare\nnot\nconsid\nfirst-lin\nagent\nbecaus\nthe\nevid\nis\nmainli\nfrom\nlower-qu\nrandom\ntrial\nand\nbecaus\nrate\nof\nadvers\neffect\nare\nhigh\n[\n19\n]\n.\nadvers\neffect\nwith\nthese\nagent\nmay\ninclud\nrebound\nheadach\n,\nakathisia\n,\nand\narrythmia\nfrom\nqt-segment\nprolong\non\necg\n(\ntabl\n1\n)\n.\nif\nthese\nmedic\nare\nuse\n,\necg\nshould\nbe\nobtain\nat\nbaselin\nand\nat\ntwo\nto\nthree\nhour\nafter\ndose\n[\n94\n]\n,\nand\npatient\nshould\nbe\nmonitor\nfor\nclinic\nsymptom\nsuggest\nof\nqt-segment\nprolong\n.\n(\nsee\n``\nacquir\nlong\nqt\nsyndrom\n:\nclinic\nmanifest\n,\ndiagnosi\n,\nand\nmanag\n''\n,\nsection\non\n'precaut\nwhen\nuse\nqt-prolong\ndrug\n'\n.\n)\n●chlorpromazin\n–\nalthough\ndata\nare\nlimit\n,\niv\nchlorpromazin\nappear\nto\nbe\neffect\nin\nthe\nacut\ntreatment\nof\nmigrain\n[\n14,16,19\n]\n.\nin\none\nof\nthe\nlarger\nclinic\ntrial\nthat\nassess\nchlorpromazin\ntreatment\nin\nthe\nemerg\ndepart\n,\n128\npatient\nwith\nmigrain\nwere\nassign\nto\nchlorpromazin\n0.1\nmg/kg\niv\nor\nplacebo\n.\nchlorpromazin\ntreatment\nwa\nassoci\nwith\nsignific\nimprov\nin\npain\n,\nnausea\n,\nphotophobia\n,\nphonophobia\n,\nand\nneed\nfor\nrescu\nmedic\nat\n60\nminut\ncompar\nwith\nplacebo\n[\n95\n]\n.\nbenefit\nextend\nto\nboth\nmigrain\nwith\naura\nand\nmigrain\nwithout\naura\n.\nthe\nnumber\nneed\nto\ntreat\n(\nnnt\n)\nto\nenabl\none\npatient\nto\nachiev\nsignific\nimprov\nat\n60\nminut\nwa\ntwo\n.\nin\naddit\n,\nchlorpromazine-tr\npatient\nhad\na\nsignificantli\nreduc\nrate\nof\nheadach\nrecurr\nat\n24\nhour\n.\ndrowsi\nand\npostur\nhypotens\nwere\nseen\nmore\nfrequent\nwith\nchlorpromazin\ntreatment\nthan\nwith\nplacebo\n.\n●ondansetron\nand\ngranisetron\n–\ntreatment\nof\nacut\nmigrain\nuse\nondansetron\nor\ngranisetron\nha\nnot\nbeen\nrigor\nevalu\n,\nalthough\nthere\nare\nreport\ndescrib\ntheir\nuse\n[\n96\n]\n.\nhowev\n,\nboth\nondansetron\nand\ngranisetron\nhave\nbeen\nassoci\nwith\na\nrel\nhigh\nincid\nof\nheadach\nas\nan\nadvers\neffect\n[\n97-99\n]\n.\nsever\nguidelin\nrecommend\nagainst\nthe\nuse\nof\nintraven\ngranisetron\nfor\nacut\nmigrain\n[\n2,19\n]\n.●droperidol\n–\nin\na\nrandom\ncontrol\ntrial\nof\nover\n300\npatient\n,\ndroperidol\n(\n2.75\nmg\n,\n5.5\nmg\n,\nand\n8.25\nmg\nim\n)\nwa\nsuperior\nto\nplacebo\nfor\nthe\ntreatment\nof\nacut\nmigrain\nattack\n[\n100\n]\n.\nhowev\n,\nthese\ndose\nwere\nassoci\nwith\nhigh\nrate\nof\nadvers\nevent\ninclud\nakathisia\nand\nasthenia\n.\nsystemat\nreview\nof\nrandom\ncontrol\ntrial\nhave\nfound\nthat\nthe\neffect\nof\nparenter\ndroperidol\n(\niv\nor\nim\n)\nfor\nacut\nmigrain\nrelief\nwa\nequal\nto\nor\nbetter\nthan\nprochlorperazin\n[\n14,16\n]\n.●haloperidol\n–\na\nplacebo-control\ntrial\nof\n40\nhospit\npatient\nfound\nthat\nhaloperidol\n(\n5\nmg\niv\n)\nwa\neffect\nfor\nmigrain\npain\nrelief\n[\n101\n]\n.\nadvers\neffect\n,\nmainli\nsedat\nand\nakathisia\n,\noccur\nin\n80\npercent\nof\npatient\nwho\nreceiv\nhaloperidol\n.\nanoth\ntrial\nrandomli\nassign\n64\nadult\npresent\nto\nthe\nemerg\ndepart\nwith\nacut\nmigrain\nto\ntreatment\nwith\neither\nhaloperidol\n5\nmg\niv\nor\nmetoclopramid\n10\nmg\niv\n[\n102\n]\n.\nthere\nwa\nno\ndiffer\nin\npain\nrelief\nbetween\nthe\ntreatment\ngroup\n,\nbut\nthe\nincid\nof\nrestless\n(\nakathisia\n)\nwa\nhigher\nin\nthe\nhaloperidol\ngroup\n(\n43\nversu\n10\npercent\n)\n.use\nin\nadjunct\ntherapi\n—\nantiemet\nare\ncommonli\nuse\nas\nadjunct\ntherapi\nto\ntreat\nmigrain\n.\nas\nan\nexampl\n,\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\ncan\nbe\ncombin\nwith\nmetoclopramid\nto\ndecreas\nnausea\nand\nvomit\n.\nthe\nefficaci\nof\nthi\napproach\nwa\nillustr\nin\na\nrandom\ntrial\nof\n421\npatient\nwith\nmigrain\nthat\ncompar\noral\nlysin\nacetylsalicyl\n(\nequival\nto\n900\nmg\nof\naspirin\n)\nplu\noral\nmetoclopramid\n(\n10\nmg\n)\nwith\noral\nsumatriptan\n(\n100\nmg\n)\nor\nplacebo\n[\n103\n]\n.\nheadach\nintens\ndecreas\nin\n57\n,\n53\n,\nand\n24\npercent\nof\npatient\n,\nrespect\n.\nthu\n,\nin\npatient\nwho\nwill\nnot\nuse\nsuppositori\n,\nor\nwho\nare\nhave\ndifficulti\ntoler\noral\nanalges\n,\nan\nanalges\nplu\nmetoclopramid\nis\na\nreason\n,\nrel\nlow-cost\nalternative.cgrp\nantagonist\n—\npharmacolog\nmodul\nof\ncalcitonin-gen\nrelat\npeptid\n(\ncgrp\n)\nactiv\nappear\nto\nmediat\ntrigeminovascular\npain\ntransmiss\nin\nmigrain\n(\nsee\n``\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n''\n)\n.\nmonoclon\nantibodi\ndirect\nagainst\nthe\ncgrp\nreceptor\nor\nligand\nare\ngiven\nby\ninject\nfor\nmigrain\nprevent\n.\nsmall-molecul\ncgrp\nantagonist\n(\nalso\nterm\n``\ngepant\n''\n)\nare\noral\noption\navail\nfor\nthe\nacut\ntreatment\nof\nmigrain\nin\npatient\nwith\neither\ninsuffici\nrespons\nor\ncontraind\n(\neg\n,\ncoronari\narteri\ndiseas\n)\nto\ntreatment\nwith\ntriptans.in\nparticular\n,\nthere\nare\nposit\nrandom\ncontrol\ntrial\nfor\nrimegep\nand\nubrogep\nin\nacut\nmigrain\n[\n104-108\n]\n.\nas\nan\nexampl\n,\none\ntrial\nrandomli\nassign\nadult\npatient\nwith\nepisod\nmigrain\nin\na\n1:1:1\nratio\nto\none\ntablet\nof\nubrogep\n100\nmg\n,\nubrogep\n50\nmg\n,\nor\nplacebo\ntaken\nwithin\nfour\nhour\nof\na\nsingl\nmigrain\nattack\n;\nan\noption\nsecond\ndose\nor\nthe\npatient\n's\nown\nrescu\nmedic\nwa\npermit\n2\nto\n48\nhour\nafter\nthe\nfirst\ndose\n[\n108\n]\n.\nwith\nefficaci\ndata\nfor\n1327\npatient\n,\nthe\nproport\nwith\npain\nfreedom\nat\ntwo\nhour\nafter\ntreatment\nwa\ngreater\nfor\nthose\nassign\nto\nthe\n100\nmg\nand\n50\nmg\ndose\nof\nubrogep\ncompar\nwith\nplacebo\n(\n21.2\n,\n19.2\n,\nand\n11.8\npercent\n,\nrespect\n)\n.\nalso\n,\nthe\nproport\nwho\nreport\nabsenc\nof\ntheir\nmost\nbothersom\nmigraine-associ\nsymptom\n(\nie\n,\nphotophobia\n,\nphonophobia\n,\nor\nnausea\n)\nat\ntwo\nhour\nafter\ntreatment\nwa\ngreater\nfor\nthose\nassign\nto\nubrogep\n100\nand\n50\nmg\ncompar\nwith\nplacebo\n(\n37.7\n,\n38.6\n,\nand\n27.8\npercent\n)\n.\nthe\nmost\ncommon\nadvers\nevent\nwere\nnausea\n,\nsomnol\n,\nand\ndri\nmouth.a\n2021\nmeta-analysi\nof\navail\ntrial\nfound\nthat\npain\nresolut\nby\ntwo\nhour\nwa\nlikeli\nwith\neither\nrimegep\n(\nrel\nrisk\n[\nrr\n]\n1.8\n,\n95\n%\nci\n1.5-2.1\n)\nor\nubrogep\n(\nrr\n1.6\n,\n95\n%\nci\n1.3-1.9\n)\nthan\nplacebo\n[\n109\n]\n.\nubrogep\nreceiv\nus\nfood\nand\ndrug\nadministr\n(\nfda\n)\napprov\nfor\nthe\ntreatment\nof\nacut\nmigrain\nin\nadult\nin\ndecemb\n2019\n[\n110\n]\n,\nand\nrimegep\nreceiv\nsimilar\nfda\napprov\nin\nfebruari\n2020\n[\n111\n]\n.\nhowev\n,\ngiven\nthe\nshort-term\n,\nsingle-attack\ndesign\nof\nthese\ntrial\n[\n105-108\n]\n,\nlong-term\ndata\nare\nneed\nto\ndetermin\nsafeti\nand\ntoler\n.\nin\naddit\n,\nthe\nefficaci\nof\ncgrp\nantagonist\ncompar\nwith\ntriptan\nis\nnot\nyet\nknown.sever\ncgrp\nantagonist\nare\napprov\nfor\nmigrain\nprevent\n,\nas\ndiscuss\nsepar\n.\n(\nsee\n``\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n,\nsection\non\n'cgrp\nantagonist\n'\n.\n)\nlasmiditan\n—\nlasmiditan\nis\na\nselect\nserotonin\n1f\nreceptor\nagonist\nthat\nlack\nvasoconstrictor\nactiv\nand\ntherefor\ncan\nbe\nuse\nfor\npatient\nwith\nrel\ncontraind\nto\ntriptan\ndue\nto\ncardiovascular\nrisk\nfactor\n[\n112\n]\n.in\na\nrandom\ntrial\nof\nover\n2200\npatient\nwith\nepisod\nmigrain\n,\nthe\nproport\nwho\nwere\nheadach\npain-fre\nat\ntwo\nhour\nwa\ngreater\nwith\nlasmiditan\n200\nmg\n(\n32\nversu\n15\npercent\nwith\nplacebo\n;\nabsolut\nrisk\ndiffer\n[\nard\n]\n17\npercent\n;\nodd\nratio\n[\nor\n]\n2.6\n,\n95\n%\nci\n2.0-3.6\n)\nand\nlasmiditan\n100\nmg\n(\n28\nversu\n15\npercent\n;\nard\n13\npercent\n;\nor\n2.2\n,\n95\n%\nci\n1.6-3.0\n)\n[\n113\n]\n.\nin\na\n2021\nmeta-analysi\ninclud\nfive\ntrial\nand\nmore\nthan\n7000\npatient\n,\nresolut\nof\npain\nat\ntwo\nhour\nlikeli\nwith\nlasmiditan\nthan\nplacebo\n(\nrel\nrisk\n[\nrr\n]\n1.95\n,\n95\n%\nci\n1.3-3.0\n)\n[\n109\n]\n.\nlasmiditan\nwa\nalso\neffect\nfor\ntreat\nacut\nmigrain\nin\nanoth\nrandom\nplacebo-control\ntrial\nof\n2310\npatient\n[\n114\n]\n.in\noctob\n2019\n,\nthe\nus\nfood\nand\ndrug\nadministr\n(\nfda\n)\napprov\nlasmiditan\noral\ntablet\nfor\nthe\nacut\ntreatment\nof\nmigrain\nin\nadult\n[\n115\n]\n.\nthe\niniti\ndose\nof\nlasmiditan\nis\n50\nor\n100\nmg\n;\nthere\nis\nno\nbenefit\nwith\ntake\na\nsecond\ndose\nfor\nthe\nsame\nmigrain\nattack\n.\nwith\nsubsequ\nattack\n,\nthe\ndose\nmay\nbe\nincreas\nto\n100\nor\n200\nmg\nas\nneed\n,\nbut\nno\nmore\nthan\none\ndose\nshould\nbe\ntaken\nin\n24\nhour\n[\n116\n]\n.the\nmost\ncommon\nadvers\nevent\nassoci\nwith\nlasmiditan\nis\ndizzi\n;\nother\nrel\nfrequent\nadvers\nevent\nare\nparesthesia\n,\nsomnol\n,\nfatigu\n,\nand\nnausea\n[\n113,114\n]\n.\ndizzi\nwith\nlasmiditan\nis\ndose-depend\nand\nlarg\nmild\nto\nmoder\nin\nsever\n,\nwith\na\nmedian\ndurat\nof\n1.5\nto\n2\nhour\n[\n117\n]\n.\nthe\ndrug\nmay\ncaus\ndrive\nimpair\n,\nand\npatient\nshould\nnot\ndrive\na\nmotor\nvehicl\n,\noper\nmachineri\n,\nor\nengag\nin\npotenti\nhazard\nactiv\nfor\nat\nleast\neight\nhour\nafter\neach\ndose\nof\nlasmiditan\n[\n116\n]\n.ergot\n—\na\nvarieti\nof\nergotamin\nprepar\n,\nalon\nand\nin\ncombin\nwith\ncaffein\nand\nother\nanalges\n,\nhave\nbeen\nuse\nfor\nthe\nabort\ntreatment\nof\nmigrain\n[\n118\n]\n.\nboth\nergotamin\nand\ndihydroergotamin\nbind\nto\n5ht\n1b/d\nreceptor\n,\njust\nas\ntriptan\ndo\n.\nas\nthe\nevid\nreview\nbelow\nsuggest\n,\nparenter\ndihydroergotamin\nis\neffect\nfor\nacut\nmigrain\n,\nwhile\nthe\neffect\nof\nergotamin\nis\nuncertain.dihydroergotamin\n—\ndihydroergotamin\nis\nan\nalpha-adrenerg\nagonist\nthat\nis\na\nweaker\narteri\nvasoconstrictor\nand\nmore\npotent\nvenoconstrictor\nthan\nergotamin\ntartrat\n.\nit\nis\nalso\na\npotent\n5-ht\n1b/1d\nreceptor\nagonist\n.\ndihydroergotamin\nha\nfewer\nside\neffect\nthan\nergotamin\n[\n7\n]\n.\nit\nis\navail\nfor\nintraven\n(\niv\n)\n,\nintramuscular\n(\nim\n)\n,\nsubcutan\n,\nand\nintranas\nuse\n.\ndihydroergotamin\nis\noften\nuse\nin\ncombin\nwith\nan\nantiemet\ndrug\n,\nand\nthi\nis\nalway\nthe\ncase\nwhen\nit\nis\ngiven\nby\nintraven\nadministration.th\nuse\nof\nintraven\ndihydroergotamin\nfor\nthe\ntreatment\nof\nchronic\nintract\nmigrain\nheadach\nor\nstatu\nmigrainosu\n(\na\ndebilit\nmigrain\nattack\nlast\nfor\n>\n72\nhour\n)\nis\ndiscuss\nsepar\n.\n(\nsee\n``\nmedic\noverus\nheadach\n:\ntreatment\nand\nprognosi\n''\n,\nsection\non\n'dihydroergotamin\n'\n.\n)\nparenter\ndihydroergotamin\n(\ndhe\n45\n)\nadminist\nwith\nan\nantiemet\nappear\nto\nbe\neffect\nfor\nacut\nmigrain\n.\nthi\nconclus\nis\nsupport\nby\nthe\nfind\nof\na\nsystemat\nreview\nthat\nanalyz\n11\nrandom\ncontrol\ntrial\nof\niv\nor\nim\ndihydroergotamin\ntherapi\nfor\nacut\nmigrain\nin\nadult\n[\n119\n]\n.\nthe\nqualiti\nof\nthe\ninclud\nstudi\nwa\nvariabl\n,\nand\nmost\nhad\nrel\nsmall\nsampl\nsize\n.\nthe\nfollow\nobserv\nwere\nreport\n:\n●in\ntwo\nstudi\n,\ndihydroergotamin\nalon\n(\nwithout\nan\nantiemet\n)\nwa\nless\neffect\non\nmost\noutcom\nmeasur\nthan\nsumatriptan\n[\n120,121\n]\n,\nand\nin\none\nstudi\nwa\nless\neffect\non\nsome\n(\nbut\nnot\nall\n)\noutcom\nmeasur\nthan\nchlorpromazin\n[\n122\n]\n.●in\neight\nstudi\n,\nthe\ncombin\nof\nparenter\ndihydroergotamin\nwith\nan\nantiemet\n(\nmost\ncommonli\nmetoclopramid\n)\nwa\nas\neffect\nas\nor\nmore\neffect\nthan\nmeperidin\n,\nvalproat\n,\nor\nketorolac\nin\nreliev\nmigrain\nheadach\nand\nprevent\nrelapses.wheth\ndihydroergotamin\ncontribut\naddit\nbenefit\nwhen\nuse\nwith\nan\nantiemet\nin\nthese\nstudi\nis\nuncertain\n,\nsinc\nthe\nantiemet\nmetoclopramid\nis\nknown\nto\nbe\neffect\nfor\nmigrain\nwhen\nuse\nalon\n(\nsee\n'metoclopramid\n'\nabov\n)\n.\nhowev\n,\nin\nsever\nstudi\ndihydroergotamin\ncombin\nwith\nan\nantiemet\nwa\nsuperior\nto\nother\nagent\ncombin\nwith\nthe\nsame\nantiemet\n,\nsuggest\nthat\ndihydroergotamin\ndoe\nhave\nindepend\nefficaci\nfor\nmigrain\n[\n122\n]\n.self-administ\nintranas\ndihydroergotamin\nha\nbeen\nfound\n,\nin\nplacebo-control\ntrial\n,\nto\nbe\nefficaci\nfor\nthe\ntreatment\nof\nmigrain\nsymptom\n[\n123,124\n]\n.\nin\none\ntrial\nof\nover\n300\npatient\nwith\nmigrain\n,\nfor\nexampl\n,\n27\npercent\nof\npatient\nwho\nadminist\n2\nmg\nof\nintranas\ndihydroergotamin\nhad\nresolut\nof\ntheir\nheadach\nwithin\n30\nminut\n[\n125\n]\n.\nby\nfour\nhour\nafter\ntreatment\n,\n70\npercent\nof\nthe\nheadach\nwere\nresolv\nand\nreturn\nwithin\n24\nhour\nin\nonli\n14\npercent\n.\nno\nseriou\nadvers\neffect\nof\ntreatment\nwere\nobserv\n.\na\ndeliveri\nsystem\ntarget\nthe\nupper\nnasal\ncaviti\nmay\nimprov\nsystem\navail\nof\ndihydroergotamin\n.\nin\nan\nopen-label\nstudi\nof\n360\npatient\nwith\nmigrain\n,\n52\npercent\nof\npatient\nreport\nresolut\nof\nthe\nmost\nbothersom\nmigrain\nsymptom\nand\n66\npercent\nreport\npain\nrelief\nat\ntwo\nhour\nwhen\nuse\ndihydroergotamin\nmesyl\ndeliv\nto\nthe\nupper\nnasal\ncaviti\n[\n124\n]\n.\nthe\nmost\ncommon\ntreatment-rel\nadvers\neffect\nwere\nnasal\ncongest\n(\n15\npercent\n)\n,\nnausea\n(\n7\npercent\n)\n,\nand\nnasal\ndiscomfort\n(\n5\npercent\n)\n.subcutan\ndihydroergotamin\nmay\nbe\nslightli\nmore\neffect\nthan\nthe\nintranas\nprepar\n,\nbut\nit\nha\nthe\ndisadvantag\nthat\nit\ndoe\nnot\ncome\nin\na\npreload\nsyring\n.\nnevertheless\n,\npatient\ncan\nbe\ntaught\nto\nself-inject\nthi\nagent\n.\none\nstudi\nrandomli\nassign\n295\npatient\nwith\nacut\nmigrain\n(\nwith\nor\nwithout\naura\n)\nto\nreceiv\n1\nmg\nof\nsubcutan\ndihydroergotamin\nor\n6\nmg\nof\nsubcutan\nsumatriptan\nsuccin\n;\na\nsecond\ninject\nof\nthe\nsame\ndrug\nwa\nuse\nin\ntwo\nhour\nif\npatient\ndid\nnot\nexperi\niniti\nrelief\n[\n120\n]\n.\nheadach\nrelief\noccur\nin\n86\nand\n83\npercent\nby\nfour\nhour\n,\nrespect\n,\na\ndiffer\nthat\nwa\nnot\nstatist\nsignific\n.\nhowev\n,\ndihydroergotamin\nwa\nmore\nlike\nto\nproduc\nrelief\nby\n24\nhour\n(\n90\nversu\n77\npercent\n)\nand\nwa\nassoci\nwith\na\nlower\nincid\nof\nrecurr\nin\nthe\n24\nhour\nafter\ntherapi\n(\n18\nversu\n45\npercent\n)\n.dihydroergotamin\nshould\nnot\nbe\nuse\nwithin\n24\nhour\nof\ntriptan\nor\nergot-lik\nagent\n.\nsimilar\nto\nthe\ntriptan\n,\ndihydroergotamin\nis\ncontraind\nin\npatient\nwith\nhypertens\nor\nischem\nheart\ndiseas\n,\nand\nin\npregnanc\nor\nbreastfeed\n.\ndihydroergotamin\nshould\nnot\nbe\nuse\nin\ncombin\nwith\nperipher\nand\ncentral\nvasoconstrictor\nor\nwith\npotent\ninhibitor\nof\ncyp3a4\n(\ninclud\nproteas\ninhibitor\n,\nazol\nantifung\n,\nand\nsome\nmacrolid\nantibiot\n)\n.ergotamin\n—\nit\nis\nunclear\nif\nit\nis\nthe\nergotamin\nitself\nor\nthe\nother\ningredi\nin\nthe\ncombin\ndrug\nthat\nprovid\nthe\nmost\neffect\n.\nthere\nare\ntwo\nobserv\nthat\nquestion\nthe\nefficaci\nof\nergotamin\nalon\n:\noral\nand\nrectal\nergotamin\nhave\na\nveri\npoor\nbioavail\n(\n2\nand\n5\npercent\n,\nrespect\n)\n[\n126\n]\n,\nand\nmost\nplacebo-control\ntrial\nof\noral\nergotamin\nalon\nhave\nfail\nto\nshow\nefficaci\nin\nthe\nrelief\nof\nmigrain\n[\n127\n]\n.\none\ncontrol\ntrial\nfound\nthat\nrectal\nsuppositori\ncontain\nergotamin\n(\n2\nmg\n)\nplu\ncaffein\n(\n100\nmg\n)\nwere\nas\neffect\nas\nsumatriptan\n(\n25\nmg\n)\nsuppositori\nfor\nmigrain\nheadach\nrelief\n[\n128,129\n]\n.\nhowev\n,\nthere\nwere\nmore\nside\neffect\namong\npatient\ntreat\nwith\nergotamine.ergotamin\ntartrat\nmay\nbe\nassoci\nwith\nsignific\nside\neffect\n,\nand\nmay\nworsen\nthe\nnausea\nand\nvomit\nassoci\nwith\nmigrain\n.\nin\naddit\n,\nvascular\nocclus\nand\nrebound\nheadach\nhave\nbeen\nreport\nwith\noral\ndose\nexceed\n6\ntablet\nper\n24\nhour\nor\n10\ntablet\nper\nweek\n.\nyear\nof\nuse\nalso\nmay\nbe\nassoci\nwith\nvalvular\nheart\ndiseas\n[\n130\n]\n.\nergot\nshould\nbe\navoid\nin\npatient\nwith\ncoronari\narteri\ndiseas\nbecaus\nthey\ncaus\nsustain\ncoronari\narteri\nconstrict\n[\n131\n]\n,\nperipher\nvascular\ndiseas\n,\nhypertens\n,\nand\nhepat\nor\nrenal\ndiseas\n.\nin\naddit\n,\nergotamin\noverus\nha\nbeen\nassoci\nwith\nan\nincreas\nrisk\nof\ncerebrovascular\n,\ncardiovascular\n,\nand\nperipher\nischem\ncomplic\n,\nparticularli\namong\nthose\nuse\ncardiovascular\ndrug\n[\n132\n]\n.\nthey\nalso\nshould\nnot\nbe\nuse\nin\npatient\nwho\nhave\nmigrain\nwith\nprolong\naura\nbecaus\nthey\nmay\nreduc\ncerebr\nblood\nflow.a\neuropean\nconsensu\npanel\nreview\nthe\nuse\nof\nergotamin\nfor\nthe\nacut\ntreatment\nof\nmigrain\nand\nconclud\nthat\nergotamin\nis\nthe\ndrug\nof\nchoic\nin\nrel\nfew\npatient\nwith\nmigrain\nbecaus\nof\nissu\nof\nefficaci\nand\nside\neffect\n[\n128\n]\n.\nsuitabl\ncandid\nmay\nbe\nthose\nwith\nprolong\ndurat\nof\nattack\n(\neg\n,\ngreater\nthan\n48\nhour\n)\nand\npossibl\nfrequent\nheadach\nrecurrence.abort\ntherapi\nplu\nparenter\ndexamethason\n—\nwhen\nad\nto\nstandard\nacut\nmigrain\ntherapi\n,\nparenter\ntreatment\nwith\ndexamethason\nreduc\nthe\nrate\nof\nearli\nheadach\nrecurr\n.\nsupport\nevid\ncome\nfrom\na\nmeta-analysi\nof\nseven\nrandom\ntrial\nconduct\nin\nemerg\ndepart\nor\nheadach\nclinic\n[\n133\n]\n.\nall\npatient\n(\nn\n=\n738\n)\nreceiv\nstandard\nabort\nmigrain\nheadach\ntreatment\n,\nand\nwere\nalso\nrandomli\nassign\nto\ntreatment\nwith\neither\na\nsingl\ndose\nof\ndexamethason\n(\nintraven\nor\nintramuscular\n,\n10\nto\n24\nmg\n)\nor\nplacebo.●in\nthe\npool\nresult\n,\ndexamethason\nwa\nsignificantli\nmore\neffect\nthan\nplacebo\nfor\nreduc\nmigrain\nrecurr\nfrom\n24\nto\n72\nhour\nafter\ntreatment\n(\nrel\nrisk\n0.74\n,\n95\n%\nci\n0.6-0.9\n)\n.\nthe\nnumber\nneed\nto\ntreat\nto\nprevent\none\nrecurr\nheadach\nwa\nnine.●dexamethason\nprovid\nno\naddit\nbenefit\nfor\nimmedi\nrelief\nof\nheadache.●ther\nwere\nno\nsignific\ndiffer\nregard\nadvers\nevent\nbetween\nthe\ndexamethason\nand\nplacebo\ngroups.a\nsecond\nmeta-analysi\n[\n134\n]\nand\na\nsystemat\nreview\n[\n135\n]\nalso\nconclud\nthat\nadjunct\nparenter\ndexamethason\nis\neffect\nfor\nreduc\nthe\nrate\nof\nmigrain\nrecurr\n.\nadjunct\ntreatment\nof\nacut\nmigrain\nwith\noral\nprednison\nwa\nnot\nbenefici\nfor\nprevent\nof\nrecurr\nheadach\nin\na\nsmall\ntrial\n[\n136\n]\n.given\nthese\ndata\n,\nwe\nrecommend\nadjunct\ntreatment\nwith\na\nsingl\ndose\nof\nparenter\ndexamethason\n(\n10\nto\n24\nmg\n)\nto\nreduc\nthe\nrisk\nof\nearli\nheadach\nrecurr\nfor\npatient\nwho\nare\ntreat\nwith\nstandard\nabort\ntherapi\nfor\nmigrain\nheadach\nin\nthe\nemerg\ndepart\nor\nclinic\n.\nhowev\n,\nfrequent\nuse\nof\nadjunct\ndexamethason\nfor\nheadach\nincreas\nthe\nrisk\nof\nglucocorticoid\ntoxic\nand\nshould\nbe\navoided.neuromodul\n—\nlimit\ndata\nfrom\nsmall\nrandom\ncontrol\ntrial\nsuggest\nbenefit\nof\nvariou\nform\nof\nneuromodul\nfor\nthe\ntreatment\nof\nacut\nmigrain\npain\n.\nthese\ntreatment\nstimul\nthe\ncentral\nor\nperipher\nnervou\nsystem\nwith\nan\nelectr\ncurrent\nor\na\nmagnet\nfield\n[\n137\n]\n.\nthey\nare\noption\nfor\npatient\nwho\nprefer\nnonpharmacolog\ntreatment\nor\nwho\nhave\nan\ninadequ\nrespons\n,\ninabl\nto\ntoler\n,\nor\ncontraind\nto\ndrug\ntreatment\nfor\nmigraine.transcutan\nsupraorbit\nnerv\nstimul\n—\ntranscutan\nsupraorbit\nnerv\nstimul\ncan\nreduc\nmigrain\npain\nintens\n,\nas\nshown\nin\nthe\nacm\ntrial\n,\nwhich\nrandomli\nassign\n109\nsubject\nhave\nan\nacut\nmigrain\nattack\nof\nat\nleast\nthree\nhour\ndurat\nto\na\none-hour\ntreatment\nsession\nwith\nextern\ntrigemin\nnerv\nstimul\nor\nsham\nstimul\n[\n138\n]\n.\npain\nwa\nassess\nuse\na\nvisual\nanalog\nscale\n,\nrang\nfrom\n0\n(\nno\npain\n)\nto\n10\n(\nmaximum\npain\n)\n.\nthe\nmean\nreduct\nin\npain\nintens\nat\none\nhour\nwa\ngreater\nfor\nthe\ntrue\nstimul\ngroup\ncompar\nwith\nthe\nsham\ngroup\n(\n-3.46\nversu\n-1.78\n)\n.\nthere\nwere\nfive\nminor\nadvers\nevent\nand\nno\nseriou\nadvers\nevent\nin\nthe\ntrue\nstimul\ngroup.th\nsupraorbit\ntranscutan\ntrigemin\nnerv\nstimul\ndevic\nuse\nin\nthi\ntrial\nis\napprov\nfor\nmarket\nin\nthe\nunit\nstate\n,\ncanada\n,\neurop\n,\nand\nsever\naddit\ncountri\n.\nthe\nevid\npertain\nto\nmigrain\nprevent\nis\nreview\nsepar\n.\n(\nsee\n``\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n,\nsection\non\n'neuromodul\n'\n.\n)\nremot\nelectr\nneuromodul\n—\ndata\nfrom\nsever\ntrial\nsuggest\nthat\na\ndevic\nappli\nnonpain\nelectr\nskin\nstimul\ncan\nreduc\nacut\nmigrain\npain\n[\n139-141\n]\n.\nthe\nstimul\ndevic\n,\ncontrol\nwith\na\nsmartphon\n,\nconsist\nof\nan\narmband\nwith\nrubber\nelectrod\nand\na\npower\nsourc\n.\nthe\narmband\nis\nappli\nand\nstimul\nstart\nas\nsoon\nas\npossibl\nafter\nthe\nonset\nof\na\nmigrain\nattack\n.\nin\na\nsham-control\ncrossov\npilot\ntrial\nof\n71\npatient\n,\nthe\nproport\nof\nrespond\nwa\nhigher\nwith\nactiv\nstimul\ncompar\nwith\nsham\nstimul\n[\n139\n]\n.\na\nlater\ntrial\nof\n252\nadult\nwith\nepisod\nmigrain\ntest\nrandom\npatient\nin\na\n1:1\nratio\nto\nreceiv\n30\nto\n45\nminut\nof\nactiv\nstimul\n(\nfrequenc\n100\nto\n120\nhz\n,\npuls\nwidth\n400\nmicrosecond\n,\nand\noutput\ncurrent\nup\nto\n40\nma\nadjust\nby\nthe\npatient\n)\nor\nsham\nstimul\n(\npuls\nfrequenc\napproxim\n0.08\nhz\n,\nmodul\npuls\nwidth\n40\nto\n550\nmicrosecond\n)\n[\n140\n]\n.\nsham\nstimul\nwa\ndesign\nto\nproduc\na\nsensat\nsimilar\nto\nactiv\nstimul\nbut\nwith\na\nfrequenc\ntoo\nlow\nto\ninduc\npain\ninhibit\n.\nat\ntwo\nhour\nafter\ntreatment\n,\nmore\npatient\nassign\nto\nactiv\nstimul\nwere\npain-fre\n(\n37\npercent\n,\nversu\n18\npercent\nwith\nsham\n,\nabsolut\nrisk\ndiffer\n[\nard\n]\n19\npercent\n)\nor\nhad\npain\nrelief\n,\ndefin\nas\nan\nimprov\nfrom\nsever\nor\nmoder\npain\nto\nmild\nor\nnone\n,\nor\nfrom\nmild\npain\nto\nnone\n(\n67\nversu\n39\npercent\n,\nard\n28\npercent\n)\n.\nmild\ndevice-associ\nadvers\nevent\noccur\nin\napproxim\n4\npercent\nand\ninclud\na\nwarm\nsensat\n,\narm\nor\nhand\nnumb\n,\nred\n,\nitch\n,\ntingl\n,\nmuscl\nspasm\n,\narm\npain\n,\nshoulder\npain\n,\nand\nneck\npain\n.\nthere\nwere\nno\nseriou\nadvers\nevents.th\nremot\nelectr\nneuromodul\ndevic\nuse\nin\nthi\ntrial\nis\napprov\nfor\nmarket\nin\nthe\nunit\nstates.transcrani\nmagnet\nstimul\n—\nthe\nefficaci\nof\nsingle-puls\ntranscrani\nmagnet\nstimul\n(\ntm\n)\nwa\ndemonstr\nin\na\nsham-control\ntrial\nof\n201\nadult\nwith\nepisod\nmigrain\nwith\naura\n[\n142\n]\n.\nthe\nanalysi\nwa\nbase\nupon\n164\npatient\nwho\ntreat\nat\nleast\none\nattack\nof\nmigrain\ndure\nthe\naura\nphase\n.\npain\nfreedom\nat\ntwo\nhour\npost-treat\nwa\nsignificantli\ngreater\nwith\nthe\ntm\ndevic\ncompar\nwith\nsham\nstimul\n(\n39\nversu\n22\npercent\n,\nabsolut\nrisk\nreduct\n17\npercent\n,\n95\n%\nci\n3-31\npercent\n)\n.\nfurthermor\n,\nsignific\nfor\na\nsustain\npain-fre\nrespons\nwa\nmaintain\nat\nboth\n24\nand\n48\nhour\n.\nthere\nwere\nno\nseriou\nadvers\nevent\nrelat\nto\nuse\nof\nthe\ndevice.th\nportabl\ntm\ndevic\nis\navail\nin\nthe\nunit\nkingdom\nand\nthe\nunit\nstate\n.\nthe\ntm\ndevic\nmay\nprove\nto\nbe\nuse\nas\na\nsecond-lin\nintervent\nfor\nthose\nwho\nhave\nmigrain\nthat\ndoe\nnot\nrespond\nto\nfirst-lin\ntherapi\nwith\ntriptan\nor\nother\nagent\ndiscuss\nabov\nor\nwho\nare\nunabl\nto\ntake\nthese\nagent\nbecaus\nof\ncontraind\nor\nintoler\n.\ntm\nshould\nnot\nbe\nuse\nto\ntreat\nmigrain\nfor\npatient\nwho\nhave\nepilepsi\n,\nsinc\nthere\nis\ntheoret\nconcern\nthat\ntm\ncould\ntrigger\nseizur\n[\n143\n]\n.noninvas\nvagu\nnerv\nstimul\n—\nnoninvas\nvagu\nnerv\nstimul\n(\nnvn\n)\nmay\nbe\nbenefici\nfor\nthe\nacut\ntreatment\nof\nepisod\nmigrain\n.\nthe\npresto\ntrial\nrandomli\nassign\nover\n240\nparticip\nto\ntreatment\nwith\na\nproprietari\nnvn\ndevic\nor\na\nsham\ndevic\n[\n144\n]\n.\nsubject\nwere\ninstruct\nto\nself-administ\nstimul\nfor\n120\nsecond\neach\nto\nright\nand\nleft\nside\nof\nthe\nneck\nwithin\n20\nminut\nfrom\nthe\nonset\nof\nmigrain\npain\n,\nand\nto\nrepeat\nstimul\n,\nif\nnot\npain-fre\n,\nat\n15\nminut\nand\n120\nminut\n.\nmore\npatient\nachiev\npain\nfreedom\nwith\nnvn\ncompar\nwith\nsham\nbut\nthe\ndiffer\nwa\nnot\nsignific\nat\n120\nminut\n(\n30\nversu\n20\npercent\n)\n.\nthe\nmost\ncommon\nadvers\neffect\nin\nthe\nnvn\ngroup\nwere\ndiscomfort\nat\nthe\napplic\nsite\nand\nnasopharyng\n.\nthe\nnvn\ndevic\nuse\nin\nthi\ntrial\nis\napprov\nfor\nmarket\nin\nthe\nunit\nstate\nand\neuropean\nunion.peripher\nnerv\nblock\n—\nnerv\nblock\ntarget\nthe\noccipit\nnerv\n,\nsphenopalatin\nganglion\n,\nand\ntrigemin\nnerv\nare\noption\nfor\nthe\nacut\ntreatment\nof\nmigrain\nin\npatient\nwho\nhave\nsever\nand\nprolong\nmigrain\nattack\n,\nand\nin\npatient\nwho\nare\nrefractori\nto\nor\nhave\ncontraind\nto\nstandard\nmigrain\ntreatment\n[\n145,146\n]\n.\nthe\nmost\nimport\ncontraind\nto\nperipher\nnerv\nblock\ninclud\nknown\nallergi\nto\na\nlocal\nanesthet\n,\nopen\nskull\ndefect\n,\nand\noverli\nskin\ninfect\n;\npregnanc\nis\na\nrel\ncontraind\n.\n(\nsee\n``\nheadach\nin\npregnant\nand\npostpartum\nwomen\n''\n.\n)\nevid\nof\nefficaci\nis\nlimit\nmainli\nto\nsmall\n,\nlow-qual\ntrial\n.\n●occipit\nnerv\nblock\n–\na\nsham-control\ntrial\nenrol\npatient\nwith\nmigrain\nfrom\nthe\nemerg\ndepart\nwho\nhad\npersist\nheadach\none\nhour\nor\nmore\nafter\ntreatment\nwith\nintraven\nmetoclopramid\n[\n147\n]\n.\nthe\nprimari\noutcom\nof\nheadach\nfreedom\nat\n30\nminut\nwa\nachiev\nby\n4\nof\n13\n(\n31\npercent\n)\ntreat\nwith\nbilater\ngreater\noccipit\nnerv\nblock\n,\nand\nnone\nof\n15\npatient\n(\n0\npercent\n)\nwho\nreceiv\nsham\ntherapi\n.\nthere\nwere\nno\ndiffer\nin\nadvers\neffect\nbetween\nthe\ntreatment\ngroups.●sphenopalatin\nganglion\nblock\n–\ncommerci\navail\nintranas\ndevic\nsupposedli\nfacilit\nblockad\nof\nthe\nsphenopalatin\nganglion\n(\nspg\n)\nby\ntopic\napplic\nand\npassiv\ndiffus\nof\nlocal\nanesthet\n.\nhowev\n,\nanatom\nresearch\nha\nshown\nthat\nthe\nspg\nis\nnot\nas\nclose\nto\nthe\nnasal\nmucosa\nas\nprevious\nbeliev\n,\nrais\ndoubt\nthat\nspg\nblockad\ncan\nbe\naccomplish\nthrough\nintranas\napplic\nof\nlocal\nanesthet\n[\n148\n]\n.nevertheless\n,\nlimit\ndata\nsuggest\nbenefit\nof\nspg\nblock\nfor\ntreatment\nof\nacut\nmigrain\n.\none\nearli\ntrial\nrandomli\nassign\npatient\nin\na\n2:1\nratio\nto\nintranas\n4\npercent\nlidocain\nor\nsalin\nplacebo\n;\na\n50\npercent\nreduct\nin\nheadach\nintens\nat\n15\nminut\nwa\nachiev\nby\n29\npatient\n(\n55\npercent\n)\ntreat\nwith\nlidocain\ncompar\nwith\n6\npatient\n(\n21\npercent\n)\nwho\nreceiv\nplacebo\n[\n149\n]\n.\na\nlater\nparallel-arm\n,\nrandom\npilot\ntrial\nenrol\npatient\nwith\nchronic\nmigrain\nand\nrandomli\nassign\nthem\nin\na\n2:1\nratio\nto\nrepetit\nspg\nblock\ntwice\nweekli\nfor\nsix\nweek\nwith\neither\n0.5\npercent\nbupivacain\nor\nsalin\n.\nwith\nefficaci\ndata\nfor\n38\npatient\n,\npain\nrate\nscore\nwere\nlower\nat\n15\nminut\n,\n30\nminut\n,\nand\n24\nhour\npostprocedur\nfor\npatient\ntreat\nwith\nbupivacain\ncompar\nwith\nthose\ntreat\nwith\nsalin\n[\n150\n]\n.\nhowev\n,\npatient\ntreat\nbupivacain\nhad\nonli\na\nmargin\nabsolut\nreduct\nin\naverag\npain\nintens\n(\n1\nto\n1.5\nunit\non\nthe\nnumer\nrate\nscale\n)\ncompar\nwith\nplacebo.opioid\nand\nbarbitur\n—\nopioid\nand\nbarbitur\nshould\nnot\nbe\nuse\nfor\nthe\ntreatment\nof\nmigrain\n,\nexcept\nas\na\nlast\nresort\n[\n151\n]\n:\n●opioid\ngener\nare\nnot\nas\neffect\nas\nmigraine-specif\nmedic\nfor\nacut\nmigrain\ntreatment\n[\n16,17,23\n]\n.\nin\naddit\n,\nthe\nuse\nof\nopioid\nis\ncomplic\nby\ntheir\npotenti\nfor\ntoler\n,\ndepend\n,\naddict\n,\nand\noverdos\n[\n15,20\n]\n.●there\nis\nno\nhigh-qual\nevid\nsupport\nthe\nefficaci\nof\nbarbitur\n(\nie\n,\nbutalbital-contain\ncompound\n)\nfor\nacut\nmigrain\ntreatment\n[\n5,20\n]\n.●the\nuse\nof\nopioid\nand\nbutalbit\nis\nassoci\nwith\nan\nincreas\nrisk\nfor\nthe\ndevelop\nof\nchronic\nmigrain\nand\nmedic\noverus\nheadach\n.\n(\nsee\n``\nchronic\nmigrain\n''\nand\n``\nmedic\noverus\nheadach\n:\netiolog\n,\nclinic\nfeatur\n,\nand\ndiagnosi\n''\n.\n)\nsocieti\nguidelin\nlink\n—\nlink\nto\nsocieti\nand\ngovernment-sponsor\nguidelin\nfrom\nselect\ncountri\nand\nregion\naround\nthe\nworld\nare\nprovid\nsepar\n.\n(\nsee\n``\nsocieti\nguidelin\nlink\n:\nmigrain\nand\nother\nprimari\nheadach\ndisord\n''\n.\n)\ninform\nfor\npatient\n—\nuptod\noffer\ntwo\ntype\nof\npatient\neduc\nmateri\n,\n``\nthe\nbasic\n''\nand\n``\nbeyond\nthe\nbasic\n.\n''\nthe\nbasic\npatient\neduc\npiec\nare\nwritten\nin\nplain\nlanguag\n,\nat\nthe\n5th\nto\n6th\ngrade\nread\nlevel\n,\nand\nthey\nanswer\nthe\nfour\nor\nfive\nkey\nquestion\na\npatient\nmight\nhave\nabout\na\ngiven\ncondit\n.\nthese\narticl\nare\nbest\nfor\npatient\nwho\nwant\na\ngener\noverview\nand\nwho\nprefer\nshort\n,\neasy-to-read\nmateri\n.\nbeyond\nthe\nbasic\npatient\neduc\npiec\nare\nlonger\n,\nmore\nsophist\n,\nand\nmore\ndetail\n.\nthese\narticl\nare\nwritten\nat\nthe\n10th\nto\n12th\ngrade\nread\nlevel\nand\nare\nbest\nfor\npatient\nwho\nwant\nin-depth\ninform\nand\nare\ncomfort\nwith\nsome\nmedic\njargon.her\nare\nthe\npatient\neduc\narticl\nthat\nare\nrelev\nto\nthi\ntopic\n.\nwe\nencourag\nyou\nto\nprint\nor\ne-mail\nthese\ntopic\nto\nyour\npatient\n.\n(\nyou\ncan\nalso\nlocat\npatient\neduc\narticl\non\na\nvarieti\nof\nsubject\nby\nsearch\non\n``\npatient\ninfo\n''\nand\nthe\nkeyword\n(\ns\n)\nof\ninterest\n.\n)\n●basic\ntopic\n(\nsee\n``\npatient\neduc\n:\nmigrain\nin\nadult\n(\nthe\nbasic\n)\n''\n)\n●beyond\nthe\nbasic\ntopic\n(\nsee\n``\npatient\neduc\n:\nmigrain\nin\nadult\n(\nbeyond\nthe\nbasic\n)\n''\nand\n``\npatient\neduc\n:\nheadach\ntreatment\nin\nadult\n(\nbeyond\nthe\nbasic\n)\n''\n)\nsummari\nand\nrecommendations●approach\nto\ntreatment\n–\nabort\ntreatment\nare\nusual\nmore\neffect\nif\nthey\nare\ngiven\nearli\nin\nthe\ncours\nof\nthe\nheadach\n;\na\nlarg\nsingl\ndose\ntend\nto\nwork\nbetter\nthan\nrepetit\nsmall\ndose\n.\nfor\npatient\nwho\npresent\nwith\nsignific\nnausea\nor\nvomit\n,\na\nnonor\n(\neg\n,\nintraven\n,\nintramuscular\n,\nor\nsubcutan\n)\nagent\nmay\nbe\nprefer\n.\n(\nsee\n'approach\nto\ntreatment\n'\nabov\n.\n)\n●patient\nwith\nmild\nto\nmoder\nmigrain\nattack\n–\nfor\npatient\nwith\nmild\nto\nmoder\nmigrain\nattack\nnot\nassoci\nwith\nvomit\nor\nsever\nnausea\n,\nwe\nsuggest\niniti\ntreatment\nwith\nsimpl\nanalges\n,\ninclud\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\nor\nacetaminophen\n,\nrather\nthan\nmigraine-specif\nagent\n(\ngrade\n2c\n)\n.\n(\nsee\n'mild\nto\nmoder\nattack\n'\nabov\nand\n'simpl\nanalges\n'\nabov\n.\n)\nfor\npatient\nunrespons\nto\nanalges\n,\nthe\ncombin\nuse\nof\nan\nnsaid\nwith\na\ntriptan\nmay\nbe\neffect\n.\nwhen\nattack\nare\nassoci\nwith\nsever\nnausea\nor\nvomit\n,\nan\nantiemet\ndrug\ncan\nbe\nuse\nalong\nwith\nanalges\n.\n(\nsee\n'triptan\nwith\nnsaid\n'\nabov\nand\n'antiemet\n'\nabov\nand\n'simpl\nanalges\n'\nabov\n.\n)\n●patient\nwith\nmoder\nto\nsever\nmigrain\nattack\n–\nfor\npatient\nwith\nmoder\nto\nsever\nmigrain\nattack\n,\nwe\nsuggest\ntreatment\nwith\na\ntriptan\nor\nthe\ncombin\nof\nsumatriptan-naproxen\n,\nrather\nthan\nother\nmigraine-specif\nagent\n(\ngrade\n2c\n)\n.\npatient\nwho\ndo\nnot\nrespond\nwell\nto\none\ntriptan\nmay\nrespond\nto\na\ndiffer\ntriptan\n.\n(\nsee\n'moder\nto\nsever\nattack\n'\nabov\nand\n'triptan\n'\nabov\nand\n'triptan\nwith\nnsaid\n'\nabov\n.\n)\naltern\noption\ninclud\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\nantagonist\n,\nlasmiditan\n,\nantiemet\ndrug\n,\nand\ndihydroergotamin\n.\n(\nsee\n'cgrp\nantagonist\n'\nabov\nand\n'lasmiditan\n'\nabov\nand\n'antiemet\n'\nabov\nand\n'ergot\n'\nabov\n.\n)\n●patient\nwith\nsever\nmigrain\nattack\nin\nan\nemerg\ndepart\n–\nfor\npatient\nwith\nrefractori\nmigrain\nattack\nwho\npresent\nto\nthe\nhospit\nemerg\ndepart\n(\ned\n)\n,\nwe\nsuggest\niniti\ntreatment\nwith\neither\nsubcutan\nsumatriptan\nor\na\nparenter\nantiemet\nagent\nrather\nthan\nother\nmigraine-specif\ndrug\n(\ngrade\n2c\n)\n.\nwhen\ngive\nintraven\n(\niv\n)\nmetoclopramid\nor\nprochlorperazin\nfor\nmigrain\n,\nwe\nsuggest\nadjunct\nuse\nof\ndiphenhydramin\nto\nprevent\nakathisia\nand\nother\ndyston\nreaction\n(\ngrade\n2c\n)\n.\n(\nsee\n'emerg\nset\n'\nabov\nand\n'triptan\n'\nabov\nand\n'antiemet\n'\nabov\n.\n)\nin\naddit\n,\nwe\nrecommend\nadjunct\ntreatment\nwith\niv\nor\nintramuscular\ndexamethason\nto\nreduc\nthe\nrisk\nof\nearli\nheadach\nrecurr\n(\ngrade\n1b\n)\n.\n(\nsee\n'abort\ntherapi\nplu\nparenter\ndexamethason\n'\nabov\n.\n)\nfor\npatient\nin\nthe\ned\nunrespons\nor\nunabl\nto\ntoler\ntriptan\nor\nantiemet\n,\niv\ndihydroergotamin\n(\ndhe\n45\n)\n1\nmg\ncombin\nwith\niv\nmetoclopramid\n10\nmg\nis\na\nreason\naltern\n.\ndihydroergotamin\nis\ncontraind\nin\npatient\nwith\nischem\nvascular\ndiseas\n.\n(\nsee\n'dihydroergotamin\n'\nabov\n.\n)\n●statu\nmigrainosu\n–\nfor\npatient\nwith\nstatu\nmigrainosu\n(\nie\n,\na\ndebilit\nattack\nlast\nfor\nmore\nthan\n72\nhour\n)\n,\nwe\nsuggest\na\ncombin\nof\nintraven\nfluid\nplu\nparenter\nmedic\n,\ninclud\nketorolac\nand\na\ndopamin\nreceptor\nblocker\n(\neg\n,\nprochlorperazin\n,\nmetoclopramid\n,\nchlorpromazin\n)\n(\ngrade\n2c\n)\n.\nother\noption\ninclud\nvalproat\nand/or\ndihydroergotamin\n;\nsome\npatient\nmay\nrequir\nadmiss\nfor\npersist\ndisabl\nsymptom\n.\n(\nsee\n'statu\nmigrainosu\n'\nabov\n.\n)\n●prophylact\ntreatment\n–\nprophylact\nheadach\ntreatment\nis\nindic\nif\nthe\nheadach\nare\nfrequent\n,\nlong\nlast\n,\nor\naccount\nfor\na\nsignific\namount\nof\ntotal\ndisabl\n.\nthi\ntopic\nis\ndiscuss\nsepar\n.\n(\nsee\n``\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n.\n)\nacknowledg\n—\nthe\neditori\nstaff\nat\nuptod\nacknowledg\nashraf\nsabahat\n,\nmd\n,\nzahid\nh\nbajwa\n,\nmd\n,\nand\njonathan\nh\nsmith\n,\nmd\n,\nwho\ncontribut\nto\nearlier\nversion\nof\nthi\ntopic\nreview\n.\nprint\noverviewa\nmigrain\nis\na\nheadach\nthat\ncan\ncaus\nsever\nthrob\npain\nor\na\npuls\nsensat\n,\nusual\non\none\nside\nof\nthe\nhead\n.\nit\n's\noften\naccompani\nby\nnausea\n,\nvomit\n,\nand\nextrem\nsensit\nto\nlight\nand\nsound\n.\nmigrain\nattack\ncan\nlast\nfor\nhour\nto\nday\n,\nand\nthe\npain\ncan\nbe\nso\nsever\nthat\nit\ninterfer\nwith\nyour\ndaili\nactiv\n.\nfor\nsome\npeopl\n,\na\nwarn\nsymptom\nknown\nas\nan\naura\noccur\nbefor\nor\nwith\nthe\nheadach\n.\nan\naura\ncan\ninclud\nvisual\ndisturb\n,\nsuch\nas\nflash\nof\nlight\nor\nblind\nspot\n,\nor\nother\ndisturb\n,\nsuch\nas\ntingl\non\none\nside\nof\nthe\nface\nor\nin\nan\narm\nor\nleg\nand\ndifficulti\nspeak\n.\nmedic\ncan\nhelp\nprevent\nsome\nmigrain\nand\nmake\nthem\nless\npain\n.\nthe\nright\nmedicin\n,\ncombin\nwith\nself-help\nremedi\nand\nlifestyl\nchang\n,\nmight\nhelp.product\n&\nservicesbook\n:\nmayo\nclinic\nfamili\nhealth\nbook\n,\n5th\neditionbook\n:\nmayo\nclinic\nguid\nto\npain\nreliefnewslett\n:\nmayo\nclinic\nhealth\nletter\n—\ndigit\neditionshow\nmore\nproduct\nfrom\nmayo\nclinic\nsymptomsmigrain\n,\nwhich\naffect\nchildren\nand\nteenag\nas\nwell\nas\nadult\n,\ncan\nprogress\nthrough\nfour\nstage\n:\nprodrom\n,\naura\n,\nattack\nand\npost-drom\n.\nnot\neveryon\nwho\nha\nmigrain\ngoe\nthrough\nall\nstage\n.\nprodromeon\nor\ntwo\nday\nbefor\na\nmigrain\n,\nyou\nmight\nnotic\nsubtl\nchang\nthat\nwarn\nof\nan\nupcom\nmigrain\n,\ninclud\n:\nconstip\nmood\nchang\n,\nfrom\ndepress\nto\neuphoria\nfood\ncrave\nneck\nstiff\nincreas\nurin\nfluid\nretent\nfrequent\nyawn\naurafor\nsome\npeopl\n,\nan\naura\nmight\noccur\nbefor\nor\ndure\nmigrain\n.\naura\nare\nrevers\nsymptom\nof\nthe\nnervou\nsystem\n.\nthey\n're\nusual\nvisual\nbut\ncan\nalso\ninclud\nother\ndisturb\n.\neach\nsymptom\nusual\nbegin\ngradual\n,\nbuild\nup\nover\nsever\nminut\nand\ncan\nlast\nup\nto\n60\nminut\n.\nexampl\nof\nmigrain\naura\ninclud\n:\nvisual\nphenomena\n,\nsuch\nas\nsee\nvariou\nshape\n,\nbright\nspot\nor\nflash\nof\nlight\nvision\nloss\npin\nand\nneedl\nsensat\nin\nan\narm\nor\nleg\nweak\nor\nnumb\nin\nthe\nface\nor\none\nside\nof\nthe\nbodi\ndifficulti\nspeak\nattacka\nmigrain\nusual\nlast\nfrom\n4\nto\n72\nhour\nif\nuntreat\n.\nhow\noften\nmigrain\noccur\nvari\nfrom\nperson\nto\nperson\n.\nmigrain\nmight\noccur\nrare\nor\nstrike\nsever\ntime\na\nmonth\n.\ndure\na\nmigrain\n,\nyou\nmight\nhave\n:\npain\nusual\non\none\nside\nof\nyour\nhead\n,\nbut\noften\non\nboth\nside\npain\nthat\nthrob\nor\npuls\nsensit\nto\nlight\n,\nsound\n,\nand\nsometim\nsmell\nand\ntouch\nnausea\nand\nvomit\npost-dromeaft\na\nmigrain\nattack\n,\nyou\nmight\nfeel\ndrain\n,\nconfus\nand\nwash\nout\nfor\nup\nto\na\nday\n.\nsome\npeopl\nreport\nfeel\nelat\n.\nsudden\nhead\nmovement\nmight\nbring\non\nthe\npain\nagain\nbriefli\n.\nwhen\nto\nsee\na\ndoctormigrain\nare\noften\nundiagnos\nand\nuntreat\n.\nif\nyou\nregularli\nhave\nsign\nand\nsymptom\nof\nmigrain\n,\nkeep\na\nrecord\nof\nyour\nattack\nand\nhow\nyou\ntreat\nthem\n.\nthen\nmake\nan\nappoint\nwith\nyour\ndoctor\nto\ndiscuss\nyour\nheadach\n.\neven\nif\nyou\nhave\na\nhistori\nof\nheadach\n,\nsee\nyour\ndoctor\nif\nthe\npattern\nchang\nor\nyour\nheadach\nsuddenli\nfeel\ndiffer\n.\nsee\nyour\ndoctor\nimmedi\nor\ngo\nto\nthe\nemerg\nroom\nif\nyou\nhave\nani\nof\nthe\nfollow\nsign\nand\nsymptom\n,\nwhich\ncould\nindic\na\nmore\nseriou\nmedic\nproblem\n:\nan\nabrupt\n,\nsever\nheadach\nlike\na\nthunderclap\nheadach\nwith\nfever\n,\nstiff\nneck\n,\nconfus\n,\nseizur\n,\ndoubl\nvision\n,\nnumb\nor\nweak\nin\nani\npart\nof\nthe\nbodi\n,\nwhich\ncould\nbe\na\nsign\nof\na\nstroke\nheadach\nafter\na\nhead\ninjuri\na\nchronic\nheadach\nthat\nis\nwors\nafter\ncough\n,\nexert\n,\nstrain\nor\na\nsudden\nmovement\nnew\nheadach\npain\nafter\nage\n50\nmore\ninformationmigrain\ncare\nat\nmayo\nclinicmigrain\nand\ngastrointestin\nproblem\n:\nis\nthere\na\nlink\n?\nrequest\nan\nappoint\nat\nmayo\nclinic\ncausesthough\nmigrain\ncaus\nare\nn't\nfulli\nunderstood\n,\ngenet\nand\nenvironment\nfactor\nappear\nto\nplay\na\nrole\n.\nchang\nin\nthe\nbrainstem\nand\nit\ninteract\nwith\nthe\ntrigemin\nnerv\n,\na\nmajor\npain\npathway\n,\nmight\nbe\ninvolv\n.\nso\nmight\nimbal\nin\nbrain\nchemic\n—\ninclud\nserotonin\n,\nwhich\nhelp\nregul\npain\nin\nyour\nnervou\nsystem\n.\nresearch\nare\nstudi\nthe\nrole\nof\nserotonin\nin\nmigrain\n.\nother\nneurotransmitt\nplay\na\nrole\nin\nthe\npain\nof\nmigrain\n,\ninclud\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\n.\nmigrain\ntriggersther\nare\na\nnumber\nof\nmigrain\ntrigger\n,\ninclud\n:\nhormon\nchang\nin\nwomen\n.\nfluctuat\nin\nestrogen\n,\nsuch\nas\nbefor\nor\ndure\nmenstrual\nperiod\n,\npregnanc\nand\nmenopaus\n,\nseem\nto\ntrigger\nheadach\nin\nmani\nwomen\n.\nhormon\nmedic\n,\nsuch\nas\noral\ncontracept\n,\nalso\ncan\nworsen\nmigrain\n.\nsome\nwomen\n,\nhowev\n,\nfind\nthat\ntheir\nmigrain\noccur\nless\noften\nwhen\ntake\nthese\nmedic\n.\ndrink\n.\nthese\ninclud\nalcohol\n,\nespeci\nwine\n,\nand\ntoo\nmuch\ncaffein\n,\nsuch\nas\ncoffe\n.\nstress\n.\nstress\nat\nwork\nor\nhome\ncan\ncaus\nmigrain\n.\nsensori\nstimuli\n.\nbright\nor\nflash\nlight\ncan\ninduc\nmigrain\n,\nas\ncan\nloud\nsound\n.\nstrong\nsmell\n—\nsuch\nas\nperfum\n,\npaint\nthinner\n,\nsecondhand\nsmoke\nand\nother\n—\ntrigger\nmigrain\nin\nsome\npeopl\n.\nsleep\nchang\n.\nmiss\nsleep\nor\nget\ntoo\nmuch\nsleep\ncan\ntrigger\nmigrain\nin\nsome\npeopl\n.\nphysic\nfactor\n.\nintens\nphysic\nexert\n,\ninclud\nsexual\nactiv\n,\nmight\nprovok\nmigrain\n.\nweather\nchang\n.\na\nchang\nof\nweather\nor\nbarometr\npressur\ncan\nprompt\na\nmigrain\n.\nmedic\n.\noral\ncontracept\nand\nvasodil\n,\nsuch\nas\nnitroglycerin\n,\ncan\naggrav\nmigrain\n.\nfood\n.\nage\nchees\nand\nsalti\nand\nprocess\nfood\nmight\ntrigger\nmigrain\n.\nso\nmight\nskip\nmeal\n.\nfood\naddit\n.\nthese\ninclud\nthe\nsweeten\naspartam\nand\nthe\npreserv\nmonosodium\nglutam\n(\nmsg\n)\n,\nfound\nin\nmani\nfood\n.\nmore\ninformationmigrain\ncare\nat\nmayo\nclinicmigrain\n:\nare\nthey\ntrigger\nby\nweather\nchang\n?\nmayo\nclinic\nminut\nweather\nmigrain\nrisk\nfactorssever\nfactor\nmake\nyou\nmore\nprone\nto\nhave\nmigrain\n,\ninclud\n:\nfamili\nhistori\n.\nif\nyou\nhave\na\nfamili\nmember\nwith\nmigrain\n,\nthen\nyou\nhave\na\ngood\nchanc\nof\ndevelop\nthem\ntoo\n.\nage\n.\nmigrain\ncan\nbegin\nat\nani\nage\n,\nthough\nthe\nfirst\noften\noccur\ndure\nadolesc\n.\nmigrain\ntend\nto\npeak\ndure\nyour\n30\n,\nand\ngradual\nbecom\nless\nsever\nand\nless\nfrequent\nin\nthe\nfollow\ndecad\n.\nsex\n.\nwomen\nare\nthree\ntime\nmore\nlike\nthan\nmen\nto\nhave\nmigrain\n.\nhormon\nchang\n.\nfor\nwomen\nwho\nhave\nmigrain\n,\nheadach\nmight\nbegin\njust\nbefor\nor\nshortli\nafter\nonset\nof\nmenstruat\n.\nthey\nmight\nalso\nchang\ndure\npregnanc\nor\nmenopaus\n.\nmigrain\ngener\nimprov\nafter\nmenopaus\n.\ncomplicationstak\npainkil\ntoo\noften\ncan\ntrigger\nseriou\nmedication-overus\nheadach\n.\nthe\nrisk\nseem\nto\nbe\nhighest\nwith\naspirin\n,\nacetaminophen\nand\ncaffein\ncombin\n.\noverus\nheadach\nmay\nalso\noccur\nif\nyou\ntake\naspirin\nor\nibuprofen\n(\nadvil\n,\nmotrin\nib\n,\nother\n)\nfor\nmore\nthan\n14\nday\na\nmonth\nor\ntriptan\n,\nsumatriptan\n(\nimitrex\n,\ntosymra\n)\nor\nrizatriptan\n(\nmaxalt\n,\nmaxalt-mlt\n)\nfor\nmore\nthan\nnine\nday\na\nmonth\n.\nmedication-overus\nheadach\noccur\nwhen\nmedic\nstop\nreliev\npain\nand\nbegin\nto\ncaus\nheadach\n.\nyou\nthen\nuse\nmore\npain\nmedic\n,\nwhich\ncontinu\nthe\ncycl\n.\nby\nmayo\nclinic\nstaff\nmigrain\ncare\nat\nmayo\nclinic\nrequest\nan\nappoint\nat\nmayo\nclinic\ndiagnosi\n&\ntreatment\njuli\n02\n,\n2021\nprint\nshare\non\n:\nfacebooktwitt\nshow\nrefer\ncutrer\nfm\n,\net\nal\n.\npathophysiolog\n,\nclinic\nmanifest\n,\nand\ndiagnosi\nof\nmigrain\nin\nadult\n.\nhttp\n:\n//www.uptodate.com/contents/search\n.\naccess\njan.\n31\n,\n2021\n.\nmigrain\ninform\npage\n.\nnation\ninstitut\nof\nneurolog\ndisord\nand\nstroke\n.\nhttp\n:\n//www.ninds.nih.gov/disorders/all-disorders/migraine-information-pag\n.\naccess\njan.\n31\n,\n2021\n.\nheadach\n:\nhope\nthrough\nresearch\n.\nnation\ninstitut\nof\nneurolog\ndisord\nand\nstroke\n.\nhttp\n:\n//www.ninds.nih.gov/disorders/patient-caregiver-education/hope-through-research/headache-hope-through-research\n.\naccess\nfeb.\n6\n,\n2021\n.\nsmith\njh\n,\net\nal\n.\nacut\ntreatment\nof\nmigrain\nin\nadult\n.\nhttp\n:\n//www.uptodate.com/contents/search\n.\naccess\njan.\n31\n,\n2021\n.\nsimon\nrp\n,\net\nal\n.\nheadach\n&\nfacial\npain\n.\nin\n:\nclinic\nneurolog\n.\n10th\ned\n.\nmcgraw\nhill\n;\n2018.\nhttp\n:\n//accessmedicine.mhmedical.com\n.\naccess\nfeb.\n14\n,\n2021\n.\nha\nh\n,\net\nal\n.\nmigrain\nheadach\nprophylaxi\n.\namerican\nfamili\nphysician\n.\n2019\n;\n99:17\n.\nkissoon\nnr\n(\nexpert\nopinion\n)\n.\nmayo\nclinic\n.\nmarch\n16\n,\n2021\n.\nsmith\njh\n,\net\nal\n.\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n.\nhttp\n:\n//www.uptodate.com/contents/search\n.\naccess\njan.\n31\n,\n2021\n.\nkleinman\nk\n,\net\nal\n.\nneurolog\n.\nin\n:\nharriet\nlane\nhandbook\n.\n22nd\ned\n.\nelsevi\n;\n2021.\nhttp\n:\n//www.clinicalkey.com\n.\naccess\nfeb.\n7\n,\n2021\n.\ntaylor\nfr\n.\nabc\n's\nof\nheadach\ntrigger\nmanag\n.\namerican\nmigrain\nfoundat\n.\nhttp\n:\n//americanmigrainefoundation.org/resource-library/abcs-of-headache-trigger-management/\n.\naccess\nfeb.\n6\n,\n2021\n.\naskmayoexpert\n.\nmigrain\n(\nadult\n)\nadjunct\ntherapi\n(\nadult\n)\n.\nmayo\nclinic\n;\n2020\n.\nintegr\nand\ncomplementari\nmigrain\ntreatment\n.\namerican\nmigrain\nfoundat\n.\nhttp\n:\n//americanmigrainefoundation.org/resource-library/integrative-migraine-treatments/\n.\naccess\nfeb.\n14\n,\n2021\n.\nriggin\nea\n.\nallscript\nepsi\n.\nmayo\nclinic\n,\nrochest\n,\nminn.\nmarch\n1\n,\n2021\n.\nfda\napprov\nnew\ntreatment\nfor\npatient\nwith\nmigrain\n.\nu.s.\nfood\nand\ndrug\nadministr\n.\nhttp\n:\n//www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-migrain\n.\naccess\napril\n20\n,\n2021\n.\nrelat\nallevi\nmigrain\npain\ninfograph\n:\nmigrain\ntreatment\n:\nbotox\n&\nnerv\nblock\nmanag\nheadach\nmayo\nclinic\nminut\nweather\nmigrain\nmayo\nclinic\nminut\n:\nprevent\nmigrain\nwith\nmagnet\nstimul\nmigrain\nmedic\nand\nantidepress\nmigrain\ntreatment\n:\ncan\nantidepress\nhelp\n?\nmigrain\nand\ngastrointestin\nproblem\n:\nis\nthere\na\nlink\n?\nmigrain\nand\nvertigo\nmigrain\n:\nare\nthey\ntrigger\nby\nweather\nchang\n?\noccipit\nnerv\nstimul\n:\neffect\nmigrain\ntreatment\n?\nocular\nmigrain\n:\nwhen\nto\nseek\nhelp\nshow\nmore\nrelat\ncontent\nassoci\nprocedur\nacupunctur\nbiofeedback\nbotox\ninject\nchiropract\nadjust\nct\nscan\nlumbar\npunctur\n(\nspinal\ntap\n)\nmassag\ntherapi\nmri\nshow\nmore\nassoci\nprocedur\nnew\nfrom\nmayo\nclinic\n'seed\n'\nfor\nsuccess\nin\nmigrain\nmanag\nnov.\n18\n,\n2021\n,\n06:00\np.m.\ncdt\nscienc\nsaturday\n:\nopioid\nprovid\nlow\nevid\nof\npain\nrelief\nfor\nmigrain\naug.\n28\n,\n2021\n,\n07:00\na.m.\ncdt\nmayo\nclinic\nminut\n:\ncan\nweather\ntrigger\nmigrain\n?\njune\n22\n,\n2021\n,\n06:39\np.m.\ncdt\nmayo\nclinic\nq\nand\na\n:\nheadach\nand\nmenstruat\njune\n17\n,\n2021\n,\n12:04\np.m.\ncdt\nweather\nmigrain\n:\nmayo\nclinic\nradio\nhealth\nminut\nnov.\n20\n,\n2020\n,\n09:24\np.m.\ncdt\nmayo\nclinic\nminut\n:\nwhi\nsummer\nweather\ncan\ntrigger\nmigrain\naug.\n12\n,\n2020\n,\n02:00\np.m.\ncdt\nshow\nmore\nnews\nfrom\nmayo\nclinic\nproduct\n&\nservic\nbook\n:\nmayo\nclinic\nfamili\nhealth\nbook\n,\n5th\nedit\nbook\n:\nmayo\nclinic\nguid\nto\npain\nrelief\nnewslett\n:\nmayo\nclinic\nhealth\nletter\n—\ndigit\nedit\nshow\nmore\nproduct\nand\nservic\nfrom\nmayo\nclinic\nmigrainesymptom\n&\ncausesdiagnosi\n&\ntreatmentdoctor\n&\ndepartmentscar\nat\nmayo\nclinic\nadvertis\nmayo\nclinic\ndoe\nnot\nendors\ncompani\nor\nproduct\n.\nadvertis\nrevenu\nsupport\nour\nnot-for-profit\nmission\n.\nadvertis\n&\nsponsorship\npolici\nopportun\nad\nchoic\nmayo\nclinic\npress\ncheck\nout\nthese\nbest-sel\nand\nspecial\noffer\non\nbook\nand\nnewslett\nfrom\nmayo\nclinic\n.\ntri\nmayo\nclinic\nhealth\nletter\n-\nget\nfree\nbooknew\n-\nback\nand\nneck\nhealthmayo\nclinic\non\ndigest\nhealthnew\n-\nlive\nyounger\nlongersimpl\n,\neffect\nhome\nremedi\ncon-20166454\npatient\ncare\n&\nhealth\ninform\ndiseas\n&\ncondit\nmigrain\ndisord\nresult\nin\nrecurr\nmoderate-sever\nheadach\n.mw-parser-output\n.hatnot\n{\nfont-styl\n:\nital\n}\n.mw-parser-output\ndiv.hatnot\n{\npadding-left:1.6em\n;\nmargin-bottom:0.5em\n}\n.mw-parser-output\n.hatnot\ni\n{\nfont-styl\n:\nnormal\n}\n.mw-parser-output\n.hatnote+link+.hatnot\n{\nmargin-top\n:\n-0.5em\n}\nthi\narticl\nis\nabout\nthe\ndisord\n.\nfor\nother\nuse\n,\nsee\nmigrain\n(\ndisambigu\n)\n.\nmedic\ncondition.mw-parser-output\n.infobox-subbox\n{\npadding:0\n;\nborder\n:\nnone\n;\nmargin\n:\n-3px\n;\nwidth\n:\nauto\n;\nmin-width:100\n%\n;\nfont-size:100\n%\n;\nclear\n:\nnone\n;\nfloat\n:\nnone\n;\nbackground-color\n:\ntranspar\n}\n.mw-parser-output\n.infobox-3cols-child\n{\nmargin\n:\nauto\n}\nmigrainewoman\nwith\nmigrain\nheadachespecialtyneurologysymptomsheadach\n,\nnausea\n,\nsensit\nto\nlight\n,\nsensit\nto\nsound\n,\nsensit\nto\nsmell\n[\n1\n]\n[\n2\n]\nusual\nonsetaround\npuberti\n[\n1\n]\ndurationrecurr\n,\nlong\nterm\n[\n1\n]\ncausesenvironment\nand\ngenet\n[\n3\n]\nrisk\nfactorsfamili\nhistori\n,\nfemal\n[\n4\n]\n[\n5\n]\ndifferenti\ndiagnosissubarachnoid\nhemorrhag\n,\nvenou\nthrombosi\n,\nidiopath\nintracrani\nhypertens\n,\nbrain\ntumor\n,\ntension\nheadach\n,\nsinus\n,\n[\n6\n]\ncluster\nheadach\n[\n7\n]\npreventionmetoprolol\n,\nvalproat\n,\ntopiram\n[\n8\n]\n[\n9\n]\nmedicationibuprofen\n,\nparacetamol\n(\nacetaminophen\n)\n,\ntriptan\n,\nergotamin\n[\n5\n]\n[\n10\n]\nfrequency~15\n%\n[\n11\n]\na\nmigrain\n(\nuk\n:\n/ˈmiːɡreɪn/\n,\nus\n:\n/ˈmaɪ-/\n)\n[\n12\n]\n[\n13\n]\nis\na\nprimari\nheadach\ndisord\ncharacter\nby\nrecurr\nheadach\nthat\nare\nmoder\nto\nsever\n.\n[\n1\n]\ntypic\n,\nepisod\naffect\none\nside\nof\nthe\nhead\n,\nare\npulsat\nin\nnatur\n,\nand\nlast\nfrom\na\nfew\nhour\nto\nthree\nday\n.\n[\n1\n]\nassoci\nsymptom\nmay\ninclud\nnausea\n,\nvomit\n,\nand\nsensit\nto\nlight\n,\nsound\n,\nor\nsmell\n.\n[\n2\n]\nthe\npain\nis\ngener\nmade\nwors\nby\nphysic\nactiv\n,\n[\n14\n]\nalthough\nregular\nexercis\nmay\nhave\nprophylact\neffect\n.\n[\n15\n]\nup\nto\none-third\nof\npeopl\naffect\nhave\naura\n:\ntypic\na\nshort\nperiod\nof\nvisual\ndisturb\nthat\nsignal\nthat\nthe\nheadach\nwill\nsoon\noccur\n.\n[\n14\n]\noccasion\n,\naura\ncan\noccur\nwith\nlittl\nor\nno\nheadach\nfollow\n,\nbut\nnot\neveryon\nha\nthi\nsymptom\n.\n[\n16\n]\nmigrain\nis\nbeliev\nto\nbe\ndue\nto\na\nmixtur\nof\nenvironment\nand\ngenet\nfactor\n.\n[\n3\n]\nabout\ntwo-third\nof\ncase\nrun\nin\nfamili\n.\n[\n5\n]\nchang\nhormon\nlevel\nmay\nalso\nplay\na\nrole\n,\nas\nmigrain\naffect\nslightli\nmore\nboy\nthan\ngirl\nbefor\npuberti\nand\ntwo\nto\nthree\ntime\nmore\nwomen\nthan\nmen\n.\n[\n4\n]\n[\n17\n]\nthe\nrisk\nof\nmigrain\nusual\ndecreas\ndure\npregnanc\nand\nafter\nmenopaus\n.\n[\n4\n]\n[\n18\n]\nthe\nunderli\nmechan\nare\nnot\nfulli\nknown\n.\n[\n18\n]\nthey\nare\n,\nhowev\n,\nbeliev\nto\ninvolv\nthe\nnerv\nand\nblood\nvessel\nof\nthe\nbrain\n.\n[\n5\n]\niniti\nrecommend\ntreatment\nis\nwith\nsimpl\npain\nmedic\nsuch\nas\nibuprofen\nand\nparacetamol\n(\nacetaminophen\n)\nfor\nthe\nheadach\n,\nmedic\nfor\nthe\nnausea\n,\nand\nthe\navoid\nof\ntrigger\n.\n[\n10\n]\nspecif\nmedic\nsuch\nas\ntriptan\nor\nergotamin\nmay\nbe\nuse\nin\nthose\nfor\nwhom\nsimpl\npain\nmedic\nare\nnot\neffect\n.\n[\n5\n]\ncaffein\nin\ncombin\nwith\nother\nanalges\nis\nsafe\nand\neffect\nin\ntreatment\nof\nacut\nmigrain\n.\n[\n19\n]\n[\n20\n]\n[\n21\n]\na\nnumber\nof\nmedic\nare\nuse\nto\nprevent\nattack\ninclud\nmetoprolol\n,\nvalproat\n,\nand\ntopiram\n.\n[\n8\n]\n[\n9\n]\nglobal\n,\napproxim\n15\n%\nof\npeopl\nare\naffect\nby\nmigrain\n.\n[\n11\n]\nin\nthe\nglobal\nburden\nof\ndiseas\nstudi\nof\n2010\n,\nit\nwa\nrank\nas\nthe\nthird\nmost\npreval\ndisord\nin\nthe\nworld\n.\n[\n22\n]\nit\nmost\noften\nstart\nat\npuberti\nand\nis\nworst\ndure\nmiddl\nage\n.\n[\n1\n]\nas\nof\n2016\n,\nit\nis\none\nof\nthe\nmost\ncommon\ncaus\nof\ndisabl\n.\n[\n23\n]\nan\nearli\ndescript\nconsist\nwith\nmigrain\nis\ncontain\nin\nthe\neber\npapyru\n,\nwritten\naround\n1500\nbc\nin\nancient\negypt\n.\n[\n24\n]\nthe\nword\nmigrain\nis\nfrom\nthe\ngreek\nἡμικρᾱνίᾱ\n(\nhēmikrāníā\n)\n,\n'pain\nin\nhalf\nof\nthe\nhead\n'\n,\n[\n25\n]\nfrom\nἡμι-\n(\nhēmi-\n)\n,\n'half\n'\n,\nand\nκρᾱνίον\n(\nkrāníon\n)\n,\n'skull\n'\n.\n[\n26\n]\n.mw-parser-output\n.toclimit-2\n.toclevel-1\nul\n,\n.mw-parser-output\n.toclimit-3\n.toclevel-2\nul\n,\n.mw-parser-output\n.toclimit-4\n.toclevel-3\nul\n,\n.mw-parser-output\n.toclimit-5\n.toclevel-4\nul\n,\n.mw-parser-output\n.toclimit-6\n.toclevel-5\nul\n,\n.mw-parser-output\n.toclimit-7\n.toclevel-6\nul\n{\ndisplay\n:\nnone\n}\ncontent\n1\nsign\nand\nsymptom\n1.1\nprodrom\nphase\n1.2\naura\nphase\n1.3\npain\nphase\n1.3.1\nsilent\nmigrain\n1.4\npostdrom\n2\ncaus\n2.1\ngenet\n2.2\ntrigger\n2.2.1\nphysiolog\naspect\n2.2.2\ndietari\naspect\n2.2.3\nenvironment\naspect\n3\npathophysiolog\n3.1\naura\n3.2\npain\n3.3\nneuromodul\n4\ndiagnosi\n4.1\nclassif\n4.2\nabdomin\nmigrain\n4.3\ndifferenti\ndiagnosi\n5\nprevent\n5.1\nmedic\n5.2\naltern\ntherapi\n5.3\ndevic\nand\nsurgeri\n6\nmanag\n6.1\nanalges\n6.2\nantiemet\n6.3\ntriptan\n6.4\ncgrp\nreceptor\nantagonist\n6.5\nergotamin\n6.6\nmagnesium\n6.7\nother\n6.8\nchildren\n6.9\nchronic\nmigrain\n7\nprognosi\n8\nepidemiolog\n9\nhistori\n10\nsocieti\nand\ncultur\n11\nresearch\n11.1\npotenti\nprevent\nmechan\n11.2\npotenti\ngender\ndepend\n12\nsee\nalso\n13\nrefer\n13.1\nnote\n14\nfurther\nread\n15\nextern\nlink\nsign\nand\nsymptom\n[\nedit\n]\nmigrain\ntypic\npresent\nwith\nself-limit\n,\nrecurr\nsever\nheadach\nassoci\nwith\nautonom\nsymptom\n.\n[\n5\n]\n[\n27\n]\nabout\n15–30\n%\nof\npeopl\nlive\nwith\nmigrain\nexperi\nepisod\nwith\naura\n,\n[\n10\n]\n[\n28\n]\nand\nthey\nalso\nfrequent\nexperi\nepisod\nwithout\naura\n.\n[\n29\n]\nthe\nsever\nof\nthe\npain\n,\ndurat\nof\nthe\nheadach\n,\nand\nfrequenc\nof\nattack\nare\nvariabl\n.\n[\n5\n]\na\nmigrain\nlast\nlonger\nthan\n72\nhour\nis\nterm\nstatu\nmigrainosu\n.\n[\n30\n]\nthere\nare\nfour\npossibl\nphase\nto\na\nmigrain\n,\nalthough\nnot\nall\nthe\nphase\nare\nnecessarili\nexperienc\n:\n[\n14\n]\nthe\nprodrom\n,\nwhich\noccur\nhour\nor\nday\nbefor\nthe\nheadach\nthe\naura\n,\nwhich\nimmedi\npreced\nthe\nheadach\nthe\npain\nphase\n,\nalso\nknown\nas\nheadach\nphase\nthe\npostdrom\n,\nthe\neffect\nexperienc\nfollow\nthe\nend\nof\na\nmigrain\nattack\nmigrain\nis\nassoci\nwith\nmajor\ndepress\n,\nbipolar\ndisord\n,\nanxieti\ndisord\n,\nand\nobsessive–compuls\ndisord\n.\nthese\npsychiatr\ndisord\nare\napproxim\n2–5\ntime\nmore\ncommon\nin\npeopl\nwithout\naura\n,\nand\n3–10\ntime\nmore\ncommon\nin\npeopl\nwith\naura\n.\n[\n31\n]\nprodrom\nphase\n[\nedit\n]\nprodrom\nor\npremonitori\nsymptom\noccur\nin\nabout\n60\n%\nof\nthose\nwith\nmigrain\n,\n[\n2\n]\n[\n32\n]\nwith\nan\nonset\nthat\ncan\nrang\nfrom\ntwo\nhour\nto\ntwo\nday\nbefor\nthe\nstart\nof\npain\nor\nthe\naura\n.\n[\n33\n]\nthese\nsymptom\nmay\ninclud\na\nwide\nvarieti\nof\nphenomena\n,\n[\n34\n]\ninclud\nalter\nmood\n,\nirrit\n,\ndepress\nor\neuphoria\n,\nfatigu\n,\ncrave\nfor\ncertain\nfood\n(\ns\n)\n,\nstiff\nmuscl\n(\nespeci\nin\nthe\nneck\n)\n,\nconstip\nor\ndiarrhea\n,\nand\nsensit\nto\nsmell\nor\nnois\n.\n[\n32\n]\nthi\nmay\noccur\nin\nthose\nwith\neither\nmigrain\nwith\naura\nor\nmigrain\nwithout\naura\n.\n[\n35\n]\nneuroimag\nindic\nthe\nlimbic\nsystem\nand\nhypothalamu\nas\nthe\norigin\nof\nprodrom\nsymptom\nin\nmigrain\n.\n[\n36\n]\naura\nphase\n[\nedit\n]\naura\nis\na\ntransient\nfocal\nneurolog\nphenomenon\nthat\noccur\nbefor\nor\ndure\nthe\nheadach\n.\n[\n2\n]\naura\nappear\ngradual\nover\na\nnumber\nof\nminut\n(\nusual\noccur\nover\n5–60\nminut\n)\nand\ngener\nlast\nless\nthan\n60\nminut\n.\n[\n37\n]\n[\n38\n]\nsymptom\ncan\nbe\nvisual\n,\nsensori\nor\nmotor\nin\nnatur\n,\nand\nmani\npeopl\nexperi\nmore\nthan\none\n.\n[\n39\n]\nvisual\neffect\noccur\nmost\nfrequent\n:\nthey\noccur\nin\nup\nto\n99\n%\nof\ncase\nand\nin\nmore\nthan\n50\n%\nof\ncase\nare\nnot\naccompani\nby\nsensori\nor\nmotor\neffect\n.\n[\n39\n]\nvisual\ndisturb\noften\nconsist\nof\na\nscintil\nscotoma\n(\nan\narea\nof\npartial\nalter\nin\nthe\nfield\nof\nvision\nwhich\nflicker\nand\nmay\ninterfer\nwith\na\nperson\n's\nabil\nto\nread\nor\ndrive\n)\n.\n[\n2\n]\nthese\ntypic\nstart\nnear\nthe\ncenter\nof\nvision\nand\nthen\nspread\nout\nto\nthe\nside\nwith\nzigzag\nline\nwhich\nhave\nbeen\ndescrib\nas\nlook\nlike\nfortif\nor\nwall\nof\na\ncastl\n.\n[\n39\n]\nusual\nthe\nline\nare\nin\nblack\nand\nwhite\nbut\nsome\npeopl\nalso\nsee\ncolor\nline\n.\n[\n39\n]\nsome\npeopl\nlose\npart\nof\ntheir\nfield\nof\nvision\nknown\nas\nhemianopsia\nwhile\nother\nexperi\nblur\n.\n[\n39\n]\nsensori\naura\nare\nthe\nsecond\nmost\ncommon\ntype\n;\nthey\noccur\nin\n30–40\n%\nof\npeopl\nwith\naura\n.\n[\n39\n]\noften\na\nfeel\nof\npins-and-needl\nbegin\non\none\nside\nin\nthe\nhand\nand\narm\nand\nspread\nto\nthe\nnose–mouth\narea\non\nthe\nsame\nside\n.\n[\n39\n]\nnumb\nusual\noccur\nafter\nthe\ntingl\nha\npass\nwith\na\nloss\nof\nposit\nsens\n.\n[\n39\n]\nother\nsymptom\nof\nthe\naura\nphase\ncan\ninclud\nspeech\nor\nlanguag\ndisturb\n,\nworld\nspin\n,\nand\nless\ncommonli\nmotor\nproblem\n.\n[\n39\n]\nmotor\nsymptom\nindic\nthat\nthi\nis\na\nhemipleg\nmigrain\n,\nand\nweak\noften\nlast\nlonger\nthan\none\nhour\nunlik\nother\naura\n.\n[\n39\n]\nauditori\nhallucin\nor\ndelus\nhave\nalso\nbeen\ndescrib\n.\n[\n40\n]\npain\nphase\n[\nedit\n]\nclassic\nthe\nheadach\nis\nunilater\n,\nthrob\n,\nand\nmoder\nto\nsever\nin\nintens\n.\n[\n37\n]\nit\nusual\ncome\non\ngradual\n[\n37\n]\nand\nis\naggrav\nby\nphysic\nactiv\n.\n[\n14\n]\nhowev\n,\nthe\neffect\nof\nphysic\nactiv\non\nmigrain\nare\ncomplex\nand\nsome\nresearch\nhave\nconclud\nthat\n,\nwhile\nexercis\ncan\ntrigger\nmigrain\nattack\n,\nregular\nexercis\nmay\nhave\na\nprophylact\neffect\nand\ndecreas\nfrequenc\nof\nattack\n.\n[\n15\n]\nthe\nfeel\nof\npulsat\npain\nis\nnot\nin\nphase\nwith\nthe\npuls\n.\n[\n41\n]\nin\nmore\nthan\n40\n%\nof\ncase\n,\nhowev\n,\nthe\npain\nmay\nbe\nbilater\nand\nneck\npain\nis\ncommonli\nassoci\nwith\nit\n.\n[\n42\n]\nbilater\npain\nis\nparticularli\ncommon\nin\nthose\nwho\nhave\nmigrain\nwithout\naura\n.\n[\n2\n]\nless\ncommonli\npain\nmay\noccur\nprimarili\nin\nthe\nback\nor\ntop\nof\nthe\nhead\n.\n[\n2\n]\nthe\npain\nusual\nlast\n4\nto\n72\nhour\nin\nadult\n,\n[\n37\n]\nhowev\nin\nyoung\nchildren\nfrequent\nlast\nless\nthan\n1\nhour\n.\n[\n43\n]\nthe\nfrequenc\nof\nattack\nis\nvariabl\n,\nfrom\na\nfew\nin\na\nlifetim\nto\nsever\na\nweek\n,\nwith\nthe\naverag\nbe\nabout\none\na\nmonth\n.\n[\n44\n]\n[\n45\n]\nthe\npain\nis\nfrequent\naccompani\nby\nnausea\n,\nvomit\n,\nsensit\nto\nlight\n,\nsensit\nto\nsound\n,\nsensit\nto\nsmell\n,\nfatigu\nand\nirrit\n.\n[\n2\n]\nmani\nthu\nseek\na\ndark\nand\nquiet\nroom\n.\n[\n46\n]\nin\na\nbasilar\nmigrain\n,\na\nmigrain\nwith\nneurolog\nsymptom\nrelat\nto\nthe\nbrain\nstem\nor\nwith\nneurolog\nsymptom\non\nboth\nside\nof\nthe\nbodi\n,\n[\n47\n]\ncommon\neffect\ninclud\na\nsens\nof\nthe\nworld\nspin\n,\nlight-headed\n,\nand\nconfus\n.\n[\n2\n]\nnausea\noccur\nin\nalmost\n90\n%\nof\npeopl\n,\nand\nvomit\noccur\nin\nabout\none-third\n.\n[\n46\n]\nother\nsymptom\nmay\ninclud\nblur\nvision\n,\nnasal\nstuffi\n,\ndiarrhea\n,\nfrequent\nurin\n,\npallor\n,\nor\nsweat\n.\n[\n48\n]\nswell\nor\ntender\nof\nthe\nscalp\nmay\noccur\nas\ncan\nneck\nstiff\n.\n[\n48\n]\nassoci\nsymptom\nare\nless\ncommon\nin\nthe\nelderli\n.\n[\n49\n]\nsilent\nmigrain\n[\nedit\n]\nsometim\n,\naura\noccur\nwithout\na\nsubsequ\nheadach\n.\n[\n39\n]\nthi\nis\nknown\nin\nmodern\nclassif\nas\na\ntypic\naura\nwithout\nheadach\n,\nor\nacephalg\nmigrain\nin\npreviou\nclassif\n,\nor\ncommonli\nas\na\nsilent\nmigrain\n.\n[\n50\n]\n[\n51\n]\nhowev\n,\nsilent\nmigrain\ncan\nstill\nproduc\ndebilit\nsymptom\n,\nwith\nvisual\ndisturb\n,\nvision\nloss\nin\nhalf\nof\nboth\neye\n,\nalter\nin\ncolor\npercept\n,\nand\nother\nsensori\nproblem\n,\nlike\nsensit\nto\nlight\n,\nsound\n,\nand\nodor\n,\nand\naura\nsudden\noutbreak\nwithout\nheadach\ncan\nbe\nscari\n.\n[\n52\n]\nit\ncan\nlast\nfrom\n15\nto\n30\nminut\n,\nusual\nno\nlonger\nthan\n60\nminut\n,\nand\nit\ncan\nrecur\nor\nappear\nas\nan\nisol\nevent\n.\n[\n51\n]\npostdrom\n[\nedit\n]\nthe\nmigrain\npostdrom\ncould\nbe\ndefin\nas\nthat\nconstel\nof\nsymptom\noccur\nonc\nthe\nacut\nheadach\nha\nsettl\n.\n[\n53\n]\nmani\nreport\na\nsore\nfeel\nin\nthe\narea\nwhere\nthe\nmigrain\nwa\n,\nand\nsome\nreport\nimpair\nthink\nfor\na\nfew\nday\nafter\nthe\nheadach\nha\npass\n.\nthe\nperson\nmay\nfeel\ntire\nor\n``\nhung\nover\n''\nand\nhave\nhead\npain\n,\ncognit\ndifficulti\n,\ngastrointestin\nsymptom\n,\nmood\nchang\n,\nand\nweak\n.\n[\n54\n]\naccord\nto\none\nsummari\n,\n``\nsome\npeopl\nfeel\nunusu\nrefresh\nor\neuphor\nafter\nan\nattack\n,\nwherea\nother\nnote\ndepress\nand\nmalais\n.\n``\n[\n55\n]\nfor\nsome\nindividu\nthi\ncan\nvari\neach\ntime\n.\ncaus\n[\nedit\n]\nthe\nunderli\ncaus\nof\nmigrain\nare\nunknown\n.\n[\n56\n]\nhowev\n,\nthey\nare\nbeliev\nto\nbe\nrelat\nto\na\nmix\nof\nenvironment\nand\ngenet\nfactor\n.\n[\n3\n]\nthey\nrun\nin\nfamili\nin\nabout\ntwo-third\nof\ncase\n[\n5\n]\nand\nrare\noccur\ndue\nto\na\nsingl\ngene\ndefect\n.\n[\n57\n]\nwhile\nmigrain\nwere\nonc\nbeliev\nto\nbe\nmore\ncommon\nin\nthose\nof\nhigh\nintellig\n,\nthi\ndoe\nnot\nappear\nto\nbe\ntrue\n.\n[\n58\n]\na\nnumber\nof\npsycholog\ncondit\nare\nassoci\n,\ninclud\ndepress\n,\nanxieti\n,\nand\nbipolar\ndisord\n,\n[\n59\n]\nas\nare\nmani\nbiolog\nevent\nor\ntrigger\n.\ngenet\n[\nedit\n]\nmain\narticl\n:\ngenet\nof\nmigrain\nheadach\nstudi\nof\ntwin\nindic\na\n34\n%\nto\n51\n%\ngenet\ninfluenc\nof\nlikelihood\nto\ndevelop\nmigrain\n.\n[\n3\n]\nthi\ngenet\nrelationship\nis\nstronger\nfor\nmigrain\nwith\naura\nthan\nfor\nmigrain\nwithout\naura\n.\n[\n29\n]\na\nnumber\nof\nspecif\nvariant\nof\ngene\nincreas\nthe\nrisk\nby\na\nsmall\nto\nmoder\namount\n.\n[\n57\n]\nsingl\ngene\ndisord\nthat\nresult\nin\nmigrain\nare\nrare\n.\n[\n57\n]\none\nof\nthese\nis\nknown\nas\nfamili\nhemipleg\nmigrain\n,\na\ntype\nof\nmigrain\nwith\naura\n,\nwhich\nis\ninherit\nin\nan\nautosom\ndomin\nfashion\n.\n[\n60\n]\n[\n61\n]\nfour\ngene\nhave\nbeen\nshown\nto\nbe\ninvolv\nin\nfamili\nhemipleg\nmigrain\n.\n[\n62\n]\nthree\nof\nthese\ngene\nare\ninvolv\nin\nion\ntransport\n.\n[\n62\n]\nthe\nfourth\nis\nan\naxon\nprotein\nassoci\nwith\nthe\nexocytosi\ncomplex\n.\n[\n62\n]\nanoth\ngenet\ndisord\nassoci\nwith\nmigrain\nis\ncadasil\nsyndrom\nor\ncerebr\nautosom\ndomin\narteriopathi\nwith\nsubcort\ninfarct\nand\nleukoencephalopathi\n.\n[\n2\n]\none\nmeta-analysi\nfound\na\nprotect\neffect\nfrom\nan\nangiotensin\nconvert\nenzym\npolymorph\non\nmigrain\n.\n[\n63\n]\nthe\ntrpm8\ngene\n,\nwhich\ncode\nfor\na\ncation\nchannel\n,\nha\nbeen\nlink\nto\nmigrain\n.\n[\n64\n]\ntrigger\n[\nedit\n]\nmigrain\nmay\nbe\ninduc\nby\ntrigger\n,\nwith\nsome\nreport\nit\nas\nan\ninfluenc\nin\na\nminor\nof\ncase\n[\n5\n]\nand\nother\nthe\nmajor\n.\n[\n65\n]\nmani\nthing\nsuch\nas\nfatigu\n,\ncertain\nfood\n,\nand\nweather\nhave\nbeen\nlabel\nas\ntrigger\n;\nhowev\n,\nthe\nstrength\nand\nsignific\nof\nthese\nrelationship\nare\nuncertain\n.\n[\n65\n]\n[\n66\n]\nmost\npeopl\nwith\nmigrain\nreport\nexperienc\ntrigger\n.\n[\n67\n]\nsymptom\nmay\nstart\nup\nto\n24\nhour\nafter\na\ntrigger\n.\n[\n5\n]\nphysiolog\naspect\n[\nedit\n]\ncommon\ntrigger\nquot\nare\nstress\n,\nhunger\n,\nand\nfatigu\n(\nthese\nequal\ncontribut\nto\ntension\nheadach\n)\n.\n[\n65\n]\npsycholog\nstress\nha\nbeen\nreport\nas\na\nfactor\nby\n50\nto\n80\n%\nof\npeopl\n.\n[\n68\n]\nmigrain\nha\nalso\nbeen\nassoci\nwith\npost-traumat\nstress\ndisord\nand\nabus\n.\n[\n69\n]\nmigrain\nepisod\nare\nmore\nlike\nto\noccur\naround\nmenstruat\n.\n[\n68\n]\nother\nhormon\ninfluenc\n,\nsuch\nas\nmenarch\n,\noral\ncontracept\nuse\n,\npregnanc\n,\nperimenopaus\n,\nand\nmenopaus\n,\nalso\nplay\na\nrole\n.\n[\n70\n]\nthese\nhormon\ninfluenc\nseem\nto\nplay\na\ngreater\nrole\nin\nmigrain\nwithout\naura\n.\n[\n58\n]\nmigrain\nepisod\ntypic\ndo\nnot\noccur\ndure\nthe\nsecond\nand\nthird\ntrimest\nof\npregnanc\n,\nor\nfollow\nmenopaus\n.\n[\n2\n]\ndietari\naspect\n[\nedit\n]\nbetween\n12\nand\n60\n%\nof\npeopl\nreport\nfood\nas\ntrigger\n.\n[\n71\n]\n[\n72\n]\nevid\nfor\nsuch\ntrigger\n,\nhowev\n,\nmostli\nreli\non\nself-report\nand\nis\nnot\nrigor\nenough\nto\nprove\nor\ndisprov\nani\nparticular\ntrigger\n.\n[\n73\n]\na\nclear\nexplan\nfor\nwhi\nfood\nmight\ntrigger\nmigrain\nis\nalso\nlack\n.\n[\n71\n]\nthere\ndoe\nnot\nappear\nto\nbe\nevid\nfor\nan\neffect\nof\ntyramin\n–\nwhich\nis\nnatur\npresent\nin\nchocol\n,\nalcohol\nbeverag\n,\nmost\nchees\nand\nprocess\nmeat\n–\non\nmigrain\n.\n[\n74\n]\nlikewis\n,\nwhile\nmonosodium\nglutam\n(\nmsg\n)\nis\nfrequent\nreport\n,\n[\n75\n]\nevid\ndoe\nnot\nconsist\nsupport\nthat\nit\nis\na\ndietari\ntrigger\n.\n[\n76\n]\nenvironment\naspect\n[\nedit\n]\na\nreview\non\npotenti\ntrigger\nin\nthe\nindoor\nand\noutdoor\nenviron\nconclud\nthat\nthere\nis\ninsuffici\nevid\nto\nconfirm\nenvironment\nfactor\nas\ncaus\nmigrain\n.\nthey\nnevertheless\nsuggest\nthat\npeopl\nlive\nwith\nmigrain\ntake\nsome\nprevent\nmeasur\nrelat\nto\nindoor\nair\nqualiti\nand\nlight\n.\nthi\ninclud\nventil\nand\nvariou\nblack\nout\nitem\nto\nreduc\nlight\nat\nthe\nmaximum\nrate\n.\n[\n77\n]\npathophysiolog\n[\nedit\n]\nanim\nof\ncortic\nspread\ndepress\nmigrain\nis\nbeliev\nto\nbe\nprimarili\na\nneurolog\ndisord\n,\n[\n78\n]\n[\n79\n]\n[\n80\n]\nwhile\nother\nbeliev\nit\nto\nbe\na\nneurovascular\ndisord\nwith\nblood\nvessel\nplay\nthe\nkey\nrole\n,\nalthough\ncurrent\nevid\ndoe\nnot\nsupport\nthi\ncomplet\n.\n[\n81\n]\n[\n82\n]\n[\n83\n]\n[\n84\n]\nother\nbeliev\nboth\nare\nlike\nimport\n.\n[\n85\n]\n[\n86\n]\n[\n87\n]\n[\n88\n]\none\ntheori\nis\nrelat\nto\nincreas\nexcit\nof\nthe\ncerebr\ncortex\nand\nabnorm\ncontrol\nof\npain\nneuron\nin\nthe\ntrigemin\nnucleu\nof\nthe\nbrainstem\n.\n[\n89\n]\naura\n[\nedit\n]\ncortic\nspread\ndepress\n,\nor\nspread\ndepress\naccord\nto\nleão\n,\nis\na\nburst\nof\nneuron\nactiv\nfollow\nby\na\nperiod\nof\ninact\n,\nwhich\nis\nseen\nin\nthose\nwith\nmigrain\nwith\naura\n.\n[\n90\n]\nthere\nare\na\nnumber\nof\nexplan\nfor\nit\noccurr\n,\ninclud\nactiv\nof\nnmda\nreceptor\nlead\nto\ncalcium\nenter\nthe\ncell\n.\n[\n90\n]\nafter\nthe\nburst\nof\nactiv\n,\nthe\nblood\nflow\nto\nthe\ncerebr\ncortex\nin\nthe\narea\naffect\nis\ndecreas\nfor\ntwo\nto\nsix\nhour\n.\n[\n90\n]\nit\nis\nbeliev\nthat\nwhen\ndepolar\ntravel\ndown\nthe\nundersid\nof\nthe\nbrain\n,\nnerv\nthat\nsens\npain\nin\nthe\nhead\nand\nneck\nare\ntrigger\n.\n[\n90\n]\npain\n[\nedit\n]\nthe\nexact\nmechan\nof\nthe\nhead\npain\nwhich\noccur\ndure\na\nmigrain\nepisod\nis\nunknown\n.\n[\n91\n]\nsome\nevid\nsupport\na\nprimari\nrole\nfor\ncentral\nnervou\nsystem\nstructur\n(\nsuch\nas\nthe\nbrainstem\nand\ndiencephalon\n)\n,\n[\n92\n]\nwhile\nother\ndata\nsupport\nthe\nrole\nof\nperipher\nactiv\n(\nsuch\nas\nvia\nthe\nsensori\nnerv\nthat\nsurround\nblood\nvessel\nof\nthe\nhead\nand\nneck\n)\n.\n[\n91\n]\nthe\npotenti\ncandid\nvessel\ninclud\ndural\narteri\n,\npial\narteri\nand\nextracrani\narteri\nsuch\nas\nthose\nof\nthe\nscalp\n.\n[\n91\n]\nthe\nrole\nof\nvasodilat\nof\nthe\nextracrani\narteri\n,\nin\nparticular\n,\nis\nbeliev\nto\nbe\nsignific\n.\n[\n93\n]\nneuromodul\n[\nedit\n]\nadenosin\n,\na\nneuromodul\n,\nmay\nbe\ninvolv\n.\n[\n94\n]\nreleas\nafter\nthe\nprogress\ncleavag\nof\nadenosin\ntriphosph\n(\natp\n)\n,\nadenosin\nact\non\nadenosin\nreceptor\nto\nput\nthe\nbodi\nand\nbrain\nin\na\nlow\nactiv\nstate\nby\ndilat\nblood\nvessel\nand\nslow\nthe\nheart\nrate\n,\nsuch\nas\nbefor\nand\ndure\nthe\nearli\nstage\nof\nsleep\n.\nadenosin\nlevel\nhave\nbeen\nfound\nto\nbe\nhigh\ndure\nmigrain\nattack\n.\n[\n94\n]\n[\n95\n]\ncaffein\n's\nrole\nas\nan\ninhibitor\nof\nadenosin\nmay\nexplain\nit\neffect\nin\nreduc\nmigrain\n.\n[\n96\n]\nlow\nlevel\nof\nthe\nneurotransmitt\nserotonin\n,\nalso\nknown\nas\n5-hydroxytryptamin\n(\n5-ht\n)\n,\nare\nalso\nbeliev\nto\nbe\ninvolv\n.\n[\n97\n]\ncalcitonin\ngene\nrelat\npeptid\n(\ncgrp\n)\nhave\nbeen\nfound\nto\nplay\na\nrole\nin\nthe\npathogenesi\nof\nthe\npain\nassoci\nwith\nmigrain\n,\nas\nlevel\nof\nit\nbecom\nelev\ndure\nan\nattack\n.\n[\n10\n]\n[\n41\n]\ndiagnosi\n[\nedit\n]\nthe\ndiagnosi\nof\na\nmigrain\nis\nbase\non\nsign\nand\nsymptom\n.\n[\n5\n]\nneuroimag\ntest\nare\nnot\nnecessari\nto\ndiagnos\nmigrain\n,\nbut\nmay\nbe\nuse\nto\nfind\nother\ncaus\nof\nheadach\nin\nthose\nwhose\nexamin\nand\nhistori\ndo\nnot\nconfirm\na\nmigrain\ndiagnosi\n.\n[\n98\n]\nit\nis\nbeliev\nthat\na\nsubstanti\nnumber\nof\npeopl\nwith\nthe\ncondit\nremain\nundiagnos\n.\n[\n5\n]\nthe\ndiagnosi\nof\nmigrain\nwithout\naura\n,\naccord\nto\nthe\nintern\nheadach\nsocieti\n,\ncan\nbe\nmade\naccord\nto\nthe\nfollow\ncriteria\n,\nthe\n``\n5\n,\n4\n,\n3\n,\n2\n,\n1\ncriteria\n''\n:\n[\n14\n]\nfive\nor\nmore\nattacks—for\nmigrain\nwith\naura\n,\ntwo\nattack\nare\nsuffici\nfor\ndiagnosi\n.\nfour\nhour\nto\nthree\nday\nin\ndurat\ntwo\nor\nmore\nof\nthe\nfollow\n:\nunilater\n(\naffect\none\nside\nof\nthe\nhead\n)\npulsat\nmoder\nor\nsever\npain\nintens\nworsen\nby\nor\ncaus\navoid\nof\nroutin\nphysic\nactiv\none\nor\nmore\nof\nthe\nfollow\n:\nnausea\nand/or\nvomit\n;\nsensit\nto\nboth\nlight\n(\nphotophobia\n)\nand\nsound\n(\nphonophobia\n)\nif\nsomeon\nexperi\ntwo\nof\nthe\nfollow\n:\nphotophobia\n,\nnausea\n,\nor\ninabl\nto\nwork\nor\nstudi\nfor\na\nday\n,\nthe\ndiagnosi\nis\nmore\nlike\n.\n[\n99\n]\nin\nthose\nwith\nfour\nout\nof\nfive\nof\nthe\nfollow\n:\npulsat\nheadach\n,\ndurat\nof\n4–72\nhour\n,\npain\non\none\nside\nof\nthe\nhead\n,\nnausea\n,\nor\nsymptom\nthat\ninterfer\nwith\nthe\nperson\n's\nlife\n,\nthe\nprobabl\nthat\nthi\nis\na\nmigrain\nis\n92\n%\n.\n[\n10\n]\nin\nthose\nwith\nfewer\nthan\nthree\nof\nthese\nsymptom\nthe\nprobabl\nis\n17\n%\n.\n[\n10\n]\nclassif\n[\nedit\n]\nmain\narticl\n:\nichd\nclassif\nand\ndiagnosi\nof\nmigrain\nmigrain\nwa\nfirst\ncomprehens\nclassifi\nin\n1988\n.\n[\n29\n]\nthe\nintern\nheadach\nsocieti\nupdat\ntheir\nclassif\nof\nheadach\nin\n2004\n.\n[\n14\n]\na\nthird\nversion\nwa\npublish\nin\n2018\n.\n[\n100\n]\naccord\nto\nthi\nclassif\n,\nmigrain\nis\na\nprimari\nheadach\ndisord\nalong\nwith\ntension-typ\nheadach\nand\ncluster\nheadach\n,\namong\nother\n.\n[\n101\n]\nmigrain\nis\ndivid\ninto\nseven\nsubclass\n(\nsome\nof\nwhich\ninclud\nfurther\nsubdivis\n)\n:\nmigrain\nwithout\naura\n,\nor\n``\ncommon\nmigrain\n''\n,\ninvolv\nmigrain\nheadach\nthat\nare\nnot\naccompani\nby\naura\n.\nmigrain\nwith\naura\n,\nor\n``\nclassic\nmigrain\n''\n,\nusual\ninvolv\nmigrain\nheadach\naccompani\nby\naura\n.\nless\ncommonli\n,\naura\ncan\noccur\nwithout\na\nheadach\n,\nor\nwith\na\nnonmigrain\nheadach\n.\ntwo\nother\nvarieti\nare\nfamili\nhemipleg\nmigrain\nand\nsporad\nhemipleg\nmigrain\n,\nin\nwhich\na\nperson\nha\nmigrain\nwith\naura\nand\nwith\naccompani\nmotor\nweak\n.\nif\na\nclose\nrel\nha\nhad\nthe\nsame\ncondit\n,\nit\nis\ncall\n``\nfamili\n''\n,\notherwis\nit\nis\ncall\n``\nsporad\n''\n.\nanoth\nvarieti\nis\nbasilar-typ\nmigrain\n,\nwhere\na\nheadach\nand\naura\nare\naccompani\nby\ndifficulti\nspeak\n,\nworld\nspin\n,\nring\nin\near\n,\nor\na\nnumber\nof\nother\nbrainstem-rel\nsymptom\n,\nbut\nnot\nmotor\nweak\n.\nthi\ntype\nwa\niniti\nbeliev\nto\nbe\ndue\nto\nspasm\nof\nthe\nbasilar\narteri\n,\nthe\narteri\nthat\nsuppli\nthe\nbrainstem\n.\nnow\nthat\nthi\nmechan\nis\nnot\nbeliev\nto\nbe\nprimari\n,\nthe\nsymptomat\nterm\nmigrain\nwith\nbrainstem\naura\n(\nmba\n)\nis\nprefer\n.\n[\n47\n]\nchildhood\nperiod\nsyndrom\nthat\nare\ncommonli\nprecursor\nof\nmigrain\ninclud\ncyclic\nvomit\n(\noccasion\nintens\nperiod\nof\nvomit\n)\n,\nabdomin\nmigrain\n(\nabdomin\npain\n,\nusual\naccompani\nby\nnausea\n)\n,\nand\nbenign\nparoxysm\nvertigo\nof\nchildhood\n(\noccasion\nattack\nof\nvertigo\n)\n.\nretin\nmigrain\ninvolv\nmigrain\nheadach\naccompani\nby\nvisual\ndisturb\nor\neven\ntemporari\nblind\nin\none\neye\n.\ncomplic\nof\nmigrain\ndescrib\nmigrain\nheadach\nand/or\naura\nthat\nare\nunusu\nlong\nor\nunusu\nfrequent\n,\nor\nassoci\nwith\na\nseizur\nor\nbrain\nlesion\n.\nprobabl\nmigrain\ndescrib\ncondit\nthat\nhave\nsome\ncharacterist\nof\nmigrain\n,\nbut\nwhere\nthere\nis\nnot\nenough\nevid\nto\ndiagnos\nit\nas\na\nmigrain\nwith\ncertainti\n(\nin\nthe\npresenc\nof\nconcurr\nmedic\noverus\n)\n.\nchronic\nmigrain\nis\na\ncomplic\nof\nmigrain\n,\nand\nis\na\nheadach\nthat\nfulfil\ndiagnost\ncriteria\nfor\nmigrain\nheadach\nand\noccur\nfor\na\ngreater\ntime\ninterv\n.\nspecif\n,\ngreater\nor\nequal\nto\n15\ndays/month\nfor\nlonger\nthan\n3\nmonth\n.\n[\n102\n]\nabdomin\nmigrain\n[\nedit\n]\nthe\ndiagnosi\nof\nabdomin\nmigrain\nis\ncontroversi\n.\n[\n103\n]\nsome\nevid\nindic\nthat\nrecurr\nepisod\nof\nabdomin\npain\nin\nthe\nabsenc\nof\na\nheadach\nmay\nbe\na\ntype\nof\nmigrain\n[\n103\n]\n[\n104\n]\nor\nare\nat\nleast\na\nprecursor\nto\nmigrain\n.\n[\n29\n]\nthese\nepisod\nof\npain\nmay\nor\nmay\nnot\nfollow\na\nmigraine-lik\nprodrom\nand\ntypic\nlast\nminut\nto\nhour\n.\n[\n103\n]\nthey\noften\noccur\nin\nthose\nwith\neither\na\nperson\nor\nfamili\nhistori\nof\ntypic\nmigrain\n.\n[\n103\n]\nother\nsyndrom\nthat\nare\nbeliev\nto\nbe\nprecursor\ninclud\ncyclic\nvomit\nsyndrom\nand\nbenign\nparoxysm\nvertigo\nof\nchildhood\n.\n[\n29\n]\ndifferenti\ndiagnosi\n[\nedit\n]\nother\ncondit\nthat\ncan\ncaus\nsimilar\nsymptom\nto\na\nmigrain\nheadach\ninclud\ntempor\narter\n,\ncluster\nheadach\n,\nacut\nglaucoma\n,\nmening\nand\nsubarachnoid\nhemorrhag\n.\n[\n10\n]\ntempor\narter\ntypic\noccur\nin\npeopl\nover\n50\nyear\nold\nand\npresent\nwith\ntender\nover\nthe\ntempl\n,\ncluster\nheadach\npresent\nwith\none-sid\nnose\nstuffi\n,\ntear\nand\nsever\npain\naround\nthe\norbit\n,\nacut\nglaucoma\nis\nassoci\nwith\nvision\nproblem\n,\nmening\nwith\nfever\n,\nand\nsubarachnoid\nhemorrhag\nwith\na\nveri\nfast\nonset\n.\n[\n10\n]\ntension\nheadach\ntypic\noccur\non\nboth\nside\n,\nare\nnot\npound\n,\nand\nare\nless\ndisabl\n.\n[\n10\n]\nthose\nwith\nstabl\nheadach\nthat\nmeet\ncriteria\nfor\nmigrain\nshould\nnot\nreceiv\nneuroimag\nto\nlook\nfor\nother\nintracrani\ndiseas\n.\n[\n105\n]\n[\n106\n]\n[\n107\n]\nthi\nrequir\nthat\nother\nconcern\nfind\nsuch\nas\npapilledema\n(\nswell\nof\nthe\noptic\ndisc\n)\nare\nnot\npresent\n.\npeopl\nwith\nmigrain\nare\nnot\nat\nan\nincreas\nrisk\nof\nhave\nanoth\ncaus\nfor\nsever\nheadach\n.\nprevent\n[\nedit\n]\nmain\narticl\n:\nprevent\nof\nmigrain\nprevent\ntreatment\nof\nmigrain\ninclud\nmedic\n,\nnutrit\nsupplement\n,\nlifestyl\nalter\n,\nand\nsurgeri\n.\nprevent\nis\nrecommend\nin\nthose\nwho\nhave\nheadach\nmore\nthan\ntwo\nday\na\nweek\n,\ncan\nnot\ntoler\nthe\nmedic\nuse\nto\ntreat\nacut\nattack\n,\nor\nthose\nwith\nsever\nattack\nthat\nare\nnot\neasili\ncontrol\n.\n[\n10\n]\nrecommend\nlifestyl\nchang\ninclud\nstop\ntobacco\nuse\nand\nreduc\nbehavior\nthat\ninterfer\nwith\nsleep\n.\n[\n108\n]\nthe\ngoal\nis\nto\nreduc\nthe\nfrequenc\n,\npain\n,\nand\ndurat\nof\nmigrain\nepisod\n,\nand\nto\nincreas\nthe\neffect\nof\nabort\ntherapi\n.\n[\n109\n]\nanoth\nreason\nfor\nprevent\nis\nto\navoid\nmedic\noverus\nheadach\n.\nthi\nis\na\ncommon\nproblem\nand\ncan\nresult\nin\nchronic\ndaili\nheadach\n.\n[\n110\n]\n[\n111\n]\nmedic\n[\nedit\n]\nprevent\nmigrain\nmedic\nare\nconsid\neffect\nif\nthey\nreduc\nthe\nfrequenc\nor\nsever\nof\nthe\nmigrain\nattack\nby\nat\nleast\n50\n%\n.\n[\n112\n]\ndue\nto\nfew\nmedic\nbe\napprov\nspecif\nfor\nthe\nprevent\ntreatment\nof\nmigrain\nheadach\n;\nmani\nmedic\nsuch\nas\nbeta-block\n,\nanticonvuls\nagent\nsuch\nas\ntopiram\nor\nsodium\nvalproat\n,\nantidepress\nsuch\nas\namitriptylin\nand\ncalcium\nchannel\nblocker\nsuch\nas\nflunarizin\nare\nuse\noff\nlabel\nfor\nthe\nprevent\ntreatment\nof\nmigrain\nheadach\n.\n[\n38\n]\nguidelin\nare\nfairli\nconsist\nin\nrate\nthe\nanticonvuls\ntopiram\nand\ndivalproex/sodium\nvalproat\n,\nand\nthe\nbeta\nblocker\npropranolol\nand\nmetoprolol\nas\nhave\nthe\nhighest\nlevel\nof\nevid\nfor\nfirst-lin\nuse\nfor\nmigrain\nprophylaxi\nin\nadult\n.\n[\n113\n]\n[\n114\n]\npropranolol\nand\ntopiram\nhave\nthe\nbest\nevid\nin\nchildren\n;\nhowev\n,\nevid\nonli\nsupport\nshort-term\nbenefit\nas\nof\n2020\n.\n[\n108\n]\n[\n115\n]\nthe\nbeta\nblocker\ntimolol\nis\nalso\neffect\nfor\nmigrain\nprevent\nand\nin\nreduc\nmigrain\nattack\nfrequenc\nand\nsever\n.\n[\n113\n]\nwhile\nbeta\nblocker\nare\noften\nuse\nfor\nfirst-lin\ntreatment\n,\nother\nantihypertens\nalso\nhave\na\nproven\neffici\nin\nmigrain\nprevent\n,\nname\nthe\ncalcium\nchannel\nblocker\nverapamil\n[\n116\n]\nand\nthe\nangiotensin\nreceptor\nblocker\ncandesartan\n.\n[\n117\n]\n[\n118\n]\ntent\nevid\nalso\nsupport\nthe\nuse\nof\nmagnesium\nsupplement\n.\n[\n119\n]\nincreas\ndietari\nintak\nmay\nbe\nbetter\n.\n[\n120\n]\nrecommend\nregard\neffect\nvari\nfor\nthe\nanticonvuls\ngabapentin\nand\npregabalin\n.\nfrovatriptan\nis\neffect\nfor\nprevent\nof\nmenstrual\nmigrain\n.\n[\n113\n]\nthe\nantidepress\namitriptylin\nand\nvenlafaxin\nare\nprobabl\nalso\neffect\n.\n[\n121\n]\nangiotensin\ninhibit\nby\neither\nan\nangiotensin-convert\nenzym\ninhibitor\nor\nangiotensin\nii\nreceptor\nantagonist\nmay\nreduc\nattack\n.\n[\n122\n]\nmedic\nin\nthe\nanti-calcitonin\ngene-rel\npeptid\n,\ninclud\neptinezumab\n,\nerenumab\n,\nfremanezumab\n,\nand\ngalcanezumab\n,\nappear\nto\ndecreas\nthe\nfrequenc\nof\nmigrain\nby\none\nto\ntwo\nper\nmonth\n.\n[\n123\n]\nthey\nare\n,\nhowev\n,\nexpens\n:\na\nyear\nof\nerenumab\ncost\n$\n6,900\nas\nof\n2019\n.\n[\n124\n]\naltern\ntherapi\n[\nedit\n]\nacupunctur\nha\na\nsmall\neffect\nin\nreduc\nmigrain\nfrequenc\n,\ncompar\nto\nsham\nacupunctur\n,\na\npractic\nwhere\nneedl\nare\nplace\nrandomli\nor\ndo\nnot\npenetr\nthe\nskin\n.\n[\n125\n]\nphysiotherapi\n,\nmassag\nand\nrelax\n,\nand\nchiropract\nmanipul\nmight\nbe\nas\neffect\nas\npropranolol\nor\ntopiram\nin\nthe\nprevent\nof\nmigrain\nheadach\n;\nhowev\n,\nthe\nresearch\nhad\nsome\nproblem\nwith\nmethodolog\n.\n[\n126\n]\n[\n127\n]\nanoth\nreview\n,\nhowev\n,\nfound\nevid\nto\nsupport\nspinal\nmanipul\nto\nbe\npoor\nand\ninsuffici\nto\nsupport\nit\nuse\n.\n[\n128\n]\ntent\nevid\nsupport\nthe\nuse\nof\nstress\nreduct\ntechniqu\nsuch\nas\ncognit\nbehavior\ntherapi\n,\nbiofeedback\n,\nand\nrelax\ntechniqu\n.\n[\n68\n]\nregular\nphysic\nexercis\nmay\ndecreas\nthe\nfrequenc\n.\n[\n15\n]\nnumer\npsycholog\napproach\nhave\nbeen\ndevelop\nthat\nare\naim\nat\nprevent\nor\nreduc\nthe\nfrequenc\nof\nmigrain\nin\nadult\ninclud\neduc\napproach\n,\nrelax\ntechniqu\n,\nassist\nin\ndevelop\ncope\nstrategi\n,\nstrategi\nto\nchang\nthe\nway\none\nthink\nof\na\nmigrain\n,\nand\nstrategi\nto\nreduc\nthe\nsymptom\nof\na\nmigrain\n.\n[\n129\n]\nthe\nmedic\nevid\nsupport\nthe\neffect\nof\nthese\ntype\nof\npsycholog\napproach\nis\nveri\nlimit\n.\n[\n129\n]\namong\naltern\nmedicin\n,\nbutterbur\nha\nthe\nbest\nevid\nfor\nit\nuse\n.\n[\n130\n]\n[\n131\n]\nhowev\n,\nunprocess\nbutterbur\ncontain\nchemic\ncall\npyrrolizidin\nalkaloid\n(\npa\n)\nwhich\ncan\ncaus\nliver\ndamag\n,\nhowev\nthere\nare\nversion\nthat\nare\npa\nfree\n.\n[\n132\n]\nin\naddit\n,\nbutterbur\nmay\ncaus\nallerg\nreaction\nin\npeopl\nwho\nare\nsensit\nto\nplant\nsuch\nas\nragwe\n.\n[\n133\n]\nthere\nis\ntent\nevid\nthat\ncoenzym\nq10\nreduc\nmigrain\nfrequenc\n.\n[\n134\n]\nfeverfew\nha\ntradit\nbeen\nuse\nas\na\ntreatment\nfor\nfever\n,\nheadach\nand\nmigrain\n,\nwomen\n’\ns\ncondit\nsuch\nas\ndifficulti\nin\nlabour\nand\nregul\nof\nmenstruat\n,\nrelief\nof\nstomach\nach\n,\ntoothach\nand\ninsect\nbite\n.\ndure\nthe\nlast\ndecad\n,\nit\nha\nmainli\nbeen\nuse\nfor\nheadach\nand\nas\na\nprevent\ntreatment\nfor\nmigrain\n.\n[\n135\n]\nthe\nplant\npart\nuse\nfor\nmedicin\nuse\nare\nthe\ndri\nleav\nor\nthe\ndri\naerial\npart\n.\nsever\nhistor\ndata\nsupport\nfeverfew\n’\ns\ntradit\nmedicin\nuse\n.\n[\n136\n]\nin\naddit\n,\nsever\nclinic\nstudi\nhave\nbeen\nperform\nassess\nthe\nefficaci\nand\nsafeti\nof\nfeverfew\nmonotherapi\nin\nthe\nprevent\nof\nmigrain\n.\n[\n137\n]\nthe\nmajor\nof\nthe\nclinic\ntrial\nfavour\nfeverfew\nover\nplacebo\n.\nthe\ndata\nalso\nsuggest\nthat\nfeverfew\nis\nassoci\nwith\nonli\nmild\nand\ntransient\nadvers\neffect\n.\nthe\nfrequenc\nof\nmigrain\nwa\nposit\naffect\nafter\ntreatment\nwith\nfeverfew\n.\nreduct\nof\nmigrain\nsever\nwa\nalso\nreport\nafter\nintak\nof\nfeverfew\nand\nincid\nof\nnausea\nand\nvomit\ndecreas\nsignificantli\n.\nno\neffect\nof\nfeverfew\nwa\nreport\nin\none\nstudi\n.\n[\n137\n]\nthere\nis\ntent\nevid\nfor\nmelatonin\nas\nan\nadd-on\ntherapi\nfor\nprevent\nand\ntreatment\nof\nmigrain\n.\n[\n138\n]\n[\n139\n]\nthe\ndata\non\nmelatonin\nare\nmix\nand\ncertain\nstudi\nhave\nhad\nneg\nresult\n.\n[\n138\n]\nthe\nreason\nfor\nthe\nmix\nfind\nare\nunclear\nbut\nmay\nstem\nfrom\ndiffer\nin\nstudi\ndesign\nand\ndosag\n.\n[\n138\n]\nmelatonin\n's\npossibl\nmechan\nof\naction\nin\nmigrain\nare\nnot\ncomplet\nclear\n,\nbut\nmay\ninclud\nimprov\nsleep\n,\ndirect\naction\non\nmelatonin\nreceptor\nin\nthe\nbrain\n,\nand\nanti-inflammatori\nproperti\n.\n[\n138\n]\n[\n140\n]\ndevic\nand\nsurgeri\n[\nedit\n]\nmedic\ndevic\n,\nsuch\nas\nbiofeedback\nand\nneurostimul\n,\nhave\nsome\nadvantag\nin\nmigrain\nprevent\n,\nmainli\nwhen\ncommon\nanti-migrain\nmedic\nare\ncontraind\nor\nin\ncase\nof\nmedic\noverus\n.\nbiofeedback\nhelp\npeopl\nbe\nconsciou\nof\nsome\nphysiolog\nparamet\nso\nas\nto\ncontrol\nthem\nand\ntri\nto\nrelax\nand\nmay\nbe\neffici\nfor\nmigrain\ntreatment\n.\n[\n141\n]\n[\n142\n]\nneurostimul\nuse\nnoninvas\nor\nimplant\nneurostimul\nsimilar\nto\npacemak\nfor\nthe\ntreatment\nof\nintract\nchronic\nmigrain\nwith\nencourag\nresult\nfor\nsever\ncase\n.\n[\n143\n]\n[\n144\n]\na\ntranscutan\nelectr\nnerv\nstimul\nand\na\ntranscrani\nmagnet\nstimul\nare\napprov\nin\nthe\nunit\nstate\nfor\nthe\nprevent\nof\nmigrain\n.\n[\n145\n]\n[\n146\n]\nthere\nis\nalso\ntent\nevid\nfor\ntranscutan\nelectr\nnerv\nstimul\ndecreas\nthe\nfrequenc\nof\nmigrain\n.\n[\n147\n]\nmigrain\nsurgeri\n,\nwhich\ninvolv\ndecompress\nof\ncertain\nnerv\naround\nthe\nhead\nand\nneck\n,\nmay\nbe\nan\noption\nin\ncertain\npeopl\nwho\ndo\nnot\nimprov\nwith\nmedic\n.\n[\n148\n]\nmanag\n[\nedit\n]\nmain\narticl\n:\nmigrain\ntreatment\nthere\nare\nthree\nmain\naspect\nof\ntreatment\n:\ntrigger\navoid\n,\nacut\nsymptomat\ncontrol\n,\nand\nmedic\nfor\nprevent\n.\n[\n5\n]\nmedic\nare\nmore\neffect\nif\nuse\nearlier\nin\nan\nattack\n.\n[\n5\n]\nthe\nfrequent\nuse\nof\nmedic\nmay\nresult\nin\nmedic\noverus\nheadach\n,\nin\nwhich\nthe\nheadach\nbecom\nmore\nsever\nand\nmore\nfrequent\n.\n[\n14\n]\nthi\nmay\noccur\nwith\ntriptan\n,\nergotamin\n,\nand\nanalges\n,\nespeci\nopioid\nanalges\n.\n[\n14\n]\ndue\nto\nthese\nconcern\nsimpl\nanalges\nare\nrecommend\nto\nbe\nuse\nless\nthan\nthree\nday\nper\nweek\nat\nmost\n.\n[\n149\n]\nanalges\n[\nedit\n]\nrecommend\niniti\ntreatment\nfor\nthose\nwith\nmild\nto\nmoder\nsymptom\nare\nsimpl\nanalges\nsuch\nas\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\nor\nthe\ncombin\nof\nparacetamol\n(\nalso\nknown\nas\nacetaminophen\n)\n,\naspirin\n,\nand\ncaffein\n.\n[\n10\n]\nsever\nnsaid\n,\ninclud\ndiclofenac\nand\nibuprofen\nhave\nevid\nto\nsupport\ntheir\nuse\n.\n[\n150\n]\n[\n151\n]\naspirin\ncan\nreliev\nmoder\nto\nsever\nmigrain\npain\n,\nwith\nan\neffect\nsimilar\nto\nsumatriptan\n.\n[\n152\n]\nketorolac\nis\navail\nin\nintraven\nand\nintramuscular\nformul\n.\n[\n10\n]\nparacetamol\n,\neither\nalon\nor\nin\ncombin\nwith\nmetoclopramid\n,\nis\nanoth\neffect\ntreatment\nwith\na\nlow\nrisk\nof\nadvers\neffect\n.\n[\n153\n]\nintraven\nmetoclopramid\nis\nalso\neffect\nby\nitself\n.\n[\n154\n]\n[\n155\n]\nin\npregnanc\n,\nparacetamol\nand\nmetoclopramid\nare\ndeem\nsafe\nas\nare\nnsaid\nuntil\nthe\nthird\ntrimest\n.\n[\n10\n]\nnaproxen\nby\nitself\nmay\nnot\nbe\neffect\nas\na\nstand-alon\nmedicin\nto\nstop\na\nmigrain\nheadach\nas\nit\nis\nonli\nweakli\nbetter\nthan\na\nplacebo\nmedic\nin\nclinic\ntrial\n.\n[\n156\n]\nantiemet\n[\nedit\n]\ntriptan\n[\nedit\n]\ntriptan\nsuch\nas\nsumatriptan\nare\nmedic\nuse\nto\nstop\nan\nactiv\nmigrain\nheadach\n(\nan\nabort\nmedic\n)\n.\ntriptan\nare\nthe\niniti\nrecommend\ntreatment\nfor\nthose\nwith\nmoder\nto\nsever\npain\nfrom\nan\nacut\nmigrain\nheadach\nor\nthose\nwith\nmilder\nsymptom\nwho\ndo\nnot\nrespond\nto\nsimpl\nanalges\n.\n[\n10\n]\ntriptan\nhave\nbeen\nshown\nto\nbe\neffect\nfor\nboth\npain\nand\nnausea\nin\nup\nto\n75\n%\nof\npeopl\n.\n[\n157\n]\n[\n158\n]\nthere\nare\ndiffer\nmethod\nor\nrout\nof\nadministr\nto\ntake\nsumatriptan\ninclud\noral\n(\nby\nmouth\n)\n,\ninject\n(\nsubcutan\n)\n,\nrectal\n,\nnasal\nspray\n,\nand\noral\ndissolv\ntablet\n.\n[\n5\n]\n[\n159\n]\n[\n160\n]\n[\n161\n]\nfor\npeopl\nwith\nmigrain\nsymptom\nsuch\nas\nnausea\nor\nvomit\n,\ntake\nthe\nabort\nmedicin\nby\nmouth\nor\nthrough\nthe\nnose\nmay\nbe\ndifficult\n.\nall\nrout\nof\nadministr\nhave\nbeen\nshown\nto\nbe\neffect\nat\nreduc\nmigrain\nsymptom\n,\nhowev\n,\nnasal\nand\ninject\nsubcutan\nadministr\nmay\nresult\nin\nmore\nside\neffect\n.\n[\n161\n]\n[\n160\n]\nthe\nadvers\neffect\nassoci\nwith\nrectal\nadministr\nhave\nnot\nbeen\nwell\nstudi\n.\n[\n159\n]\nsome\npeopl\nmay\nfind\nthat\nthey\nrespond\nto\none\ntype\nof\nsumatripton\nbetter\nthan\nanoth\n.\n[\n10\n]\nmost\nside\neffect\nare\nmild\n,\ninclud\nflush\n;\nhowev\n,\nrare\ncase\nof\nmyocardi\nischemia\nhave\noccur\n.\n[\n5\n]\nthey\nare\nthu\nnot\nrecommend\nfor\npeopl\nwith\ncardiovascular\ndiseas\n,\n[\n10\n]\nwho\nhave\nhad\na\nstroke\n,\nor\nhave\nmigrain\nthat\nare\naccompani\nby\nneurolog\nproblem\n.\n[\n162\n]\nin\naddit\n,\ntriptan\nshould\nbe\nprescrib\nwith\ncaution\nfor\nthose\nwith\nrisk\nfactor\nfor\nvascular\ndiseas\n.\n[\n162\n]\nwhile\nhistor\nnot\nrecommend\nin\nthose\nwith\nbasilar\nmigrain\nthere\nis\nno\nspecif\nevid\nof\nharm\nfrom\ntheir\nuse\nin\nthi\npopul\nto\nsupport\nthi\ncaution\n.\n[\n47\n]\ntriptan\nare\nnot\naddict\n,\nbut\nmay\ncaus\nmedication-overus\nheadach\nif\nuse\nmore\nthan\n10\nday\nper\nmonth\n.\n[\n163\n]\nsumatriptan\ndoe\nnot\nprevent\nother\nmigrain\nheadach\nfrom\nstart\nin\nthe\nfutur\n.\n[\n160\n]\nfor\nincreas\neffect\nat\nstop\nmigrain\nsymptom\n,\na\ncombin\ntherapi\nthat\ninclud\nsumatriptan\nand\nnaproxen\nmay\nbe\nsuggest\n.\n[\n164\n]\ncgrp\nreceptor\nantagonist\n[\nedit\n]\ncgrp\nreceptor\nantagonist\ntarget\ncalcitonin\ngene-rel\npeptid\nor\nit\nreceptor\nto\nprevent\nmigrain\nheadach\nor\nreduc\ntheir\nsever\n.\n[\n38\n]\ncgrp\nis\na\nsignal\nmolecul\nas\nwell\nas\na\npotent\nvasodil\nthat\nis\ninvolv\nin\nthe\ndevelop\nof\na\nmigrain\nheadach\n.\n[\n38\n]\nthere\nare\nfour\ninject\nmonoclon\nantibodi\nthat\ntarget\ncgrp\nor\nit\n's\nreceptor\n(\neptinezumab\n,\nerenumab\n,\nfremanezumab\nand\ngalcanezumab\n)\nand\nthe\nmedic\nhave\ndemonstr\nefficaci\nin\nthe\nprevent\ntreatment\nof\nepisod\nand\nchronic\nmigrain\nheadach\nin\nphase\n3\nrandom\nclinic\ntrial\n.\n[\n38\n]\neptinezumab\nis\navail\nas\nan\ninfus\neveri\nthree\nmonth\n,\nerenumab\nand\ngalcanezumab\nare\nonc\nmonthli\ninject\nand\nfremanezumab\nis\na\nmonthli\nor\nquarterli\ninject\n.\nergotamin\n[\nedit\n]\nergotamin\nand\ndihydroergotamin\nare\nolder\nmedic\nstill\nprescrib\nfor\nmigrain\n,\nthe\nlatter\nin\nnasal\nspray\nand\ninject\nform\n.\n[\n5\n]\n[\n165\n]\nthey\nappear\nequal\neffect\nto\nthe\ntriptan\n[\n166\n]\nand\nexperi\nadvers\neffect\nthat\ntypic\nare\nbenign\n.\n[\n167\n]\nin\nthe\nmost\nsever\ncase\n,\nsuch\nas\nthose\nwith\nstatu\nmigrainosu\n,\nthey\nappear\nto\nbe\nthe\nmost\neffect\ntreatment\noption\n.\n[\n167\n]\nthey\ncan\ncaus\nvasospasm\ninclud\ncoronari\nvasospasm\nand\nare\ncontraind\nin\npeopl\nwith\ncoronari\narteri\ndiseas\n.\n[\n168\n]\nmagnesium\n[\nedit\n]\nmagnesium\nis\nrecogn\nas\nan\ninexpens\n,\nover-the-count\nsupplement\nwhich\nsome\nstudi\nhave\nshown\nto\nbe\neffect\nin\nboth\nprevent\nand\ntreat\nmigrain\nin\nintraven\nform\n.\n[\n169\n]\nother\n[\nedit\n]\nintraven\nmetoclopramid\n,\nintraven\nprochlorperazin\n,\nor\nintranas\nlidocain\nare\nother\npotenti\noption\n.\n[\n10\n]\n[\n155\n]\nmetoclopramid\nor\nprochlorperazin\nare\nthe\nrecommend\ntreatment\nfor\nthose\nwho\npresent\nto\nthe\nemerg\ndepart\n.\n[\n10\n]\n[\n155\n]\nhaloperidol\nmay\nalso\nbe\nuse\nin\nthi\ngroup\n.\n[\n155\n]\n[\n165\n]\na\nsingl\ndose\nof\nintraven\ndexamethason\n,\nwhen\nad\nto\nstandard\ntreatment\nof\na\nmigrain\nattack\n,\nis\nassoci\nwith\na\n26\n%\ndecreas\nin\nheadach\nrecurr\nin\nthe\nfollow\n72\nhour\n.\n[\n170\n]\nspinal\nmanipul\nfor\ntreat\nan\nongo\nmigrain\nheadach\nis\nnot\nsupport\nby\nevid\n.\n[\n128\n]\nit\nis\nrecommend\nthat\nopioid\nand\nbarbitur\nnot\nbe\nuse\ndue\nto\nquestion\nefficaci\n,\naddict\npotenti\n,\nand\nthe\nrisk\nof\nrebound\nheadach\n.\n[\n10\n]\n[\n38\n]\nthere\nis\ntent\nevid\nthat\npropofol\nmay\nbe\nuse\nif\nother\nmeasur\nare\nnot\neffect\n.\n[\n171\n]\noccipit\nnerv\nstimul\n,\nmay\nbe\neffect\nbut\nha\nthe\ndownsid\nof\nbe\ncost-expens\nand\nha\na\nsignific\namount\nof\ncomplic\n.\n[\n172\n]\nthere\nis\nmodest\nevid\nfor\nthe\neffect\nof\nnon-invas\nneuromodulatori\ndevic\n,\nbehavior\ntherapi\nand\nacupunctur\nin\nthe\ntreatment\nof\nmigrain\nheadach\n.\n[\n38\n]\nthere\nis\nlittl\nto\nno\nevid\nfor\nthe\neffect\nof\nphysic\ntherapi\n,\nchiropract\nmanipul\nand\ndietari\napproach\nto\nthe\ntreatment\nof\nmigrain\nheadach\n.\n[\n38\n]\nbehavior\ntreatment\nof\nmigrain\nheadach\nmay\nbe\nhelp\nfor\nthose\nwho\nmay\nnot\nbe\nabl\nto\ntake\nmedic\n(\nfor\nexampl\npregnant\nwomen\n)\n.\n[\n38\n]\nfeverfew\nis\nregist\nas\na\ntradit\nherbal\nmedicin\nin\nthe\nnordic\ncountri\nunder\nthe\nbrand\nname\nglitinum\n,\nonli\npowder\nfeverfew\nis\napprov\nin\nthe\nherbal\ncommun\nmonograph\nissu\nby\neuropean\nmedicin\nagenc\n(\nema\n)\n.\nsexual\nactiv\n,\nparticularli\norgasm\n,\nmay\nprovid\nrelief\nfor\nsome\nmigraineur\n.\n[\n173\n]\nchildren\n[\nedit\n]\nibuprofen\nhelp\ndecreas\npain\nin\nchildren\nwith\nmigrain\nand\nis\nthe\niniti\nrecommend\ntreatment\n.\n[\n174\n]\n[\n175\n]\nparacetamol\ndoe\nnot\nappear\nto\nbe\neffect\nin\nprovid\npain\nrelief\n.\n[\n174\n]\ntriptan\nare\neffect\n,\nthough\nthere\nis\na\nrisk\nof\ncaus\nminor\nside\neffect\nlike\ntast\ndisturb\n,\nnasal\nsymptom\n,\ndizzi\n,\nfatigu\n,\nlow\nenergi\n,\nnausea\n,\nor\nvomit\n.\n[\n174\n]\n[\n176\n]\nibuprofen\nshould\nbe\nuse\nless\nthan\nhalf\nthe\nday\nin\na\nmonth\nand\ntriptan\nless\nthan\na\nthird\nof\nthe\nday\nin\na\nmonth\nto\ndecreas\nthe\nrisk\nof\nmedic\noverus\nheadach\n.\n[\n175\n]\nchronic\nmigrain\n[\nedit\n]\ntopiram\nand\nbotulinum\ntoxin\n(\nbotox\n)\nhave\nevid\nin\ntreat\nchronic\nmigrain\n.\n[\n121\n]\n[\n177\n]\nbotulinum\ntoxin\nha\nbeen\nfound\nto\nbe\nuse\nin\nthose\nwith\nchronic\nmigrain\nbut\nnot\nthose\nwith\nepisod\none\n.\n[\n178\n]\n[\n179\n]\nthe\nanti-cgrp\nmonoclon\nantibodi\nerenumab\nwa\nfound\nin\none\nstudi\nto\ndecreas\nchronic\nmigrain\nby\n2.4\nday\nmore\nthan\nplacebo\n.\n[\n180\n]\nprognosi\n[\nedit\n]\n''\nmigrain\nexist\non\na\ncontinuum\nof\ndiffer\nattack\nfrequenc\nand\nassoci\nlevel\nof\ndisabl\n.\n``\n[\n181\n]\nfor\nthose\nwith\noccasion\n,\nepisod\nmigrain\n,\na\n``\nproper\ncombin\nof\ndrug\nfor\nprevent\nand\ntreatment\nof\nmigrain\nattack\n''\ncan\nlimit\nthe\ndiseas\n's\nimpact\non\npatient\n'\nperson\nand\nprofession\nlive\n.\n[\n182\n]\nbut\nfewer\nthan\nhalf\nof\npeopl\nwith\nmigrain\nseek\nmedic\ncare\nand\nmore\nthan\nhalf\ngo\nundiagnos\nand\nundertr\n.\n[\n183\n]\n``\nrespons\nprevent\nand\ntreatment\nof\nmigrain\nis\nincred\nimport\n''\nbecaus\nevid\nshow\n``\nan\nincreas\nsensit\nafter\neach\nsuccess\nattack\n,\neventu\nlead\nto\nchronic\ndaili\nmigrain\nin\nsome\nindividu\n.\n``\n[\n182\n]\nrepeat\nmigrain\nresult\nin\n``\nreorgan\nof\nbrain\ncircuitri\n,\n''\ncaus\n``\nprofound\nfunction\nas\nwell\nas\nstructur\nchang\nin\nthe\nbrain\n.\n``\n[\n184\n]\n``\none\nof\nthe\nmost\nimport\nproblem\nin\nclinic\nmigrain\nis\nthe\nprogress\nfrom\nan\nintermitt\n,\nself-limit\ninconveni\nto\na\nlife-chang\ndisord\nof\nchronic\npain\n,\nsensori\namplif\n,\nand\nautonom\nand\naffect\ndisrupt\n.\nthi\nprogress\n,\nsometim\nterm\nchronif\nin\nthe\nmigrain\nliteratur\n,\nis\ncommon\n,\naffect\n3\n%\nof\nmigraineur\nin\na\ngiven\nyear\n,\nsuch\nthat\n8\n%\nof\nmigraineur\nhave\nchronic\nmigrain\nin\nani\ngiven\nyear\n.\n''\nbrain\nimageri\nreveal\nthat\nthe\nelectrophysiolog\nchang\nseen\ndure\nan\nattack\nbecom\nperman\nin\npeopl\nwith\nchronic\nmigrain\n;\n``\nthu\n,\nfrom\nan\nelectrophysiolog\npoint\nof\nview\n,\nchronic\nmigrain\ninde\nresembl\na\nnever-end\nmigrain\nattack\n.\n``\n[\n184\n]\nsever\nmigrain\nrank\nin\nthe\nhighest\ncategori\nof\ndisabl\n,\naccord\nto\nthe\nworld\nhealth\norgan\n,\nwhich\nuse\nobject\nmetric\nto\ndetermin\ndisabl\nburden\nfor\nthe\nauthorit\nannual\nglobal\nburden\nof\ndiseas\nreport\n.\nthe\nreport\nclassifi\nsever\nmigrain\nalongsid\nsever\ndepress\n,\nactiv\npsychosi\n,\nquadriplegia\n,\nand\nterminal-stag\ncancer\n.\n[\n185\n]\nmigrain\nwith\naura\nappear\nto\nbe\na\nrisk\nfactor\nfor\nischem\nstroke\n[\n186\n]\ndoubl\nthe\nrisk\n.\n[\n187\n]\nbe\na\nyoung\nadult\n,\nbe\nfemal\n,\nuse\nhormon\nbirth\ncontrol\n,\nand\nsmoke\nfurther\nincreas\nthi\nrisk\n.\n[\n186\n]\nthere\nalso\nappear\nto\nbe\nan\nassoci\nwith\ncervic\narteri\ndissect\n.\n[\n188\n]\nmigrain\nwithout\naura\ndoe\nnot\nappear\nto\nbe\na\nfactor\n.\n[\n189\n]\nthe\nrelationship\nwith\nheart\nproblem\nis\ninconclus\nwith\na\nsingl\nstudi\nsupport\nan\nassoci\n.\n[\n186\n]\nmigrain\ndoe\nnot\nappear\nto\nincreas\nthe\nrisk\nof\ndeath\nfrom\nstroke\nor\nheart\ndiseas\n.\n[\n190\n]\nprevent\ntherapi\nof\nmigrain\nin\nthose\nwith\nmigrain\nwith\naura\nmay\nprevent\nassoci\nstroke\n.\n[\n191\n]\npeopl\nwith\nmigrain\n,\nparticularli\nwomen\n,\nmay\ndevelop\nhigher\nthan\naverag\nnumber\nof\nwhite\nmatter\nbrain\nlesion\nof\nunclear\nsignific\n.\n[\n192\n]\nepidemiolog\n[\nedit\n]\ndisability-adjust\nlife\nyear\nfor\nmigrain\nper\n100,000\ninhabit\nin\n2004\n.mw-parser-output\n.refbegin\n{\nfont-size:90\n%\n;\nmargin-bottom:0.5em\n}\n.mw-parser-output\n.refbegin-hanging-ind\n>\nul\n{\nmargin-left:0\n}\n.mw-parser-output\n.refbegin-hanging-ind\n>\nul\n>\nli\n{\nmargin-left:0\n;\npadding-left:3.2em\n;\ntext-ind\n:\n-3.2em\n}\n.mw-parser-output\n.refbegin-hanging-ind\nul\n,\n.mw-parser-output\n.refbegin-hanging-ind\nul\nli\n{\nlist-styl\n:\nnone\n}\n@\nmedia\n(\nmax-width:720px\n)\n{\n.mw-parser-output\n.refbegin-hanging-ind\n>\nul\n>\nli\n{\npadding-left:1.6em\n;\ntext-ind\n:\n-1.6em\n}\n}\n.mw-parser-output\n.refbegin-column\n{\nmargin-top:0.3em\n}\n.mw-parser-output\n.refbegin-column\nul\n{\nmargin-top:0\n}\n.mw-parser-output\n.refbegin-column\nli\n{\npage-break-insid\n:\navoid\n;\nbreak-insid\n:\navoid-column\n}\n.mw-parser-output\n.legend\n{\npage-break-insid\n:\navoid\n;\nbreak-insid\n:\navoid-column\n}\n.mw-parser-output\n.legend-color\n{\ndisplay\n:\ninline-block\n;\nmin-width:1.25em\n;\nheight:1.25em\n;\nline-height:1.25\n;\nmargin:1px\n0\n;\ntext-align\n:\ncenter\n;\nborder:1px\nsolid\nblack\n;\nbackground-color\n:\ntranspar\n;\ncolor\n:\nblack\n}\n.mw-parser-output\n.legend-text\n{\n}\nno\ndata\n<\n45\n45–65\n65–85\n85–105\n105–125\n125–145\n145–165\n165–185\n185–205\n205–225\n225–245\n>\n245\nworldwid\n,\nmigrain\naffect\nnearli\n15\n%\nor\napproxim\none\nbillion\npeopl\n.\n[\n11\n]\nit\nis\nmore\ncommon\nin\nwomen\nat\n19\n%\nthan\nmen\nat\n11\n%\n.\n[\n11\n]\nin\nthe\nunit\nstate\n,\nabout\n6\n%\nof\nmen\nand\n18\n%\nof\nwomen\nexperi\na\nmigrain\nattack\nin\na\ngiven\nyear\n,\nwith\na\nlifetim\nrisk\nof\nabout\n18\n%\nand\n43\n%\nrespect\n.\n[\n5\n]\nin\neurop\n,\nmigrain\naffect\n12–28\n%\nof\npeopl\nat\nsome\npoint\nin\ntheir\nlive\nwith\nabout\n6–15\n%\nof\nadult\nmen\nand\n14–35\n%\nof\nadult\nwomen\nget\nat\nleast\none\nyearli\n.\n[\n17\n]\nrate\nof\nmigrain\nare\nslightli\nlower\nin\nasia\nand\nafrica\nthan\nin\nwestern\ncountri\n.\n[\n58\n]\n[\n193\n]\nchronic\nmigrain\noccur\nin\napproxim\n1.4\nto\n2.2\n%\nof\nthe\npopul\n.\n[\n194\n]\nthese\nfigur\nvari\nsubstanti\nwith\nage\n:\nonset\nof\nmigrain\nis\nmost\ncommonli\nbetween\n15\nand\n24\nyear\nof\nage\n,\nand\noccur\nmost\nfrequent\nin\nthose\n35\nto\n45\nyear\nof\nage\n.\n[\n5\n]\nin\nchildren\n,\nabout\n1.7\n%\nof\n7\nyear\nold\nand\n3.9\n%\nof\nthose\nbetween\n7\nand\n15\nexperi\nmigrain\n,\nwith\nthe\ncondit\nbe\nslightli\nmore\ncommon\nin\nboy\nbefor\npuberti\n.\n[\n195\n]\nchildren\nas\nyoung\nas\ntwo\nyear\nmay\nbe\naffect\n.\n[\n174\n]\ndure\nadolesc\n,\nmigrain\nbecom\nmore\ncommon\namong\nwomen\n[\n195\n]\nand\nthi\npersist\nfor\nthe\nrest\nof\nthe\nlifespan\n,\nbe\ntwice\nas\ncommon\namong\nelderli\nfemal\nthan\nmale\n.\n[\n196\n]\nin\nwomen\nmigrain\nwithout\naura\nare\nmore\ncommon\nthan\nmigrain\nwith\naura\n;\nhowev\nin\nmen\nthe\ntwo\ntype\noccur\nwith\nsimilar\nfrequenc\n.\n[\n58\n]\ndure\nperimenopaus\nsymptom\noften\nget\nwors\nbefor\ndecreas\nin\nsever\n.\n[\n196\n]\nwhile\nsymptom\nresolv\nin\nabout\ntwo\nthird\nof\nthe\nelderli\n,\nin\n3\nto\n10\n%\nthey\npersist\n.\n[\n49\n]\nhistori\n[\nedit\n]\nthe\nhead\nach\n,\ngeorg\ncruikshank\n(\n1819\n)\nan\nearli\ndescript\nconsist\nwith\nmigrain\nis\ncontain\nin\nthe\neber\npapyru\n,\nwritten\naround\n1500\nbce\nin\nancient\negypt\n.\n[\n24\n]\nin\n200\nbce\n,\nwrite\nfrom\nthe\nhippocrat\nschool\nof\nmedicin\ndescrib\nthe\nvisual\naura\nthat\ncan\npreced\nthe\nheadach\nand\na\npartial\nrelief\noccur\nthrough\nvomit\n.\n[\n197\n]\na\nsecond-centuri\ndescript\nby\naretaeu\nof\ncappadocia\ndivid\nheadach\ninto\nthree\ntype\n:\ncephalalgia\n,\ncephalea\n,\nand\nheterocrania\n.\n[\n198\n]\ngalen\nof\npergamon\nuse\nthe\nterm\nhemicrania\n(\nhalf-head\n)\n,\nfrom\nwhich\nthe\nword\nmigrain\nwa\neventu\nderiv\n.\n[\n198\n]\nhe\nalso\npropos\nthat\nthe\npain\naros\nfrom\nthe\nmening\nand\nblood\nvessel\nof\nthe\nhead\n.\n[\n197\n]\nmigrain\nwa\nfirst\ndivid\ninto\nthe\ntwo\nnow\nuse\ntype\n–\nmigrain\nwith\naura\n(\nmigrain\nophthalmiqu\n)\nand\nmigrain\nwithout\naura\n(\nmigrain\nvulgair\n)\nin\n1887\nby\nloui\nhyacinth\nthoma\n,\na\nfrench\nlibrarian\n.\n[\n197\n]\nthe\nmystic\nvision\nof\nhildegard\nvon\nbingen\n,\nwhich\nshe\ndescrib\nas\n“\nreflect\nof\nthe\nlive\nlight\n''\n,\nare\nconsist\nwith\nthe\nvisual\naura\nexperienc\ndure\nmigrain\n.\n[\n199\n]\na\ntrepan\nskull\n,\nfrom\nthe\nneolith\n.\nthe\nperimet\nof\nthe\nhole\nin\nthe\nskull\nis\nround\noff\nby\ningrowth\nof\nnew\nboni\ntissu\n,\nindic\nthat\nthe\nperson\nsurviv\nthe\noper\n.\ntrepan\n,\nthe\ndeliber\ndrill\nof\nhole\ninto\na\nskull\n,\nwa\npractic\nas\nearli\nas\n7,000\nbce\n.\n[\n24\n]\nwhile\nsometim\npeopl\nsurviv\n,\nmani\nwould\nhave\ndie\nfrom\nthe\nprocedur\ndue\nto\ninfect\n.\n[\n200\n]\nit\nwa\nbeliev\nto\nwork\nvia\n``\nlet\nevil\nspirit\nescap\n''\n.\n[\n201\n]\nwilliam\nharvey\nrecommend\ntrepan\nas\na\ntreatment\nfor\nmigrain\nin\nthe\n17th\ncenturi\n.\n[\n202\n]\nwhile\nmani\ntreatment\nfor\nmigrain\nhave\nbeen\nattempt\n,\nit\nwa\nnot\nuntil\n1868\nthat\nuse\nof\na\nsubstanc\nwhich\neventu\nturn\nout\nto\nbe\neffect\nbegan\n.\n[\n197\n]\nthi\nsubstanc\nwa\nthe\nfungu\nergot\nfrom\nwhich\nergotamin\nwa\nisol\nin\n1918\n.\n[\n203\n]\nmethysergid\nwa\ndevelop\nin\n1959\nand\nthe\nfirst\ntriptan\n,\nsumatriptan\n,\nwa\ndevelop\nin\n1988\n.\n[\n203\n]\ndure\nthe\n20th\ncenturi\nwith\nbetter\nstudy-design\n,\neffect\nprevent\nmeasur\nwere\nfound\nand\nconfirm\n.\n[\n197\n]\nsocieti\nand\ncultur\n[\nedit\n]\nmigrain\nis\na\nsignific\nsourc\nof\nboth\nmedic\ncost\nand\nlost\nproduct\n.\nit\nha\nbeen\nestim\nthat\nmigrain\nis\nthe\nmost\ncostli\nneurolog\ndisord\nin\nthe\neuropean\ncommun\n,\ncost\nmore\nthan\n€27\nbillion\nper\nyear\n.\n[\n204\n]\nin\nthe\nunit\nstate\n,\ndirect\ncost\nhave\nbeen\nestim\nat\n$\n17\nbillion\n,\nwhile\nindirect\ncost\n—\nsuch\nas\nmiss\nor\ndecreas\nabil\nto\nwork\n—\nis\nestim\nat\n$\n15\nbillion\n.\n[\n205\n]\nnearli\na\ntenth\nof\nthe\ndirect\ncost\nis\ndue\nto\nthe\ncost\nof\ntriptan\n.\n[\n205\n]\nin\nthose\nwho\ndo\nattend\nwork\nwith\na\nmigrain\n,\neffect\nis\ndecreas\nby\naround\na\nthird\n.\n[\n204\n]\nneg\nimpact\nalso\nfrequent\noccur\nfor\na\nperson\n's\nfamili\n.\n[\n204\n]\nresearch\n[\nedit\n]\npotenti\nprevent\nmechan\n[\nedit\n]\ntranscrani\nmagnet\nstimul\nshow\npromis\n[\n10\n]\n[\n206\n]\nas\ndoe\ntranscutan\nsupraorbit\nnerv\nstimul\n.\n[\n207\n]\nthere\nis\npreliminari\nevid\nthat\na\nketogen\ndiet\nmay\nhelp\nprevent\nepisod\nand\nlong-term\nmigrain\n.\n[\n208\n]\n[\n209\n]\npotenti\ngender\ndepend\n[\nedit\n]\nwhile\nno\ndefinit\nproof\nha\nbeen\nfound\nlink\nmigrain\nto\ngender\n,\nstatist\ndata\nindic\nthat\nwomen\nmay\nbe\nmore\nprone\nto\nsuffer\nfrom\nmigrain\n,\nshow\nmigrain\nincid\nthree\ntime\nhigher\namong\nwomen\nthan\nmen\n.\n[\n210\n]\n[\n211\n]\nthe\nsocieti\nfor\nwomen\n’\ns\nhealth\nresearch\nha\nalso\nmention\nhormon\ninfluenc\n,\nmainli\nestrogen\n,\nas\nhave\na\nconsider\nrole\nin\nprovok\nmigrain\npain\n.\nstudi\nand\nresearch\nrelat\nto\nthe\ngender\ndepend\nof\nmigrain\nare\nstill\nongo\n,\nand\nconclus\nhave\nyet\nto\nbe\nachiev\n.\n[\n212\n]\n[\n213\n]\n[\n214\n]\nsee\nalso\n[\nedit\n]\nmigrain\naura\nfoundat\nrefer\n[\nedit\n]\n.mw-parser-output\n.reflist\n{\nfont-size:90\n%\n;\nmargin-bottom:0.5em\n;\nlist-style-typ\n:\ndecim\n}\n.mw-parser-output\n.reflist\n.refer\n{\nfont-size:100\n%\n;\nmargin-bottom:0\n;\nlist-style-typ\n:\ninherit\n}\n.mw-parser-output\n.reflist-columns-2\n{\ncolumn-width:30em\n}\n.mw-parser-output\n.reflist-columns-3\n{\ncolumn-width:25em\n}\n.mw-parser-output\n.reflist-column\n{\nmargin-top:0.3em\n}\n.mw-parser-output\n.reflist-column\nol\n{\nmargin-top:0\n}\n.mw-parser-output\n.reflist-column\nli\n{\npage-break-insid\n:\navoid\n;\nbreak-insid\n:\navoid-column\n}\n.mw-parser-output\n.reflist-upper-alpha\n{\nlist-style-typ\n:\nupper-alpha\n}\n.mw-parser-output\n.reflist-upper-roman\n{\nlist-style-typ\n:\nupper-roman\n}\n.mw-parser-output\n.reflist-lower-alpha\n{\nlist-style-typ\n:\nlower-alpha\n}\n.mw-parser-output\n.reflist-lower-greek\n{\nlist-style-typ\n:\nlower-greek\n}\n.mw-parser-output\n.reflist-lower-roman\n{\nlist-style-typ\n:\nlower-roman\n}\n^\na\nb\nc\nd\ne\nf\n.mw-parser-output\ncite.cit\n{\nfont-styl\n:\ninherit\n}\n.mw-parser-output\n.citat\nq\n{\nquot\n:\n''\n\\n''\n''\n''\n\\n''\n''\n''\n'\n''\n''\n'\n''\n}\n.mw-parser-output\n.id-lock-fre\na\n,\n.mw-parser-output\n.citat\n.cs1-lock-fre\na\n{\nbackground\n:\nlinear-gradi\n(\ntranspar\n,\ntranspar\n)\n,\nurl\n(\n``\n//upload.wikimedia.org/wikipedia/commons/6/65/lock-green.svg\n''\n)\nright\n0.1em\ncenter/9px\nno-repeat\n}\n.mw-parser-output\n.id-lock-limit\na\n,\n.mw-parser-output\n.id-lock-registr\na\n,\n.mw-parser-output\n.citat\n.cs1-lock-limit\na\n,\n.mw-parser-output\n.citat\n.cs1-lock-registr\na\n{\nbackground\n:\nlinear-gradi\n(\ntranspar\n,\ntranspar\n)\n,\nurl\n(\n``\n//upload.wikimedia.org/wikipedia/commons/d/d6/lock-gray-alt-2.svg\n''\n)\nright\n0.1em\ncenter/9px\nno-repeat\n}\n.mw-parser-output\n.id-lock-subscript\na\n,\n.mw-parser-output\n.citat\n.cs1-lock-subscript\na\n{\nbackground\n:\nlinear-gradi\n(\ntranspar\n,\ntranspar\n)\n,\nurl\n(\n``\n//upload.wikimedia.org/wikipedia/commons/a/aa/lock-red-alt-2.svg\n''\n)\nright\n0.1em\ncenter/9px\nno-repeat\n}\n.mw-parser-output\n.cs1-subscript\n,\n.mw-parser-output\n.cs1-registr\n{\ncolor\n:\n#\n555\n}\n.mw-parser-output\n.cs1-subscript\nspan\n,\n.mw-parser-output\n.cs1-registr\nspan\n{\nborder-bottom:1px\ndot\n;\ncursor\n:\nhelp\n}\n.mw-parser-output\n.cs1-ws-icon\na\n{\nbackground\n:\nlinear-gradi\n(\ntranspar\n,\ntranspar\n)\n,\nurl\n(\n``\n//upload.wikimedia.org/wikipedia/commons/4/4c/wikisource-logo.svg\n''\n)\nright\n0.1em\ncenter/12px\nno-repeat\n}\n.mw-parser-output\ncode.cs1-cod\n{\ncolor\n:\ninherit\n;\nbackground\n:\ninherit\n;\nborder\n:\nnone\n;\npad\n:\ninherit\n}\n.mw-parser-output\n.cs1-hidden-error\n{\ndisplay\n:\nnone\n;\nfont-size:100\n%\n}\n.mw-parser-output\n.cs1-visible-error\n{\nfont-size:100\n%\n}\n.mw-parser-output\n.cs1-maint\n{\ndisplay\n:\nnone\n;\ncolor\n:\n#\n33aa33\n;\nmargin-left:0.3em\n}\n.mw-parser-output\n.cs1-format\n{\nfont-size:95\n%\n}\n.mw-parser-output\n.cs1-kern-left\n,\n.mw-parser-output\n.cs1-kern-wl-left\n{\npadding-left:0.2em\n}\n.mw-parser-output\n.cs1-kern-right\n,\n.mw-parser-output\n.cs1-kern-wl-right\n{\npadding-right:0.2em\n}\n.mw-parser-output\n.citat\n.mw-selflink\n{\nfont-weight\n:\ninherit\n}\n''\nheadach\ndisord\nfact\nsheet\nn°277\n''\n.\noctob\n2012\n.\narchiv\nfrom\nthe\norigin\non\n16\nfebruari\n2016\n.\nretriev\n15\nfebruari\n2016\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\ni\nj\nk\nsimon\nrp\n,\naminoff\nmj\n,\ngreenberg\nda\n(\n2009\n)\n.\nclinic\nneurolog\n(\n7\ned.\n)\n.\nnew\nyork\n,\nn.i\n:\nlang\nmedic\nbooks/mcgraw-hil\n.\npp\n.\n85–88\n.\nisbn\n9780071664332\n.\n^\na\nb\nc\nd\npian\nm\n,\nlulli\np\n,\nfarinelli\ni\n,\nsimeoni\ns\n,\nde\nfilippi\ns\n,\npatacchioli\nfr\n,\nmartelletti\np\n(\ndecemb\n2007\n)\n.\n``\ngenet\nof\nmigrain\nand\npharmacogenom\n:\nsome\nconsider\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n8\n(\n6\n)\n:\n334–9\n.\ndoi:10.1007/s10194-007-0427-2\n.\npmc\n2779399\n.\npmid\n18058067\n.\n^\na\nb\nc\nlay\ncl\n,\nbroner\nsw\n(\nmay\n2009\n)\n.\n``\nmigrain\nin\nwomen\n''\n.\nneurolog\nclinic\n.\n27\n(\n2\n)\n:\n503–11\n.\ndoi:10.1016/j.ncl.2009.01.002\n.\npmid\n19289228\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\ni\nj\nk\nl\nm\nn\no\np\nq\nr\ns\nbartleson\njd\n,\ncutrer\nfm\n(\nmay\n2010\n)\n.\n``\nmigrain\nupdat\n.\ndiagnosi\nand\ntreatment\n''\n.\nminnesota\nmedicin\n.\n93\n(\n5\n)\n:\n36–41\n.\npmid\n20572569\n.\n^\nolesen\nj\n(\n2006\n)\n.\nthe\nheadach\n.\nlippincott\nwilliam\n&\nwilkin\n.\np.\n424\n.\nisbn\n9780781754002\n.\narchiv\nfrom\nthe\norigin\non\n8\nseptemb\n2017\n.\n^\n``\ncluster\nheadach\n''\n.\namerican\nmigrain\nfoundat\n.\n15\nfebruari\n2017\n.\narchiv\nfrom\nthe\norigin\non\n9\nmay\n2018\n.\nretriev\n23\noctob\n2017\n.\n^\na\nb\narmstrong\nc\n(\napril\n2013\n)\n.\n``\naan/ah\nupdat\nrecommend\nfor\nmigrain\nprevent\nin\nadult\n''\n.\namerican\nfamili\nphysician\n.\n87\n(\n8\n)\n:\n584–5\n.\npmid\n23668450\n.\n^\na\nb\nlind\nm\n,\nmullen\nwm\n,\nchronicl\nep\n,\nmccrori\ndc\n(\njune\n2013\n)\n.\n``\nvalproat\n(\nvalproic\nacid\nor\nsodium\nvalproat\nor\na\ncombin\nof\nthe\ntwo\n)\nfor\nthe\nprophylaxi\nof\nepisod\nmigrain\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n6\n)\n:\ncd010611\n.\ndoi:10.1002/14651858.cd010611\n.\npmid\n23797677\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\ni\nj\nk\nl\nm\nn\no\np\nq\nr\ns\nt\ngilmor\nb\n,\nmichael\nm\n(\nfebruari\n2011\n)\n.\n``\ntreatment\nof\nacut\nmigrain\nheadach\n''\n.\namerican\nfamili\nphysician\n.\n83\n(\n3\n)\n:\n271–80\n.\npmid\n21302868\n.\n^\na\nb\nc\nd\nvo\nt\n,\nflaxman\nad\n,\nnaghavi\nm\n,\nlozano\nr\n,\nmichaud\nc\n,\nezzati\nm\n,\net\nal\n.\n(\ndecemb\n2012\n)\n.\n``\nyear\nlive\nwith\ndisabl\n(\nyld\n)\nfor\n1160\nsequela\nof\n289\ndiseas\nand\ninjuri\n1990-2010\n:\na\nsystemat\nanalysi\nfor\nthe\nglobal\nburden\nof\ndiseas\nstudi\n2010\n''\n.\nlancet\n.\n380\n(\n9859\n)\n:\n2163–96\n.\ndoi:10.1016/s0140-6736\n(\n12\n)\n61729-2\n.\npmc\n6350784\n.\npmid\n23245607\n.\n^\nwell\n,\njohn\nc.\n(\n2008\n)\n.\nlongman\npronunci\ndictionari\n(\n3rd\ned.\n)\n.\nlongman\n.\nisbn\n978-1-4058-8118-0\n.\n^\njone\n,\ndaniel\n(\n2011\n)\n.\nroach\n,\npeter\n;\nsetter\n,\njane\n;\nesl\n,\njohn\n(\neds.\n)\n.\ncambridg\nenglish\npronounc\ndictionari\n(\n18th\ned.\n)\n.\ncambridg\nunivers\npress\n.\nisbn\n978-0-521-15255-6\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\nheadach\nclassif\nsubcommitte\nof\nthe\nintern\nheadach\nsocieti\n(\n2004\n)\n.\n``\nthe\nintern\nclassif\nof\nheadach\ndisord\n:\n2nd\nedit\n''\n.\ncephalalgia\n.\n24\nsuppl\n1\n(\nsuppl\n1\n)\n:\n9–160\n.\ndoi:10.1111/j.1468-2982.2004.00653.x\n.\npmid\n14979299.\nas\npdf\narchiv\n31\nmarch\n2010\nat\nthe\nwayback\nmachin\n^\na\nb\nc\namin\nfm\n,\naristeid\ns\n,\nbaraldi\nc\n,\nczapinska-ciepiela\nek\n,\nariadni\ndd\n,\ndi\nlenola\nd\n,\net\nal\n.\n(\nseptemb\n2018\n)\n.\n``\nthe\nassoci\nbetween\nmigrain\nand\nphysic\nexercis\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n19\n(\n1\n)\n:\n83.\ndoi:10.1186/s10194-018-0902-i\n.\npmc\n6134860\n.\npmid\n30203180\n.\n^\npryse-phillip\nw\n(\n2003\n)\n.\ncompanion\nto\nclinic\nneurolog\n(\n2nd\ned.\n)\n.\noxford\n:\noxford\nunivers\npress\n.\np.\n587\n.\nisbn\n9780195159387\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\na\nb\nstovner\nlj\n,\nzwart\nja\n,\nhagen\nk\n,\nterwindt\ngm\n,\npascual\nj\n(\napril\n2006\n)\n.\n``\nepidemiolog\nof\nheadach\nin\neurop\n''\n.\neuropean\njournal\nof\nneurolog\n.\n13\n(\n4\n)\n:\n333–45\n.\ndoi:10.1111/j.1468-1331.2006.01184.x\n.\npmid\n16643310\n.\ns2cid\n7490176\n.\n^\na\nb\n``\nnind\nmigrain\ninform\npage\n''\n.\nnation\ninstitut\nof\nneurolog\ndisord\nand\nstroke\n.\n3\nnovemb\n2015\n.\narchiv\nfrom\nthe\norigin\non\n16\nfebruari\n2016\n.\nretriev\n15\nfebruari\n2016\n.\n^\nnowaczewska\nm\n,\nwiciński\nm\n,\nkaźmierczak\nw\n(\njuli\n2020\n)\n.\n``\nthe\nambigu\nrole\nof\ncaffein\nin\nmigrain\nheadach\n:\nfrom\ntrigger\nto\ntreatment\n''\n.\nnutrient\n.\n12\n(\n8\n)\n:\n2259.\ndoi:10.3390/nu12082259\n.\npmc\n7468766\n.\npmid\n32731623\n.\n^\nshapiro\nre\n,\ncowan\nr\n(\n2017-01-10\n)\n.\n``\ncaffein\nand\nmigrain\n''\n.\namerican\nmigrain\nfoundat\n.\nretriev\n2021-06-08\n.\n^\ndiener\nhc\n,\ncharl\na\n,\ngoadsbi\npj\n,\nholl\nd\n(\noctob\n2015\n)\n.\n``\nnew\ntherapeut\napproach\nfor\nthe\nprevent\nand\ntreatment\nof\nmigrain\n''\n.\nthe\nlancet\n.\nneurolog\n.\n14\n(\n10\n)\n:\n1010–22\n.\ndoi:10.1016/s1474-4422\n(\n15\n)\n00198-2\n.\npmid\n26376968\n.\ns2cid\n26523013\n.\n^\ngobel\nh.\n``\n1\n.\nmigrain\n''\n.\nichd-3\nthe\nintern\nclassif\nof\nheadach\ndisord\n3rd\nedit\n.\nretriev\n22\noctob\n2020\n.\n^\nvo\n,\ntheo\n;\net\nal\n.\n(\ngbd\n2016\ndiseas\nand\ninjuri\nincid\nand\npreval\ncollabor\n)\n(\nseptemb\n2017\n)\n.\n``\nglobal\n,\nregion\n,\nand\nnation\nincid\n,\npreval\n,\nand\nyear\nlive\nwith\ndisabl\nfor\n328\ndiseas\nand\ninjuri\nfor\n195\ncountri\n,\n1990-2016\n:\na\nsystemat\nanalysi\nfor\nthe\nglobal\nburden\nof\ndiseas\nstudi\n2016\n''\n.\nlancet\n.\n390\n(\n10100\n)\n:\n1211–1259\n.\ndoi:10.1016/s0140-6736\n(\n17\n)\n32154-2\n.\npmc\n5605509\n.\npmid\n28919117\n.\n^\na\nb\nc\nmiller\nn\n(\n2005\n)\n.\nwalsh\nand\nhoyt\n's\nclinic\nneuro-ophthalmolog\n(\n6\ned.\n)\n.\nphiladelphia\n,\npa.\n:\nlippincott\nwilliam\n&\nwilkin\n.\np.\n1275\n.\nisbn\n9780781748117\n.\narchiv\nfrom\nthe\norigin\non\n12\nmarch\n2017\n.\n^\nliddel\nhg\n,\nscott\nr.\n``\nἡμικρανία\n''\n.\na\ngreek-english\nlexicon\n.\narchiv\nfrom\nthe\norigin\non\n8\nnovemb\n2013.\non\nperseu\n^\nanderson\nk\n,\nanderson\nle\n,\nglanz\nwd\n(\n1994\n)\n.\nmosbi\n's\nmedic\n,\nnurs\n&\nalli\nhealth\ndictionari\n(\n4\ned.\n)\n.\nmosbi\n.\np.\n998\n.\nisbn\n978-0-8151-6111-0\n.\n^\nbigal\nme\n,\nlipton\nrb\n(\njune\n2008\n)\n.\n``\nthe\nprognosi\nof\nmigrain\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n21\n(\n3\n)\n:\n301–8\n.\ndoi:10.1097/wco.0b013e328300c6f5\n.\npmid\n18451714\n.\ns2cid\n34805084\n.\n^\ngutman\nsa\n(\n2008\n)\n.\nquick\nrefer\nneurosci\nfor\nrehabilit\nprofession\n:\nthe\nessenti\nneurolog\nprincipl\nunderli\nrehabilit\npractic\n(\n2\ned.\n)\n.\nthorofar\n,\nnj\n:\nslack\n.\np.\n231\n.\nisbn\n9781556428005\n.\narchiv\nfrom\nthe\norigin\non\n12\nmarch\n2017\n.\n^\na\nb\nc\nd\ne\nthe\nheadach\n,\npg\n232–233\n^\nje\nolesen\n(\n2006\n)\n.\nthe\nheadach\n(\n3\ned.\n)\n.\nphiladelphia\n:\nlippincott\nwilliam\n&\nwilkin\n.\np.\n512\n.\nisbn\n9780781754002\n.\narchiv\nfrom\nthe\norigin\non\n22\ndecemb\n2016\n.\n^\nbaskin\nsm\n,\nlipchik\ngl\n,\nsmitherman\nta\n(\noctob\n2006\n)\n.\n``\nmood\nand\nanxieti\ndisord\nin\nchronic\nheadach\n''\n.\nheadach\n.\n46\nsuppl\n3\n:\ns76-87\n.\ndoi:10.1111/j.1526-4610.2006.00559.x\n.\npmid\n17034402\n.\ns2cid\n35451906\n.\n^\na\nb\nlynn\ndj\n,\nnewton\nhb\n,\nrae-grant\na\n(\n2004\n)\n.\nthe\n5-minut\nneurolog\nconsult\n.\nphiladelphia\n:\nlippincott\nwilliam\n&\nwilkin\n.\np.\n26\n.\nisbn\n9780683307238\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\nbuzzi\nmg\n,\ncologno\nd\n,\nformisano\nr\n,\nrossi\np\n(\noctober–decemb\n2005\n)\n.\n``\nprodrom\nand\nthe\nearli\nphase\nof\nthe\nmigrain\nattack\n:\ntherapeut\nrelev\n''\n.\nfunction\nneurolog\n.\n20\n(\n4\n)\n:\n179–83\n.\npmid\n16483458\n.\n^\nrossi\np\n,\nambrosini\na\n,\nbuzzi\nmg\n(\noctober–decemb\n2005\n)\n.\n``\nprodrom\nand\npredictor\nof\nmigrain\nattack\n''\n.\nfunction\nneurolog\n.\n20\n(\n4\n)\n:\n185–91\n.\npmid\n16483459\n.\n^\nropper\nah\n,\nadam\nrd\n,\nvictor\nm\n,\nsamuel\nma\n(\n2009\n)\n.\nadam\nand\nvictor\n's\nprincipl\nof\nneurolog\n(\n9\ned.\n)\n.\nnew\nyork\n:\nmcgraw-hil\nmedic\n.\npp\n.\nchapter\n10\n.\nisbn\n9780071499927\n.\n^\nmay\na\n,\nburstein\nr\n(\nnovemb\n2019\n)\n.\n``\nhypothalam\nregul\nof\nheadach\nand\nmigrain\n''\n.\ncephalalgia\n.\n39\n(\n13\n)\n:\n1710–1719\n.\ndoi:10.1177/0333102419867280\n.\npmc\n7164212\n.\npmid\n31466456\n.\n^\na\nb\nc\nd\ntintin\n,\njudith\ne.\n(\n2010\n)\n.\nemerg\nmedicin\n:\na\ncomprehens\nstudi\nguid\n(\nemerg\nmedicin\n(\ntintin\n)\n)\n.\nnew\nyork\n:\nmcgraw-hil\ncompani\n.\npp\n.\n1116–1117\n.\nisbn\n978-0-07-148480-0\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\ni\nashina\nm\n(\nnovemb\n2020\n)\n.\n``\nmigrain\n''\n.\nthe\nnew\nengland\njournal\nof\nmedicin\n.\n383\n(\n19\n)\n:\n1866–1876\n.\ndoi:10.1056/nejmra1915327\n.\npmid\n33211930\n.\ns2cid\n227078662\n.\n^\na\nb\nc\nd\ne\nf\ng\nh\ni\nj\nk\nthe\nheadach\n,\npp\n.\n407–419\n^\nslap\n,\ngb\n(\n2008\n)\n.\nadolesc\nmedicin\n.\nphiladelphia\n,\npa\n:\nmosby/elsevi\n.\np.\n105\n.\nisbn\n9780323040730\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\na\nb\nqubti\nw\n,\npatniyot\ni\n(\njune\n2020\n)\n.\n``\nmigrain\npathophysiolog\n''\n.\npediatr\nneurolog\n.\n107\n:\n1–6\n.\ndoi:10.1016/j.pediatrneurol.2019.12.014\n.\npmid\n32192818\n.\ns2cid\n213191464\n.\n^\ntepper\nsj\n,\ntepper\nde\n(\n1\njanuari\n2011\n)\n.\nthe\ncleveland\nclinic\nmanual\nof\nheadach\ntherapi\n.\nnew\nyork\n:\nspringer\n.\np.\n6\n.\nisbn\n9781461401780\n.\narchiv\nfrom\nthe\norigin\non\n22\ndecemb\n2016\n.\n^\nbigal\nme\n,\narruda\nma\n(\njuli\n2010\n)\n.\n``\nmigrain\nin\nthe\npediatr\npopul\n--\nevolv\nconcept\n''\n.\nheadach\n.\n50\n(\n7\n)\n:\n1130–43\n.\ndoi:10.1111/j.1526-4610.2010.01717.x\n.\npmid\n20572878\n.\ns2cid\n23256755\n.\n^\nje\nolesen\n(\n2006\n)\n.\nthe\nheadach\n(\n3\ned.\n)\n.\nphiladelphia\n:\nlippincott\nwilliam\n&\nwilkin\n.\np.\n238\n.\nisbn\n9780781754002\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\ndalessio\n(\n2001\n)\n.\nsilberstein\nsd\n,\nlipton\nrb\n,\ndalessio\ndj\n(\neds.\n)\n.\nwolff\n's\nheadach\nand\nother\nhead\npain\n(\n7\ned.\n)\n.\noxford\n:\noxford\nunivers\npress\n.\np.\n122\n.\nisbn\n9780195135183\n.\n^\na\nb\nlisak\nrp\n,\ntruong\ndd\n,\ncarrol\nw\n,\nbhidayasiri\nr\n(\n2009\n)\n.\nintern\nneurolog\n:\na\nclinic\napproach\n.\nchichest\n,\nuk\n:\nwiley-blackwel\n.\np.\n670\n.\nisbn\n9781405157384\n.\n^\na\nb\nc\nkaniecki\nrg\n(\njune\n2009\n)\n.\n``\nbasilar-typ\nmigrain\n''\n.\ncurrent\npain\nand\nheadach\nreport\n.\n13\n(\n3\n)\n:\n217–20\n.\ndoi:10.1007/s11916-009-0036-7\n.\npmid\n19457282\n.\ns2cid\n22242504\n.\n^\na\nb\njoel\ns.\nglaser\n(\n1999\n)\n.\nneuro-ophthalmolog\n(\n3\ned.\n)\n.\nphiladelphia\n:\nlippincott\nwilliam\n&\nwilkin\n.\np.\n555\n.\nisbn\n9780781717298\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\na\nb\nsirven\nji\n,\nmalamut\nbl\n(\n2008\n)\n.\nclinic\nneurolog\nof\nthe\nolder\nadult\n(\n2\ned.\n)\n.\nphiladelphia\n:\nwolter\nkluwer\nhealth/lippincott\nwilliam\n&\nwilkin\n.\np.\n197\n.\nisbn\n9780781769471\n.\narchiv\nfrom\nthe\norigin\non\n12\nmarch\n2017\n.\n^\ndr.\njennif\nrobble\n(\n21\naugust\n2019\n)\n.\n``\nsilent\nmigrain\n:\na\nguid\n''\n.\namerican\nmigrain\nfoundat\n.\nretriev\n22\njanuari\n2021\n.\n^\na\nb\nhe\ny\n,\nli\ny\n,\nnie\nz\n(\nfebruari\n2015\n)\n.\n``\ntypic\naura\nwithout\nheadach\n:\na\ncase\nreport\nand\nreview\nof\nthe\nliteratur\n''\n.\njournal\nof\nmedic\ncase\nreport\n.\n9\n(\n1\n)\n:\n40.\ndoi:10.1186/s13256-014-0510-7\n.\npmc\n4344793\n.\npmid\n25884682\n.\n^\njayn\nleonard\n(\nmedic\nreview\nby\nseunggu\nhan\n,\nm.d\n.\n)\n(\n7\nseptemb\n2018\n)\n.\n``\nsilent\nmigrain\n:\nsymptom\n,\ncaus\n,\ntreatment\n,\nprevent\n''\n.\nwww.medicalnewstoday.com\n.\nmedic\nnew\ntoday\n.\nretriev\n22\njanuari\n2021\n.\n^\nbose\np\n,\ngoadsbi\npj\n(\njune\n2016\n)\n.\n``\nthe\nmigrain\npostdrom\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n29\n(\n3\n)\n:\n299–301\n.\ndoi:10.1097/wco.0000000000000310\n.\npmid\n26886356\n.\ns2cid\n22445093\n.\n^\nkelman\nl\n(\nfebruari\n2006\n)\n.\n``\nthe\npostdrom\nof\nthe\nacut\nmigrain\nattack\n''\n.\ncephalalgia\n.\n26\n(\n2\n)\n:\n214–20\n.\ndoi:10.1111/j.1468-2982.2005.01026.x\n.\npmid\n16426278\n.\ns2cid\n21519111\n.\n^\nhalpern\nal\n,\nsilberstein\nsd\n(\n2005\n)\n.\n``\nch\n.\n9\n:\nthe\nmigrain\nattack—a\nclinic\ndescript\n''\n.\nin\nkaplan\npw\n,\nfisher\nrs\n(\neds.\n)\n.\nimit\nof\nepilepsi\n(\n2\ned.\n)\n.\nnew\nyork\n:\ndemo\nmedic\n.\nisbn\n978-1-888799-83-5\n.\nnbk7326\n.\n^\nrobbin\nms\n,\nlipton\nrb\n(\napril\n2010\n)\n.\n``\nthe\nepidemiolog\nof\nprimari\nheadach\ndisord\n''\n.\nseminar\nin\nneurolog\n.\n30\n(\n2\n)\n:\n107–19\n.\ndoi:10.1055/s-0030-1249220\n.\npmid\n20352581\n.\n^\na\nb\nc\nschürk\nm\n(\njanuari\n2012\n)\n.\n``\ngenet\nof\nmigrain\nin\nthe\nage\nof\ngenome-wid\nassoci\nstudi\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n13\n(\n1\n)\n:\n1–9\n.\ndoi:10.1007/s10194-011-0399-0\n.\npmc\n3253157\n.\npmid\n22072275\n.\n^\na\nb\nc\nd\nthe\nheadach\n,\npp\n.\n238–40\n^\nthe\nheadach\n,\npp\n.\n246–247\n^\nde\nvri\nb\n,\nfrant\nrr\n,\nferrari\nmd\n,\nvan\nden\nmaagdenberg\nam\n(\njuli\n2009\n)\n.\n``\nmolecular\ngenet\nof\nmigrain\n''\n.\nhuman\ngenet\n.\n126\n(\n1\n)\n:\n115–32\n.\ndoi:10.1007/s00439-009-0684-z\n.\npmid\n19455354\n.\ns2cid\n20119237\n.\n^\nmontagna\np\n(\nseptemb\n2008\n)\n.\n``\nmigrain\ngenet\n''\n.\nexpert\nreview\nof\nneurotherapeut\n.\n8\n(\n9\n)\n:\n1321–30\n.\ndoi:10.1586/14737175.8.9.1321\n.\npmid\n18759544\n.\ns2cid\n207195127\n.\n^\na\nb\nc\nducro\na\n(\nmay\n2013\n)\n.\n``\n[\ngenet\nof\nmigrain\n]\n''\n.\nrevu\nneurologiqu\n.\n169\n(\n5\n)\n:\n360–71\n.\ndoi:10.1016/j.neurol.2012.11.010\n.\npmid\n23618705\n.\n^\nwan\nd\n,\nwang\nc\n,\nzhang\nx\n,\ntang\nw\n,\nchen\nm\n,\ndong\nz\n,\nyu\ns\n(\n1\njanuari\n2016\n)\n.\n``\nassoci\nbetween\nangiotensin-convert\nenzym\ninsertion/delet\npolymorph\nand\nmigrain\n:\na\nmeta-analysi\n''\n.\nthe\nintern\njournal\nof\nneurosci\n.\n126\n(\n5\n)\n:\n393–9\n.\ndoi:10.3109/00207454.2015.1025395\n.\npmid\n26000817\n.\ns2cid\n34902092\n.\n^\ndussor\ng\n,\ncao\nyq\n(\noctob\n2016\n)\n.\n``\ntrpm8\nand\nmigrain\n''\n.\nheadach\n.\n56\n(\n9\n)\n:\n1406–1417\n.\ndoi:10.1111/head.12948\n.\npmc\n5335856\n.\npmid\n27634619\n.\n^\na\nb\nc\nlevi\nd\n,\nstrassman\nam\n,\nburstein\nr\n(\njune\n2009\n)\n.\n``\na\ncritic\nview\non\nthe\nrole\nof\nmigrain\ntrigger\nin\nthe\ngenesi\nof\nmigrain\npain\n''\n.\nheadach\n.\n49\n(\n6\n)\n:\n953–7\n.\ndoi:10.1111/j.1526-4610.2009.01444.x\n.\npmid\n19545256\n.\ns2cid\n31707887\n.\n^\nmartin\npr\n(\njune\n2010\n)\n.\n``\nbehavior\nmanag\nof\nmigrain\nheadach\ntrigger\n:\nlearn\nto\ncope\nwith\ntrigger\n''\n.\ncurrent\npain\nand\nheadach\nreport\n.\n14\n(\n3\n)\n:\n221–7\n.\ndoi:10.1007/s11916-010-0112-z\n.\npmid\n20425190\n.\ns2cid\n5511782\n.\n^\npavlov\njm\n,\nbuse\ndc\n,\nsollar\ncm\n,\nhaut\ns\n,\nlipton\nrb\n(\n2014\n)\n.\n``\ntrigger\nfactor\nand\npremonitori\nfeatur\nof\nmigrain\nattack\n:\nsummari\nof\nstudi\n''\n.\nheadach\n.\n54\n(\n10\n)\n:\n1670–9\n.\ndoi:10.1111/head.12468\n.\npmid\n25399858\n.\ns2cid\n25016889\n.\n^\na\nb\nc\nradat\nf\n(\nmay\n2013\n)\n.\n``\n[\nstress\nand\nmigrain\n]\n''\n.\nrevu\nneurologiqu\n.\n169\n(\n5\n)\n:\n406–12\n.\ndoi:10.1016/j.neurol.2012.11.008\n.\npmid\n23608071\n.\n^\npeterlin\nbl\n,\nkatsnelson\nmj\n,\ncalhoun\nah\n(\noctob\n2009\n)\n.\n``\nthe\nassoci\nbetween\nmigrain\n,\nunipolar\npsychiatr\ncomorbid\n,\nand\nstress-rel\ndisord\nand\nthe\nrole\nof\nestrogen\n''\n.\ncurrent\npain\nand\nheadach\nreport\n.\n13\n(\n5\n)\n:\n404–12\n.\ndoi:10.1007/s11916-009-0066-1\n.\npmc\n3972495\n.\npmid\n19728969\n.\n^\nchai\nnc\n,\npeterlin\nbl\n,\ncalhoun\nah\n(\njune\n2014\n)\n.\n``\nmigrain\nand\nestrogen\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n27\n(\n3\n)\n:\n315–24\n.\ndoi:10.1097/wco.0000000000000091\n.\npmc\n4102139\n.\npmid\n24792340\n.\n^\na\nb\nfinocchi\nc\n,\nsivori\ng\n(\nmay\n2012\n)\n.\n``\nfood\nas\ntrigger\nand\naggrav\nfactor\nof\nmigrain\n''\n.\nneurolog\nscienc\n.\n33\nsuppl\n1\n(\n1\n)\n:\ns77-80\n.\ndoi:10.1007/s10072-012-1046-5\n.\npmid\n22644176\n.\ns2cid\n19582697\n.\n^\nrockett\nfc\n,\nde\noliveira\nvr\n,\ncastro\nk\n,\nchave\nml\n,\nperla\na\n,\nperri\nid\n(\njune\n2012\n)\n.\n``\ndietari\naspect\nof\nmigrain\ntrigger\nfactor\n''\n.\nnutrit\nreview\n.\n70\n(\n6\n)\n:\n337–56\n.\ndoi:10.1111/j.1753-4887.2012.00468.x\n.\npmid\n22646127\n.\n^\nholzhamm\nj\n,\nwöber\nc\n(\napril\n2006\n)\n.\n``\n[\nalimentari\ntrigger\nfactor\nthat\nprovok\nmigrain\nand\ntension-typ\nheadach\n]\n''\n[\nalimentari\ntrigger\nfactor\nthat\nprovok\nmigrain\nand\ntension-typ\nheadach\n]\n.\nschmerz\n(\nin\ngerman\n)\n.\n20\n(\n2\n)\n:\n151–9\n.\ndoi:10.1007/s00482-005-0390-2\n.\npmid\n15806385\n.\n^\njansen\nsc\n,\nvan\ndusseldorp\nm\n,\nbottema\nkc\n,\nduboi\nae\n(\nseptemb\n2003\n)\n.\n``\nintoler\nto\ndietari\nbiogen\namin\n:\na\nreview\n''\n.\nannal\nof\nallergi\n,\nasthma\n&\nimmunolog\n.\n91\n(\n3\n)\n:\n233–40\n,\nquiz\n241–2\n,\n296.\ndoi:10.1016/s1081-1206\n(\n10\n)\n63523-5\n.\npmid\n14533654\n.\n[\nperman\ndead\nlink\n]\n^\nsun-edelstein\nc\n,\nmauskop\na\n(\njune\n2009\n)\n.\n``\nfood\nand\nsupplement\nin\nthe\nmanag\nof\nmigrain\nheadach\n''\n(\npdf\n)\n.\nthe\nclinic\njournal\nof\npain\n.\n25\n(\n5\n)\n:\n446–52\n.\nciteseerx\n10.1.1.530.1223.\ndoi:10.1097/ajp.0b013e31819a6f65\n.\npmid\n19454881\n.\ns2cid\n3042635\n.\narchiv\n(\npdf\n)\nfrom\nthe\norigin\non\n13\naugust\n2017\n.\n^\nfreeman\nm\n(\noctob\n2006\n)\n.\n``\nreconsid\nthe\neffect\nof\nmonosodium\nglutam\n:\na\nliteratur\nreview\n''\n.\njournal\nof\nthe\namerican\nacademi\nof\nnurs\npractition\n.\n18\n(\n10\n)\n:\n482–6\n.\ndoi:10.1111/j.1745-7599.2006.00160.x\n.\npmid\n16999713\n.\ns2cid\n21084909\n.\n^\nfriedman\ndi\n,\nde\nver\ndye\nt\n(\njune\n2009\n)\n.\n``\nmigrain\nand\nthe\nenviron\n''\n.\nheadach\n.\n49\n(\n6\n)\n:\n941–52\n.\ndoi:10.1111/j.1526-4610.2009.01443.x\n.\npmid\n19545255\n.\ns2cid\n29764274\n.\n^\nandreou\nap\n,\nedvinsson\nl\n(\ndecemb\n2019\n)\n.\n``\nmechan\nof\nmigrain\nas\na\nchronic\nevolut\ncondit\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n20\n(\n1\n)\n:\n117.\ndoi:10.1186/s10194-019-1066-0\n.\npmc\n6929435\n.\npmid\n31870279\n.\n^\n``\nwhat\nis\nmigrain\n?\n''\n.\nmigrain\nresearch\nfoundat\n.\narchiv\nfrom\nthe\norigin\non\n4\njune\n2020\n.\n^\n``\nmigrain\ninform\npage\n''\n.\nnation\ninstitut\nof\nneurolog\ndisord\nand\nstroke\n.\narchiv\nfrom\nthe\norigin\non\n10\njune\n2020\n.\n^\nhoffmann\nj\n,\nbaca\nsm\n,\nakerman\ns\n(\napril\n2019\n)\n.\n``\nneurovascular\nmechan\nof\nmigrain\nand\ncluster\nheadach\n''\n.\njournal\nof\ncerebr\nblood\nflow\nand\nmetabol\n.\n39\n(\n4\n)\n:\n573–594\n.\ndoi:10.1177/0271678x17733655\n.\npmc\n6446418\n.\npmid\n28948863\n.\n^\nbrennan\nkc\n,\ncharl\na\n(\njune\n2010\n)\n.\n``\nan\nupdat\non\nthe\nblood\nvessel\nin\nmigrain\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n23\n(\n3\n)\n:\n266–74\n.\ndoi:10.1097/wco.0b013e32833821c1\n.\npmc\n5500293\n.\npmid\n20216215\n.\n^\nspiri\n,\ndaniel\n;\ntitomanlio\n,\nluigi\n;\npogliani\n,\nlaura\n;\nzuccotti\n,\ngianvincenzo\n(\n1\njanuari\n2012\n)\n.\n``\npathophysiolog\nof\nmigrain\n:\nthe\nneurovascular\ntheori\n''\n.\nheadach\n:\ncaus\n,\ntreatment\nand\nprevent\n:\n51–64\n.\n^\ngoadsbi\npj\n(\njanuari\n2009\n)\n.\n``\nthe\nvascular\ntheori\nof\nmigrain\n--\na\ngreat\nstori\nwreck\nby\nthe\nfact\n''\n.\nbrain\n.\n132\n(\npt\n1\n)\n:\n6–7\n.\ndoi:10.1093/brain/awn321\n.\npmid\n19098031\n.\n^\ndodick\ndw\n(\napril\n2008\n)\n.\n``\nexamin\nthe\nessenc\nof\nmigrain\n--\nis\nit\nthe\nblood\nvessel\nor\nthe\nbrain\n?\na\ndebat\n''\n.\nheadach\n.\n48\n(\n4\n)\n:\n661–7\n.\ndoi:10.1111/j.1526-4610.2008.01079.x\n.\npmid\n18377395\n.\ns2cid\n6272233\n.\n^\nchen\nd\n,\nwillis-park\nm\n,\nlundberg\ngp\n(\noctob\n2020\n)\n.\n``\nmigrain\nheadach\n:\nis\nit\nonli\na\nneurolog\ndisord\n?\nlink\nbetween\nmigrain\nand\ncardiovascular\ndisord\n''\n.\ntrend\nin\ncardiovascular\nmedicin\n.\n30\n(\n7\n)\n:\n424–430\n.\ndoi:10.1016/j.tcm.2019.10.005\n.\npmid\n31679956\n.\n^\njacob\nb\n,\ndussor\ng\n(\ndecemb\n2016\n)\n.\n``\nneurovascular\ncontribut\nto\nmigrain\n:\nmove\nbeyond\nvasodil\n''\n.\nneurosci\n.\n338\n:\n130–144\n.\ndoi:10.1016/j.neuroscience.2016.06.012\n.\npmc\n5083225\n.\npmid\n27312704\n.\n^\nmason\nbn\n,\nrusso\naf\n(\n2018\n)\n.\n``\nvascular\ncontribut\nto\nmigrain\n:\ntime\nto\nrevisit\n?\n''\n.\nfrontier\nin\ncellular\nneurosci\n.\n12\n:\n233.\ndoi:10.3389/fncel.2018.00233\n.\npmc\n6088188\n.\npmid\n30127722\n.\n^\ndodick\ndw\n,\ngargu\njj\n(\naugust\n2008\n)\n.\n``\nwhi\nmigrain\nstrike\n''\n.\nscientif\namerican\n.\n299\n(\n2\n)\n:\n56–63\n.\nbibcode:2008sciam.299b\n..\n56d\n.\ndoi:10.1038/scientificamerican0808-56\n.\npmid\n18666680\n.\n^\na\nb\nc\nd\nthe\nheadach\n,\nchp\n.\n28\n,\npp\n.\n269–72\n^\na\nb\nc\nolesen\nj\n,\nburstein\nr\n,\nashina\nm\n,\ntfelt-hansen\np\n(\njuli\n2009\n)\n.\n``\norigin\nof\npain\nin\nmigrain\n:\nevid\nfor\nperipher\nsensitis\n''\n.\nthe\nlancet\n.\nneurolog\n.\n8\n(\n7\n)\n:\n679–90\n.\ndoi:10.1016/s1474-4422\n(\n09\n)\n70090-0\n.\npmid\n19539239\n.\ns2cid\n20452008\n.\n^\nakerman\ns\n,\nholland\npr\n,\ngoadsbi\npj\n(\nseptemb\n2011\n)\n.\n``\ndiencephal\nand\nbrainstem\nmechan\nin\nmigrain\n''\n.\nnatur\nreview\n.\nneurosci\n.\n12\n(\n10\n)\n:\n570–84\n.\ndoi:10.1038/nrn3057\n.\npmid\n21931334\n.\ns2cid\n8472711\n.\n^\nshevel\ne\n(\nmarch\n2011\n)\n.\n``\nthe\nextracrani\nvascular\ntheori\nof\nmigrain\n--\na\ngreat\nstori\nconfirm\nby\nthe\nfact\n''\n.\nheadach\n.\n51\n(\n3\n)\n:\n409–417\n.\ndoi:10.1111/j.1526-4610.2011.01844.x\n.\npmid\n21352215\n.\ns2cid\n6939786\n.\n^\na\nb\nburnstock\ng\n(\n1\njanuari\n2016\n)\n.\n``\npurinerg\nmechan\nand\npain\n''\n.\nin\nbarrett\nje\n(\ned.\n)\n.\npharmacolog\nmechan\nand\nthe\nmodul\nof\npain\n.\nadvanc\nin\npharmacolog\n.\npharmacolog\nmechan\nand\nthe\nmodul\nof\npain\n.\n75\n.\nacadem\npress\n.\npp\n.\n91–137\n.\ndoi:10.1016/bs.apha.2015.09.001\n.\nisbn\n9780128038833\n.\npmid\n26920010\n.\n^\ndavidoff\nr\n(\n14\nfebruari\n2002\n)\n.\nmigrain\n:\nmanifest\n,\npathogenesi\n,\nand\nmanag\n.\noxford\nunivers\npress\n.\nisbn\n978-0-19-803135-2\n.\n^\nlipton\nrb\n,\ndiener\nhc\n,\nrobbin\nms\n,\ngara\nsy\n,\npatel\nk\n(\noctob\n2017\n)\n.\n``\ncaffein\nin\nthe\nmanag\nof\npatient\nwith\nheadach\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n18\n(\n1\n)\n:\n107.\ndoi:10.1186/s10194-017-0806-2\n.\npmc\n5655397\n.\npmid\n29067618\n.\n^\nhamel\ne\n(\nnovemb\n2007\n)\n.\n``\nserotonin\nand\nmigrain\n:\nbiolog\nand\nclinic\nimplic\n''\n.\ncephalalgia\n.\n27\n(\n11\n)\n:\n1293–300\n.\ndoi:10.1111/j.1468-2982.2007.01476.x\n.\npmid\n17970989\n.\ns2cid\n26543041\n.\n^\namerican\nheadach\nsocieti\n(\nseptemb\n2013\n)\n.\n``\nfive\nthing\nphysician\nand\npatient\nshould\nquestion\n''\n.\nchoos\nwise\n:\nan\niniti\nof\nthe\nabim\nfoundat\n.\narchiv\nfrom\nthe\norigin\non\n6\ndecemb\n2013\n.\nretriev\n10\ndecemb\n2013\n.\nlewi\ndw\n,\ndorbad\nd\n(\nseptemb\n2000\n)\n.\n``\nthe\nutil\nof\nneuroimag\nin\nthe\nevalu\nof\nchildren\nwith\nmigrain\nor\nchronic\ndaili\nheadach\nwho\nhave\nnormal\nneurolog\nexamin\n''\n.\nheadach\n.\n40\n(\n8\n)\n:\n629–32\n.\ndoi:10.1046/j.1526-4610.2000.040008629.x\n.\npmid\n10971658\n.\ns2cid\n14443890\n.\nsilberstein\nsd\n(\nseptemb\n2000\n)\n.\n``\npractic\nparamet\n:\nevidence-bas\nguidelin\nfor\nmigrain\nheadach\n(\nan\nevidence-bas\nreview\n)\n:\nreport\nof\nthe\nqualiti\nstandard\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\n''\n.\nneurolog\n.\n55\n(\n6\n)\n:\n754–62\n.\ndoi:10.1212/wnl.55.6.754\n.\npmid\n10993991\n.\nmedic\nadvisori\nsecretariat\n(\n2010\n)\n.\n``\nneuroimag\nfor\nthe\nevalu\nof\nchronic\nheadach\n:\nan\nevidence-bas\nanalysi\n''\n.\nontario\nhealth\ntechnolog\nassess\nseri\n.\n10\n(\n26\n)\n:\n1–57\n.\npmc\n3377587\n.\npmid\n23074404\n.\n^\ncousin\ng\n,\nhijazz\ns\n,\nvan\nde\nlaar\nfa\n,\nfahey\nt\n(\njul–aug\n2011\n)\n.\n``\ndiagnost\naccuraci\nof\nthe\nid\nmigrain\n:\na\nsystemat\nreview\nand\nmeta-analysi\n''\n.\nheadach\n.\n51\n(\n7\n)\n:\n1140–8\n.\ndoi:10.1111/j.1526-4610.2011.01916.x\n.\npmid\n21649653\n.\ns2cid\n205684294\n.\n^\n``\nheadach\nclassif\ncommitte\nof\nthe\nintern\nheadach\nsocieti\n(\nih\n)\nthe\nintern\nclassif\nof\nheadach\ndisord\n,\n3rd\nedit\n''\n.\ncephalalgia\n.\n38\n(\n1\n)\n:\n1–211\n.\njanuari\n2018.\ndoi:10.1177/0333102417738202\n.\npmid\n29368949\n.\n^\nnappi\ng\n(\nseptemb\n2005\n)\n.\n``\nintroduct\nto\nthe\nnew\nintern\nclassif\nof\nheadach\ndisord\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n6\n(\n4\n)\n:\n203–4\n.\ndoi:10.1007/s10194-005-0185-i\n.\npmc\n3452009\n.\npmid\n16362664\n.\n^\nnegro\na\n,\nrocchietti-march\nm\n,\nfiorillo\nm\n,\nmartelletti\np\n(\ndecemb\n2011\n)\n.\n``\nchronic\nmigrain\n:\ncurrent\nconcept\nand\nongo\ntreatment\n''\n.\neuropean\nreview\nfor\nmedic\nand\npharmacolog\nscienc\n.\n15\n(\n12\n)\n:\n1401–20\n.\npmid\n22288302\n.\n^\na\nb\nc\nd\ndavidoff\nra\n(\n2002\n)\n.\nmigrain\n:\nmanifest\n,\npathogenesi\n,\nand\nmanag\n(\n2\ned.\n)\n.\noxford\n[\nu.a\n.\n]\n:\noxford\nuniv\n.\npress\n.\np.\n81\n.\nisbn\n9780195137057\n.\narchiv\nfrom\nthe\norigin\non\n22\ndecemb\n2016\n.\n^\nrussel\ng\n,\nabu-arafeh\ni\n,\nsymon\ndn\n(\n2002\n)\n.\n``\nabdomin\nmigrain\n:\nevid\nfor\nexist\nand\ntreatment\noption\n''\n.\npaediatr\ndrug\n.\n4\n(\n1\n)\n:\n1–8\n.\ndoi:10.2165/00128072-200204010-00001\n.\npmid\n11817981\n.\ns2cid\n12289726\n.\n^\nlewi\ndw\n,\ndorbad\nd\n(\nseptemb\n2000\n)\n.\n``\nthe\nutil\nof\nneuroimag\nin\nthe\nevalu\nof\nchildren\nwith\nmigrain\nor\nchronic\ndaili\nheadach\nwho\nhave\nnormal\nneurolog\nexamin\n''\n.\nheadach\n.\n40\n(\n8\n)\n:\n629–32\n.\ndoi:10.1046/j.1526-4610.2000.040008629.x\n.\npmid\n10971658\n.\ns2cid\n14443890\n.\n^\nsilberstein\nsd\n(\nseptemb\n2000\n)\n.\n``\npractic\nparamet\n:\nevidence-bas\nguidelin\nfor\nmigrain\nheadach\n(\nan\nevidence-bas\nreview\n)\n:\nreport\nof\nthe\nqualiti\nstandard\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\n''\n.\nneurolog\n.\n55\n(\n6\n)\n:\n754–62\n.\ndoi:10.1212/wnl.55.6.754\n.\npmid\n10993991\n.\n^\nmedic\nadvisori\nsecretariat\n(\n2010\n)\n.\n``\nneuroimag\nfor\nthe\nevalu\nof\nchronic\nheadach\n:\nan\nevidence-bas\nanalysi\n''\n.\nontario\nhealth\ntechnolog\nassess\nseri\n.\n10\n(\n26\n)\n:\n1–57\n.\npmc\n3377587\n.\npmid\n23074404\n.\n^\na\nb\noskoui\nm\n,\npringsheim\nt\n,\nbillinghurst\nl\n,\npotreb\ns\n,\ngersz\nem\n,\ngloss\nd\n,\net\nal\n.\n(\nseptemb\n2019\n)\n.\n``\npractic\nguidelin\nupdat\nsummari\n:\npharmacolog\ntreatment\nfor\npediatr\nmigrain\nprevent\n:\nreport\nof\nthe\nguidelin\ndevelop\n,\ndissemin\n,\nand\nimplement\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\nand\nthe\namerican\nheadach\nsocieti\n''\n.\nneurolog\n.\n93\n(\n11\n)\n:\n500–509\n.\ndoi:10.1212/wnl.0000000000008105\n.\npmc\n6746206\n.\npmid\n31413170\n.\n^\nmodi\ns\n,\nlowder\ndm\n(\njanuari\n2006\n)\n.\n``\nmedic\nfor\nmigrain\nprophylaxi\n''\n.\namerican\nfamili\nphysician\n.\n73\n(\n1\n)\n:\n72–8\n.\npmid\n16417067\n.\n^\ndiener\nhc\n,\nlimmroth\nv\n(\naugust\n2004\n)\n.\n``\nmedication-overus\nheadach\n:\na\nworldwid\nproblem\n''\n.\nthe\nlancet\n.\nneurolog\n.\n3\n(\n8\n)\n:\n475–83\n.\ndoi:10.1016/s1474-4422\n(\n04\n)\n00824-5\n.\npmid\n15261608\n.\ns2cid\n43840120\n.\n^\nfritsch\ng\n,\ndiener\nhc\n(\nnovemb\n2002\n)\n.\n``\nmedic\noverus\nheadach\n--\nwhat\nis\nnew\n?\n''\n.\nexpert\nopinion\non\ndrug\nsafeti\n.\n1\n(\n4\n)\n:\n331–8\n.\ndoi:10.1517/14740338.1.4.331\n.\npmid\n12904133\n.\ns2cid\n23422679\n.\n^\nkaniecki\nr\n,\nluca\ns\n(\n2004\n)\n.\n``\ntreatment\nof\nprimari\nheadach\n:\nprevent\ntreatment\nof\nmigrain\n''\n.\nstandard\nof\ncare\nfor\nheadach\ndiagnosi\nand\ntreatment\n.\nchicago\n:\nnation\nheadach\nfoundat\n.\npp\n.\n40–52\n.\n^\na\nb\nc\nloder\ne\n,\nburch\nr\n,\nrizzoli\np\n(\njune\n2012\n)\n.\n``\nthe\n2012\nahs/aan\nguidelin\nfor\nprevent\nof\nepisod\nmigrain\n:\na\nsummari\nand\ncomparison\nwith\nother\nrecent\nclinic\npractic\nguidelin\n''\n.\nheadach\n.\n52\n(\n6\n)\n:\n930–45\n.\ndoi:10.1111/j.1526-4610.2012.02185.x\n.\npmid\n22671714\n.\ns2cid\n540800\n.\n^\nlind\nm\n,\nmullen\nwm\n,\nchronicl\nep\n,\nmccrori\ndc\n(\njune\n2013\n)\n.\n``\nantiepilept\nother\nthan\ngabapentin\n,\npregabalin\n,\ntopiram\n,\nand\nvalproat\nfor\nthe\nprophylaxi\nof\nepisod\nmigrain\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n2021\n(\n6\n)\n:\ncd010608\n.\ndoi:10.1002/14651858.cd010608\n.\npmc\n8221229\n.\npmid\n23797674\n.\n^\nlocher\nc\n,\nkossowski\nj\n,\nkoechlin\nh\n,\nlam\ntl\n,\nbarthel\nj\n,\nberd\ncb\n,\net\nal\n.\n(\napril\n2020\n)\n.\n``\nefficaci\n,\nsafeti\n,\nand\naccept\nof\npharmacolog\ntreatment\nfor\npediatr\nmigrain\nprophylaxi\n:\na\nsystemat\nreview\nand\nnetwork\nmeta-analysi\n''\n.\njama\npediatr\n.\n174\n(\n4\n)\n:\n341–349\n.\ndoi:10.1001/jamapediatrics.2019.5856\n.\npmc\n7042942\n.\npmid\n32040139\n.\n^\nmerison\nk\n,\njacob\nh\n(\nnovemb\n2016\n)\n.\n``\ndiagnosi\nand\ntreatment\nof\nchildhood\nmigrain\n''\n.\ncurrent\ntreatment\noption\nin\nneurolog\n.\n18\n(\n11\n)\n:\n48.\ndoi:10.1007/s11940-016-0431-4\n.\npmid\n27704257\n.\ns2cid\n28302667\n.\n^\ndorosch\nt\n,\nganzer\nca\n,\nlin\nm\n,\nseifan\na\n(\nseptemb\n2019\n)\n.\n``\nefficaci\nof\nangiotensin-convert\nenzym\ninhibitor\nand\nangiotensin\nreceptor\nblocker\nin\nthe\nprevent\ntreatment\nof\nepisod\nmigrain\nin\nadult\n''\n.\ncurrent\npain\nand\nheadach\nreport\n.\n23\n(\n11\n)\n:\n85.\ndoi:10.1007/s11916-019-0823-8\n.\npmid\n31515634\n.\ns2cid\n202557362\n.\n^\ncern\nr\n,\nmashavi\nm\n,\nzimlichman\nr\n(\n2011\n)\n.\n``\ndifferenti\nclinic\nprofil\nof\ncandesartan\ncompar\nto\nother\nangiotensin\nreceptor\nblocker\n''\n.\nvascular\nhealth\nand\nrisk\nmanag\n.\n7\n:\n749–59\n.\ndoi:10.2147/vhrm.s22591\n.\npmc\n3253768\n.\npmid\n22241949\n.\n^\nrajapaks\nt\n,\npringsheim\nt\n(\napril\n2016\n)\n.\n``\nnutraceut\nin\nmigrain\n:\na\nsummari\nof\nexist\nguidelin\nfor\nuse\n''\n.\nheadach\n.\n56\n(\n4\n)\n:\n808–16\n.\ndoi:10.1111/head.12789\n.\npmid\n26954394\n.\ns2cid\n31097792\n.\n^\nteigen\nl\n,\nboe\ncj\n(\nseptemb\n2015\n)\n.\n``\nan\nevidence-bas\nreview\nof\noral\nmagnesium\nsupplement\nin\nthe\nprevent\ntreatment\nof\nmigrain\n''\n.\ncephalalgia\n.\n35\n(\n10\n)\n:\n912–22\n.\ndoi:10.1177/0333102414564891\n.\npmid\n25533715\n.\ns2cid\n25398410\n.\n^\na\nb\nsilberstein\nsd\n,\nholland\ns\n,\nfreitag\nf\n,\ndodick\ndw\n,\nargoff\nc\n,\nashman\ne\n(\napril\n2012\n)\n.\n``\nevidence-bas\nguidelin\nupdat\n:\npharmacolog\ntreatment\nfor\nepisod\nmigrain\nprevent\nin\nadult\n:\nreport\nof\nthe\nqualiti\nstandard\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\nand\nthe\namerican\nheadach\nsocieti\n''\n.\nneurolog\n.\n78\n(\n17\n)\n:\n1337–45\n.\ndoi:10.1212/wnl.0b013e3182535d20\n.\npmc\n3335452\n.\npmid\n22529202\n.\n^\nshamliyan\nta\n,\nchoi\njy\n,\nramakrishnan\nr\n,\nmiller\njb\n,\nwang\nsy\n,\ntaylor\nfr\n,\nkane\nrl\n(\nseptemb\n2013\n)\n.\n``\nprevent\npharmacolog\ntreatment\nfor\nepisod\nmigrain\nin\nadult\n''\n.\njournal\nof\ngener\nintern\nmedicin\n.\n28\n(\n9\n)\n:\n1225–37\n.\ndoi:10.1007/s11606-013-2433-1\n.\npmc\n3744311\n.\npmid\n23592242\n.\n^\nibekw\n,\na.\n;\nperra\n,\nc.\n;\nmierzwinski-urban\n,\nm.\n(\n2016\n)\n.\n``\nmonoclon\nantibodi\nto\nprevent\nmigrain\nheadach\n''\n.\npmid\n30855775\n.\ncite\njournal\nrequir\n|journal=\n(\nhelp\n)\n^\nloder\ne\n,\nrenthal\nw\n(\nmarch\n2019\n)\n.\n``\ncalcitonin\ngene-rel\npeptid\nmonoclon\nantibodi\ntreatment\nfor\nmigrain\n''\n.\njama\nintern\nmedicin\n.\n179\n(\n3\n)\n:\n421–422\n.\ndoi:10.1001/jamainternmed.2018.7536\n.\npmid\n30640381\n.\ns2cid\n58601441\n.\n^\nlind\nk\n,\nallai\ng\n,\nbrinkhau\nb\n,\nfei\ny\n,\nmehr\nm\n,\nvertosick\nea\n,\net\nal\n.\n(\njune\n2016\n)\n.\n``\nacupunctur\nfor\nthe\nprevent\nof\nepisod\nmigrain\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n2018\n(\n6\n)\n:\ncd001218\n.\ndoi:10.1002/14651858.cd001218.pub3\n.\npmc\n4977344\n.\npmid\n27351677\n.\n^\nchaibi\na\n,\ntuchin\npj\n,\nrussel\nmb\n(\napril\n2011\n)\n.\n``\nmanual\ntherapi\nfor\nmigrain\n:\na\nsystemat\nreview\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n12\n(\n2\n)\n:\n127–33\n.\ndoi:10.1007/s10194-011-0296-6\n.\npmc\n3072494\n.\npmid\n21298314\n.\n^\nmillstin\nd\n,\nchen\ncy\n,\nbauer\nb\n(\nmay\n2017\n)\n.\n``\ncomplementari\nand\nintegr\nmedicin\nin\nthe\nmanag\nof\nheadach\n''\n.\nbmj\n.\n357\n:\nj1805\n.\ndoi:10.1136/bmj.j1805\n.\npmid\n28512119\n.\ns2cid\n19155758\n.\n^\na\nb\nposadzki\np\n,\nernst\ne\n(\njune\n2011\n)\n.\n``\nspinal\nmanipul\nfor\nthe\ntreatment\nof\nmigrain\n:\na\nsystemat\nreview\nof\nrandom\nclinic\ntrial\n''\n.\ncephalalgia\n.\n31\n(\n8\n)\n:\n964–70\n.\ndoi:10.1177/0333102411405226\n.\npmid\n21511952\n.\ns2cid\n31205541\n.\n^\na\nb\nsharp\nl\n,\ndudeney\nj\n,\nwilliam\nac\n,\nnichola\nm\n,\nmcphee\ni\n,\nbailli\na\n,\net\nal\n.\n(\njuli\n2019\n)\n.\n``\npsycholog\ntherapi\nfor\nthe\nprevent\nof\nmigrain\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n7\n:\ncd012295\n.\ndoi:10.1002/14651858.cd012295.pub2\n.\npmc\n6603250\n.\npmid\n31264211\n.\n^\nholland\ns\n,\nsilberstein\nsd\n,\nfreitag\nf\n,\ndodick\ndw\n,\nargoff\nc\n,\nashman\ne\n(\napril\n2012\n)\n.\n``\nevidence-bas\nguidelin\nupdat\n:\nnsaid\nand\nother\ncomplementari\ntreatment\nfor\nepisod\nmigrain\nprevent\nin\nadult\n:\nreport\nof\nthe\nqualiti\nstandard\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\nand\nthe\namerican\nheadach\nsocieti\n''\n.\nneurolog\n.\n78\n(\n17\n)\n:\n1346–53\n.\ndoi:10.1212/wnl.0b013e3182535d0c\n.\npmc\n3335449\n.\npmid\n22529203\n.\n^\npringsheim\nt\n,\ndavenport\nw\n,\nmacki\ng\n,\nworthington\ni\n,\naubé\nm\n,\nchristi\nsn\n,\net\nal\n.\n(\nmarch\n2012\n)\n.\n``\ncanadian\nheadach\nsocieti\nguidelin\nfor\nmigrain\nprophylaxi\n''\n.\nthe\ncanadian\njournal\nof\nneurolog\nscienc\n.\n39\n(\n2\nsuppl\n2\n)\n:\ns1-59\n.\npmid\n22683887\n.\n^\n``\nbutterbur\n:\nuse\n,\nside\neffect\n,\ninteract\n,\ndosag\n,\nand\nwarn\n''\n.\nwww.webmd.com\n.\nretriev\n7\ndecemb\n2019\n.\n^\n``\nbutterbur\n''\n.\nnccih\n.\n8\nfebruari\n2012\n.\nretriev\n7\ndecemb\n2019\n.\n^\nlittarru\ngp\n,\ntiano\nl\n(\nnovemb\n2005\n)\n.\n``\nclinic\naspect\nof\ncoenzym\nq10\n:\nan\nupdat\n''\n.\ncurrent\nopinion\nin\nclinic\nnutrit\nand\nmetabol\ncare\n.\n8\n(\n6\n)\n:\n641–6\n.\ndoi:10.1097/01.mco.0000171123.60665.16\n.\npmid\n16205466\n.\ns2cid\n25010508\n.\n^\ngroenewegen\nwa\n,\nknight\ndw\n,\nheptinstal\ns\n(\n1992\n)\n.\n``\nprogress\nin\nthe\nmedicin\nchemistri\nof\nthe\nherb\nfeverfew\n''\n.\nprogress\nin\nmedicin\nchemistri\n.\n29\n:\n217–38\n.\ndoi:10.1016/s0079-6468\n(\n08\n)\n70009-2\n.\nisbn\n9780444894724\n.\npmid\n1475370\n.\n^\nbarn\n,\nj\n;\nanderson\n,\nla\n;\nphilipson\n,\njd\n(\n2007\n)\n.\nherbal\nmedicin\n.\n3rd\ned\n.\nlondon\n:\npharmaceut\npress\n.\n^\na\nb\nema\n.\n``\nassess\nreport\non\ntanacetum\nparthenium\n(\nl.\n)\nschultz\nbip.\n,\nherba\n''\n(\npdf\n)\n.\nwww.ema.europa.eu\n.\nretriev\n8\njuli\n2020\n.\n^\na\nb\nc\nd\ngelfand\naa\n,\ngoadsbi\npj\n(\nseptemb\n2016\n)\n.\n``\nthe\nrole\nof\nmelatonin\nin\nthe\ntreatment\nof\nprimari\nheadach\ndisord\n''\n.\nheadach\n(\nreview\n)\n.\n56\n(\n8\n)\n:\n1257–66\n.\ndoi:10.1111/head.12862\n.\npmc\n5012937\n.\npmid\n27316772\n.\n^\nlong\nr\n,\nzhu\ny\n,\nzhou\ns\n(\njanuari\n2019\n)\n.\n``\ntherapeut\nrole\nof\nmelatonin\nin\nmigrain\nprophylaxi\n:\na\nsystemat\nreview\n''\n.\nmedicin\n.\n98\n(\n3\n)\n:\ne14099\n.\ndoi:10.1097/md.0000000000014099\n.\npmc\n6370052\n.\npmid\n30653130\n.\n^\nnesbitt\nad\n,\nleschzin\ngd\n,\npeatfield\nrc\n(\nseptemb\n2014\n)\n.\n``\nheadach\n,\ndrug\nand\nsleep\n''\n.\ncephalalgia\n(\nreview\n)\n.\n34\n(\n10\n)\n:\n756–66\n.\ndoi:10.1177/0333102414542662\n.\npmid\n25053748\n.\ns2cid\n33548757\n.\n^\nnestoriuc\ny\n,\nmartin\na\n(\nmarch\n2007\n)\n.\n``\nefficaci\nof\nbiofeedback\nfor\nmigrain\n:\na\nmeta-analysi\n''\n.\npain\n.\n128\n(\n1–2\n)\n:\n111–27\n.\ndoi:10.1016/j.pain.2006.09.007\n.\npmid\n17084028\n.\ns2cid\n23351902\n.\n^\nnestoriuc\ny\n,\nmartin\na\n,\nrief\nw\n,\nandrasik\nf\n(\nseptemb\n2008\n)\n.\n``\nbiofeedback\ntreatment\nfor\nheadach\ndisord\n:\na\ncomprehens\nefficaci\nreview\n''\n.\nappli\npsychophysiolog\nand\nbiofeedback\n.\n33\n(\n3\n)\n:\n125–40\n.\ndoi:10.1007/s10484-008-9060-3\n.\npmid\n18726688\n.\ns2cid\n29122354\n.\n^\nschoenen\nj\n,\nallena\nm\n,\nmagi\nd\n(\n2010\n)\n.\n``\nneurostimul\ntherapi\nin\nintract\nheadach\n''\n.\nin\nvinken\npj\n,\nbruyn\ngw\n(\neds.\n)\n.\nheadach\n.\nhandbook\nof\nclinic\nneurolog\n.\n97.\npp\n.\n443–50\n.\ndoi:10.1016/s0072-9752\n(\n10\n)\n97037-1\n.\nisbn\n9780444521392\n.\npmid\n20816443\n.\n^\nreed\nkl\n,\nblack\nsb\n,\nbanta\ncj\n,\nwill\nkr\n(\nmarch\n2010\n)\n.\n``\ncombin\noccipit\nand\nsupraorbit\nneurostimul\nfor\nthe\ntreatment\nof\nchronic\nmigrain\nheadach\n:\niniti\nexperi\n''\n.\ncephalalgia\n.\n30\n(\n3\n)\n:\n260–71\n.\ndoi:10.1111/j.1468-2982.2009.01996.x\n.\npmid\n19732075\n.\ns2cid\n18639211\n.\n^\n``\nfda\nallow\nmarket\nof\nfirst\nmedic\ndevic\nto\nprevent\nmigrain\nheadach\n''\n.\nfood\nand\ndrug\nadministr\n.\n11\nmarch\n2014\n.\narchiv\nfrom\nthe\norigin\non\n25\njuli\n2014\n.\nretriev\n25\njuli\n2014\n.\n^\n``\nfda\napprov\ntranscrani\nmagnet\nstimul\n''\n(\npdf\n)\n.\narchiv\n(\npdf\n)\nfrom\nthe\norigin\non\n21\nfebruari\n2014\n.\n^\ntao\nh\n,\nwang\nt\n,\ndong\nx\n,\nguo\nq\n,\nxu\nh\n,\nwan\nq\n(\nmay\n2018\n)\n.\n``\neffect\nof\ntranscutan\nelectr\nnerv\nstimul\nfor\nthe\ntreatment\nof\nmigrain\n:\na\nmeta-analysi\nof\nrandom\ncontrol\ntrial\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n19\n(\n1\n)\n:\n42.\ndoi:10.1186/s10194-018-0868-9\n.\npmc\n5975046\n.\npmid\n29845369\n.\nwe\nfound\nsignific\nreduct\nof\nmonthli\nheadach\nday\n^\nkung\nta\n,\nguyuron\nb\n,\ncederna\nps\n(\njanuari\n2011\n)\n.\n``\nmigrain\nsurgeri\n:\na\nplastic\nsurgeri\nsolut\nfor\nrefractori\nmigrain\nheadach\n''\n.\nplastic\nand\nreconstruct\nsurgeri\n.\n127\n(\n1\n)\n:\n181–189\n.\ndoi:10.1097/prs.0b013e3181f95a01\n.\npmid\n20871488\n.\ns2cid\n18817383\n.\n^\n``\namerican\nheadach\nsocieti\nfive\nthing\nphysician\nand\npatient\nshould\nquestion\n''\n.\nchoos\nwise\n.\narchiv\nfrom\nthe\norigin\non\n3\ndecemb\n2013\n.\nretriev\n24\nnovemb\n2013\n.\n^\nrabbi\nr\n,\nderri\ns\n,\nmoor\nra\n(\napril\n2013\n)\n.\n``\nibuprofen\nwith\nor\nwithout\nan\nantiemet\nfor\nacut\nmigrain\nheadach\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n4\n)\n:\ncd008039\n.\ndoi:10.1002/14651858.cd008039.pub3\n.\npmc\n4161114\n.\npmid\n23633348\n.\n^\nderri\ns\n,\nrabbi\nr\n,\nmoor\nra\n(\napril\n2013\n)\n.\n``\ndiclofenac\nwith\nor\nwithout\nan\nantiemet\nfor\nacut\nmigrain\nheadach\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n4\n)\n:\ncd008783\n.\ndoi:10.1002/14651858.cd008783.pub3\n.\npmc\n4164457\n.\npmid\n23633360\n.\n^\nkirthi\nv\n,\nderri\ns\n,\nmoor\nra\n(\napril\n2013\n)\n.\n``\naspirin\nwith\nor\nwithout\nan\nantiemet\nfor\nacut\nmigrain\nheadach\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n4\n)\n:\ncd008041\n.\ndoi:10.1002/14651858.cd008041.pub3\n.\npmc\n4163048\n.\npmid\n23633350\n.\n^\nderri\ns\n,\nmoor\nra\n(\napril\n2013\n)\n.\n``\nparacetamol\n(\nacetaminophen\n)\nwith\nor\nwithout\nan\nantiemet\nfor\nacut\nmigrain\nheadach\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n4\n)\n:\ncd008040\n.\ndoi:10.1002/14651858.cd008040.pub3\n.\npmc\n4161111\n.\npmid\n23633349\n.\n^\neken\nc\n(\nmarch\n2015\n)\n.\n``\ncritic\nreapprais\nof\nintraven\nmetoclopramid\nin\nmigrain\nattack\n:\na\nsystemat\nreview\nand\nmeta-analysi\n''\n.\nthe\namerican\njournal\nof\nemerg\nmedicin\n.\n33\n(\n3\n)\n:\n331–7\n.\ndoi:10.1016/j.ajem.2014.11.013\n.\npmid\n25579820\n.\n^\na\nb\nc\nd\norr\nsl\n,\nfriedman\nbw\n,\nchristi\ns\n,\nminen\nmt\n,\nbamford\nc\n,\nkelley\nne\n,\ntepper\nd\n(\njune\n2016\n)\n.\n``\nmanag\nof\nadult\nwith\nacut\nmigrain\nin\nthe\nemerg\ndepart\n:\nthe\namerican\nheadach\nsocieti\nevid\nassess\nof\nparenter\npharmacotherapi\n''\n.\nheadach\n.\n56\n(\n6\n)\n:\n911–40\n.\ndoi:10.1111/head.12835\n.\npmid\n27300483\n.\n^\nlaw\n,\nsimon\n;\nderri\n,\nsheena\n;\nmoor\n,\nr.\nandrew\n(\n2013-10-20\n)\n.\n``\nnaproxen\nwith\nor\nwithout\nan\nantiemet\nfor\nacut\nmigrain\nheadach\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n10\n)\n:\ncd009455\n.\ndoi:10.1002/14651858.cd009455.pub2\n.\nissn\n1469-493x\n.\npmc\n6540401\n.\npmid\n24142263\n.\n^\nsingh\n,\nrashmi\nb.\nhalker\n;\nvanderpluym\n,\njuliana\nh.\n;\nmorrow\n,\nallison\ns.\n;\nurtecho\n,\nmeritxel\n;\nnayfeh\n,\ntarek\n;\nroldan\n,\nvictor\nd.\ntorr\n;\nfarah\n,\nmagdoleen\nh.\n;\nhasan\n,\nbashar\n;\nsaadi\n,\nsamer\n(\n2020\n)\n.\nacut\ntreatment\nfor\nepisod\nmigrain\n.\nahrq\ncompar\neffect\nreview\n.\nrockvil\n(\nmd\n)\n:\nagenc\nfor\nhealthcar\nresearch\nand\nqualiti\n(\nus\n)\n.\npmid\n33411427\n.\n^\njohnston\nmm\n,\nrapoport\nam\n(\naugust\n2010\n)\n.\n``\ntriptan\nfor\nthe\nmanag\nof\nmigrain\n''\n.\ndrug\n.\n70\n(\n12\n)\n:\n1505–18\n.\ndoi:10.2165/11537990-000000000-00000\n.\npmid\n20687618\n.\ns2cid\n41613179\n.\n^\na\nb\nderri\n,\nchristoph\nj.\n;\nderri\n,\nsheena\n;\nmoor\n,\nr.\nandrew\n(\n2012-02-15\n)\n.\n``\nsumatriptan\n(\nrectal\nrout\nof\nadministr\n)\nfor\nacut\nmigrain\nattack\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n2\n)\n:\ncd009664\n.\ndoi:10.1002/14651858.cd009664\n.\nissn\n1469-493x\n.\npmc\n4170908\n.\npmid\n22336868\n.\n^\na\nb\nc\nderri\n,\nchristoph\nj.\n;\nderri\n,\nsheena\n;\nmoor\n,\nr.\nandrew\n(\n2012-02-15\n)\n.\n``\nsumatriptan\n(\nintranas\nrout\nof\nadministr\n)\nfor\nacut\nmigrain\nattack\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n2\n)\n:\ncd009663\n.\ndoi:10.1002/14651858.cd009663\n.\nissn\n1469-493x\n.\npmc\n4164476\n.\npmid\n22336867\n.\n^\na\nb\nderri\n,\nchristoph\nj.\n;\nderri\n,\nsheena\n;\nmoor\n,\nr.\nandrew\n(\n2012-02-15\n)\n.\n``\nsumatriptan\n(\nsubcutan\nrout\nof\nadministr\n)\nfor\nacut\nmigrain\nattack\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n(\n2\n)\n:\ncd009665\n.\ndoi:10.1002/14651858.cd009665\n.\nissn\n1469-493x\n.\npmc\n4164380\n.\npmid\n22336869\n.\n^\na\nb\n``\ngener\nmigrain\ndrug\ncould\nreliev\nyour\npain\nand\nsave\nyou\nmoney\n''\n.\nbest\nbuy\ndrug\n.\nconsum\nreport\n.\narchiv\nfrom\nthe\norigin\non\n4\naugust\n2013\n.\n^\ntepper\nsj\n,\ntepper\nde\n(\napril\n2010\n)\n.\n``\nbreak\nthe\ncycl\nof\nmedic\noverus\nheadach\n''\n.\ncleveland\nclinic\njournal\nof\nmedicin\n.\n77\n(\n4\n)\n:\n236–42\n.\ndoi:10.3949/ccjm.77a.09147\n.\npmid\n20360117\n.\ns2cid\n36333666\n.\n^\nlaw\ns\n,\nderri\ns\n,\nmoor\nra\n(\napril\n2016\n)\n.\n``\nsumatriptan\nplu\nnaproxen\nfor\nthe\ntreatment\nof\nacut\nmigrain\nattack\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n4\n:\ncd008541\n.\ndoi:10.1002/14651858.cd008541.pub3\n.\npmc\n6485397\n.\npmid\n27096438\n.\n^\na\nb\nsumamo\nschellenberg\n,\ne.\n;\ndryden\n,\nd.\nm.\n;\npasichnyk\n,\nd.\n;\nha\n,\nc.\n;\nvanderm\n,\nb.\n;\nfriedman\n,\nb.\nw.\n;\ncolman\n,\ni.\n;\nrow\n,\nb.\nh.\n(\n2012\n)\n.\n``\nacut\nmigrain\ntreatment\nin\nemerg\nset\n''\n.\npmid\n23304741\n.\ncite\njournal\nrequir\n|journal=\n(\nhelp\n)\n^\nkelley\nne\n,\ntepper\nde\n(\njanuari\n2012\n)\n.\n``\nrescu\ntherapi\nfor\nacut\nmigrain\n,\npart\n1\n:\ntriptan\n,\ndihydroergotamin\n,\nand\nmagnesium\n''\n.\nheadach\n.\n52\n(\n1\n)\n:\n114–28\n.\ndoi:10.1111/j.1526-4610.2011.02062.x\n.\npmid\n22211870\n.\ns2cid\n45767513\n.\n^\na\nb\nmorren\nja\n,\ngalvez-jimenez\nn\n(\ndecemb\n2010\n)\n.\n``\nwhere\nis\ndihydroergotamin\nmesyl\nin\nthe\nchang\nlandscap\nof\nmigrain\ntherapi\n?\n''\n.\nexpert\nopinion\non\npharmacotherapi\n.\n11\n(\n18\n)\n:\n3085–93\n.\ndoi:10.1517/14656566.2010.533839\n.\npmid\n21080856\n.\ns2cid\n44639896\n.\n^\ntfelt-hansen\np\n,\nsaxena\npr\n,\ndahlöf\nc\n,\npascual\nj\n,\nláinez\nm\n,\nhenri\np\n,\net\nal\n.\n(\njanuari\n2000\n)\n.\n``\nergotamin\nin\nthe\nacut\ntreatment\nof\nmigrain\n:\na\nreview\nand\neuropean\nconsensu\n''\n.\nbrain\n.\n123\n(\npt\n1\n)\n:\n9–18\n.\ndoi:10.1093/brain/123.1.9\n.\npmid\n10611116\n.\n^\nyablon\nla\n,\nmauskop\na\n(\n2011\n)\n.\n``\nmagnesium\nin\nheadach\n''\n.\nin\nvink\nr\n,\nnechifor\nm\n(\neds.\n)\n.\nmagnesium\nin\nthe\ncentral\nnervou\nsystem\n.\nadelaid\n(\nau\n)\n:\nunivers\nof\nadelaid\npress\n.\nisbn\n978-0-9870730-5-1\n.\npmid\n29920023\n.\nretriev\n19\naugust\n2020\n.\n^\ncolman\ni\n,\nfriedman\nbw\n,\nbrown\nmd\n,\ninn\ngd\n,\ngrafstein\ne\n,\nrobert\nte\n,\nrow\nbh\n(\njune\n2008\n)\n.\n``\nparenter\ndexamethason\nfor\nacut\nsever\nmigrain\nheadach\n:\nmeta-analysi\nof\nrandomis\ncontrol\ntrial\nfor\nprevent\nrecurr\n''\n.\nbmj\n.\n336\n(\n7657\n)\n:\n1359–61\n.\ndoi:10.1136/bmj.39566.806725.b\n.\npmc\n2427093\n.\npmid\n18541610\n.\n^\npiatka\nc\n,\nbeckett\nrd\n(\nfebruari\n2020\n)\n.\n``\npropofol\nfor\ntreatment\nof\nacut\nmigrain\nin\nthe\nemerg\ndepart\n:\na\nsystemat\nreview\n''\n.\nacadem\nemerg\nmedicin\n.\n27\n(\n2\n)\n:\n148–160\n.\ndoi:10.1111/acem.13870\n.\npmid\n31621134\n.\n^\nvukov\ncvetkov\nv\n,\njensen\nrh\n(\njanuari\n2019\n)\n.\n``\nneurostimul\nfor\nthe\ntreatment\nof\nchronic\nmigrain\nand\ncluster\nheadach\n''\n.\nacta\nneurologica\nscandinavica\n.\n139\n(\n1\n)\n:\n4–17\n.\ndoi:10.1111/ane.13034\n.\npmid\n30291633\n.\ns2cid\n52923061\n.\n^\nhambach\n,\na.\n;\nfrese\n,\na.\n;\never\n,\ns.\n(\n2013\n)\n.\n``\nsexuel\naktivität\nund\nkopfschmerz\n''\n.\nnervenheilkund\n(\nin\ngerman\n)\n.\ngeorg\nthiem\nverlag\nkg\n.\n32\n(\n3\n)\n:\n118–122\n.\ndoi:10.1055/s-0038-1628490\n.\nissn\n0722-1541\n.\n^\na\nb\nc\nd\nricher\nl\n,\nbillinghurst\nl\n,\nlinsdel\nma\n,\nrussel\nk\n,\nvanderm\nb\n,\ncrumley\net\n,\net\nal\n.\n(\napril\n2016\n)\n.\n``\ndrug\nfor\nthe\nacut\ntreatment\nof\nmigrain\nin\nchildren\nand\nadolesc\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n4\n(\n10\n)\n:\ncd005220\n.\ndoi:10.1002/14651858.cd005220.pub2\n.\npmc\n6516975\n.\npmid\n27091010\n.\n^\na\nb\noskoui\nm\n,\npringsheim\nt\n,\nholler-managan\ny\n,\npotreb\ns\n,\nbillinghurst\nl\n,\ngloss\nd\n,\net\nal\n.\n(\nseptemb\n2019\n)\n.\n``\npractic\nguidelin\nupdat\nsummari\n:\nacut\ntreatment\nof\nmigrain\nin\nchildren\nand\nadolesc\n:\nreport\nof\nthe\nguidelin\ndevelop\n,\ndissemin\n,\nand\nimplement\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\nand\nthe\namerican\nheadach\nsocieti\n''\n.\nneurolog\n.\n93\n(\n11\n)\n:\n487–499\n.\ndoi:10.1212/wnl.0000000000008095\n.\npmid\n31413171\n.\n^\nwang\n,\nguihua\n;\ntan\n,\ntianlin\n;\nliu\n,\nyao\n;\nhong\n,\npeiwei\n(\n2020\n)\n.\n``\ndrug\nfor\nacut\nattack\nof\npediatr\nmigrain\n:\na\nnetwork\nmeta-analysi\nof\nrandom\ncontrol\ntrial\n''\n.\nclinic\nneurolog\nand\nneurosurgeri\n.\n195\n:\n105853.\ndoi:10.1016/j.clineuro.2020.105853\n.\nissn\n1872-6968\n.\npmid\n32464520\n.\ns2cid\n215814011\n.\n^\nherd\ncp\n,\ntomlinson\ncl\n,\nrick\nc\n,\nscotton\nwj\n,\nedward\nj\n,\nive\nn\n,\net\nal\n.\n(\njune\n2018\n)\n.\n``\nbotulinum\ntoxin\nfor\nthe\nprevent\nof\nmigrain\nin\nadult\n''\n.\nthe\ncochran\ndatabas\nof\nsystemat\nreview\n.\n2018\n(\n6\n)\n:\ncd011616\n.\ndoi:10.1002/14651858.cd011616.pub2\n.\npmc\n6513576\n.\npmid\n29939406\n.\n^\njackson\njl\n,\nkuriyama\na\n,\nhayashino\ny\n(\napril\n2012\n)\n.\n``\nbotulinum\ntoxin\na\nfor\nprophylact\ntreatment\nof\nmigrain\nand\ntension\nheadach\nin\nadult\n:\na\nmeta-analysi\n''\n.\njama\n.\n307\n(\n16\n)\n:\n1736–45\n.\ndoi:10.1001/jama.2012.505\n.\npmid\n22535858\n.\n^\nsimpson\ndm\n,\nhallett\nm\n,\nashman\nej\n,\ncomella\ncl\n,\ngreen\nmw\n,\ngronseth\ngs\n,\net\nal\n.\n(\nmay\n2016\n)\n.\n``\npractic\nguidelin\nupdat\nsummari\n:\nbotulinum\nneurotoxin\nfor\nthe\ntreatment\nof\nblepharospasm\n,\ncervic\ndystonia\n,\nadult\nspastic\n,\nand\nheadach\n:\nreport\nof\nthe\nguidelin\ndevelop\nsubcommitte\nof\nthe\namerican\nacademi\nof\nneurolog\n''\n.\nneurolog\n.\n86\n(\n19\n)\n:\n1818–26\n.\ndoi:10.1212/wnl.0000000000002560\n.\npmc\n4862245\n.\npmid\n27164716\n.\n^\nmarkham\na\n(\njuli\n2018\n)\n.\n``\nerenumab\n:\nfirst\nglobal\napprov\n''\n.\ndrug\n.\n78\n(\n11\n)\n:\n1157–1161\n.\ndoi:10.1007/s40265-018-0944-0\n.\npmid\n29968151\n.\ns2cid\n49559342\n.\n^\nsilberstein\n,\nstephen\nd.\n;\nlee\n,\nlulu\n;\ngandhi\n,\nkavita\n;\nfitzgerald\n,\ntimothi\n;\nbell\n,\njvawnna\n;\ncohen\n,\njoshua\nm.\n(\n2018\n)\n.\n``\nhealth\ncare\nresourc\nutil\nand\nmigrain\ndisabl\nalong\nthe\nmigrain\ncontinuum\namong\npatient\ntreat\nfor\nmigrain\n''\n.\nheadach\n:\nthe\njournal\nof\nhead\nand\nface\npain\n.\n58\n(\n10\n)\n:\n1579–1592\n.\ndoi:10.1111/head.13421\n.\npmid\n30375650\n.\ns2cid\n53114546\n.\n^\na\nb\n``\nmigrain\ninform\npage\n:\nprognosi\narchiv\n2020-06-10\nat\nthe\nwayback\nmachin\n,\n''\nnation\ninstitut\nfor\nneurolog\ndisord\nand\nstroke\n(\nnind\n)\n,\nnation\ninstitut\nof\nhealth\n(\nus\n)\n.\n^\n``\nfact\nand\nfigur\n''\n.\nthe\nmigrain\ntrust\n.\n^\na\nb\nbrennan\n,\nkc\n;\npietrobon\n,\nd\n(\nmarch\n2018\n)\n.\n``\na\nsystem\nneurosci\napproach\nto\nmigrain\n''\n.\nneuron\n.\n97\n(\n5\n)\n:\n1004–1021\n.\ndoi:10.1016/j.neuron.2018.01.029\n.\npmc\n6402597\n.\npmid\n29518355\n.\n^\nworld\nhealth\norgan\n(\n2008\n)\n.\n``\ndisabl\nclass\nfor\nthe\nglobal\nburden\nof\ndiseas\nstudi\n''\n(\ntabl\n8\n)\n,\nthe\nglobal\nburden\nof\ndiseas\n:\n2004\nupdat\n,\np\n33\n.\n^\na\nb\nc\nschürk\nm\n,\nrist\npm\n,\nbigal\nme\n,\nbure\nje\n,\nlipton\nrb\n,\nkurth\nt\n(\noctob\n2009\n)\n.\n``\nmigrain\nand\ncardiovascular\ndiseas\n:\nsystemat\nreview\nand\nmeta-analysi\n''\n.\nbmj\n.\n339\n:\nb3914\n.\ndoi:10.1136/bmj.b3914\n.\npmc\n2768778\n.\npmid\n19861375\n.\n^\nkurth\nt\n,\nchabriat\nh\n,\nbousser\nmg\n(\njanuari\n2012\n)\n.\n``\nmigrain\nand\nstroke\n:\na\ncomplex\nassoci\nwith\nclinic\nimplic\n''\n.\nthe\nlancet\n.\nneurolog\n.\n11\n(\n1\n)\n:\n92–100\n.\ndoi:10.1016/s1474-4422\n(\n11\n)\n70266-6\n.\npmid\n22172624\n.\ns2cid\n31939284\n.\n^\nrist\npm\n,\ndiener\nhc\n,\nkurth\nt\n,\nschürk\nm\n(\njune\n2011\n)\n.\n``\nmigrain\n,\nmigrain\naura\n,\nand\ncervic\narteri\ndissect\n:\na\nsystemat\nreview\nand\nmeta-analysi\n''\n.\ncephalalgia\n.\n31\n(\n8\n)\n:\n886–96\n.\ndoi:10.1177/0333102411401634\n.\npmc\n3303220\n.\npmid\n21511950\n.\n^\nkurth\nt\n(\nmarch\n2010\n)\n.\n``\nthe\nassoci\nof\nmigrain\nwith\nischem\nstroke\n''\n.\ncurrent\nneurolog\nand\nneurosci\nreport\n.\n10\n(\n2\n)\n:\n133–9\n.\ndoi:10.1007/s11910-010-0098-2\n.\npmid\n20425238\n.\ns2cid\n27227332\n.\n^\nschürk\nm\n,\nrist\npm\n,\nshapiro\nre\n,\nkurth\nt\n(\nseptemb\n2011\n)\n.\n``\nmigrain\nand\nmortal\n:\na\nsystemat\nreview\nand\nmeta-analysi\n''\n.\ncephalalgia\n.\n31\n(\n12\n)\n:\n1301–14\n.\ndoi:10.1177/0333102411415879\n.\npmc\n3175288\n.\npmid\n21803936\n.\n^\nweinberg\nj\n(\nmarch\n2007\n)\n.\n``\nstroke\nand\nmigrain\n''\n.\ncurrent\ncardiolog\nreport\n.\n9\n(\n1\n)\n:\n13–9\n.\ndoi:10.1007/s11886-007-0004-i\n.\npmid\n17362679\n.\ns2cid\n46681674\n.\n^\nhougaard\na\n,\namin\nfm\n,\nashina\nm\n(\njune\n2014\n)\n.\n``\nmigrain\nand\nstructur\nabnorm\nin\nthe\nbrain\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n27\n(\n3\n)\n:\n309–14\n.\ndoi:10.1097/wco.0000000000000086\n.\npmid\n24751961\n.\n^\nwang\nsj\n(\nmarch\n2003\n)\n.\n``\nepidemiolog\nof\nmigrain\nand\nother\ntype\nof\nheadach\nin\nasia\n''\n.\ncurrent\nneurolog\nand\nneurosci\nreport\n.\n3\n(\n2\n)\n:\n104–8\n.\ndoi:10.1007/s11910-003-0060-7\n.\npmid\n12583837\n.\ns2cid\n24939546\n.\n^\nnatoli\njl\n,\nmanack\na\n,\ndean\nb\n,\nbutler\nq\n,\nturkel\ncc\n,\nstovner\nl\n,\nlipton\nrb\n(\nmay\n2010\n)\n.\n``\nglobal\npreval\nof\nchronic\nmigrain\n:\na\nsystemat\nreview\n''\n.\ncephalalgia\n.\n30\n(\n5\n)\n:\n599–609\n.\ndoi:10.1111/j.1468-2982.2009.01941.x\n.\npmid\n19614702\n.\ns2cid\n5328642\n.\n^\na\nb\nhershey\nad\n(\nfebruari\n2010\n)\n.\n``\ncurrent\napproach\nto\nthe\ndiagnosi\nand\nmanag\nof\npaediatr\nmigrain\n''\n.\nthe\nlancet\n.\nneurolog\n.\n9\n(\n2\n)\n:\n190–204\n.\ndoi:10.1016/s1474-4422\n(\n09\n)\n70303-5\n.\npmid\n20129168\n.\ns2cid\n12603488\n.\n^\na\nb\nnappi\nre\n,\nsanc\ng\n,\ndetaddei\ns\n,\nornati\na\n,\nchiovato\nl\n,\npolatti\nf\n(\njune\n2009\n)\n.\n``\nhormon\nmanag\nof\nmigrain\nat\nmenopaus\n''\n.\nmenopaus\nintern\n.\n15\n(\n2\n)\n:\n82–6\n.\ndoi:10.1258/mi.2009.009022\n.\npmid\n19465675\n.\ns2cid\n23204921\n.\n^\na\nb\nc\nd\ne\nborsook\nd\n(\n2012\n)\n.\nthe\nmigrain\nbrain\n:\nimag\n,\nstructur\n,\nand\nfunction\n.\nnew\nyork\n:\noxford\nunivers\npress\n.\npp\n.\n3–11\n.\nisbn\n9780199754564\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\na\nb\nsteven\nd.\nwaldman\n(\n2011\n)\n.\npain\nmanag\n(\n2\ned.\n)\n.\nphiladelphia\n,\npa\n:\nelsevier/saund\n.\npp\n.\n2122–2124\n.\nisbn\n9781437736038\n.\n^\n``\nsex\n(\nism\n)\n,\ndrug\n,\nand\nmigrain\n''\n.\ndistil\n.\nscienc\nhistori\ninstitut\n.\n15\njanuari\n2019\n.\nretriev\n6\nfebruari\n2020\n.\n^\nmargaret\nc\n,\nsimon\nm\n(\n2002\n)\n.\nhuman\nosteolog\n:\nin\narchaeolog\nand\nforens\nscienc\n(\nrepr\n.\ned.\n)\n.\ncambridg\n[\netc\n.\n]\n:\ncambridg\nunivers\npress\n.\np.\n345\n.\nisbn\n9780521691468\n.\narchiv\nfrom\nthe\norigin\non\n17\njune\n2013\n.\n^\ncolen\nc\n(\n2008\n)\n.\nneurosurgeri\n.\ncolen\npublish\n.\np.\n1\n.\nisbn\n9781935345039\n.\n^\ndaniel\nbt\n(\n2010\n)\n.\nmigrain\n.\nbloomington\n,\nin\n:\nauthorhous\n.\np.\n101\n.\nisbn\n9781449069629\n.\narchiv\nfrom\nthe\norigin\non\n13\nmarch\n2017\n.\n^\na\nb\ntfelt-hansen\npc\n,\nkoehler\npj\n(\nmay\n2011\n)\n.\n``\none\nhundr\nyear\nof\nmigrain\nresearch\n:\nmajor\nclinic\nand\nscientif\nobserv\nfrom\n1910\nto\n2010\n''\n.\nheadach\n.\n51\n(\n5\n)\n:\n752–78\n.\ndoi:10.1111/j.1526-4610.2011.01892.x\n.\npmid\n21521208\n.\ns2cid\n31940152\n.\n^\na\nb\nc\nstovner\nlj\n,\nandré\nc\n(\njune\n2008\n)\n.\n``\nimpact\nof\nheadach\nin\neurop\n:\na\nreview\nfor\nthe\neurolight\nproject\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n9\n(\n3\n)\n:\n139–46\n.\ndoi:10.1007/s10194-008-0038-6\n.\npmc\n2386850\n.\npmid\n18418547\n.\n^\na\nb\nmennini\nfs\n,\ngitto\nl\n,\nmartelletti\np\n(\naugust\n2008\n)\n.\n``\nimprov\ncare\nthrough\nhealth\neconom\nanalys\n:\ncost\nof\nill\nand\nheadach\n''\n.\nthe\njournal\nof\nheadach\nand\npain\n.\n9\n(\n4\n)\n:\n199–206\n.\ndoi:10.1007/s10194-008-0051-9\n.\npmc\n3451939\n.\npmid\n18604472\n.\n^\nmagi\nd\n,\njensen\nr\n,\nschoenen\nj\n(\njune\n2012\n)\n.\n``\nneurostimul\ntherapi\nfor\nprimari\nheadach\ndisord\n:\npresent\nand\nfutur\n''\n.\ncurrent\nopinion\nin\nneurolog\n.\n25\n(\n3\n)\n:\n269–76\n.\ndoi:10.1097/wco.0b013e3283532023\n.\npmid\n22543428\n.\n^\njürgen\ntp\n,\nleon\nm\n(\njune\n2013\n)\n.\n``\npearl\nand\npitfal\n:\nneurostimul\nin\nheadach\n''\n.\ncephalalgia\n.\n33\n(\n8\n)\n:\n512–25\n.\ndoi:10.1177/0333102413483933\n.\npmid\n23671249\n.\ns2cid\n42537455\n.\n^\nbarbanti\np\n,\nfofi\nl\n,\naurilia\nc\n,\negeo\ng\n,\ncaprio\nm\n(\nmay\n2017\n)\n.\n``\nketogen\ndiet\nin\nmigrain\n:\nrational\n,\nfind\nand\nperspect\n''\n.\nneurolog\nscienc\n(\nreview\n)\n.\n38\n(\nsuppl\n1\n)\n:\n111–115\n.\ndoi:10.1007/s10072-017-2889-6\n.\npmid\n28527061\n.\ns2cid\n3805337\n.\n^\ngross\nec\n,\nklement\nrj\n,\nschoenen\nj\n,\nd'agostino\ndp\n,\nfischer\nd\n(\napril\n2019\n)\n.\n``\npotenti\nprotect\nmechan\nof\nketon\nbodi\nin\nmigrain\nprevent\n''\n.\nnutrient\n.\n11\n(\n4\n)\n:\n811.\ndoi:10.3390/nu11040811\n.\npmc\n6520671\n.\npmid\n30974836\n.\n^\nartero-moral\nm\n,\ngonzález-rodríguez\ns\n,\nferrer-montiel\na\n(\n2018\n)\n.\n``\ntrp\nchannel\nas\npotenti\ntarget\nfor\nsex-rel\ndiffer\nin\nmigrain\npain\n''\n.\nfrontier\nin\nmolecular\nbioscienc\n.\n5\n:\n73.\ndoi:10.3389/fmolb.2018.00073\n.\npmc\n6102492\n.\npmid\n30155469\n.\n^\nstewart\n,\nwalter\nf.\n;\nlipton\n,\nrichard\nb.\n;\ncelentano\n,\ndavid\nd.\n;\nreed\n,\nmichael\nl.\n(\n1992-01-01\n)\n.\n``\npreval\nof\nmigrain\nheadach\nin\nthe\nunit\nstate\n:\nrelat\nto\nage\n,\nincom\n,\nrace\n,\nand\nother\nsociodemograph\nfactor\n''\n.\njama\n.\n267\n(\n1\n)\n:\n64–69\n.\ndoi:10.1001/jama.1992.03480010072027\n.\nissn\n0098-7484\n.\npmid\n1727198\n.\n^\n``\nspeed\nprogress\nin\nmigrain\nrequir\nunravel\nsex\ndiffer\n''\n.\nswhr\n.\n2018-08-28\n.\nretriev\n2021-03-17\n.\n^\n``\nmigrain\nin\nwomen\nneed\nmore\nsex-specif\nresearch\n''\n.\nmigrain\nagain\n.\n2021-03-11\n.\nretriev\n2021-03-17\n.\n^\nschroeder\nra\n,\nbrand\nj\n,\nbuse\ndc\n,\ncalhoun\na\n,\neikermann-haert\nk\n,\ngolden\nk\n,\net\nal\n.\n(\naugust\n2018\n)\n.\n``\nsex\nand\ngender\ndiffer\nin\nmigraine-evalu\nknowledg\ngap\n''\n.\njournal\nof\nwomen\n's\nhealth\n.\n27\n(\n8\n)\n:\n965–973\n.\ndoi:10.1089/jwh.2018.7274\n.\npmid\n30129895\n.\ns2cid\n52048078\n.\nnote\n[\nedit\n]\nolesen\nj\n(\n2006\n)\n.\nthe\nheadach\n(\n3\ned.\n)\n.\nphiladelphia\n:\nlippincott\nwilliam\n&\nwilkin\n.\nisbn\n9780781754002\n.\nfurther\nread\n[\nedit\n]\nashina\nm\n(\nnovemb\n2020\n)\n.\nropper\nah\n(\ned.\n)\n.\n``\nmigrain\n''\n.\nthe\nnew\nengland\njournal\nof\nmedicin\n.\n383\n(\n19\n)\n:\n1866–1876\n.\ndoi:10.1056/nejmra1915327\n.\npmid\n33211930\n.\ns2cid\n227078662\n.\nextern\nlink\n[\nedit\n]\nwikipedia\n's\nhealth\ncare\narticl\ncan\nbe\nview\nofflin\nwith\nthe\nmedic\nwikipedia\napp\n.\nextern\naudio\nsex\n(\nism\n)\n,\ndrug\n,\nand\nmigrain\n,\ndistil\npodcast\n,\nscienc\nhistori\ninstitut\n,\n15\njanuari\n2019\nmigrain\nat\ncurli\n2019\nguidelin\non\nmigrain\nprevent\nin\nchildren\n2019\nguidelin\non\nmigrain\ntreatment\nin\nchildren\nclassificationdicd-10\n:\ng43icd-9-cm\n:\n346omim\n:\n157300mesh\n:\nd008881diseasesdb\n:\n8207extern\nresourcesmedlineplu\n:\n000709emedicin\n:\nneuro/218\nneuro/517\nemerg/230\nneuro/529pati\nuk\n:\nmigrain\n.mw-parser-output\n.navbox\n{\nbox-siz\n:\nborder-box\n;\nborder:1px\nsolid\n#\na2a9b1\n;\nwidth:100\n%\n;\nclear\n:\nboth\n;\nfont-size:88\n%\n;\ntext-align\n:\ncenter\n;\npadding:1px\n;\nmargin:1em\nauto\n0\n}\n.mw-parser-output\n.navbox\n.navbox\n{\nmargin-top:0\n}\n.mw-parser-output\n.navbox+.navbox\n,\n.mw-parser-output\n.navbox+.navbox-styles+.navbox\n{\nmargin-top\n:\n-1px\n}\n.mw-parser-output\n.navbox-inn\n,\n.mw-parser-output\n.navbox-subgroup\n{\nwidth:100\n%\n}\n.mw-parser-output\n.navbox-group\n,\n.mw-parser-output\n.navbox-titl\n,\n.mw-parser-output\n.navbox-abovebelow\n{\npadding:0.25em\n1em\n;\nline-height:1.5em\n;\ntext-align\n:\ncenter\n}\n.mw-parser-output\n.navbox-group\n{\nwhite-spac\n:\nnowrap\n;\ntext-align\n:\nright\n}\n.mw-parser-output\n.navbox\n,\n.mw-parser-output\n.navbox-subgroup\n{\nbackground-color\n:\n#\nfdfdfd\n}\n.mw-parser-output\n.navbox-list\n{\nline-height:1.5em\n;\nborder-color\n:\n#\nfdfdfd\n}\n.mw-parser-output\n.navbox-list-with-group\n{\ntext-align\n:\nleft\n;\nborder-left-width:2px\n;\nborder-left-styl\n:\nsolid\n}\n.mw-parser-output\ntr+tr\n>\n.navbox-abovebelow\n,\n.mw-parser-output\ntr+tr\n>\n.navbox-group\n,\n.mw-parser-output\ntr+tr\n>\n.navbox-imag\n,\n.mw-parser-output\ntr+tr\n>\n.navbox-list\n{\nborder-top:2px\nsolid\n#\nfdfdfd\n}\n.mw-parser-output\n.navbox\nth\n,\n.mw-parser-output\n.navbox-titl\n{\nbackground-color\n:\n#\nccf\n}\n.mw-parser-output\n.navbox-abovebelow\n,\n.mw-parser-output\nth.navbox-group\n,\n.mw-parser-output\n.navbox-subgroup\n.navbox-titl\n{\nbackground-color\n:\n#\nddf\n}\n.mw-parser-output\n.navbox-subgroup\n.navbox-group\n,\n.mw-parser-output\n.navbox-subgroup\n.navbox-abovebelow\n{\nbackground-color\n:\n#\ne6e6ff\n}\n.mw-parser-output\n.navbox-even\n{\nbackground-color\n:\n#\nf7f7f7\n}\n.mw-parser-output\n.navbox-odd\n{\nbackground-color\n:\ntranspar\n}\n.mw-parser-output\n.navbox\n.hlist\ntd\ndl\n,\n.mw-parser-output\n.navbox\n.hlist\ntd\nol\n,\n.mw-parser-output\n.navbox\n.hlist\ntd\nul\n,\n.mw-parser-output\n.navbox\ntd.hlist\ndl\n,\n.mw-parser-output\n.navbox\ntd.hlist\nol\n,\n.mw-parser-output\n.navbox\ntd.hlist\nul\n{\npadding:0.125em\n0\n}\n.mw-parser-output\n.navbox\n.navbar\n{\ndisplay\n:\nblock\n;\nfont-size:100\n%\n}\n.mw-parser-output\n.navbox-titl\n.navbar\n{\nfloat\n:\nleft\n;\ntext-align\n:\nleft\n;\nmargin-right:0.5em\n}\n.mw-parser-output\n.navbar\n{\ndisplay\n:\ninlin\n;\nfont-size:88\n%\n;\nfont-weight\n:\nnormal\n}\n.mw-parser-output\n.navbar-collaps\n{\nfloat\n:\nleft\n;\ntext-align\n:\nleft\n}\n.mw-parser-output\n.navbar-boxtext\n{\nword-spacing:0\n}\n.mw-parser-output\n.navbar\nul\n{\ndisplay\n:\ninline-block\n;\nwhite-spac\n:\nnowrap\n;\nline-height\n:\ninherit\n}\n.mw-parser-output\n.navbar-bracket\n:\n:befor\n{\nmargin-right\n:\n-0.125em\n;\ncontent\n:\n''\n[\n``\n}\n.mw-parser-output\n.navbar-bracket\n:\n:after\n{\nmargin-left\n:\n-0.125em\n;\ncontent\n:\n''\n]\n''\n}\n.mw-parser-output\n.navbar\nli\n{\nword-spac\n:\n-0.125em\n}\n.mw-parser-output\n.navbar\na\n>\nspan\n,\n.mw-parser-output\n.navbar\na\n>\nabbr\n{\ntext-decor\n:\ninherit\n}\n.mw-parser-output\n.navbar-mini\nabbr\n{\nfont-vari\n:\nsmall-cap\n;\nborder-bottom\n:\nnone\n;\ntext-decor\n:\nnone\n;\ncursor\n:\ninherit\n}\n.mw-parser-output\n.navbar-ct-ful\n{\nfont-size:114\n%\n;\nmargin:0\n7em\n}\n.mw-parser-output\n.navbar-ct-mini\n{\nfont-size:114\n%\n;\nmargin:0\n4em\n}\n.mw-parser-output\n.infobox\n.navbar\n{\nfont-size:100\n%\n}\n.mw-parser-output\n.navbox\n.navbar\n{\ndisplay\n:\nblock\n;\nfont-size:100\n%\n}\n.mw-parser-output\n.navbox-titl\n.navbar\n{\nfloat\n:\nleft\n;\ntext-align\n:\nleft\n;\nmargin-right:0.5em\n}\nvtediseas\nof\nthe\nnervou\nsystem\n,\nprimarili\ncnsinflammationbrain\nenceph\nviral\nenceph\nherpesvir\nenceph\nlimbic\nenceph\nenceph\nlethargica\ncavern\nsinu\nthrombosi\nbrain\nabscess\namoeb\nbrain\nand\nspinal\ncord\nencephalomyel\nacut\ndissemin\nmening\nmeningoenceph\nbrain/encephalopathydegenerativeextrapyramid\nandmov\ndisord\nbasal\nganglia\ndiseas\nparkinson\npd\npostencephalit\nnm\npkan\ntauopathi\npsp\nstriatonigr\ndegener\nhemiballismu\nhd\noa\ndyskinesia\ndystonia\nstatu\ndystonicu\nspasmod\ntorticolli\nmeige'\nblepharospasm\nathetosi\nchorea\nchoreoathetosi\nmyoclonu\nmyoclon\nepilepsi\nakathisia\ntremor\nessenti\ntremor\nintent\ntremor\nrestless\nleg\nstiff-person\ndementia\ntauopathi\nalzheimer'\nearly-onset\nprimari\nprogress\naphasia\nfrontotempor\ndementia/frontotempor\nlobar\ndegener\npick'\ndementia\nwith\nlewi\nbodi\nposterior\ncortic\natrophi\nvascular\ndementia\nmitochondri\ndiseas\nleigh\nsyndrom\ndemyelin\nautoimmun\ninflammatori\nmultipl\nsclerosi\nfor\nmore\ndetail\ncoverag\n,\nsee\ntemplat\n:\ndemyelin\ndiseas\nof\ncn\nepisodic/paroxysmalseizur\nand\nepilepsi\nfocal\ngeneralis\nstatu\nepilepticu\nfor\nmore\ndetail\ncoverag\n,\nsee\ntemplat\n:\nepilepsi\nheadach\nmigrain\ncluster\ntension\nfor\nmore\ndetail\ncoverag\n,\nsee\ntemplat\n:\nheadach\ncerebrovascular\ntia\nstroke\nfor\nmore\ndetail\ncoverag\n,\nsee\ntemplat\n:\ncerebrovascular\ndiseas\nother\nsleep\ndisord\nfor\nmore\ndetail\ncoverag\n,\nsee\ntemplat\n:\nsleep\ncsf\nintracrani\nhypertens\nhydrocephalu\nnormal\npressur\nhydrocephalu\nchoroid\nplexu\npapilloma\nidiopath\nintracrani\nhypertens\ncerebr\nedema\nintracrani\nhypotens\nother\nbrain\nherniat\nrey\nsyndrom\nhepat\nencephalopathi\ntoxic\nencephalopathi\nhashimoto\n's\nencephalopathi\nboth/eitherdegenerativesa\nfriedreich\n's\nataxia\nataxia–telangiectasia\nmnd\numn\nonli\n:\nprimari\nlater\nsclerosi\npseudobulbar\npalsi\nhereditari\nspastic\nparaplegia\nlmn\nonli\n:\ndistal\nhereditari\nmotor\nneuronopathi\nspinal\nmuscular\natrophi\nsma\nsmax1\nsmax2\ndsma1\ncongenit\ndsma\nspinal\nmuscular\natrophi\nwith\nlower\nextrem\npredomin\n(\nsmale\n)\nsmaled1\nsmaled2a\nsmaled2b\nsma-pch\nsma-pm\nprogress\nmuscular\natrophi\nprogress\nbulbar\npalsi\nfazio–lond\ninfantil\nprogress\nbulbar\npalsi\nboth\n:\namyotroph\nlater\nsclerosi\nvteheadacheprimaryichd\n1\nmigrain\nfamili\nhemipleg\nretin\nmigrain\nichd\n2\ntension\nmix\ntension\nmigrain\nichd\n3\ncluster\nchronic\nparoxysm\nhemicrania\nsunct\nichd\n4\nhemicrania\ncontinua\nthunderclap\nheadach\nsexual\nheadach\nnew\ndaili\npersist\nheadach\nhypnic\nheadach\nsecondaryichd\n5\nmigralepsi\nichd\n7\nictal\nheadach\npost-dural-punctur\nheadach\nichd\n8\nhangov\nmedic\noverus\nheadach\nichd\n13\ntrigemin\nneuralgia\noccipit\nneuralgia\nextern\ncompress\nheadach\ncold-stimulu\nheadach\noptic\nneuriti\npostherpet\nneuralgia\ntolosa–hunt\nsyndrom\nother\northostat\nvascular\nvteantimigrain\nprepar\n(\nn02c\n)\nanalgesic/abortiveserotonergicsergolin\ndihydroergocryptin\ndihydroergotamin\nergotamin\n(\n+caffein\n,\n+chlorcyclizine/caffein\n)\nlisurid\nmethylergometrin\nmethysergid\n5-ht1\nagoniststriptan\nalmotriptan\navitriptan\neletriptan\nfrovatriptan\nnaratriptan\nrizatriptan\nsumatriptan\nzolmitriptan\nditan\nalniditan§\nlasmiditan\nother\ndimetotiazin\ndotarizin\niprazochrom\noxetoron\npizotifen\ncgrp-r\nantagonist\natogep\nrimegep\nubrogep\nother\nparacetamol\n#\namidrin\nprophylacticcalcium\nchannel\nblocker\ndotarizin\nlomerizin\nverapamil\nflunarizin\nprogestogen\nflumedroxon\nacet\nsympatholyt\nbeta\nblocker\npropranolol\n#\ntimolol\nclonidin\ntricycl\nantidepress\namitriptylin\nnortriptylin\nimipramin\nanticonvuls\ncarbamazepin\noxcarbazepin\ntopiram\nvalproat\nanti-cgrp/cgrp-r\nmab\neptinezumab\nerenumab\nfremanezumab\ngalcanezumab\n#\nwho-em\n‡withdrawn\nfrom\nmarket\nclinic\ntrial\n:\n†phase\niii\n§never\nto\nphase\niii\nauthor\ncontrol\ngener\nintegr\nauthor\nfile\n(\ngermani\n)\nnation\nlibrari\nfranc\n(\ndata\n)\nunit\nstate\njapan\ncroatia\nother\nmicrosoft\nacadem\n2\n<\nimg\nsrc=\n''\n//en.wikipedia.org/wiki/speci\n:\ncentralautologin/start\n?\ntype=1x1\n''\nalt=\n''\n''\ntitle=\n''\n''\nwidth=\n''\n1\n''\nheight=\n''\n1\n''\nstyle=\n''\nborder\n:\nnone\n;\nposit\n:\nabsolut\n;\n''\n/\n>\nretriev\nfrom\n``\nhttp\n:\n//en.wikipedia.org/w/index.php\n?\ntitle=migrain\n&\noldid=1057390672\n''\ncommon\nsymptom\nof\na\nmigrain\nthe\nmain\nsymptom\nof\na\nmigrain\nis\nusual\nan\nintens\nheadach\non\n1\nside\nof\nthe\nhead\n.\nthe\npain\nis\nusual\na\nmoder\nor\nsever\nthrob\nsensat\nthat\nget\nwors\nwhen\nyou\nmove\nand\nprevent\nyou\ncarri\nout\nnormal\nactiv\n.\nin\nsome\ncase\n,\nthe\npain\ncan\noccur\non\nboth\nside\nof\nyour\nhead\nand\nmay\naffect\nyour\nface\nor\nneck\n.\naddit\nsymptom\nother\nsymptom\ncommonli\nassoci\nwith\na\nmigrain\ninclud\n:\nfeel\nsick\nbe\nsick\nincreas\nsensit\nto\nlight\nand\nsound\n,\nwhich\nis\nwhi\nmani\npeopl\nwith\na\nmigrain\nwant\nto\nrest\nin\na\nquiet\n,\ndark\nroom\nsome\npeopl\nalso\noccasion\nexperi\nother\nsymptom\n,\ninclud\n:\nsweat\npoor\nconcentr\n,\nfeel\nveri\nhot\nor\nveri\ncold\ntummi\n(\nabdomin\n)\npain\ndiarrhoea\nnot\neveryon\nwith\na\nmigrain\nexperi\nthese\naddit\nsymptom\nand\nsome\npeopl\nmay\nexperi\nthem\nwithout\nhave\na\nheadach\n.\nthe\nsymptom\nof\na\nmigrain\nusual\nlast\nbetween\n4\nhour\nand\n3\nday\n,\nalthough\nyou\nmay\nfeel\nveri\ntire\nfor\nup\nto\na\nweek\nafterward\n.\nsymptom\nof\naura\nabout\n1\nin\n3\npeopl\nwith\nmigrain\nhave\ntemporari\nwarn\nsymptom\n,\nknown\nas\naura\n,\nbefor\na\nmigrain\n.\nthese\ninclud\n:\nvisual\nproblem\n–\nsuch\nas\nsee\nflash\nlight\n,\nzig-zag\npattern\nor\nblind\nspot\nnumb\nor\na\ntingl\nsensat\nlike\npin\nand\nneedl\n–\nwhich\nusual\nstart\nin\n1\nhand\nand\nmove\nup\nyour\narm\nbefor\naffect\nyour\nface\n,\nlip\nand\ntongu\nfeel\ndizzi\nor\noff\nbalanc\ndifficulti\nspeak\nloss\nof\nconscious\n–\nalthough\nthi\nis\nunusu\naura\nsymptom\ntypic\ndevelop\nover\nthe\ncours\nof\nabout\n5\nminut\nand\nlast\nfor\nup\nto\nan\nhour\n.\nsome\npeopl\nmay\nexperi\naura\nfollow\nby\nonli\na\nmild\nheadach\nor\nno\nheadach\nat\nall\n.\nwhen\nto\nget\nmedic\nadvic\nyou\nshould\nsee\na\ngp\nif\nyou\nhave\nfrequent\nor\nsever\nmigrain\nsymptom\nthat\ncan\nnot\nbe\nmanag\nwith\noccasion\nuse\nof\nover-the-count\npainkil\n,\nsuch\nas\nparacetamol\n.\ntri\nnot\nto\nuse\nthe\nmaximum\ndosag\nof\npainkil\non\na\nregular\nor\nfrequent\nbasi\nas\nthi\ncould\nmake\nit\nharder\nto\ntreat\nheadach\nover\ntime\n.\nyou\nshould\nalso\nmake\nan\nappoint\nto\nsee\na\ngp\nif\nyou\nhave\nfrequent\nmigrain\n(\non\nmore\nthan\n5\nday\na\nmonth\n)\n,\neven\nif\nthey\ncan\nbe\ncontrol\nwith\nmedicin\n,\nas\nyou\nmay\nbenefit\nfrom\nprevent\ntreatment\n.\nyou\nshould\ncall\n999\nfor\nan\nambul\nimmedi\nif\nyou\nor\nsomeon\nyou\n're\nwith\nexperi\n:\nparalysi\nor\nweak\nin\n1\nor\nboth\narm\nor\n1\nside\nof\nthe\nface\nslur\nor\ngarbl\nspeech\na\nsudden\nagonis\nheadach\nresult\nin\na\nsever\npain\nunlik\nanyth\nexperienc\nbefor\nheadach\nalong\nwith\na\nhigh\ntemperatur\n(\nfever\n)\n,\nstiff\nneck\n,\nmental\nconfus\n,\nseizur\n,\ndoubl\nvision\nand\na\nrash\nthese\nsymptom\nmay\nbe\na\nsign\nof\na\nmore\nseriou\ncondit\n,\nsuch\nas\na\nstroke\nor\nmening\n,\nand\nshould\nbe\nassess\nby\na\ndoctor\nas\nsoon\nas\npossibl\n.\nfind\nout\nmore\nabout\ndiagnos\nmigrain\nstage\nof\na\nmigrain\nmigrain\noften\ndevelop\nin\ndistinct\nstage\n,\nalthough\nnot\neveryon\ngoe\nthrough\nall\nof\nthese\n:\nprodrom\n(\npre-headach\n)\nstage\n–\nchang\nin\nmood\n,\nenergi\nlevel\n,\nbehaviour\nand\nappetit\nthat\ncan\noccur\nsever\nhour\nor\nday\nbefor\nan\nattack\naura\n–\nusual\nvisual\nproblem\n,\nsuch\nas\nflash\nof\nlight\nor\nblind\nspot\n,\nwhich\ncan\nlast\nfor\n5\nminut\nto\nan\nhour\nheadach\nstage\n–\nusual\na\npulsat\nor\nthrob\npain\non\n1\nside\nof\nthe\nhead\n,\noften\naccompani\nby\nfeel\nsick\n,\nvomit\nor\nextrem\nsensit\nto\nbright\nlight\nand\nloud\nsound\n,\nwhich\ncan\nlast\nfor\n4\nto\n72\nhour\nresolut\nstage\n–\nwhen\nthe\nheadach\nand\nother\nsymptom\ngradual\nfade\naway\n,\nalthough\nyou\nmay\nfeel\ntire\nfor\na\nfew\nday\nafterward\npage\nlast\nreview\n:\n10\nmay\n2019\nnext\nreview\ndue\n:\n10\nmay\n2022\npreviou\n:\nmigrain\nnext\n:\ncaus\nwhat\nare\nmigrain\nsymptom\n?\na\nmigrain\nisn\n’\nt\njust\nan\naverag\nheadach\n.\nmigrain\nare\nstrong\n,\npound\nheadach\ntypic\non\none\nside\nof\nthe\nhead.migrain\nusual\ninclud\nsever\nother\nsymptom\n.\nthey\n’\nre\nsometim\npreced\nby\nwarn\nsymptom\ncall\naura\n.\nthese\nsymptom\nmay\ninclud\nflash\nof\nlight\n,\nvisual\n“\nfloater\n,\n”\nor\ntingl\nsensat\nin\nyour\narm\nand\nlegs.migrain\nepisod\n,\nwhich\ncan\nlast\nfor\nhour\nor\nday\n,\ncan\ngreatli\naffect\nyour\nlife\n.\naccord\nto\nthe\nnation\ninstitut\nof\nneurolog\ndisord\nand\nstroke\n,\ntrust\nsourc\nmigrain\nare\nexperienc\nby\n12\npercent\nof\nthe\nu.s.\nadult\npopul\n.\nmani\nof\nthese\nmigrain\nare\ncaus\nby\nthe\nactiv\nof\nnerv\nfiber\nin\nthe\nblood\nvessel\nof\nthe\nbrain.th\nclassic\nmigrain\nevolv\nthrough\nfour\nsepar\nstage\n.\neach\nstage\nha\ndiffer\nsymptom\n.\nthese\nstage\ninclud\n:\nthe\nprodrom\n(\npremonitori\n)\nstageth\naura\n(\nvisual\nsymptom\nor\ntingl\n)\nthe\nheadach\n(\nmain\nattack\n)\nstageth\npostdrom\n(\nrecoveri\n)\nstagenot\nall\npeopl\nwho\nget\nmigrain\nexperi\nall\nof\nthe\nstage\n.\nprodrom\nstageth\npremonitori\nor\nprodrom\nstage\ncan\nstart\nanywher\nfrom\none\nhour\nto\ntwo\nday\nbefor\nyour\nmigrain\nbegin\n.\nsymptom\nthat\nmay\nindic\nthat\na\nmigrain\nis\ncome\non\ninclud\n:\nfatiguemood\nchang\n,\nsuch\nas\nanxieti\nor\ndepressionthirstcrav\nfor\nsugari\nfoodstight\nor\nsore\nneckconstipationirritabilityfrequ\nyawn\naura\nstageth\naura\nstage\nhappen\nright\nbefor\nor\ndure\na\nmigrain\n.\naura\nare\nusual\nvisual\ndisturb\n,\nbut\ncan\ninvolv\nother\nsensat\n.\nsymptom\nbuild\nup\ngradual\nand\nlast\nfor\nabout\n20\nto\n60\nminut\n.\nabout\n30\npercent\nof\npeopl\nwho\nexperi\nmigrain\nhave\nmigrain\nwith\naura.symptom\nof\nan\naura\ncan\ninclud\n:\nsee\nbright\nspot\nor\nflash\nof\nlight\nvision\nloss\nor\nsee\ndark\nspotstingl\nsensat\nin\nan\narm\nor\nleg\ndescrib\nas\n“\npin\nand\nneedl\n”\nspeech\nproblem\nor\ninabl\nto\nspeak\n(\naphasia\n)\nring\nin\nthe\near\n(\ntinnitu\n)\nmain\nattack\nstageth\nattack\nstage\ninclud\nthe\nheadach\nand\nother\nsymptom\n.\nit\ncan\nlast\nfor\na\nfew\nhour\nto\na\nfew\ndays.dur\nan\nattack\n,\nyou\nmight\nexperi\nthe\nfollow\nsymptom\n:\npulsat\nor\nthrob\npain\non\none\nor\nboth\nside\nof\nthe\nheadextrem\nsensit\nto\nlight\n,\nsound\n,\nor\nsmellsworsen\npain\ndure\nphysic\nactivitynausea\nand\nvomitingabdomin\npain\nor\nheartburnloss\nof\nappetitelightheadednessblur\nvisionfaintingif\nyou\nhave\na\nmigrain\n,\nyou\n’\nll\noften\nfeel\nthe\nneed\nto\nlie\ndown\nin\nthe\ndark\nand\nquiet\nto\nescap\nfrom\nlight\n,\nsound\n,\nand\nmovement\n.\nthi\nis\none\nof\nthe\nmain\ndiffer\nbetween\nmigrain\nand\nother\ntype\nof\nheadach\n.\nfortun\n,\nyou\nmay\nfind\nthat\nsleep\nfor\nan\nhour\nor\ntwo\ncan\nhelp\nend\nan\nattack\n.\nrecoveri\nstagedur\nthe\nrecoveri\n(\npostdrom\n)\nstage\n,\nyou\nmay\nfeel\ntire\nand\ndrain\n.\nthe\nmigrain\nfade\nslowli\n.\nsome\npeopl\nreport\nfeel\nof\neuphoria\n.\nmigrain\nvs.\ntension\nheadachestens\nheadach\nand\nmigrain\nmay\ncaus\nveri\nsimilar\nsymptom\n.\nmigrain\nsymptom\ntend\nto\nbe\nmore\nsever\nthan\ntension\nheadaches.with\na\ntension\nheadach\n,\nyour\npain\nis\nusual\nmild\nto\nmoder\nthroughout\nyour\nhead\n,\nand\ndisappear\nwithin\na\nfew\nhour\n.\nmigrain\ntend\nto\nlast\nlonger\nand\nare\noften\ndebilitating.tens\nheadach\ndon\n’\nt\ntypic\ncaus\nani\nvisual\nside\neffect\nlike\naura\nor\nphysic\nside\neffect\nlike\nnausea\nor\nvomit\n.\ntension\nheadach\ncan\nmake\nyou\nfeel\nsensit\nto\nlight\nor\nsound\nbut\nusual\nnot\nboth\n.\nsinu\nheadach\nare\noften\nconfus\nfor\nmigrain\nbecaus\nthey\nshare\nmani\nsymptom\n,\ninclud\npressur\nin\nthe\nsinus\nand\nwateri\neye\n.\nsinu\nheadach\nare\nusual\nonli\nmoder\npain\nand\ncan\nbe\ntreat\nwith\nsinu\ntreatment\nor\nother\nallergi\nmedic\n.\nmigrain\nvs.\ncluster\nheadachesclust\nheadach\ndiffer\nfrom\nmigrain\nmainli\nin\nthat\nthey\nfollow\npattern\nof\noccurr\n.\nthey\n“\ncluster\n”\ntogeth\nin\nshort\n,\nepisod\nattack\ndure\na\nperiod\nof\nweek\nor\nmonth\n.\nsometim\n,\nan\nentir\nyear\ncan\npass\nbetween\ntwo\nheadach\ncluster\n.\nmigrain\ntend\nnot\nto\nfollow\nthi\nkind\nof\npattern.symptom\nof\nmigrain\nand\ncluster\nheadach\nare\nsimilar\n.\nin\nboth\ncase\n,\npain\nis\nsever\n.\ncluster\nheadach\ncan\ncaus\nmani\ndistinct\nsymptom\nthat\nmigrain\ndon\n’\nt\ncaus\n,\ninclud\n:\nred\n,\nbloodshot\neyesswel\nof\nthe\neyelid\n(\nedema\n)\nshrink\nof\nthe\npupil\n(\nmiosi\n)\nrunni\nnose\nor\ncongest\ndroop\nof\nthe\neyelid\n(\nptosi\n)\nagit\n,\nannoy\n,\nor\nrestless\ndure\na\nheadach\nif\nyou\nobserv\nani\nof\nthese\nsymptom\ndure\na\nsever\nheadach\n,\nyou\n’\nre\nlike\nexperienc\na\ncluster\nheadach\n,\nnot\na\nmigrain\n.\nyour\ndoctor\ncan\nusual\ndiagnos\ncluster\nheadach\nby\nexamin\nthe\nnerv\nin\nyour\neye\nor\ndiscov\nan\nabnorm\ndure\nmri\nscan\nlink\nto\ncluster\nheadach\n.\ntalk\nto\nyour\ndoctor\nabout\nget\ncheck\nfor\ncluster\nheadach\nif\nyou\nhave\nthese\nsymptom\n.\nrelief\nand\ntreatmentmed\nfor\npain\nrelief\nmay\nbe\nenough\nto\ntreat\nyour\nsymptom\n.\ncommon\npain\nreliev\nthat\ncan\nhelp\nmigrain\nsymptom\ninclud\n:\nibuprofenaspirinacetaminophen\n(\ntylenol\n)\nexcedrin\n(\naspirin\n,\nacetaminophen\n,\nand\ncaffein\n)\nif\nyour\npain\ncontinu\n,\ntalk\nto\nyour\ndoctor\nabout\nother\ntreatment\noption\n.\nmigrain\npreventionif\nyou\nhave\nat\nleast\nsix\nmigrain\nper\nmonth\nor\nthree\nmigrain\na\nmonth\nthat\nsever\ninterfer\nwith\nyour\ndaili\nlife\n,\nyour\ndoctor\nmay\nrecommend\nprevent\nmedic\nthat\nare\neffect\nagainst\nmigrain\nsymptom\n,\ninclud\n:\nbeta-block\n,\nsuch\nas\npropranolol\nor\ntimolol\n,\nfor\nhigh\nblood\npressur\nor\ncoronari\ndiseasescalcium\nchannel\nblocker\n,\nsuch\nas\nverapamil\n,\nfor\nhigh\nblood\npressuretricycl\nantidepress\n,\nsuch\nas\namitriptylin\n,\nfor\ncontrol\nserotonin\nand\nother\nchemic\nin\nyour\nbrainantiseizur\ndrug\n,\nsuch\nas\nvalproat\n(\nin\nmoder\ndose\n)\npain\nreliev\n,\nsuch\nas\nnaproxencgrp\nantagonist\n,\na\nnew\nclass\nof\ndrug\napprov\nto\nprevent\nmigrainesther\ncan\nbe\nside\neffect\nof\nthese\nmedic\n.\nalso\n,\ntalk\nto\nyour\ndoctor\nabout\nlifestyl\nchang\nthat\ncan\nhelp\ndecreas\nmigrain\n.\nthing\nlike\nquit\nsmoke\n,\nget\nplenti\nof\nsleep\n,\navoid\ntrigger\nfrom\ncertain\nfood\n,\nand\nstay\nhydrat\ncan\nbe\nuse\n.\nsome\naltern\nmedicin\nare\noften\nuse\nto\naid\nin\nreliev\nmigrain\nsymptom\n,\ninclud\n:\nacupuncturecognit\nbehavior\ntherapi\n,\na\ntype\nof\ntherapi\nthat\ninstruct\nyou\non\nhow\nyour\nbehavior\nand\nthink\ncan\nchang\nthe\nway\nyou\nperceiv\nyour\nmigrain\npainherb\n,\nsuch\nas\nfeverfewriboflavin\n(\nb-2\n)\nmagnesium\nsupplement\n(\nif\nyou\nhave\nlow\nlevel\nof\nmagnesium\nin\nyour\nbodi\n)\nyour\ndoctor\nmay\nrecommend\nthat\nyou\ntri\nthese\naltern\noption\nif\nmedicin\ntreatment\naren\n’\nt\nwork\nfor\nyou\nor\nif\nyou\nwant\nto\ntake\ngreater\ncontrol\nof\nprevent\ncare\nfor\nyour\nmigrain\n.\nmigrain\nin\nchildren\nand\nteensaround\n10\npercent\nof\nchildren\nand\nteen\nexperi\nmigrain\n.\nsymptom\nare\ngener\nsimilar\nto\nmigrain\nin\nadult\n.\nteen\nare\nalso\nmore\nlike\nto\nhave\nchronic\nmigrain\n(\ncm\n)\n,\nwhich\ncaus\nmigrain\nfor\nsever\nhour\na\nday\nfor\nover\n15\nday\nof\nthe\nmonth\nacross\nthree\nor\nmore\nmonth\n.\ncm\nmay\ncaus\nyour\nchild\nto\nmiss\nschool\nor\nsocial\nactivities.migrain\ncan\nbe\npass\non\ngenet\n.\nif\nyou\nor\nyour\nchild\n’\ns\nother\nbiolog\nparent\nha\na\nhistori\nof\nmigrain\n,\nyour\nchild\nha\na\n50\npercent\nchanc\nof\nhave\nthem\n.\nif\nboth\nyou\nand\nthe\nother\nparent\nhave\na\nmigrain\nhistori\n,\nyour\nchild\nha\na\n75\npercent\nchanc\n.\nplu\n,\nmani\nthing\ncan\ntrigger\nyour\nchild\n’\ns\nmigrain\n,\ninclud\n:\nstresscaffeinemed\n,\ninclud\nbirth\ncontrol\nand\nasthma\ntreatmentroutin\nchangesfind\nout\nwhat\n’\ns\ncaus\nyour\nchild\n’\ns\nmigrain\n,\nthen\ntalk\nto\nyour\ndoctor\nabout\nthe\nbest\nway\nto\ntreat\nand\nprevent\nmigrain\n.\nin\naddit\nto\nmedic\n,\nyour\ndoctor\nmay\nrecommend\nrelax\ntechniqu\nand\nprevent\ntherapi\nso\nthat\nyour\nchild\ncan\nbetter\nunderstand\nand\nmanag\ntheir\nmigrain\n.\noutlookmigrain\npain\ncan\nbe\nsever\n,\nand\noften\nunbear\n.\ndepress\nis\nmore\nlike\nto\noccur\nin\nthose\nwho\nexperi\nmigrain\nthan\nthose\nwho\ndo\nnot\n.\nmedic\nand\nother\ntreatment\nare\navail\nto\nreduc\nthe\nfrequenc\nand\nsever\nof\nyour\nmigraines.if\nyou\nregularli\nget\nmigrain\n,\nmake\nan\nappoint\nwith\nyour\ndoctor\nto\ndiscuss\nyour\nsymptom\nand\na\ntreatment\nplan\n.\nwe\ninclud\nproduct\nwe\nthink\nare\nuse\nfor\nour\nreader\n.\nif\nyou\nbuy\nthrough\nlink\non\nthi\npage\n,\nwe\nmay\nearn\na\nsmall\ncommiss\n.\nhere\n’\ns\nour\nprocess.migrain\nis\na\nmedic\ncondit\nthat\ninvolv\nsever\n,\nrecur\nheadach\nand\nother\nsymptom\n.\na\nmigrain\nepisod\nis\na\ntype\nof\nheadach\n.\nan\nepisod\nusual\noccur\nin\nstage\nand\ncan\nlast\nfor\nsever\nday\n.\nsever\ncase\ncan\naffect\na\nperson\n’\ns\ndaili\nlife\n,\ninclud\ntheir\nabil\nto\nwork\nor\nstudy.migrain\ncan\naffect\npeopl\nin\ndiffer\nway\n,\nand\nthe\ntrigger\n,\nsever\n,\nsymptom\n,\nand\nfrequenc\ncan\nvari\n.\nsome\npeopl\nhave\nmore\nthan\none\nepisod\neach\nweek\n,\nwhile\nother\nhave\nthem\nonli\noccasionally.in\n2018\n,\nresearch\nfound\nthat\nmore\nthan\n15\n%\ntrust\nsourc\nof\nadult\nin\nthe\nunit\nstate\nhad\nexperienc\na\nmigrain\nepisod\nor\na\nsever\nheadach\nwithin\nthe\nlast\n3\nmonth\n.\nresearch\nfrom\n2015\nfound\nthat\nmigrain\naffect\njust\nover\n19\n%\ntrust\nsourc\nof\nfemal\nand\n9\n%\nof\nmale\n.\nepisod\noften\noccur\nin\npeopl\nage\n18–44\nyear\n,\nbut\nthey\ncan\nhappen\nat\nani\ntime\n,\ninclud\ndure\nchildhood.symptomsshar\non\npinteresteujarim\nphotography/getti\nimagessymptom\nof\nmigrain\ntend\nto\noccur\nin\nstage\n:\nbefor\nthe\nheadach\n:\naccord\nto\nresearch\nfrom\n2008\n,\n20–60\n%\ntrust\nsourc\nof\npeopl\nwith\nmigrain\nexperi\nsymptom\nthat\nstart\nhour\nor\nday\nbefor\nthe\nheadach\n.\nat\nthi\nstage\n,\na\nperson\nmight\nexperi\na\n“\nprodrom\n,\n”\nwhich\nmay\ninvolv\nemot\nchang\n,\nspecif\ndepress\nand\nirrit\n.\na\nprodrom\ncan\nalso\ninclud\nyawn\n,\ndizzi\n,\nthirst\n,\nfrequent\nurin\n,\nand\nsensit\nto\nlight\nand\nsound\n.\nsometim\nan\naura\ncan\noccur\n.\nthi\ninvolv\nphysic\nor\nsensori\nsymptom\n,\nsuch\nas\nflash\nlight\nin\nthe\nfield\nof\nvision\n.\ndure\nthe\nheadach\n:\nalongsid\na\nmild\nto\nsever\n,\nthrob\nor\npuls\nheadach\n,\nsymptom\nmay\ninclud\nnausea\n,\nvomit\n,\nneck\npain\n,\ndizzi\n,\nand\nnasal\ncongest\n.\nresolut\n:\nafter\nthe\nheadach\n,\ntired\nand\nirrit\nmay\nlast\nanoth\n2\nday\n.\nthi\nis\nsometim\ncall\nthe\n“\nmigrain\nhangover.\n”\nother\ncommon\nfeatur\nof\nmigrain\nare\n:\nhead\npain\nthat\nworsen\ndure\nphysic\nactiv\nor\nstrainingan\ninabl\nto\nperform\nregular\nactiv\ndue\nto\nthe\npainincreas\nsensit\nto\nlight\nand\nsound\nthat\ncan\nsometim\nbe\nreliv\nby\nlie\nquietli\nin\na\ndarken\nroom\nother\nsymptom\nmay\ninclud\nsweat\n,\nfeel\nunusu\nhot\nor\ncold\n,\na\nstomachach\n,\nand\ndiarrhea.find\nout\nwhat\nels\ncan\ncaus\na\nheadach\n,\nnausea\n,\nand\nfatigu\nhere.migrain\nvs.\nheadachea\nmigrain\nepisod\nis\ndiffer\nfrom\na\ntypic\nheadach\n.\nthe\nexperi\nis\ndiffer\n,\nand\nthey\ncan\nhave\ndiffer\ncauses.writ\ndown\nthe\nsymptom\nand\nwhen\nthey\noccur\ncan\nhelp\na\nperson\nand\ntheir\nhealthcar\nprofession\nidentifi\nmigrain\nepisod\n.\nkeep\nthi\njournal\nfor\nat\nleast\n8\nweek\n,\nand\nnote\ndown\n:\nthe\ntime\nthat\nsymptom\nstartposs\ntrigger\n,\nsuch\nas\nstress\nor\nmenstruationth\nnatur\nof\nthe\nheadacheani\nother\nsymptomshow\nlong\nthe\nsymptom\nlastani\nnotic\nindic\nof\nmigrain\n,\nsuch\nas\nan\nauraani\nmedic\nand\ntheir\neffectslearn\nmore\nabout\nthe\ndiffer\nbetween\nmigrain\nand\na\nheadach\nhere.caus\nand\ntriggersexpert\nthink\nthat\nmigrain\nepisod\nmay\nstem\nfrom\nchang\nin\nthe\nbrain\nthat\naffect\nthe\n:\nway\nnerv\ncommunicatebal\nof\nchemic\nblood\nvesselsgenet\nfeatur\nmay\nalso\nplay\na\nrole\n—\nhave\na\nfamili\nhistorytrust\nsourc\nof\nmigrain\nis\na\ncommon\nrisk\nfactor.migrain\ntrigger\nvari\nfrom\nperson\nto\nperson\n.\nthey\ncommonli\ninclud\n:\nhormon\nchang\n,\nsuch\nas\nthose\nrelat\nto\nmenstruationemot\ntrigger\n,\nsuch\nas\nstress\n,\ndepress\n,\nanxieti\n,\nand\nexcitementdietari\nfactor\n,\ninclud\nalcohol\n,\ncaffein\n,\nchocol\n,\nnut\n,\nchees\n,\ncitru\nfruit\n,\nand\nfood\ncontain\nthe\naddit\ntyramin\nand\nmonosodium\nglutam\n(\nmsg\n)\nmedic\n,\nsuch\nas\nsleep\npill\n,\nhormon\nreplac\ntherapi\n(\nhrt\n)\n,\nand\nsome\nbirth\ncontrol\npillsenvironment\nfactor\n,\ninclud\nflicker\nscreen\n,\nstrong\nsmell\n,\nsecondhand\nsmoke\n,\nloud\nnois\n,\nhumid\n,\nstuffi\nroom\n,\ntemperatur\nchang\n,\nand\nbright\nlightssom\nother\npossibl\ntrigger\ninclud\n:\ntirednessa\nlack\nof\nsleepshould\nand\nneck\ntensionpoor\nposturephys\noverexertionlow\nblood\nsugarjet\nlagirregular\nmealtimesdehydrationavoid\ntrigger\n,\nwhen\npossibl\n,\nmay\nhelp\nreduc\nthe\nfrequenc\nof\nmigrain\nepisodes.what\ncaus\nheadach\n?\nfind\nout\nhere.advertisementse\na\ndoctor\nfrom\nyour\nphonetelu\nhealth\nmycare™\nlet\nyou\nsee\na\nlocal\ndoctor\nright\nfrom\nyour\nphone—day\nor\nnight\n,\n7\nday\na\nweek\n.\nthe\napp\nis\nfree\nto\ndownload\nand\nconsult\nare\ncover\nby\nohip.get\nthe\nappresearch\ndata\non\nrace\nand\nethnicitymigrain\ncan\nbe\na\ndebilit\ncondit\nthat\nis\nunderdiagnos\nand\nchalleng\nto\ntreat\n.\nthi\ncan\nbe\nseen\nespeci\nin\nbipoc\n(\nblack\n,\nindigen\n,\nand\npeopl\nof\ncolor\n)\npopul\n.\npeopl\nof\ncolor\nare\nless\nlike\nto\nreceiv\nthe\ndiagnosi\nof\nmigrain\nand\nthe\ntreatment\nthan\nwhite\npeopl\n.\nin\nfact\n,\nonli\n47\n%\nof\nafrican\namericanstrust\nsourc\nhave\nan\noffici\nmigrain\ndiagnosi\n,\ncompar\nwith\n70\n%\nof\nwhite\npeopl\nin\nthe\ncountri\n.\nand\nother\nresearch\nfound\nthat\nlatino\npeopl\nare\n50\n%\nless\nlike\nto\nreceiv\na\nformal\nmigrain\ndiagnosi\nthan\nwhite\npeopl\n.\nthese\ndispar\ncan\nimpact\ntreatment\nand\ntherapi\n.\nwhile\nthese\nfigur\ncould\nlead\nto\nthe\nconclus\nthat\nwhite\npeopl\nexperi\nmore\nmigrain\nepisod\nthan\nother\ngroup\n,\nan\nanalysi\nof\nnine\nstudiestrust\nsourc\nlook\nat\nthe\naverag\npreval\nof\nsever\nheadach\nor\nmigrain\nfrom\n2005\nto\n2012\nin\nthe\nu.s.\nfound\nthat\nthe\npreval\nrate\nof\nepisod\nacross\nall\ngroup\nwere\nsimilar:17.7\n%\nof\nnativ\namerican\npeople15.5\n%\nof\nwhite\npeople14.5\n%\nof\nhispan\npeople14.45\n%\nof\nblack\npeople9.2\n%\nof\nasian\npeopl\nfurthermor\n,\nfemal\nin\nall\ngroup\nwere\napproxim\ntwice\nas\nlike\nto\nexperi\nmigrain\nepisod\nthan\nmale\n.\noveral\n,\nstudi\nthat\ndiscuss\nmigrain\nand\nuse\nracial\nand\nethnic\ndiffer\nfor\nclariti\noften\ndo\nnot\nconsid\ncontribut\nfactor\n.\nfurther\nresearch\nis\nwarrant\n,\nand\nthi\nshould\nconsid\nbehavior\n,\nenvironment\n,\ngenet\n,\nand\nsocioeconom\nfactor\n,\nas\nwell\nas\naccess\nto\nhealthcare.risk\nfactorsanyon\ncan\ndevelop\nmigrain\n,\nand\nthere\nis\na\nslightli\nhigher\nrisk\nfor\npeopl\nwith\n:\ndepressionbipolar\ndisorderfibromyalgiairrit\nbowel\nsyndromeoveract\nbladdersleep\ndisordersobsessive-compuls\ndisorderanxietyi\nthere\na\nlink\nbetween\nmigrain\nand\ncovid-19\n?\ntreatmentther\nis\nno\ncure\nfor\nmigrain\n.\nhowev\n,\nmedic\ncan\ntreat\nthe\nsymptom\nwhen\nthey\naris\n,\nand\npeopl\ncan\ntake\nstep\nto\nreduc\nthe\nfrequenc\nand\nsever\nof\nepisod\n.\nbut\nkeep\nin\nmind\nthat\nthese\nmedic\ncan\nhave\nside\neffects.medicationspain\nrelief\nand\nother\ntype\nof\nmedic\ncan\noften\nhelp\n.\ntake\nmedic\nas\nsoon\nas\nsymptom\nstart\nmay\nkeep\nthem\nfrom\nbecom\nsevere.som\nover-the-count\npain\nrelief\nmedic\nthat\nmay\nbenefit\npeopl\nwith\nmigrain\ninclud\n:\nnaproxen\n(\nalev\n)\nibuprofen\n(\nadvil\n)\nacetaminophen\n(\ntylenol\n)\nother\noption\ninclud\n:\ntriptan\n,\nsuch\nas\nsumatriptan\n(\nimitrex\n)\n,\nto\nhelp\nrevers\nthe\nbrain\nchang\nthat\noccur\ndure\nan\nepisodeantiemet\nto\nmanag\nani\nnausea\nand\nvomitinggep\nto\nblock\na\nprotein\ninvolv\nin\ninflamm\nand\npain\n,\ncall\ncalcitonin\ngene-rel\npeptid\n(\ncgrp\n)\nditan\n,\nwhich\ninteract\nwith\n5-ht1f\nreceptor\non\nthe\nsensori\nnerv\nand\nblood\nvesselsit\nis\nimport\nto\navoid\noverus\nmedic\nbecaus\noverus\ncan\ncaus\na\nrebound\nheadach\n.\na\nhealthcar\nprofession\ncan\nhelp\na\nperson\ndecid\nhow\nmuch\nof\neach\nmedic\nis\nsafe\nand\neffect\n.\nfind\nsome\ntip\nfor\ninstant\nmigrain\nrelief\nhere.hom\nand\nnatur\nremediessom\nhome\ncare\nstrategi\nthat\ncan\nhelp\nreliev\nmigrain\nsymptom\ninclud\n:\nuse\nflexibl\ncold\npack\nor\nmasksstay\nin\na\nquiet\n,\ndarken\nroomsleep\n,\nwhen\nnecessaryth\nfollow\nsupplement\nmight\nhelp\nprevent\nmigrain\n.\nhowev\n,\nthere\nis\nlimit\nevid\nthat\nthey\nwork\n,\nand\nnot\nmuch\nis\nknown\nabout\ntheir\nside\neffect\n:\nherbal\nextract\n,\nsuch\nas\nfeverfewmagnesiumcoenzym\n10butterburriboflavinoth\nnondrug\napproach\nmay\ninclud\nacupuncturetrust\nsourc\nand\nneck\nexercis\nor\nphysic\ntherapy.befor\ntri\nani\nof\nthese\n,\nspeak\nwith\na\nhealthcar\nprofession\n.\nresearch\nha\nnot\nshown\nthat\nthese\napproach\nwork\n.\nvariou\nproduct\nthat\nclaim\nto\nhelp\nreliev\nmigrain\nare\navail\nfor\npurchas\nonline.anyon\nlook\nfor\nan\naltern\ntherapi\n,\nsuch\nas\nacupunctur\n,\nshould\ngo\nto\na\nqualifi\nand\nexperienc\nprofessional.what\nare\nsome\nnatur\nremedi\nfor\na\nheadach\n?\nhealthlin\nnewsletterhealthlin\n's\nmigrain\nnewslett\ncan\nhelpwhen\ndeal\nwith\nheadach\nor\nmigrain\n,\nit\ncan\nbe\nhard\nto\nfilter\nout\nthe\nnois\nand\nnavig\nyour\ninbox\n.\nhealthlin\ngive\nyou\naction\nadvic\nfrom\ndoctor\nthat\n's\ninclus\nand\nroot\nin\nmedic\nexpertise.sign\nup\nnowhow\nto\nprevent\nmigrain\nepisodeswhil\nit\nis\nnot\nalway\npossibl\nto\nprevent\nmigrain\nepisod\n,\nthere\nare\nway\nto\nreduc\ntheir\nfrequenc\nand\nseverity.medicationsth\nfollow\nprescript\ndrug\nmay\nhelp\nreduc\nthe\nnumber\nof\nepisod\nthat\na\nperson\nwith\nsever\nmigrain\nexperi\n:\ntopiram\n(\ntrokendi\nxr\n)\n,\nan\nantiseizur\ndrugpropanolol\n(\ninder\n)\n,\nfor\ntreat\nhigh\nblood\npressureantidepress\nmedicationsbotoxgep\nand\ncgrp\ninhibitorsit\nmay\ntake\nsever\nweek\nto\nsee\nan\nimprov\n.\nthe\nbest\ntreatment\nin\nchildren\nor\nadolesc\nmay\nbe\ndiffer\nfrom\nthat\nin\nadult\n.\na\nhealthcar\nprofession\ncan\nhelp\nrecommend\nthe\nmost\neffect\napproach.identifi\nand\navoid\ntriggersa\nmigrain\nepisod\nsometim\nhappen\nin\nrespons\nto\na\ntrigger\n.\nto\nidentifi\na\ntrigger\n,\na\nperson\nmight\nkeep\na\ndiari\nand\nrecord\nhow\nthey\nfelt\nand\nwhat\nthey\ndid\n,\nate\n,\nand\ndrank\nbefor\nthe\nsymptom\nappeared.it\nmay\nbe\nparticularli\nhelp\nto\navoid\n:\nlow\nblood\nsugarphys\noverexertionstresscertain\nfood\n,\nsuch\nas\nchocol\nand\nani\nthat\ncontain\ntyramin\nor\nmsgcertain\nmedic\n,\ninclud\nhrt\nand\nsome\nbirth\ncontrol\npillsbright\nlight\nand\nflicker\nscreensth\nfollow\nstrategi\nmay\nhelp\nreduc\nthe\nfrequenc\nof\nmigrain\nepisod\n:\nget\nenough\nsleepreduc\nstressdrink\nplenti\nof\nwaterhav\nhealthi\npostureavoid\nknown\ndietari\ntrigger\n,\nsuch\nas\ncaffein\n,\nalcohol\n,\nand\ncheeseget\nregular\nphysic\nexerciseif\nmake\nthese\nchang\ndoe\nnot\neas\nthe\nsever\nand\nfrequenc\nof\nmigrain\nepisod\n,\na\ndoctor\nmay\nsuggest\nmedic\nor\nother\noption\n.\nto\ndiscov\nmore\nevidence-bas\ninform\nand\nresourc\nfor\nheadach\nand\nmigrain\n,\nvisit\nour\ndedic\nhub.typesther\nare\nvariou\ntype\nof\nmigrain\n.\na\nmajor\ndistinguish\nfactor\nis\nwhether\nthey\ninvolv\naura\n—\nsensori\nchang\n.\nmigrain\nwith\nauraaura\nis\na\ndisturb\nof\nthe\nsens\nin\nthe\nearli\nstage\nof\na\nmigrain\nepisode.aura\ncan\ninvolv\n:\nhave\nconfus\nthought\nor\nexperiencesse\nstrang\n,\nsparkl\n,\nor\nflash\nlight\nthat\nare\nnot\ntherese\nzig-zag\nline\nof\nlighthav\nblind\nspot\nor\nblank\npatch\nin\nthe\nfield\nof\nvisionhav\na\npin\nand\nneedl\nsensat\nin\nan\narm\nor\nleghav\ndifficulti\nspeakinghav\nweak\nin\nthe\nshoulder\n,\nneck\n,\nor\nlimbsse\nthing\nthat\nare\nnot\nthere\nout\nof\none\neye\n,\nsuch\nas\ntranspar\nstring\nof\nobjectsnot\nbe\nabl\nto\nsee\npart\nof\nsometh\nclearlyhav\npart\nof\nthe\nfield\nof\nvision\ndisappear\n,\nthen\nreappeara\nvisual\naura\nmay\nfeel\nlike\nthe\naftermath\nof\na\nveri\nbright\ncamera\nflash\n,\nbut\nthe\nvisual\nchang\nmay\nlast\nfor\nsever\nminut\nor\nup\nto\n1\nhour\n.\nanyon\nexperienc\nan\naura\nfor\nthe\nfirst\ntime\nshould\ncontact\na\nhealthcar\nprofession\nto\nrule\nout\nseriou\nneurolog\nproblem\n,\nsuch\nas\na\nstroke\nor\na\nbrain\ntumor.find\nout\nmore\nabout\nmigrain\naura\nhere.migrain\nwithout\nauramor\ncommonli\n,\na\nperson\nexperi\nno\nsensori\ndisturb\nbefor\nan\nepisod\n.\naccord\nto\nthe\nmigrain\ntrust\n,\n70–90\n%\nof\nepisod\noccur\nwithout\naura.oth\ntypessom\nother\ntype\nof\nmigrain\ninclud\n:\nchronic\nmigrain\n:\nthi\ninvolv\nhave\nan\nepisod\non\nmore\nthan\n15\nday\nper\nmonth.menstru\nmigrain\n:\nthi\noccur\nin\na\npattern\nthat\nfollow\nthe\nmenstrual\ncycle.hemipleg\nmigrain\n:\nthi\ncaus\ntemporari\nweak\non\none\nside\nof\nthe\nbodi\n,\nand\nit\nis\nveri\nrare.abdomin\nmigrain\n:\nthi\ninvolv\nmigrain\nepisod\nwith\nirregular\nfunction\nin\nthe\ngut\nand\nabdomen\n,\noften\nwith\nnausea\nor\nvomit\n.\nit\nmainli\naffect\nchildren\nunder\n14\nyear\nof\nage.vestibular\nmigrain\n:\nsever\nvertigo\nis\na\nsymptom\nof\nthi\ntype.basilar\nmigrain\n:\nthi\nrare\ntype\nis\nalso\ncall\n“\nmigrain\nwith\nbrainstem\naura\n,\n”\nand\nit\ncan\naffect\nneurolog\nfunction\n,\nsuch\nas\nspeech\n.\nanyon\nwho\nmay\nbe\nexperienc\nani\nneurolog\nsymptom\nshould\nget\nmedic\nattent\n.\nand\npeopl\nwho\nneed\ntreatment\nfor\nmigrain\nshould\nconsult\na\nhealthcar\nprofessional.diagnosisth\nintern\nheadach\nsocieti\nrecommend\nthe\n“\n5\n,\n4\n,\n3\n,\n2\n,\n1\n”\ncriteria\nto\ndiagnos\nmigrain\nwithout\naura\n.\nthese\nnumber\nstand\nfor\n:\nhave\n5\nor\nmore\nepisod\n,\neach\nlast\n4\nhour\nto\n3\ndayshav\na\nheadach\nwith\nat\nleast\n2\nof\nthe\nfollow\nqualiti\n:\n–\noccur\non\none\nside–\npulsating–\ncaus\nmoderate-to-sever\npain\naggrav\nby\nactivityhav\nat\nleast\n1\naddit\nsymptom\n,\nsuch\nas\n:\n–\nnausea–\nvomiting–\nsensit\nto\nlight–\nsensit\nto\nsoundth\ndoctor\nmay\nrecommend\nimag\nor\nother\ntest\nto\nexclud\nother\ncaus\nof\nthe\nsymptom\n,\nsuch\nas\na\ntumor\n,\nmening\n,\nor\na\nstroke\n.\nwhen\nto\nsee\na\ndoctora\nperson\nshould\nconsult\na\nhealthcar\nprofession\nif\nthey\nexperi\n:\nwhat\nseem\nlike\na\nfirst\nmigrain\nepisod\nworsen\nor\nunusu\nmigrain\nsymptomssever\nsymptomsif\nani\nof\nthe\nfollow\noccur\n,\nseek\nimmedi\nmedic\nhelp\n:\nan\nunusu\nsever\nheadachevisu\ndisturbancesa\nloss\nof\nsensationdifficulti\nspeakingthes\ncould\nindic\nanoth\ncondit\nthat\nmay\nneed\nurgent\nattent\n,\nsuch\nas\na\nstroke\n.\nwhen\nis\nit\nsensibl\nto\nworri\nabout\na\nheadach\n?\nsummarymigrain\nis\na\nmedic\ncondit\nthat\ninvolv\na\nheadach\nand\nother\nsymptom\n.\nit\nis\nnot\njust\na\nbad\nheadach\n,\nand\nit\ncan\nhave\na\nsignific\nimpact\non\ndaili\nlife\n,\nmake\nit\ndifficult\nto\nwork\nand\ndo\neveryday\nactiv\n.\nidentifi\nand\navoid\ntrigger\ncan\noften\nhelp\nreduc\nthe\nfrequenc\nor\nsever\nof\nepisod\n,\nthough\nit\nis\nnot\nalway\npossibl\nto\nprevent\nthem.med\nand\nother\ntreatment\ncan\nhelp\nmanag\nmigrain\nsymptom\n.\nanyon\nwho\nha\nconcern\nshould\ncontact\na\nhealthcar\nprofessional.read\nthe\narticl\nin\nspanish.advertisementse\na\ndoctor\nfrom\nyour\nphonetelu\nhealth\nmycare™\nlet\nyou\nsee\na\nlocal\ndoctor\nright\nfrom\nyour\nphone—day\nor\nnight\n,\n7\nday\na\nweek\n.\nthe\napp\nis\nfree\nto\ndownload\nand\nconsult\nare\ncover\nby\nohip.get\nthe\napp\nwhat\nare\nthe\nsymptom\nof\na\nmigrain\n?\nindividu\nmigrain\nare\nmoder\nto\nsever\nin\nintens\n,\noften\ncharacter\nby\na\nthrob\nor\npound\nfeel\n.\nalthough\nthey\nare\nfrequent\none-sid\n,\nthey\nmay\noccur\nanywher\non\nthe\nhead\n,\nneck\nand\nface\n—\nor\nall\nover\n.\nat\ntheir\nworst\n,\nthey\nare\ntypic\nassoci\nwith\nsensit\nto\nlight\n,\nnois\nand/or\nsmell\n.\nnausea\nis\none\nof\nthe\nmost\ncommon\nsymptom\nand\nit\nworsen\nwith\nactiv\n,\nwhich\noften\nresult\nin\npatient\ndisabl\n.\nin\nmani\nrespect\n,\nmigrain\nare\nmuch\nlike\nalcohol-rel\nhangov\n.\nmigrain\npain\ncan\nbe\nfelt\nin\nthe\nface\n,\nwhere\nit\nmay\nbe\nmistaken\nfor\nsinu\nheadach\n—\nor\nin\nthe\nneck\n,\nwhere\nit\nmay\nbe\nmistaken\nfor\narthriti\nor\nmuscl\nspasm\n.\ncomplic\nthe\ndiagnosi\nof\nmigrain\nis\nthat\nthe\nheadach\nmay\nbe\naccompani\nby\nother\n``\nsinu\nlike\n''\nsymptom\n,\ninclud\nwater\neye\n,\nnasal\ncongest\nand\na\nsens\nof\nfacial\npressur\n.\nmost\npatient\nwho\nthink\nthey\nhave\nsinu\nheadach\nin\nfact\nhave\nmigrain\n.\nin\nup\nto\n25\npercent\nof\npatient\n,\nthe\nmigrain\nheadach\npain\nmay\nbe\npreced\nby\nan\naura\n,\na\ntemporari\nneurolog\nsyndrom\nthat\nslowli\nprogress\nand\nthen\ntypic\nresolv\njust\nas\nthe\npain\nbegin\n.\nwhile\nthe\nmost\ncommon\ntype\nof\nmigrain\naura\ninvolv\nvisual\ndisturb\n(\nflash\nlight\n,\nzigzag\n,\nblind\nspot\n)\n,\nmani\npeopl\nexperi\nnumb\n,\nconfus\n,\ntroubl\nspeak\n,\nvertigo\n(\nspin\ndizzi\n)\nand\nother\nstrokelik\nneurolog\nsymptom\n.\nsome\npatient\nmay\nexperi\naura\nwithout\nheadach\n.\nhow\npreval\nare\nmigrain\n?\nmigrain\nare\nabout\nthree\ntime\nmore\ncommon\nin\nwomen\nthan\nmen\n,\nand\nmay\naffect\nmore\nthan\n12\npercent\nof\nthe\nu.s.\nadult\npopul\n.\nmigrain\noften\nrun\nin\nfamili\n,\nand\ncan\nstart\nas\nearli\nas\nelementari\nschool\nbut\nmost\noften\nin\nearli\nadulthood\n.\nthey\noften\nfade\naway\nlater\nin\nlife\n,\nbut\ncan\nstrike\nat\nani\ntime\n.\nthe\nmost\ncommon\ncaus\nof\nrecur\n,\ndisabl\nheadach\npain\n,\nmigrain\nare\nalso\nthe\nmost\ncommon\nunderli\ncaus\nof\ndisabl\nchronic\n,\ndaili\nheadach\npain\n.\nwhile\nmigrain\nare\nthe\nno\n.\n1\nreason\nthat\npatient\nsee\na\nneurologist\n,\nmost\ncase\nare\nhandl\nby\nprimari\ncare\nphysician\n.\nwhat\ntrigger\na\nmigrain\n?\nthing\nthat\ncan\nmake\nthe\nheadach\nmore\nlike\nto\noccur\ninclud\n:\nalcohol\nweather\nchang\nlack\nof\nsleep\nschedul\nchang\ndehydr\nhunger\ncertain\nfood\nstrong\nsmell\nteeth\ngrind\nat\nnight\nmenstruat\nhow\nare\nmigrain\ndiagnos\n?\ndespit\ntheir\ndramat\nsymptom\n,\nmigrain\nare\nalmost\nnever\ndue\nto\nan\nunderli\nproblem\nthat\nwill\nshow\nup\non\nani\ntest\n,\neven\non\nbrain\nmri\n.\nmani\nexpert\ndo\nnot\nrecommend\nbrain\nimag\nat\nall\n,\neven\nin\nsever\ncase\n,\nas\nlong\nas\nthe\npatient\n's\nsymptom\nare\ntypic\nfor\nmigrain\nand\na\nthorough\nneurolog\nexamin\nis\nnormal\n.\nthere\nare\nextrem\nrare\nfamili\nthat\nhave\nmigrain\nas\na\nresult\nof\na\nsingl\ngenet\nmutat\nin\none\nof\nfour\nknown\ngene\nthat\ncan\nlead\nto\nthe\ncondit\ncall\nfamili\nhemipleg\nmigrain\n.\nthere\nare\nno\ngenet\ntest\nfor\nthe\nvast\nmajor\nof\npatient\n.\nbecaus\nthe\ncondit\ncan\nnot\nbe\ndiagnos\nby\nscan\nor\nblood\ntest\n,\nthe\ndiagnosi\nis\n``\nclinic\n''\n—\nmade\nby\nan\nexperienc\nphysician\n.\nhow\nare\nmigrain\ntreat\n?\nmigrain\nthat\nare\nsever\n,\nfrequent\nor\naccompani\nby\nneurolog\nsymptom\nare\nbest\ntreat\nprevent\n,\nusual\nwith\na\ncombin\nof\ndietari\nmodif\n,\nlifestyl\nchang\n,\nvitamin\nand\ndaili\nprescript\nmedic\n.\nmost\nof\nour\nbest\nprevent\nmedic\nare\noften\nuse\nfor\nother\nmedic\npurpos\nas\nwell\n;\nthe\nmajor\nare\nblood\npressur\ndrug\n,\nantidepress\nor\nepilepsi\nmedic\n.\nindividu\nheadach\nattack\nare\nbest\ntreat\nearli\n,\noften\nwith\none\nor\nmore\nof\nthe\nfollow\ntype\nof\nmedic\n:\ntriptan\n,\nnonsteroid\nanti-inflammatori\ndrug\n(\nnsaid\n)\n,\nanti-emet\n(\nanti-nausea\n)\n,\nand\nsometim\nnarcot\nor\nsteroid\n.\nmigrain\ntypic\nlast\na\nfew\nhour\nto\na\ncoupl\nof\nday\nand\nrespond\nwell\nto\nspecif\ntreatment\n.\nhowev\n,\nin\nsome\npatient\n,\nthe\nmigrain\nis\nparticularli\nsever\nand\nlong-last\n—\nand\nmay\neven\nbecom\nchronic\n,\noccur\ncontinu\nfor\nweek\n,\nmonth\nor\neven\nyear\n.\nif\nimproperli\nmanag\nor\nleft\nuntreat\n,\nintermitt\nmigrain\nmay\nessenti\ntransform\ninto\na\nchronic\ndaili\nheadach\n,\nwith\ncontinu\nand\nsmolder\nsymptom\nthat\nperiod\nerupt\ninto\na\n``\nfull-blown\n''\nmigrain\n.\nthi\ncondit\nis\nextrem\ndifficult\nto\ntreat\n.\nother\npatient\nmay\ndevelop\nincreasingli\nfrequent\nheadach\nas\na\nresult\nof\noverus\ntheir\nshort-act\nheadach\nmedic\n.\nsee\nmedic\noverus\nheadach\n.\nwhile\nthey\nare\nconsid\nprimari\nheadach\n,\nmean\nthey\nhave\nno\nknown\nunderli\ncaus\n,\nmigrain\nare\nassoci\nwith\nan\nincreas\nrisk\nof\nstroke\n,\nbrain\nscar\nas\nseen\non\nmri\nscan\n,\na\nheart\ndefect\ncall\na\npatent\nforamen\noval\n(\npfo\n)\nand\nother\nmedic\ncondit\n.\nat\nthe\njohn\nhopkin\nheadach\ncenter\n,\nlocat\nat\nthe\njohn\nhopkin\nbayview\nmedic\ncenter\n,\nwe\nhave\nexpert\nphysic\ntherapist\n,\nnutritionist\nand\npsychologist\nwho\nwork\nclose\nwith\nour\nneurologist\nto\nhelp\nmanag\npatient\nwith\nfrequent\nmigrain\n.\nbiofeedback\nand\nrelax\ntechniqu\nare\navail\nto\ncomplement\nour\nstandard\nmedic\ntreatment\n.\nbrain\n&\nnervou\nsystem\nmigrain\nsymptom\nmigrain\nguid\nmigrain\nguid\nsymptom\ncaus\ndiagnosi\ntreatment\nprevent\ncope\nsymptom\nof\na\nmigrain\nthe\nsymptom\nand\nstage\nof\na\nmigrain\nattack\nby\nteri\nrobert\nteri\nrobert\nlinkedin\nteri\nrobert\nis\na\nwriter\n,\npatient\neduc\n,\nand\npatient\nadvoc\nfocus\non\nmigrain\nand\nheadach\n.\nlearn\nabout\nour\neditori\nprocess\nupdat\non\njune\n06\n,\n2021\nmedic\nreview\nby\nnichola\nr.\nmetru\n,\nmd\n<\nimg\nsrc=\n''\nhttp\n:\n//www.verywellhealth.com/thmb/rvcaktjiz9tfkjhrfrm8rolimhm=/80x80/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/nicholas-metrus_1000-41893b3fb9e84f3e99cf0f18b2464fdb.jpg\n''\nsrcset=\n''\nhttp\n:\n//www.verywellhealth.com/thmb/dk3gyqjkdx5zrigobh_6euwae7m=/80x0/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/nicholas-metrus_1000-41893b3fb9e84f3e99cf0f18b2464fdb.jpg\n80w\n''\nalt=\n''\nnichola\nmetru\n''\nwidth=\n''\n80\n''\nheight=\n''\n80\n''\nclass=\n''\nimg\n--\nnoscript\nmntl-author-tooltip__imag\n''\n/\n>\nmedic\nreview\nby\nnichola\nr.\nmetru\n,\nmd\nlinkedin\nnichola\nr.\nmetru\n,\nmd\n,\nis\nboard-certifi\nin\nneurolog\nand\nneuro-oncolog\n.\nhe\ncurrent\nwork\nat\nthe\nglasser\nbrain\ntumor\ncenter\nwith\natlant\nhealth\nsystem\nin\nsummit\n,\nnew\njersey\n.\nlearn\nabout\nour\nmedic\nreview\nboard\nprint\ntabl\nof\ncontent\nview\nall\ntabl\nof\ncontent\nfrequent\nsymptom\nrare\nsymptom\ncomplications/sub-group\nwhen\nto\nsee\na\ndoctor\nnext\nin\nmigrain\nguid\ncaus\nand\nrisk\nfactor\nof\nmigrain\nwhile\nmigrain\nare\ncommonli\nthought\nof\nas\njust\nbad\nheadach\n,\nthey\noften\ninvolv\nother\nsymptom\nas\nwell\n.\nyou\ncan\nexperi\nup\nto\nfour\nphase\ndure\na\nmigrain\nepisod\n,\neach\nof\nwhich\ncan\nbe\nrecogn\nby\nit\nown\nset\nof\ncharacterist\n.\nyour\nmigrain\nattack\nmay\nnot\nall\nbe\nexactli\nthe\nsame\n,\nbut\nrecogn\nthe\nrang\nof\nsymptom\nthat\ncan\noccur\ncan\nhelp\ntip\nyou\noff\nas\nto\nif\nwhat\nyou\n're\nexperienc\ncould\nbe\na\nmigrain\n.\nif\nyou\n're\nalreadi\ndiagnos\n,\nknow\nwhere\nthese\nsymptom\nfit\ninto\nthe\ntypic\nsequenc\nof\nstage\ncan\nhelp\nyou\ndecid\nwhen\nto\ntake\nyour\nmedic\n.\nmigrain\nmay\nresult\nin\nmedication-rel\ncomplic\n,\nand\nrare\n,\na\nmigrain\ncan\ninduc\na\nseriou\nhealth\ncomplic\n.\nother\ncondit\n,\nsuch\nas\ntransient\nischem\nattack\n(\ntia\n)\nand\nmultipl\nsclerosi\n(\nms\n)\ncan\nproduc\nsymptom\nsimilar\nto\nthose\nof\na\nmigrain\n,\nso\nyou\nmay\nneed\nto\nseek\nmedic\nattent\nif\nyou\nhave\nani\nwarn\nsign\n.\n<\nimg\nsrc=\n''\nhttp\n:\n//www.verywellhealth.com/thmb/umqaibimtxg2klpap3uqad7rlqm=/2084x3126/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/migraines-overview-4583061-5c70295bc9e77c000149e4b4.png\n''\nsrcset=\n''\nhttp\n:\n//www.verywellhealth.com/thmb/p451z-frnibnbp24jnt26d8pfhe=/300x0/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/migraines-overview-4583061-5c70295bc9e77c000149e4b4.png\n300w\n,\nhttp\n:\n//www.verywellhealth.com/thmb/fdyug_up99nhxx1zmiyvtrswlly=/378x0/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/migraines-overview-4583061-5c70295bc9e77c000149e4b4.png\n378w\n,\nhttp\n:\n//www.verywellhealth.com/thmb/ef60t99dkrdk-p5el-urihug00i=/456x0/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/migraines-overview-4583061-5c70295bc9e77c000149e4b4.png\n456w\n,\nhttp\n:\n//www.verywellhealth.com/thmb/xp25sc11tlp3er6ijnmj_sxza0o=/614x0/filt\n:\nno_upscal\n(\n)\n:\nmax_byt\n(\n150000\n)\n:\nstrip_icc\n(\n)\n:\nformat\n(\nwebp\n)\n/migraines-overview-4583061-5c70295bc9e77c000149e4b4.png\n614w\n''\nalt=\n''\nsymptom\nof\nmigrain\n''\nwidth=\n''\n2084\n''\nheight=\n''\n3126\n''\nclass=\n''\nimg\n--\nnoscript\n``\n/\n>\nillustr\nby\ncindi\nchung\n,\nverywel\n.\nfrequent\nsymptom\nmigrain\nepisod\ncan\ninclud\nsever\nstage\n:\nprodom\n,\naura\n,\nheadach\n,\nand\npostdrom\n.\nyou\nmay\ncycl\nthrough\nall\nof\nthese\nphase\nwhen\nyou\nhave\na\nmigrain\n,\nor\nyou\nmight\nexperi\njust\none\n,\ntwo\n,\nor\nthree\nof\nthem\n.\nthe\nheadach\nphase\nis\nthe\nmost\ncommon\n,\nwhile\nthe\naura\nis\nthe\nleast\ncommon\n.\nprodrom\nthe\nprodrom\nis\ncharacter\nby\npremonitori\nsymptom\nof\nan\nimpend\nmigrain\nand\nit\ncan\nbegin\nhour\nor\nday\nbefor\na\nmigrain\nepisod\nreach\nit\npeak\nintens\n.\nmost\npeopl\nwith\nmigrain\nexperi\nprodrom\nsymptom\n,\nand\ntake\nmigrain\nmedic\ndure\nthi\nstage\nmay\nstop\nthe\nepisod\nfrom\nprogress\n.\ntypic\nsymptom\ndure\na\nprodrom\nare:1﻿\nfood\ncrave\nconstip\nor\ndiarrhea\nmood\nchang\n:\nsad\n,\nirrit\n,\nanxieti\nmuscl\nstiff\nor\nsore\n,\nespeci\nin\nthe\nneck\nfatigu\nexcess\nyawn\nnausea\nfluid\nretent\n,\nbloat\nincreas\nfrequenc\nof\nurin\ndifficulti\nconcentr\nvivid\ndream\nsensit\nto\nlight\n,\nsound\n,\nor\nsmell\nfeel\ncold\naura\napproxim\none-third\nof\nmigraineur\nexperi\naura\n,\nwhich\nusual\nfollow\nthe\nprodrom\nand\nlast\nfor\nless\nthan\nan\nhour.2﻿\nthi\nstage\nis\ncharacter\nby\nneurolog\nsymptom\n,\nand\nit\ncan\nbe\nquit\nterrifi\n,\nespeci\nwhen\nyou\nexperi\nit\nfor\nthe\nfirst\ntime\n.\nsymptom\nof\na\nmigrain\naura\ncan\ninclud\n:\nvisual\nchang\n:\nflash\nlight\n,\nwavi\nline\n,\nspot\n,\npartial\nloss\nof\nvision\n,\nblind\nspot\n,\nblurri\nvision\ntingl\n,\nnumb\n,\nor\nhypersensit\nof\nthe\nface\nor\nextrem\nvertigo\n(\na\nsens\nthat\nthe\nroom\nis\nspin\n)\ndifficulti\nfind\nword\nand/or\nspeak\nconfus\npartial\nparalysi\nolfactori\nhallucin\n(\nsmell\nodor\nthat\nare\nn't\nthere\n)\nauditori\nhallucin\n(\nhear\nthing\nthat\nare\nnot\nthere\n)\na\ndecreas\nor\nloss\nof\nhear\nan\noverview\nof\nmigrain\nwith\naura\nheadach\nthe\nhead\npain\nof\na\nmigrain\nis\noften\ndescrib\nas\nthrob\n,\npound\n,\nor\npulsat\n.\nyou\nmay\nalso\nexperi\nother\nsymptom\nalong\nwith\nthe\nhead\npain\n.\nthi\nphase\nusual\nlast\nfrom\nfour\nto\n72\nhours.1﻿\ncommon\ncharacterist\nof\nthe\nheadach\nphase\nmay\ninclud\n:\nhemicrani\n(\non\none\nside\nof\nthe\nhead\n)\npain\nthat\ncan\nshift\nto\nthe\nother\nside\nor\nbecom\nbilater\nphonophobia\n(\nsensit\nto\nsound\n)\nphotophobia\n(\nsensit\nto\nlight\n)\nnausea\nand\nvomit\ndiarrhea\nor\nconstip\nnasal\ncongest\nand/or\nrunni\nnose\nsad\nor\nanxieti\nhot\nflash\nand\nchill\ndizzi\ndehydr\nor\nfluid\nretent\nmigrain\neffect\nare\nnot\nlimit\nto\nthe\nhead\nand\noften\naffect\nthe\nneck\n,\nshoulder\n,\narm\n,\nor\nthe\nentir\nbodi\n.\nthe\nsymptom\nare\noften\nworsen\nby\nactiv\nsuch\nas\nwalk\n,\nride\nin\na\ncar\n,\nor\nexercis\n.\npostdrom\nafter\nthe\nmost\nintens\nphase\nof\na\nmigrain\n,\nyou\nmay\nexperi\na\npostdrom\nbefor\nyour\nmigrain\nattack\nis\ncomplet\nover\n.\nthe\nsymptom\nof\npostdrom\ninclude:1﻿\nfatiguemood\nchang\n,\nwhich\ncan\ninclud\nsad\n,\nanxieti\n,\nor\nelev\nmoodmuscl\nachesdizzi\nor\nlightheadednessdifficulti\nconcentratingstiff\nneckscalp\ntender\nmani\npeopl\ndescrib\npostdrom\nas\nfeel\n``\nlike\na\nzombi\n''\nor\nhungov\n.\npostdrom\nsymptom\ncan\nbe\nassoci\nwith\nabnorm\ncerebr\nblood\nflow\nand\nelectroencephalogram\n(\neeg\n)\npattern\nfor\nup\nto\n24\nhour\nafter\nthe\nend\nof\nthe\nheadach\nstage.3﻿\neven\nif\nyou\ndo\nnot\nexperi\nthe\nheadach\nstage\n,\nyou\nmay\nstill\nexperi\na\npostdrom\nphase\n.\nconcurr\nphase\nmigrain\nstage\nmay\noverlap\n,\nsometim\nwith\nthe\naura\noccur\nat\nthe\nsame\ntime\nas\nthe\nprodrom\n,\nheadach\n,\nor\npostdrom\n.\nprodrom\nsymptom\nmay\nlinger\neven\nas\nthe\nheadach\npeak\n,\nand\npostdrom\nsymptom\ncan\nbegin\nbefor\nthe\nheadach\nstart\nto\nresolv\n.\nchildhood\nmigrain\nchildren\nalso\nexperi\nmigrain\n,\nand\nthe\nsymptom\ncan\ndiffer\nfrom\nthose\nof\nadult\n.\nif\nyou\nnote\nthe\nfollow\nsymptom\nin\nyour\nchild\n,\nmigrain\nmay\nbe\nthe\ncaus\n,\nespeci\nif\nyour\nchild\nha\na\nfamili\nhistori\nof\nthe\ncondition:4\nstomachachenauseadizzinessmot\nsicknessmoodinessexcess\nsleepi\nbe\nsure\nto\ndiscuss\nthese\nsymptom\nwith\nyour\nhealthcar\nprovid\n.\nthey\ncould\nbe\nsign\nof\nanoth\nmedic\ncondit\n,\nbut\nif\nmigrain\nare\nthe\ncaus\n,\nyour\nchild\ncan\ntake\nmedic\nto\nhelp\nprevent\nand\ntreat\nepisod\n.\nwhen\nchildren\nhave\nmigrain\nrare\nsymptom\nrare\nsymptom\nare\ntypic\nassoci\nwith\nmigrain\nsubtyp\n,\nand\nwhile\nthey\nmay\nbe\nsimilar\nto\na\nmigrain\naura\n,\nthe\nmain\ndiffer\nis\nthat\nthese\nunusu\nsymptom\nare\nusual\nthe\nmost\npromin\naspect\nof\nthe\nmigrain\nepisod\n.\nweak\nweak\n,\ntypic\nin\none\narm\n,\noccur\nwith\nhemipleg\nmigraine.5﻿\nif\nyou\nhave\nhemipleg\nmigrain\n,\nyou\nmay\nalso\nexperi\nsever\nmigrain\nstage\nand\nother\naura\nsymptom\n.\nthere\nis\na\nstrong\nhereditari\ntendenc\nto\ndevelop\nthi\ntype\nof\nmigrain\n.\nstomachach\nmore\ncommon\nin\nchildren\nthan\nadult\n,\nabdomin\nmigrain\nis\ncharacter\nby\nstomachach\nthat\noccur\nwithout\na\ngastrointestin\ncaus\nand\nmay\ninvolv\nnausea\nand\nvomit\n.\nparalysi\nof\neye\nmovement\ndoubl\nvision\n,\nblur\nvision\n,\na\ndroopi\neyelid\n,\nor\nan\nobviou\ninabl\nto\nmove\none\neye\ncan\nbe\na\nsign\nof\nophthalmopleg\nmigrain\n.\nabsent\nheadach\nalthough\nnot\nveri\ncommon\n,\nyou\ncan\nhave\na\nmigrain\naura\nwithout\na\nheadach\n.\nthere\nare\nsever\nterm\nuse\nto\ndescrib\nthi\nexperi\n,\ninclud\n``\nsilent\nmigrain\n,\n''\n``\nsans-migrain\n,\n''\nand\n``\nmigrain\nequival\n.\n''\nwhen\nthere\n's\nno\nheadach\n,\nis\nit\nstill\na\nmigrain\n?\ncomplications/\nsub-group\nindic\nmigrain\ndo\nnot\ntypic\ncaus\ncomplic\n,\nalthough\nthey\ncan\n.\nthe\nmost\ncommon\ncomplic\nare\nrelat\nto\nmedic\nuse\n.\nmedic\neffect\nside\neffect\nof\noverus\ncan\ninclud\nstomach\npain\nand\ngastrointestin\nbleed\nfrom\ntake\nhigh\ndose\nof\nnonsteroid\nanti-inflammatori\n(\nnsaid\n)\n.\nother\nmedic\n,\ninclud\ntriptan\nand\nergot\nmedic\n,\ncan\ncaus\nside\neffect\nsuch\nas\ndizzi\n,\ntingl\n,\nor\neven\nvascular\ncomplic\nwhen\ntaken\nat\nhigher\ndose\nthan\ndirect\n.\nkeep\nin\nmind\nthat\nall\nmedications—wheth\nover-the-count\nor\nprescription—\ncan\ncaus\nside\neffect\neven\nat\nrecommend\ndose\n.\nmedic\nrebound\nheadach\nor\nmedic\nwithdraw\nheadach\ncan\noccur\nwhen\nyou\ntake\nmigrain\nmedic\nat\nhigh\ndose\nor\nfor\na\nprolong\ntime\nand\nthen\nabruptli\nstop\n.\nbe\nsure\nto\ndiscuss\na\nmedic\nplan\nwith\nyour\nhealthcar\nprovider—and\nif\nit\nis\nn't\nwork\n,\nthen\ndiscuss\nanoth\nplan\ninstead\nof\ntake\nextra\nmedic\nto\ndeal\nwith\nyour\nmigrain\n.\nmedic\nthat\ncaus\noverus\nheadach\nmigrain\ncomplic\ncomplic\nfrom\na\nmigrain\nitself\ninclud\nsome\nseriou\nconcern\nthat\nrequir\nmedic\nattent\n:\nstatu\nmigrainosu\n:\nif\nyour\nmigrain\nlast\nlonger\nthan\n72\nhour\ndespit\ntreatment\n,\nit\n's\nterm\nstatu\nmigrainosu\n,\na\ncondit\nthat\nis\nunlik\nto\nresolv\nwith\nyour\nregular\nprescript\n.\nyou\nshould\nseek\nmedic\nattent\nbecaus\nyou\nmay\nneed\ntreatment\nwith\nintraven\n(\niv\n)\nmedication.6﻿\nmigrain\ninfarct\n:\nan\ninfarct\nin\nthe\nbrain\nis\na\ntype\nof\nstroke\ncaus\nby\nlack\nof\nblood\nflow\n.\na\nmigrain\ninfarct\nbegin\nwith\nmigrain\nsymptom\nthat\ncan\neventu\ninvolv\nstroke\nsymptom\nand\nmay\nproduc\nperman\nneurolog\neffect\n.\nseizur\n:\na\nconvuls\nepisod\nthat\nmay\nbe\ncharacter\nby\ninvoluntari\nshake\nor\njerk\nmay\noccur\nas\na\nresult\nof\na\nmigrain\n.\nthe\nphysiolog\nreason\nfor\nthi\ncomplic\nis\nnot\nwell\nunderstood\n.\nmigrain\ncomplic\nwhen\nto\nsee\na\nhealthcar\nprovider/go\nto\nthe\nhospit\nmigrain\ndo\nnot\nnormal\nrequir\nemerg\nmedic\nattent\n.\nthe\ntreatment\nis\nrealli\nbase\non\na\nplan\nfor\nboth\nprevent\nand\ntreatment\nof\nacut\nattack\n.\nnevertheless\n,\nwhen\nyou\nare\nnot\nsure\nif\nyour\nsymptom\nare\ncaus\nby\na\nmigrain\n,\nor\nwhen\nyour\nmigrain\npattern\nchang\n,\nyou\nneed\nto\nseek\nmedic\nattent\n.\nurgent\nmedic\ncare\nsymptom\nsuch\nas\nparalysi\n,\nloss\nof\nsensat\n,\ndifficulti\ncommun\n,\nloss\nof\nvision\n,\nand\ndoubl\nvision\ncan\nall\nbe\nmanifest\nof\na\nstroke\n,\nms\n,\nmening\n,\nseizur\n,\nand\nother\nneurolog\nillnesses.7﻿\nif\nyou\nexperi\nani\nof\nthese\nrare\nsymptom\nand\nthey\nhave\nnot\nbeen\nattribut\nto\nmigrain\n(\nor\nif\nyou\n're\nunsur\nof\ntheir\nconnect\n)\n,\nthen\nyou\nshould\nget\nprompt\nmedic\nattent\n.\neven\nif\nyou\nhave\na\ndiagnosi\nof\nmigrain\n,\nyou\nshould\nhave\na\nmedic\nevalu\nif\nyour\nheadach\noccur\nwith\ncertain\nfeatur\n,\ninclud\n:\nthe\nworst\nheadach\nof\nyour\nlifefeversrecurr\nvomiting/ca\nn't\nkeep\nanyth\ndownhead\ntraumafalling/\ninabl\nto\nbalanc\ntalk\nto\nyour\nhealthcar\nprovid\nif\nyour\nmigrain\npattern\nchang\nin\nfrequenc\nor\nintens\nor\nif\nyour\nsymptom\nchang\n,\nyou\nshould\ntalk\nto\nyour\nhealthcar\nprovid\n.\nyou\nmay\nneed\na\ndiagnost\nevalu\nor\na\nchang\nin\nyour\ntreatment\nplan\n.\nfrequent\nask\nquestion\nwhat\ncaus\nmigrain\n?\nmigrain\nmay\nbe\ntrig\nby\nalcohol\nconsumpt\n,\nchang\nin\nweather\nor\nsleep\npattern\n,\nextrem\nfatigu\n,\nhormon\nchang\ndure\nmenstruat\n,\ncaffein\n,\nsensit\nto\nchemic\nor\npreserv\nin\nfood\n,\nsmoke\n,\nstrong\nperfum\n,\nand\nlight.8\nhow\ncommon\nare\nmigrain\nheadach\n?\napproxim\n12\n%\nof\namerican\nsuffer\nfrom\nmigrain\n,\nand\nabout\n75\n%\nof\nthose\nare\nwomen.8\nhow\nlong\ndo\nmigrain\nheadach\nlast\n?\nmigrain\nheadach\ncan\nlast\nanywher\nfrom\nhour\nto\nday\n.\nthe\naverag\nmigrain\nheadach\nlast\nabout\nfour\nhours.8\nwhat\nare\nthe\ncaus\nand\nrisk\nfactor\nof\nmigrain\n?\nwa\nthi\npage\nhelp\n?\nthank\nfor\nyour\nfeedback\n!\nsign\nup\nfor\nour\nhealth\ntip\nof\nthe\nday\nnewslett\n,\nand\nreceiv\ndaili\ntip\nthat\nwill\nhelp\nyou\nlive\nyour\nhealthiest\nlife\n.\nsign\nup\nyou\n're\nin\n!\nthank\nyou\n,\n,\nfor\nsign\nup\n.\nthere\nwa\nan\nerror\n.\npleas\ntri\nagain\n.\nyou\ncan\nopt-out\nat\nani\ntime\n.\nfor\nmore\ndetail\n,\nsee\nour\nprivaci\npolici\n.\nwhat\nare\nyour\nconcern\n?\nother\ninaccur\nhard\nto\nunderstand\nsubmit\n8\nsourc\nverywel\nhealth\nuse\nonli\nhigh-qual\nsourc\n,\ninclud\npeer-review\nstudi\n,\nto\nsupport\nthe\nfact\nwithin\nour\narticl\n.\nread\nour\neditori\nprocess\nto\nlearn\nmore\nabout\nhow\nwe\nfact-check\nand\nkeep\nour\ncontent\naccur\n,\nreliabl\n,\nand\ntrustworthi\n.\namerican\nmigrain\nfoundat\n.\nthe\ntimelin\nof\na\nmigrain\nattack\n.\n2018\n.\ndodick\ndw\n.\na\nphase-by-phas\nreview\nof\nmigrain\npathophysiolog\n.\nheadach\n.\n2018\n;\n58\nsuppl\n1:4-16.\ndoi:10.1111/head.13300\ncao\nz\n,\nlin\nct\n,\nchuang\nch\n,\net\nal\n.\nresting-st\neeg\npower\nand\ncoher\nvari\nbetween\nmigrain\nphase\n.\nj\nheadach\npain\n.\n2016\n;\n17\n(\n1\n)\n:102.\ndoi:10.1177/0271678x17729783\namerican\nacademi\nof\npediatr\n.\nmigrain\nheadach\nin\nchildren\n.\nupdat\nmay\n17\n,\n2016\n.\namerican\nmigrain\nfoundat\n.\nsporad\nand\nfamili\nhemipleg\nmigrain\n.\n2017\n.\nkaniecki\nr.\nnation\nheadach\nfoundat\n.\ncase\nstudi\nissu\n:\nstatu\nmigrainosu\n.\nmigrain\n.\nmerck\nmanual\nprofession\nversion\n.\nupdat\njune\n2018\n.\ncleveland\nclinic\n.\nmigrain\nheadach\n.\nupdat\nmarch\n3\n,\n2021\n.\naddit\nread\nhansen\njm\n,\nschankin\ncj\n.\ncerebr\nhemodynam\nin\nthe\ndiffer\nphase\nof\nmigrain\nand\ncluster\nheadach\n.\nj\ncereb\nblood\nflow\nmetab\n.\n2017\n;\n1:271678x17729783\n.\ndoi:10.1177/0271678x17729783\nirwin\ns\n,\nbarmherzig\nr\n,\ngelfand\na.\nrecurr\ngastrointestin\ndisturb\n:\nabdomin\nmigrain\nand\ncyclic\nvomit\nsyndrom\n.\ncurr\nneurol\nneurosci\nrep.\n2017\n;\n17\n(\n3\n)\n:21.\ndoi:10.1007/s11910-017-0731-4